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The	   female	   reproductive	   hormone	   oestrogen	   influences	   cardiovascular	   and	  
thermoregulatory	  control.	  A	  dramatic	  decline	  in	  oestrogen	  during	  the	  menopause	  causes	  
cardiovascular	   and	   thermoregulatory	   dysfunction	   resulting	   in	   hot	   flushes	   (HFs).	   HFs	  
consist	   of	   feelings	   of	   intense	   heat	   with	   rapid	   increases	   in	   cutaneous	   vasodilation	   and	  
sweating	   that	   severely	   affect	   quality	   of	   life	   and	   increase	   cardiovascular	   disease	   risk.	  
Treatment	   using	   hormone	   replacement	   therapy	   for	   HFs	   is	   contraindicated	   in	   some	  
symptomatic	  females	  meaning	  an	  alternative	  strategy	  is	  warranted.	  Exercise	  training	  may	  
reduce	  HFs;	  however	  no	  study	  to	  date	  has	  examined	  the	  physiological	  mechanisms	  that	  
cause	  changes	  in	  the	  frequency	  and	  severity	  of	  HFs	  following	  a	  period	  of	  exercise	  training.	  
Exercise	   training	   is	   known	   to	   enhance	   thermoregulatory	   efficiency	   via	   an	   earlier	   core	  
temperature	  onset	  for	  cutaneous	  vasodilation	  and	  sweating	  in	  pre-­‐menopausal	  females.	  
Exercise	   training	   is	   also	   known	   to	   positively	   impact	   vascular	   function	   in	   the	   conduit,	  
cutaneous	   and	   cerebral	   vessels	   and	   thus	   can	   also	   decrease	   cardiovascular	   risk	   in	  
symptomatic	  post-­‐menopausal	   females.	  Heat	   acclimation	   interventions	   target	   the	   same	  
thermoregulatory	   and	   cardiovascular	   physiological	   mechanisms,	   and	   may	   also	   be	  
beneficial.	   The	   primary	   aim	   of	   this	   thesis	  was	   to	   (i)	   examine	  whether	   exercise	   training	  
reduces	   objectively	   measured	   HFs	   via	   improving	   cardiovascular	   and	   thermoregulatory	  
dysfunction	  in	  symptomatic	  post-­‐menopausal	  females,	  and	  to	  (ii)	  assess	  the	  efficacy	  of	  an	  
exercise-­‐independent	   stimulus	   in	   improving	   thermoregulatory	   and	   cardiovascular	  
function	  in	  pre-­‐menopausal	  females.	  
	  
Twenty-­‐one	   symptomatic	   post-­‐menopausal	   females	   completed	   a	   16-­‐week	   exercise	  
training	   intervention	   (n=14,	   52±4y,	   29±6	   kg/m2)	   or	   a	   no-­‐exercise	   control	   intervention	  
(n=7,	   52±6y,	   30±7	   kg/m2).	   Cardiorespiratory	   fitness	   (VO2peak)	   and	   brachial	   artery	  
endothelial	   function	   was	   assessed	   using	   flow-­‐mediated	   dilation	   (FMD).	   Participants	  
underwent	   a	   passive	   heat	   stress	   in	   a	   water-­‐perfused	   suit	   (~48ºC)	   to	   obtain	   core	  
temperature	   thresholds	   and	   sensitivities	   for	   cutaneous	   vascular	   conductance	   (CVC)	   and	  
sweat	  rate	  at	  two	  sites	  (chest	  and	  forearm).	  Middle	  cerebral	  artery	  velocity	  (MCAv)	  was	  
measured	   at	   rest	   and	   throughout	   the	   heat	   stress.	   All	   measurements	   were	   repeated	  
following	   the	   intervention	  period.	  HFs	   reduced	  by	  39	  HF·wk	   (95%	  CI=	  31,	   47)	   following	  
exercise	  training	  compared	  to	  no	  change	  in	  control.	  HF-­‐severity	  reduced	  by	  101	  (AU)	  (95%	  
CI=	   80,	   121)	   following	   exercise	   training	   compared	   to	   no	   change	   in	   control.	  VO2peak	   and	  
FMD	  improved	  (P<0.05),	  along	  with	  a	  lower	  core	  temperature	  following	  exercise	  training	  
[0.14ºC	   (95%	   CI=0.03,	   0.20;	   P=0.04)].	   Sweat	   rate	   and	   CVC	   body/core	   temperature	  
thresholds	  occurred	  ~0.22ºC	  earlier	  alongside	  an	  increase	  in	  sweating	  sensitivity,	  at	  both	  
sites,	  following	  exercise	  training.	  Resting	  MCAv	  was	  3.12	  cm/s	  (95%	  CI,	  1.20,	  5.01;	  P=0.03)	  
higher,	  with	  decreases	  in	  MCAv	  attenuated	  during	  heat	  stress,	  following	  exercise	  training.	  
	  
HFs	   recorded	   in	   symptomatic	   females	   during	   the	   passive	   heat	   stress	   prior	   to	   and	  
following	  the	  exercise	  training	  (n=9)	  or	  no-­‐exercise	  control	  (n=6)	  intervention	  were	  used	  
to	  assess	  changes	   in	   thermoregulatory	  and	   (cerebro)vascular	   responses	  during	  an	  acute	  
HF.	   HFs	   were	   objectively	   identified	   and	   divided	   into	   eight	   equal	   segments,	   with	   each	  
segment	  representing	  12.5%	  of	  HF	  duration,	  for	  analysis.	  Exercise	  training	  decreased	  HF	  
duration	  by	  63s	  (95%	  CI,	  14,	  113;	  P=0.08)	  compared	  to	  a	  negligible	  decrease	  of	  17s	  (95%	  
CI,	  -­‐43,	  66)	  following	  control.	  Chest	  sweat	  rate	  decreased	  by	  0.04	  mg·∙cm2·∙min-­‐1	  (95%	  CI,	  
0.02,	  0.06;	  P=0.01)	  during	  HFs	  after	  exercise	   training	  compared	   to	  no	  change	   in	  control	  
(P>0.05).	  This	  was	  accompanied	  by	  a	  reduction	  in	  chest	  skin	  blood	  flow	  of	  26	  AU	  (95%	  CI,	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21,	  30;	  P=0.01)	  during	  HFs	  following	  exercise	  training	  compared	  to	  no	  change	  in	  control	  
(P=0.10).	   MCAv	   was	   attenuated	   by	   3.4	   cm/s	   (95%	   CI,	   0.7,	   5.1;	   P<0.001)	   during	   a	   HF	  
following	  exercise	  training	  compared	  to	  control	  [0.6	  cm/s	  (95%	  CI,	  -­‐0.7,	  1.8;	  P=0.93)].	  
	  
Eighteen	  pre-­‐menopausal	  females	  (25±8y)	  were	  assigned	  to	  3x30-­‐min	  of	  cycling	  exercise	  
(70%	  HRmax)	   or	  warm	  water	   immersion	   (42ºC)	   to	   the	   level	   of	   the	   sternum	   for	   8-­‐weeks.	  
FMD	  (P=0.003)	  and	  VO2peak	   (P<0.001)	   improved	   following	  both	   interventions.	  Core	  body	  
temperature	  reduced	  by	  0.14ºC	  (95%	  CI,	  0.04,	  0.23;	  P=0.004)	  following	  both	   interventions.	  
Sweat	  rate	  mean	  body	  temperature	  thresholds	  at	  the	  chest	  and	  forearm	  occurred	  0.10ºC	  
(95%	   CI=-­‐0.14,	   0.33,	   P<0.001)	   and	   0.19ºC	   (0.12,	   0.23ºC,	   P<0.001)	   earlier	   following	   the	  
interventions,	  alongside	  an	   increase	   in	   sweat	   rate	   sensitivity	  of	  1.18	  mg·∙cm2·∙min-­‐1	   (95%	  
CI=	  0.68,	  1.67;	  P<0.001)	  following	  water	  immersion	  compared	  to	  0.28	  mg·∙cm2·∙min-­‐1	  (95%	  
CI=	   0.23,	   0.78)	   following	   exercise	   training.	   CVC	   core	   temperature	   thresholds	   occurred	  
~0.20ºC	   earlier	   at	   the	   chest	   and	   forearm	   (P<0.001).	   Resting	  MCAv	  was	   2.30	   cm/s	   (95%	  
CI=1.20,	   3.34;	   P<0.001)	   higher,	   with	   decreases	   in	  MCAv	   attenuated	   during	   heat	   stress,	  
following	  both	  interventions.	  	  
	  
The	  findings	  from	  this	  thesis	  suggest	  that	  reductions	  in	  the	  frequency	  and	  severity	  of	  HFs	  
with	   exercise	   training	   are	   mediated	   by	   improvements	   in	   thermoregulatory	   function,	  
alongside	   cerebral,	   conduit	   and	   cutaneous	   adaptation.	   This	   coincided	   with	   objective	  
reductions	  in	  HF	  severity	  following	  exercise	  training,	  with	  attenuation	  in	  the	  physiological	  
perturbations	   observed	   during	   an	   acute	   HF.	   Consequently,	   interventions	   that	   target	  
thermoregulatory	   function	  may	   be	   useful	   in	   reducing	   post-­‐menopausal	   HFs.	   In	   keeping	  
with	   the	   exercise	  mediated	   physiological	   changes,	  warm	  water	   immersion	   training	   also	  
elicits	  similar	  favourable	  thermoregulatory,	  conduit-­‐	  and	  cerebrovascular	  adaptations	  to	  a	  
period	   of	  moderate	   intensity	   exercise	   training	   in	   pre-­‐menopausal	   females.	   	   Immersion	  
therapy	  may	  therefore	  be	  applicable	  to	  HF-­‐symptomatic	  post-­‐menopausal	  females.	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CHAPTER	  1:	  INTRODUCTION	  
	  
	   	  
2	  
	  
Female	   reproductive	   hormones	   have	   a	   profound	   influence	   on	   nonreproductive	   organs	  
and	   systems.	   The	   primary	   ovarian	   hormone	   oestrogen	   exerts	   a	   significant	   influence	   on	  
the	   integrative	  mechanisms	   that	   regulate	  cardiovascular	  and	   thermoregulatory	   function	  
(Charkoudian	  and	  Stachenfeld,	  2014).	  Endogenous	  oestrogen	  is	  secreted	  cyclically	  during	  
the	   female	   menstrual	   cycle	   and	   reduces	   core	   body	   temperature	   (Brooks	   et	   al.,	   1997,	  
Charkoudian,	   2003),	   enhances	   conduit	   artery	   and	   cutaneous	   vascular	   function	  
(Hashimoto	  et	   al.,	   1995,	  Kawano	  et	   al.,	   1996,	  Williams	  et	   al.,	   2001,	  Charkoudian,	   2001,	  
Charkoudian	  and	  Johnson,	  1997b)	  and	  brain	  blood	  flow	  (Krejza	  et	  al.,	  2004).	  	  	  
	  
The	   onset	   of	   the	   female	   menopause	   occurs	   between	   the	   age	   of	   ~47-­‐55	   years	   and	   is	  
characterised	   by	   a	   dramatic	   reduction	   in	   oestrogen	   causing	   dysfunction	   in	   the	  
cardiovascular	   and	   thermoregulatory	   control	   systems	   (Freedman,	   2001,	   Freedman,	  
2014b).	  The	  menopause	  is	  a	  time	  of	  life	  associated	  with	  increased	  cardiovascular	  disease	  
risk	  e.g.	  atherosclerosis,	  thought	  to	  be	  largely	  due	  to	  the	  decline	  in	  oestrogen	  (Zaydun	  et	  
al.,	   2006,	   Rexrode	   et	   al.,	   2003,	   Weinberg	   et	   al.,	   2006).	   Nevertheless,	   the	   major	  
pathophysiological	  symptom	  of	  the	  menopause	   in	  ~70%	  of	   females	   is	   the	  occurrence	  of	  
hot	   flushes	   (HFs)	   (Kronenberg,	   1990).	   	   A	   HF	   is	   defined	   as	   the	   sudden	   and	   intense	  
sensation	   of	   heat	   causing	   skin	   reddening,	   flushing	   and	   profuse	   sweating	   (Freedman,	  
2014a).	  The	  occurrence	  of	  HFs	  are	  likely	   linked	  to	  disruptions	  to	  core	  body	  temperature	  
and	   dysfunctional	   thermoregulatory	   control	   that	   are	   evident	   during	   the	   menopausal	  
transition	   (Kronenberg,	   2010,	   Freedman,	   2001,	   Freedman,	   2014a,	   Freedman	   and	   Krell,	  
1999).	   Importantly,	   there	   is	   also	   evidence	   of	   higher	   cardiovascular	   risk	   in	   post-­‐
menopausal	   females	   who	   suffer	   from	   HFs	   compared	   to	   asymptomatic	   females	  




Pharmacological	  treatment	  for	  HFs	  is	  usually	  hormone	  replacement	  therapy	  (HRT).	  Whilst	  
effective	   in	   alleviating	   HFs	   (Maclennan	   et	   al.,	   2004,	   Utian	   et	   al.,	   2004),	   uptake	   of	   this	  
treatment	  modality	  is	  poor	  due	  to	  concerns	  about	  increased	  risk	  of	  cardiovascular	  disease	  
(Rossouw	  et	  al.,	   2002,	  Manson	  et	  al.,	   2003),	  breast	   cancer	   (Beral,	  2003,	  Manson,	  2014,	  
Tworoger	  et	  al.,	  2005)	  and	  other	  contraindications	   including	  age,	  time	  since	  menopause	  
and	   absence	   of	   ovaries	   (Rossouw	   et	   al.,	   2007,	   NICE,	   2009,	   Ossewaarde	   et	   al.,	   2005).	  
Clearly,	   alternative	   treatments	   are	   required	   but	   other	   pharmacological	   and	   non-­‐
pharmacological	  options	  are	  limited	  due	  to	  lack	  of	  evidence.	  Exercise	  training	  has	  recently	  
been	  suggested	  as	  a	   lifestyle	  modification	  that	  reduces	  HFs	   in	  post-­‐menopausal	  females	  
(Daley	   et	   al.,	   2009).	   For	   example,	   a	   recent	   combined	   randomised	   control	   trial	   found	   a	  
reduction	   in	   self-­‐reported	   HFs	   following	   6-­‐months	   of	   unsupervised	   exercise	   training,	  
alongside	  improvements	  in	  symptoms	  of	  depression	  and	  sleep	  quality	  (Luoto	  et	  al.,	  2012,	  
Moilanen	  et	  al.,	  2012).	  Not	  all	   studies	  have	   reported	   reduced	  HFs	   following	  a	  period	  of	  
exercise	   training	   (Sternfeld	   et	   al.,	   2014,	   Wilbur	   et	   al.,	   2005),	   which	   may	   be	   due	   to	  
differences	   in	   exercise	   mode	   and	   prescription	   (i.e.	   walking,	   duration,	   intensity),	   and	  
programme	  supervision.	  Improvement	  in	  the	  frequency	  and	  intensity	  of	  HFs	  with	  exercise	  
training	  is	  difficult	  to	  elucidate,	  since	  no	  studies	  to	  date	  have	  reported	  the	  physiological	  
adaptations	   that	   occur	   following	   exercise	   training	   interventions	   in	   post-­‐menopausal	  
females.	  Furthermore,	  published	  studies	  generally	   rely	  on	  subjective	  markers	   i.e.	  a	   self-­‐
reported	   HF	   diary,	   as	   the	   outcome	   measure.	   In	   addition,	   no	   previous	   research	   has	  
investigated	   the	   potential	   physiological	   mechanisms	   by	   which	   exercise	   training	   can	  
improve	   menopausal	   HFs	   or,	   in	   other	   words,	   the	   effect	   of	   an	   exercise	   training	  
intervention	   on	   the	   thermoregulatory	   and	   cardiovascular	   dysfunction	   associated	   with	  
menopausal	   HFs.	   Therefore	   aim	   1	   of	   this	   thesis	   was	   to	   determine	   whether	   improving	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thermoregulatory	   control	   and	   vascular	   function	   with	   exercise	   training	   would	   alleviate	  
post-­‐menopausal	  HFs.	  
	  
The	  acute	  physiological	  changes	  that	  occur	  during	  a	  HF	  are	  not	  only	  rapid	  in	  onset	  but	  can	  
be	  extreme	  (e.g.	  ~80%	  change	  in	  cutaneous	  blood	  flow)	  and	  can	  last	  ~10	  mins	  in	  severe	  
cases	   (Kronenberg,	   1990).	   Research	   investigating	   the	   acute	   thermoregulatory,	  
cardiovascular	  and	  cerebrovascular	  changes	  that	  occur	  during	  a	  HF	  suggests	  a	  rapid	  onset	  
of	  cutaneous	  vasodilation	  and	  sweating	  that	  is	  predominantly	  neurally	  mediated	  (Hubing	  
et	  al.,	  2010,	  Low	  et	  al.,	  2010)	  and	   is	   followed	  by	  a	  reduction	   in	  core	  body	  temperature.	  
Additionally,	   acute	   reductions	   (~5-­‐30%)	   in	   brain	   blood	   flow	   and	   blood	   pressure	   are	  
evident	  whilst	  heart	  rate	  increases	  (Lucas	  et	  al.,	  2013,	  Low	  et	  al.,	  2008a).	  No	  study	  to	  date	  
has	  examined	   if	  these	  acute	  physiological	  changes	  are	   linked	  to	  objective	  HF	  severity	  or	  
are	  responsive	  to	  interventions.	  Therefore	  aim	  2	  of	  this	  thesis	  was	  to	  compare	  the	  acute	  
thermoregulatory	  and	  (cerebro)vascular	  changes	  that	  occur	  during	  HFs	  following	  a	  period	  
of	  exercise	  training	  in	  symptomatic	  post-­‐menopausal	  females.	  
	  
The	   impact	   of	   exercise	   training	   on	   thermoregulatory	   and	   cardiovascular	   control	   in	   pre-­‐
menopausal	   females	   is	   well	   reported	   (Ichinose	   et	   al.,	   2009,	   Kuwahara	   et	   al.,	   2005a,	  
Kuwahara	   et	   al.,	   2005b,	   Armstrong	   et	   al.,	   2005).	   Cardiovascular	   and	   thermoregulatory	  
adaptations	   may	   also	   be	   possible	   using	   other	   interventions	   that	   target	   the	   same	  
physiological	   mechanisms.	   For	   example,	   repeated	   exposure	   to	   external	   passive	   heat	  
stress	  over	  a	  short	  time-­‐frame	  i.e.	  10	  days	  (e.g.	  resting	  in	  a	  hot	  and	  humid	  environment)	  
induces	  thermoregulatory	  (Eichna	  et	  al.,	  1950,	  Fox	  et	  al.,	  1963a,	  Fox	  et	  al.,	  1963b,	  Shido	  
et	   al.,	   1999,	   Armstrong	   and	   Kenney,	   1993)	   and	   cardiovascular	   (Imamura	   et	   al.,	   2001,	  
Kihara	  et	  al.,	  2002)	  adaptations.	  However	  a	  strong	  criticism	  of	  this	  technique	  is	  to	  induce	  
5	  
	  
the	  necessary	  changes	  in	  core	  body	  temperature	  is	  time	  consuming.	  More	  recently	  local	  
warm	   water	   immersion	   training	   has	   shown	   improvements	   in	   cutaneous	   and	   conduit	  
artery	   endothelial-­‐dependent	   function	   (Carter	   et	   al.,	   2014a,	   Naylor	   et	   al.,	   2011).	   The	  
effect	   of	   a	   whole-­‐body,	   repeated,	   warm	   water	   immersion	   training	   programme	   on	  
thermoregulatory	   and	   (cerebro)vascular	   function	   is,	   to	   date,	   unknown.	   This	   may	   be	  
important	   as	   targeting	   HFs	   with	   interventions	   (exercise	   or	   passive	   heat	   training)	   that	  
improve	   thermoregulatory	   and	   (cerebro)vascular	   control	   may	   constitute	   a	   viable	  
alternative	   to	   HRT	   in	   post-­‐menopausal	   females.	   However,	   the	   physiological	   impact	   of	  
exercise	   training	   and	   heat	   interventions,	   e.g.	   warm	   water	   immersion	   has	   not	   been	  
directly	   compared.	   Therefore	   aim	   3	   of	   this	   thesis	   was	   to	   compare	   the	   effects	   of	   an	  
exercise	   training	   intervention	  with	   whole-­‐body	  warm	  water	   immersion	   training	   in	   pre-­‐
menopausal	  females	  on	  thermoregulatory	  and	  (cerebro)vascular	  function.	  
	  
In	  summary,	  there	  is	  evidence	  that	  cardiovascular	  and	  thermoregulatory	  control	  is	  under	  
direct	   influence	   from	  female	  reproductive	  hormones.	  Oestrogen	  has	  a	  cardio-­‐protective	  
effect	  on	  the	  female	  vasculature	   i.e.	  endothelial	  dysfunction	  evident	  at	  the	  onset	  of	  the	  
menopause,	   whilst	   temperature	   control	   becomes	   dysfunctional.	   This	   reduction	   in	  
oestrogen	  leads	  to	  the	  occurrence	  of	  HFs	  in	  post-­‐menopausal	  females.	  Exercise	  training	  is	  
a	  potential	  non-­‐pharmacological	  treatment.	  Yet,	  the	  underlying	  physiological	  mechanisms	  
that	   lead	   to	   reductions	   in	   HFs	   with	   exercise	   training,	   or	   other	   interventions	   that	   can	  
improve	   thermoregulatory	   and	   (cerebro)vascular	   function,	   are	   not	   yet	   understood.	  
Therefore	   the	   overarching	   aim	   of	   this	   thesis	   is	   to	   explore	   the	   impact	   of	   exercise	   and	  
thermal	   training	   interventions	   on	   thermoregulatory	   and	   (cerebro)vascular	   function	   in	  




The	  aims	  of	  this	  thesis	  are	  to:	  
1. Determine	   whether	   improving	   thermoregulatory	   control	   and	   (cerebro)vascular	  
function	   with	   exercise	   training	   alleviate	   HFs	   in	   post-­‐menopausal	   females	  
compared	  to	  a	  no-­‐exercise	  control	  group.	  
2. Compare	  the	  acute	  physiological	  thermoregulatory	  and	  (cerebro)vascular	  changes	  
that	   occur	   during	   HFs	   prior	   to	   and	   following	   a	   16-­‐week	   exercise	   intervention	  
compared	  to	  a	  no-­‐exercise	  control	  group.	  
3. Compare	   the	   effects	   of	   an	   exercise	   training	   intervention	   with	   warm	   water	  
immersion	   training	   in	   pre-­‐menopausal	   females	   on	   thermoregulatory	   and	  
(cerebro)vascular	  function.	  
1.2	  Objectives	  
The	  aims	  outlined	  above	  will	  be	  achieved	  through	  the	  following	  objectives:	  
In	  line	  with	  Aim	  1:	  
1. Engage	   symptomatic	   post-­‐menopausal	   females	   in	   either	   a	   16-­‐week	   supervised	  
moderate	  intensity	  aerobic	  exercise	  programme	  or	  a	  16-­‐week	  no-­‐exercise	  control	  
period.	  
2. Compare	   the	   effect	   of	   exercise	   training	   and	   no-­‐exercise	   control	   on	   cardio-­‐
respiratory	  fitness	  and	  conduit	  artery	  endothelial	  function.	  
3. Compare	   the	   effects	   of	   exercise	   training	   and	   no-­‐exercise	   control	   on	   subjective	  
frequency	  and	  severity	  reports	  of	  HFs	  using	  a	  validated	  7-­‐day	  questionnaire.	  
4. Use	   a	   passive	   heat	   stress	   to	   directly	   assess	   the	   vascular	   and	   thermoregulatory	  
adaptations	   in	   symptomatic	   post-­‐menopausal	   females	   following	   a	   16-­‐week	  




In	  line	  with	  Aim	  2:	  
5. Directly	   measure	   the	   physiological,	   vascular	   and	   thermoregulatory	   responses	  
during	  a	  menopausal	  HF	  	  
6. Compare	   the	   effects	   of	   exercise	   training	  or	   no-­‐exercise	   control	   interventions	   on	  
the	  physiological	  perturbations	  that	  occur	  during	  a	  HF.	  
	  
In	  line	  with	  Aim	  3:	  
7. Engage	  pre-­‐menopausal	  females	  in	  an	  8-­‐week	  moderate	  intensity	  aerobic	  cycling	  
training	   or	   warm-­‐water	   immersion	   training	   programme	   and	   compare	  
thermoregulatory	  and	  (cerebro)vascular	  adaptations	  using	  a	  passive	  heat	  stress.	  
8. Compare	   the	   effect	   of	   exercise	   training	   and	  warm	  water	   immersion	   training	   on	  
cardio-­‐respiratory	  fitness	  and	  conduit	  artery	  endothelial	  function	  following	  the	  8-­‐
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2.1	  Menstrual	  cycle	  
The	   female	   menstrual	   cycle	   comprises	   of	   the	   hypothalamus,	   the	   pituitary	   gland,	   the	  
ovaries	   and	   the	   uterus	   that	   interact	   synergistically	   to	   cause	   cyclical	   hormonal	   changes	  
that	   are	   essential	   for	   human	   reproduction.	   The	   cyclical	   variation	   in	   reproductive	  
hormones	   begins	   at	   the	   age	   of	   menarche	   and	   ceases	   at	   the	   menopause.	   Each	   cycle	  
typically	  lasts	  ~28	  days,	  but	  ranges	  from	  21-­‐35	  days.	  The	  menstrual	  cycle	  consists	  of	  three	  
distinct	   phases	   (follicular,	   ovulatory	   and	   luteal)	   and	   the	   hormones	   follicle-­‐stimulating	  
hormone	   (FSH),	   luteinising	   hormone	   (LH),	   progesterone	   and	   oestrogens	   are	   stimulated	  
and	  inhibited	  during	  the	  different	  phases	  (Figure	  2.1).	  
Figure	  2.1	  Schematic	  representing	  the	  changes	  in	  anterior	  pituitary	  and	  ovarian	  hormones	  
throughout	  the	  female	  menstrual	  cycle.	  
	  
Gonadotropin-­‐releasing	   hormone	   (GnRH)	   secreted	   by	   the	   hypothalamus	   controls	   the	  
female	   menstrual	   cycle,	   and	   stimulates	   the	   release	   of	   FSH	   and	   LH	   from	   the	   anterior	  
pituitary.	   Both	   FSH	   and	   LH	   stimulate	   the	   ovarian	   follicles	   to	   secrete	   progesterone	   and	  
importantly	  oestrogens,	  with	  β-­‐estradiol	  the	  most	  abundant.	  During	  the	  follicular	  phase,	  
oestrogens	  secreted	  by	  ovarian	  follicles	  suppress	  the	  production	  of	  LH	  until	  a	  threshold	  is	  
reached	   and	   a	   subsequent	   surge	   in	   LH	   is	   released	   to	   prepare	   the	   body	   for	   ovulation	  
(Figure	  2.1).	  	  During	  the	  luteal	  phase,	  FSH	  and	  LH	  cause	  the	  dominant	  follicle	  to	  transform	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into	  the	  corpus	  luteum,	  which	  secretes	  progesterone.	  It	  is	  the	  surge	  in	  progesterone	  that	  
induces	   the	   production	   of	   oestrogens	   in	   luteal	   phase.	   These	   hormones	   suppress	   the	  
release	   of	   FSH	   and	   LH,	   resulting	   in	   atrophy	   of	   the	   corpus	   luteum	   and	   subsequently	  
progesterone	  declines	  triggering	  menstruation.	  	  
	  
The	  hormones	  involved	  in	  the	  menstrual	  cycle	  have	  also	  been	  shown	  to	  impact	  on	  other	  
physiological	   mechanisms	   besides	   reproductive	   function.	   The	   cyclical	   changes	   in	  
oestrogen	  and	  progesterone	  affect	  thermoregulatory	  control	  and	  cardiovascular	  function	  
in	  females	  (Charkoudian	  and	  Stachenfeld,	  2014).	  	  The	  focus	  of	  this	  literature	  review	  is	  to	  
discuss	   the	   impact	   of	   female	   reproductive	   hormones,	   with	   a	   specific	   emphasis	   on	  
oestrogen,	   on	   thermoregulatory,	   conduit	   and	   cerebrovascular	   function	   at	   rest	   and	   in	  
response	  to	  exercise	  training.	  
2.2	  Thermoregulation	  	  
The	   human	   body	   maintains	   core	   body	   temperature	   around	   a	   set	   point	   of	   ~37°C,	  
orchestrated	   by	   changes	   in	   the	   generation	   and	   conservation	   of	   heat	   (metabolism,	  
shivering	   and	   cutaneous	   vasoconstriction)	   and	   heat	   loss	   (cutaneous	   vasodilation	   and	  
sweating)	   in	   response	   to	   a	   variety	   of	   internal	   and	   external	   stimuli.	   Early	   in	   the	   20th	  
century,	   the	   existence	   of	   a	   thermoregulatory	   centre	  within	   the	   hypothalamic	   region	   of	  
the	  brain	  was	  identified	  (Kahn,	  1904).	  It	  is	  now	  well	  established	  that	  the	  central	  control	  of	  
thermoregulation	  is	   located	  in	  the	  preoptic/anterior	  hypothalamus	  (PO/AH)	  of	  the	  brain	  
(Boulant,	   2006,	   Boulant,	   2000,	   Boulant,	   1996),	   which	   is	   the	   primary	   site	   that	   contains	  
both	  temperature-­‐sensitive	  and	  temperature-­‐insensitive	  neurons	  that	  interact	  to	  control	  
core	  body	  temperature	  (Charkoudian	  and	  Stachenfeld,	  2014,	  Boulant,	  2006)	  Figure	  2.2).	  
Afferent	   information	   from	   the	   skin	   surface,	   spinal	   and	   visceral	   thermal	   receptors	   are	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important	   for	   optimal	   core	   body	   temperature	   regulation	   in	   response	   to	   alterations	   to	  
both	   internal	   and	   external	   environments.	   Thus,	   skin	   temperature	   afferent	   information	  
will	   augment	   heat	   dissipation	   responses	   under	   heat	   stress	   and	   will	   also	   increase	   heat	  
generation	  responses	  in	  cooler	  environments	  (Charkoudian	  and	  Stachenfeld,	  2014).	  When	  
the	   PO/AH	   neurons	   receive	   afferent	   signals	   above	   a	   threshold	   temperature	   there	   are	  
proportional	  increases	  in	  the	  efferent	  responses	  of	  cutaneous	  vasodilation	  and	  sweating,	  
alongside	   behavioural	   changes	   that	   promote	   heat	   loss	   and	   peripheral	   cooling	   (Boulant,	  
2006).	  Each	  of	  these	  responses	  is	  unique	  and	  is	  evoked	  at	  slightly	  different	  hypothalamic	  
temperatures,	  known	  as	  the	  set-­‐point	  and/or	  temperature	  threshold.	  With	  this	   in	  mind,	  
the	   ultimate	   effectors	   of	   thermoregulatory	   responses	   to	   heat	   stress	   are	   the	   cutaneous	  




Figure	  2.2	  Human	  thermoregulatory	  control	  occurs	  via	  negative	  feedback.	  (A)	  Increases	  in	  
internal	   and/or	   skin	   temperature	   are	   sensed	   by	   the	   Preoptic-­‐anterior	   hypothalamus	  
(PO/AH)	   that	   results	   in	   increased	   heat	   dissipation,	   via	   cutaneous	   vasodilation	   and	  
sweating	   responses.	   This	   corrects	   the	   increase	   in	   temperature.	   (B)	   Decreased	   internal	  
and/or	   skin	   temperature	   results	   in	   reflex	   decreases	   in	   heat	   dissipation	   (cutaneous	  
vasoconstriction)	  and	  increased	  heat	  generation	  (shivering).	  This	  corrects	  the	  decreases	  in	  
internal	   temperature.	   CNS	   =	   Central	   Nervous	   System.	   Minus	   signs	   (-­‐)	   refer	   to	   the	  




2.2.1	  The	  skin	  
The	  skin	  is	  a	  vital	  component	  of	  human	  thermoregulation.	  The	  arterioles	  and	  venules	  of	  
the	  cutaneous	  microcirculation	  represent	  two	  vital	  physiologically	  important	  areas	  in	  the	  
skin,	  located	  in	  the	  dermis	  plexus	  in	  both	  superficial	  and	  deep	  skin	  layers	  (Kellogg,	  2006).	  
Most	  of	  the	  microvasculature	  is	  contained	  within	  the	  superficial	  papillary	  dermis	  1-­‐2mm	  
below	   the	   epidermal	   surface	   (Figure	   2.3),	   and	   consist	   of	   high-­‐resistance	   terminal	  
arterioles,	  papillary	  loops	  (true	  capillaries)	  and	  post-­‐capillary	  venules.	  	  
	  
	  
Figure	   2.3	   Sectional	   of	   the	   skin	   (cutaneous	   membrane)	   and	   subcutaneous	   layer;	  
consisting	  of	  a	  superficial,	  thin	  epidermis	  and	  a	  deep,	  thicker	  dermis.	  Deep	  to	  the	  skin	  is	  
the	  subcutaneous	  layer,	  which	  attaches	  the	  dermis	  to	  the	  underlying	  organs	  and	  tissues.	  
Smooth	  muscle,	  nerves	  and	  sweat	  glands	  are	  located	  in	  the	  dermis	  layer.	  
	  
	  
The	   papillary	   loops	   are	   located	   close	   to	   the	   dermal-­‐epidermal	   junction,	   with	   this	   site	  
maintaining	   a	   high	   thermal	   gradient	   due	   to	   its	   large	   surface	   area	   and	   high	   blood	   flow,	  
acting	   as	   a	   major	   determinant	   for	   heat	   exchange	   (Rowell,	   1974a,	   Charkoudian	   and	  
Stachenfeld,	   2014).	   Blood	   flow	   through	   the	   papillary	   loops	   is	   controlled	   by	   highly	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innervated	  arterioles	  that	  consist	  of	  a	  lining	  of	  endothelial	  cells	  that	  are	  encompassed	  by	  
two	  layers	  of	  vascular	  smooth	  muscle	  cells.	  The	  upper	  and	  lower	  plexuses	  are	  located	  in	  
both	  glabrous,	  or	  non-­‐hairy,	  (plantar	  feet,	  palms	  and	  lips)	  and	  nonglabrous	  skin	  (most	  of	  
the	  body	   surface	   including	   the	   limbs,	   torso	  and	  head),	  with	  arteriovenous	  anastomoses	  
(AVAs)	   primarily	   found	   in	   glabrous	   skin	   (Johnson	   et	   al.,	   1986,	   Roddie,	   2003).	   AVAs	   are	  
extensively	   innervated	   by	   sympathetic	   adrenergic	   fibres	   (vasoconstrictor	   nerves)	   which	  
control	   blood	   flow	   through	   the	   AVAs.	   An	   increase	   in	   sympathetic	   activity	   to	   the	   AVAs	  
during	   mild-­‐to-­‐moderate	   cold	   stress	   causes	   vasoconstriction,	   whereas	   a	   reduction	   in	  
sympathetic	  activity	  during	  heat	  stress	  causes	  a	  drop	  in	  vasoconstrictor	  tone	  that	  elevates	  
skin	  blood	  flow.	  A	  transient	  reduction	   in	  sympathetic	  activity	  to	  the	  AVAs	  also	  mediates	  
cold-­‐induced	  vasodilation	  during	  a	  prolonged	   severe	   cold-­‐stress	   (Roddie,	   2003).	  Resting	  
skin	   blood	   flow	   in	   normothermia,	  when	   cutaneous	   arterioles	   are	   under	  minimal	   neural	  
tone,	   is	   approximately	  250	  mL·∙min	   (30	   to	  40	  mL·∙min-­‐1·∙100g-­‐1	  of	   skin)	  which	   results	   in	  a	  
heat	   dissipation	   of	   approximately	   80-­‐90	   Kcal·∙hour	   which	   is	   equal	   to	   metabolic	   heat	  
production	  (Johnson,	  1996).	  	  
	  
A	   reduction	   in	   skin/core	   temperature,	   or	   if	   skin	   temperature	   is	   lower	   than	   core	  
temperature,	  triggers	  a	  thermoregulatory	  reflex-­‐mediated	  reduction	  in	  skin	  blood	  flow	  to	  
conserve	   body	   heat,	   through	   enhanced	   arteriolar	   vasoconstrictor	   tone	   that	   enables	   an	  
arteriolar	   vasoconstriction,	   and	   hence	   reduced	   skin	   blood	   flow.	   Equally,	   during	   heat	  
exposure	   (when	   skin	   temperature	   rises	   above	   core	   temperature)	   or	   exercise-­‐induced	  
increases	  in	  body	  temperature,	  vasoconstrictor	  activity	  is	  reduced	  and	  active	  vasodilator	  
tone	   to	   the	   cutaneous	   arterioles	   is	   engaged	   to	   trigger	   cutaneous	   vasodilation	   and	  
subsequently	  sweat	  rate	  to	  promote	  evaporative	  heat	  loss	  and	  skin	  cooling	  	  (Johnson	  et	  
al.,	  2014,	  Rowell,	  1974b).	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During	   whole-­‐body	   heat	   stress,	   there	   is	   a	   steady	   increase	   in	   skin	   blood	   flow	   that	  
correlates	  most	  closely	  with	  core	  body	  temperature	  (Taylor	  and	  Bishop,	  1993),	  whilst	  the	  
clearest	  role	  for	  skin	  temperature	  is	  that	  it	  affects	  the	  threshold	  for	  internal	  temperature	  
at	   which	   skin	   blood	   flow	   begins	   to	   rise	   exponentially	   (see	   2.2.4	   core	   temperature	  
threshold	  and	  sensitivity)	  (Brengelmann	  et	  al.,	  1981,	  Farrell	  and	  Bishop,	  1995).	  Clearly,	  at	  
higher	   skin	   temperatures	   the	   internal	   threshold	   temperature	   for	   increasing	   skin	   blood	  
flow	  (alongside	  sweating)	   is	   lowered	  such	   that	   thermoregulatory	  effector	   responses	  are	  
initiated	  to	  stimulate	  heat	  loss	  earlier.	  Both	  local	  and	  reflex	  (neural)	  effectors	  contribute	  
to	  changes	  in	  skin	  blood	  flow	  during	  environmental	  stress.	  	  
2.2.1.1	  Neural	  control	  of	  skin	  blood	  flow.	  
Skin	  blood	  flow	  is	  controlled	  by	  both	  neurogenic	  (reflex)	  and	  local	  thermal	  mechanisms.	  In	  
nonglabrous	  skin,	  neurogenic	  changes	  in	  the	  cutaneous	  circulation	  are	  unique	  in	  that	  they	  
are	  mediated	  by	  dual	  sympathetic	  neural	  mechanisms	  (Kellogg	  et	  al.,	  2002),	  that	  are	  the	  
primary	   effectors	   of	   thermoregulatory	   control.	   These	   consist	   of	   non-­‐adrenergic	  
vasoconstrictor	   nerves	   (as	   also	   found	   in	   glabrous	   skin)	   and	   the	   sympathetic	   active	  
vasodilator	  system	  (Charkoudian,	  2003,	   Johnson	  et	  al.,	  2014,	  Lewis	  and	  Pickering,	  1931)	  
(Figure	  2.4).	  In	  contrast,	  the	  vasoconstrictor	  response	  with	  cooling	  is	  dependent	  on	  intact	  
noradrenergic	   cutaneous	   active	   vasoconstrictor	   nerves.	   The	   mechanisms	   of	   (cold-­‐
induced)	  vasoconstriction	  have	  been	  reviewed	  extensively	  (Johnson	  et	  al.,	  2014,	  Johnson	  
and	  Kellogg,	  2010a)	  and	  are	  only	  included	  in	  this	  literature	  review	  in	  relation	  to	  their	  role	  








Figure	   2.4	   Summary	   of	   the	   mechanisms	   that	   contribute	   to	   reflex	   cutaneous	   active	  
vasodilation.	   The	   left	   panel	   displays	   a	   typical	   trace	   of	   the	   skin	   blood	   flow	   response	   to	  
whole-­‐body	   heating.	   The	   initial	   rise	   in	   skin	   blood	   flow	   is	   from	   the	   release	   of	  
vasoconstrictor	   tone,	   with	   the	   subsequent	   rise	   attributed	   to	   active	   cutaneous	  
vasodilation.	   The	   right	   panel	   displays	   a	   schematic	   of	   the	   current	   theory	   of	   active	  
cutaneous	  vasodilation	  (Johnson	  et	  al,	  2014).	  
	  
Sympathetic	   vasoconstrictor	   nerves	   are	   tonically	   active	   in	   normothermic	   environments	  
(Brengelmann	   et	   al.,	   1981).	   Subtle	   changes	   in	   the	   activity	   of	   this	   system	   during	   daily	  
activities	   or	   ambient	   temperature	   are	   responsible	   for	   the	   maintenance	   of	   body	  
temperature,	  with	  decreases	  in	  vasoconstrictor	  nerve	  activity	  during	  exposure	  to	  slightly	  
warmer	  environments	  causing	  a	  passive	  vasodilation	  with	  relatively	  small	  changes	  in	  skin	  
blood	   flow	   responsible	   for	   larger	   changes	   in	   heat	   dissipation	   (Charkoudian	   and	  
Stachenfeld,	  2014).	  This	  allows	  for	  a	  zone	  of	  thermoregulation	  that	  is	  controlled	  solely	  by	  
changes	   in	   vasomotor	   tone.	  During	  heat	   stress	   the	  withdrawal	  of	   vasoconstrictor	  nerve	  
activity	  is	  responsible	  for	  between	  10-­‐20%	  of	  cutaneous	  vasodilation	  (Brengelmann	  et	  al.,	  
1981).	  In	  contrast,	  the	  sympathetic	  active	  vasodilator	  system	  is	  unique	  to	  human	  skin	  and	  
does	  not	  demonstrate	  tonic	  activity,	  and	  is	  predominantly	  responsible	  (80-­‐90%)	  for	  large	  
increases	  in	  skin	  blood	  flow	  during	  hyperthermia,	  via	  active	  vasodilator	  nerve	  activation	  in	  
the	  skin	  (Rowell,	  1974b).	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The	   mechanisms	   responsible	   for	   cutaneous	   active	   vasodilation	   are	   complex.	  
Nevertheless,	  the	  initiation	  of	  active	  cutaneous	  vasodilation	  is	  by	  cholinergic	  nerves	  and	  
co-­‐transmitters	   (Johnson	   et	   al.,	   2014).	   	   The	   action	   of	   acetylcholine	   (ACh)	   on	   the	  
mechanisms	   of	   cutaneous	   vasodilation	   are	   mostly	   apparent	   in	   effecting	   the	   initial	  
vasodilator	   responses	   to	   whole	   body	   heating,	   but	   not	   in	   maintaining	   those	   responses	  
during	  prolonged	  heat	   stress	   (Johnson	  et	   al.,	   2014,	   Kellogg,	   2006,	   Kellogg	   et	   al.,	   1995).	  
Kellogg	  et	  al.	  (1995)	  used	  Botulinum	  A,	  a	  toxin	  which	  prevents	  the	  release	  of	  ACh	  and	  its	  
associated	  cotransmitters	  from	  cholinergic	  nerves	  (Dolly	  and	  Aoki,	  2006),	  and	  established	  
that	  cutaneous	  active	  vasodilation	  is	  abolished	  in	  the	  treated	  area	  during	  heat	  stress,	  yet	  
the	  reflex	  noradrenergic	  vasoconstrictor	  responses	  to	  cooling	  effects	  were	  unchanged.	  In	  
line	  with	  previous	  studies	  (Fox	  and	  Hilton,	  1958,	  Roddie,	  2003,	  Shastry	  et	  al.,	  2000)	  they	  
also	   found	   that	   atropine	   treatment	   (ACh	   inhibitor)	   prior	   to	   whole-­‐body	   heat	   stress	  
delayed,	  and	  slightly	  attenuated	  the	  cutaneous	  active	  vasodilator	  response	  to	  heat	  stress	  
(Kellogg	   et	   al.,	   1995).	   It	   thus	   appears	   that	   cutaneous	   active	   vasodilation	   is	   only	   partly	  
mediated	   by	   ACh	   during	   the	   initial	   stages	   of	   heat	   stress,	   and	   ~80%	  of	   the	   vasodilatory	  
response	  is	  mediated	  by	  cholinergic	  nerve	  co-­‐transmitters	  (Johnson	  et	  al.,	  2014).	  	  
	  
Shibasaki	  et	  al.	  (2002)	  postulated	  that	  ACh	  released	  from	  cholinergic	  nerves	  during	  heat	  
stress	  causes	  vasodilation	  via	  muscarinic	  receptor	  mediated	  NO	  production.	  Kellogg	  et	  al.	  
(1998)	   established	   that	   the	   increase	   in	   skin	   blood	   flow	   mediated	   by	   active	   cutaneous	  
vasodilation	  during	  heat	  stress	  was	  significantly	  reduced	  by	  infusing	  the	  NOS	  inhibitor	  NG-­‐
monomethyl-­‐L-­‐arginine	   (L-­‐NMMA).	   The	   infusion	   of	   L-­‐NMMA	   beyond	   cutaneous	  
vasodilation	  during	  heat	  stress	  reduced	  forearm	  skin	  blood	  flow	  by	  ~30%	  (Shastry	  et	  al.,	  
1998).	   It	   is	  widely	  accepted	  that	  30-­‐45%	  of	   the	   increases	   in	  skin	  blood	  flow	  during	  heat	  
stress	   are	   mediated	   by	   nitric	   oxide	   synthase	   (NOS)	   and	   the	   generation	   of	   NO,	   as	   the	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inhibition	   of	   NO	   and	   of	   soluble	   guanylyl	   cyclase	   (sGC)	   (a	   secondary	   messenger	   in	  
mediating	   the	   effects	   of	   NO)	   attenuates	   cutaneous	   active	   vasodilation	   during	   thermal	  
stress	  (Kellogg	  et	  al.,	  2011).	  The	  remainder	  of	  the	  cutaneous	  active	  vasodilator	  response	  
to	   heat	   stress	   is	   presumed	   to	   be	   due	   to	   pathways	   that	   are	   independent	   of	   NO	   and	  
secondary	   NO-­‐dependent	   mechanisms	   (Johnson	   et	   al.,	   2014,	   Kellogg,	   2006),	   such	   as	  
vasoactive	   intestinal	   peptide,	   substance	   P,	   histamine	   and	   prostanoids	   (Bennett	   et	   al.,	  
2003,	  Kellogg	  et	  al.,	  1995).	  	  These	  are	  summarised	  in	  Figure	  2.4.	  	  
2.2.1.2	  Local	  control	  of	  skin	  blood	  flow	  
In	   response	   to	   alterations	   in	   local	   skin	   temperature,	   cutaneous	   blood	   flow	   changes	   via	  
local	  temperature-­‐dependent	  mechanisms.	  The	  vasoconstrictor	  response	  to	  local	  cooling	  
have	  been	  reviewed	  extensively	  (Hodges	  and	  Johnson,	  2009),	  with	  neuropeptide-­‐Y	  (NPY)	  
and	   noradrenaline	   playing	   significant	   roles	   in	   the	   reflex	   vasoconstrictor	   response.	  	  
Vasodilator	   mechanisms	   that	   underlie	   the	   cutaneous	   hyperaemic	   response	   to	   local	  
heating	   of	   human	   skin	   are	   different	   than	   those	   involved	   in	   reflex	   cutaneous	   active	  
vasodilation.	  The	  local	  control	  of	  skin	  blood	  flow	  does	  not	  require	  reflex	  innervation	  but	  
includes	   locally	  mediated	  vasodilation	  dependent	  on	  the	  degree	  and	  speed	  of	   local	  skin	  
warming	  (Johnson	  and	  Kellogg,	  2010a),	  with	  a	  local	  skin	  temperature	  of	  ~42°C	  leading	  to	  
maximal	   skin	   vasodilation	   (Black	   et	   al.,	   2008b,	   Johnson	   et	   al.,	   1986).	   The	   current	  
understanding	   of	   the	   skin	   blood	   flow	   response	   to	   local	   heating	   includes	   complex	  
interactions	   between	   neural	   components	   and	   locally	   produced	   chemical	   messengers	  
(Johnson	   and	   Kellogg,	   2010b).	   Local	   heating	   of	   nonglabrous	   skin	   results	   in	   a	   bi-­‐phasic	  
response,	   characterised	   by	   an	   early	   transient	   peak	   predominantly	   mediated	   by	   neural	  
factors,	  followed	  by	  a	  brief	  nadir	  and	  a	  more	  prolonged	  secondary	  increase	  in	  skin	  blood	  
flow	   to	   a	   plateau	   that	   is	   predominantly	   a	   result	   of	   locally	   produced	   chemical	   factors	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(Minson	  et	  al.,	  2001).	  Sustained	  heating	  at	  the	  plateau	  phase	  eventually	  results	  in	  a	  return	  
of	  skin	  blood	  flow	  to	  resting	  levels	  despite	  the	  continuation	  of	   local	  heating	  highlighting	  
that	  bio-­‐availability	  of	  the	  local	  chemical	  factors	  involved	  in	  vasodilation	  are	  limited.	  
	  
Minson	  et	  al.	  (2001)	  reported	  a	  50%	  reduction	  in	  the	  initial	  peak	  response	  to	  local	  heating	  
following	   the	   blockade	   of	   local	   nerve	   function	   using	   a	   topical	   anaesthetic	   cream.	  
Interestingly,	   the	   blockade	   of	   all	   sensory	   afferent	   and	   sympathetic	   efferent	   activity	  
proximal	   to	   the	   site	   of	   local	   heating	   had	   no	   effect	   on	   increases	   in	   skin	   blood	   flow,	  
suggesting	  that	  the	  activation	  of	  local	  sensory	  nerves	  acting	  via	  an	  axon-­‐reflex,	  and	  not	  a	  
central	   perception	   of	   heat	   by	   the	   CNS,	  was	   required	   for	   cutaneous	   vasodilation.	   NO	   is	  
known	  to	  play	  a	  role	  in	  the	  sensory	  nerve	  contribution	  to	  the	  axon	  reflex	  component	  of	  
local	  heating,	  with	  L-­‐NAME	  infusion	  blocking	  NOS	  and	  subsequently	  removing	  (Hodges	  et	  
al.,	   2008)	   and/or	   delaying	   (Houghton	   et	   al.,	   2006)	   the	   axon	   reflex	   response.	   It	   was	  
recently	   suggested	   that	   the	   NO	   component	   of	   the	   axon	   reflex	   is	   due	   to	   activation	   of	  
transient	  receptor	  vanilloid	   (TRVP-­‐1)	  channels	  that	  are	   located	  on	  free	  nerve	  endings	  of	  
sensory	   skin	   fibres	   (Wong	  and	  Fieger,	  2010),	   as	  TRVP-­‐1	   is	   known	   to	  be	  activated	  by,	  or	  
increase	  the	  production	  of,	  NO	  (Lin	  et	  al.,	  2007,	  Vriens	  et	  al.,	  2009).	  	  
	  
The	   prolonged	   plateau	   phase	   of	   local	   temperature-­‐dependent	   vasodilation	   has	   been	  
shown	  to	  be	  mediated	  by	   the	   local	  generation	  of	  NO,	  and	   is	   significantly	  attenuated	  by	  
~50%	   by	   pre-­‐treating	   the	   warmed	   skin	   with	   the	   NOS-­‐inhibitor	   L-­‐NAME	   (Kellogg	   et	   al.,	  
1999,	  Minson	  et	  al.,	  2001,	  Gooding	  et	  al.,	  2006).	  NO	  is	  thought	  to	  contribute	  ~60%	  to	  the	  
longer	  plateau	  phase	  in	  local	  cutaneous	  vasodilation,	  with	  the	  remaining	  ~40%	  attributed	  
to	   endothelial-­‐derived	   hyperpolarising	   factor	   (EDHF)	   that	   causes	   vasodilation	   via	  




Sweating	   increases	   the	   dissipation	   of	   heat	   from	   the	   body	   when	   internal	   and/or	   skin	  
temperature	   rises,	   with	   increases	   in	   skin	   blood	   flow	   necessary	   to	   initiate	   and	   increase	  
sweating	  (Smith	  et	  al.,	  2013b).	  The	  evaporation	  of	  sweat	   from	  the	  eccrine	  sweat	  glands	  
cools	  the	  skin	  such	  that	  heat	  dissipation	  can	  occur	  more	  effectively	  and	  efficiently	  at	  the	  
skin	   surface.	   Eccrine	   sweat	   glands	   are	   distributed	   over	   nearly	   the	   entire	   body	   surface,	  
with	  the	  number	  varying	  from	  1.6	  to	  4	  million,	  with	  sweat	  gland	  density	  associated	  with	  
thermoregulation	  being	  greatest	  on	  the	  forehead,	  upper	  limbs,	  the	  trunk	  and	  lower	  limbs	  
(Kondo	  et	  al.,	  1998,	  Sato	  and	  Dobson,	  1970).	  	  	  
	  
The	  structure	  of	  the	  eccrine	  sweat	  gland	  consists	  of	  a	  bulbous	  secretory	  coil	  leading	  to	  a	  
duct,	  with	  the	  secretory	  coil	  located	  in	  the	  lower	  dermis	  with	  the	  duct	  extending	  through	  
the	  dermal	  layer	  that	  opens	  directly	  onto	  the	  surface	  of	  the	  skin	  (Figure	  2.3).	  The	  uncoiled	  
dimension	  of	   the	  secretory	  portion	  of	   the	  gland	   is	  between	  2-­‐5mm	  in	   length	  and	  30-­‐50	  
µm	  in	  diameter,	  whilst	  the	  secretory	  coil	  ranges	  from	  1-­‐8	  x10-­‐3	  mm3	  (Sato	  and	  Sato,	  1983).	  
The	  size	  of	  the	  sweat	  gland	  has	  been	  found	  to	  be	   important,	  with	  Sato	  and	  Sato	  (1983)	  
establishing	  a	  positive	  correlation	  between	  the	   individual	  sweat	  gland	  size	  and	  maximal	  
sweat	   gland	   sweat	   rate	   production.	   The	   identification	   of	   neural	   tracks	   in	   humans	   is	  
somewhat	  challenging,	  meaning	  the	  exact	  neurological	  pathways	  that	  are	  responsible	  for	  
sweating	  are	  not	  entirely	  understood.	  	  
2.2.2.1	  Neural	  control	  of	  sweat	  rate	  
Efferent	   sympathetic	   cholinergic	   nerves	   innervate	   eccrine	   sweat	   glands	   to	   induce	  
sweating,	  releasing	  ACh.	  ACh	  then	  binds	  to	  cholinergic	  muscarinic	  receptors	  at	  the	  sweat	  
gland	   (Randall	   and	   Kimura,	   1955,	   Torres	   et	   al.,	   1991).	   Increases	   in	   sweat	   rate	   occur	  
20	  
	  
through	  a	  combination	  of	   increasing	  the	  number	  of	  sweat	  glands	  that	  are	  activated	  and	  
increasing	   the	  amount	  of	   sweat	   released	  per	   gland	   (Randall,	   1946,	   Kondo	  et	   al.,	   2001).	  
The	   initial	   increase	   in	   sweat	   rate	   relates	   to	   a	   greater	   number	   of	   activated	   glands,	  with	  
further	   elevations	   in	   the	   sweat	   rate	   response	   occurring	   through	   increases	   in	   gland	  
secretion	  (Kondo	  et	  al.,	  2001),	  with	  average	  maximum	  sweat	  rate	  outputs	  ~1.4	  L/hour	  in	  
healthy	  individuals	  (Shibasaki	  et	  al.,	  2006).	  	  
	  
The	  local	  and	  systemic	  administration	  of	  atropine	  (muscarinic-­‐receptor	  agonist)	  abolishes	  
sweating	  during	  heat	  stress,	  and	  also	  in	  response	  to	  the	  exogenous	  administration	  of	  ACh	  
or	   its	   associated	   analogues.	   This	   strongly	   suggests	   that	   sweating	   primarily	   occurs	   via	  
muscarinic	  receptor	  stimulation	  (Foster	  and	  Weiner,	  1970,	  Kellogg	  et	  al.,	  1995,	  Kolka	  and	  
Stephenson,	   1987,	   MacIntyre	   et	   al.,	   1968).	   A	   number	   of	   possible	   co-­‐transmitters	   e.g.	  
vasoactive	   intestinal	   polypeptide,	   have	   been	   identified	   in	   and	   adjacent	   to	   cholinergic	  
sudomotor	   nerve	   terminals	   (Spreca	   et	   al.,	   2000,	   Tainio	   et	   al.,	   1987,	   Yamashita	   et	   al.,	  
1987),	  however	  the	  role	  of	  these	  peptides	  in	  modulating	  sweat	  rate	  remains	  unclear.	  
	  
Lee	   and	   Mack	   (2006)	   reported	   that	   muscarinic-­‐receptor	   mediated	   (pharmacologically-­‐
induced)	  sweating	  is	  reduced	  by	  NOS	  inhibition,	  supporting	  the	  suggestion	  that	  NO	  acts	  to	  
augment	   local	   sweat	   gland	   activity.	   However,	   the	   authors	   concluded	   that	   they	   did	   not	  
know	  whether	  NOS	  inhibitors	  acted	  by	  blocking	  an	  intrinsic	  NOS	  system	  within	  the	  eccrine	  
sweat	   gland	   cells,	   or	   reduced	   NO	   production	   in	   adjacent	   tissues	   i.e.	   the	   vascular	  
endothelium,	  that	  were	  dependent	  on	  skin	  blood	  flow.	  It	   is	  proposed	  that	  the	  impact	  of	  
NOS	  inhibition	  on	  local	  sweat	  rate	  may	  depend	  on	  the	  existence	  of	  adequate	  sudomotor	  
activity	   mediated	   by	   muscarinic-­‐receptors	   during	   thermal	   stress	   (Welch	   et	   al.,	   2009).	  
Consequently,	  NO	  may	  augment	  local	  sweat	  rate	  by	  directly	  influencing	  ACh	  release	  from	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sympathetic	  sudomotor	  nerves	  and	  augment	  sweat	  gland	  production,	  although	  this	  is	  yet	  
to	  be	  established.	  	  
2.2.2.2	  Local	  control	  of	  sweat	  rate	  
Sweating	   responses,	   can	   be	   influenced	   by	   changes	   in	   skin	   and	   local	   temperature	  
(Vanbeaumont	   and	   Bullard,	   1965,	   Wingo	   et	   al.,	   2010,	   Nielsen	   and	   Nielsen,	   1965).	   For	  
example,	   changes	   in	   skin	   temperature	   can	   modify	   sweat	   rate,	   as	   evidenced	   by	  
accentuated	  sweating	  with	   local	  skin	  heating	  (MacIntyre	  et	  al.,	  1968,	  Nadel	  et	  al.,	  1971,	  
Ogawa,	  1970),	  and	  attenuation	  with	  cooling	  (Bullard	  et	  al.,	  1967,	  Crawshaw	  et	  al.,	  1975,	  
Nadel	   et	   al.,	   1971),	   despite	   increases	   in	   core	   body	   temperature	   and/or	   a	   stable	  whole	  
body	   skin	   temperature.	   Additionally,	   reduced	   sweat	   rates	   are	   reported	   during	   limb	  
ischemia	   where	   blood	   flow	   is	   severely	   reduced	   (MacIntyre	   et	   al.,	   1968,	   Collins	   et	   al.,	  
1959).	  	  
	  
Wingo	  et	  al.,	  (2010)	  recently	  established	  that	  decreases	  in	  skin	  blood	  flow	  and	  local	  skin	  
temperature	   independently	   attenuate	   sweat	   rate	   relative	   to	   mean	   body	   temperature	  
during	   whole-­‐body	   heat	   stress.	   The	   precise	   mechanisms	   for	   this	   modulation	   have	   not	  
been	   elucidated,	   but	   may	   relate	   to	   reductions	   in	   shear	   stress-­‐mediated	   NO	   release	  
inducing	   reduced	   sweating	   (Lee	   and	  Mack,	   2006,	  Welch	   et	   al.,	   2009)	   secondary	   to	   skin	  
blood	   flow.	   There	  may	   also	   be	   direct	   effects	   of	   decreased	   local	   temperature	   on	   sweat	  
gland	  receptors	  or	  neurotransmitter	   release,	  or	  an	   indirect	   temperature	   lowering	  effect	  




2.2.4	  Core	  body	  temperature	  threshold	  and	  sensitivity	  
Reflex	  control	  of	  skin	  blood	  flow	  and	  sweating	  (effectors)	  can	  be	  studied	  by	  evaluating	  the	  
response	   as	   a	   function	   of	   body	   temperature,	  with	   factors	   that	   influence	   threshold	   and	  
sensitivity	  of	  the	  effector	  responses	  providing	  insight	  into	  altered	  central	  and	  peripheral	  
control	  mechanisms	  (Charkoudian	  and	  Stachenfeld,	  2014,	  Shibasaki	  et	  al.,	  2006).	  A	  core	  
body	  temperature	  threshold	  can	  be	  identified	  at	  which	  the	  onset	  of	  the	  effector	  response	  
occurs,	  with	  the	  slope	  of	  the	  post-­‐threshold	  relationship	  analysed	  to	  provide	  an	  index	  of	  














A	  rightward	  shift	   in	  the	  core	  temperature	  threshold	  and/or	  a	  decrease	   in	  sensitivity	  will	  
decrease	  the	  amount	  of	  heat	  dissipation	  for	  a	  given	  core	  temperature	  resulting	  in	  a	  less	  
efficient	  heat	   loss.	  Conversely,	  a	  shift	  to	  the	   left	  or	   increase	   in	  sensitivity	  will	  result	   in	  a	  
	  
Figure	  2.5	  Schematic	  example	  of	  cutaneous	  vasodilation	  (and/or	  sweating)	  as	  a	  function	  
of	   core	   body	   temperature.	   As	   core	   temperature	   increases,	   a	   threshold	   is	   reached	   at	  
which	  the	  heat	  dissipation	  mechanism	  begins	  to	  increase.	  The	  slope	  of	  the	  relationship	  
beyond	  this	  threshold	  is	  referred	  to	  as	  the	  sensitivity.	  A	  rightward	  shift	  in	  the	  threshold	  
and/or	  a	  decrease	   in	  the	  sensitivity	  will	  decrease	  the	  heat	  dissipation	  for	  a	  given	  core	  
temperature.	  Vertical	  lines	  show	  the	  change	  in	  the	  amount	  of	  a	  given	  effector	  response	  




more	  efficient	  heat	  loss.	  Examples	  of	  factors	  that	  can	  modify	  the	  heat	  loss	  mechanisms	  of	  
cutaneous	  vasodilation	  and	  sweating	  are	  exercise	  training	  (Ichinose	  et	  al.,	  2009,	  Ichinose-­‐
Kuwahara	   et	   al.,	   2010,	   Okazaki	   et	   al.,	   2002),	   heat	   acclimation	   (Armstrong	   et	   al.,	   2005,	  
Lorenzo	   et	   al.,	   2010)	   ageing	   (Smith	   et	   al.,	   2013a,	   Holowatz	   and	   Kenney,	   2010)	   and	  
reproductive	   hormone	   status	   (Kuwahara	   et	   al.,	   2005a,	   Charkoudian	   and	   Stachenfeld,	  
2014,	  Charkoudian	  et	  al.,	  1999).	  	  
	  
2.2.5	  Reproductive	  hormones	  and	  temperature	  control	  
The	   cyclical	   changes	   in	   oestrogen	   and	   progesterone	   during	   the	  menstrual	   cycle	  modify	  
resting	  core	  body	  temperature	  with	  an	  increase	  of	  ~0.5°C,	  in	  the	  mid-­‐luteal	  phase	  when	  
progesterone	   and	   oestrogen	   are	   elevated	   compared	   with	   early-­‐follicular	   when	   both	  
hormones	  are	  low	  (Charkoudian	  and	  Johnson,	  2000,	  Inoue	  et	  al.,	  2005).	  	  These	  alterations	  
also	  cause	  a	  rightward	  shift	  in	  the	  core	  temperature	  threshold	  for	  both	  active	  cutaneous	  
vasodilation	  and	  sweating	   in	   response	  to	  heat	  stress	  during	   the	  mid-­‐luteal	  phase	  of	   the	  
menstrual	  cycle	  (Charkoudian,	  2010,	  Charkoudian	  and	  Johnson,	  1997a,	  Inoue	  et	  al.,	  2005),	  
but	  no	  differences	  in	  cutaneous	  vasodilation	  sensitivity	  or	  total	  sweating	  output	  (Inoue	  et	  
al.,	  2005).	  This	  shift	  also	  occurs	  with	  exogenous	  progestins	  and	  oestrogens	  found	  in	  oral	  
contraceptives	  (Stachenfeld	  et	  al.,	  2000,	  Charkoudian	  and	  Johnson,	  1997b,	  Grucza	  et	  al.,	  
1993,	   Houghton	   et	   al.,	   2005),	   and	   is	   consistent	   with	   a	   shift	   in	   the	   onset	   of	   reflex	  
cutaneous	   vasodilation	   in	   response	   to	   an	   elevated	   core	   temperature	   during	   passive	  
heating	  (Charkoudian	  and	  Johnson,	  1997a)	  and	  acute	  exercise	  (Rogers	  and	  Baker,	  1997).	  
This	   shift	   also	  persists	   in	   the	  presence	  of	   local	   noradrenergic	   inhibition	  using	  bretylium	  
highlighting	   a	   shift	   in	   the	   central	   (neural)	   control	   of	   the	   cutaneous	   active	   vasodilator	  
system	  to	  higher	  internal	  temperatures	  with	  these	  hormones	  (Charkoudian	  and	  Johnson,	  
1997b,	   Charkoudian	   and	   Stachenfeld,	   2014).	   The	   sensitivity	   of	   cutaneous	   active	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vasodilation	  beyond	  the	  threshold	  appears	  to	  be	  unaltered	  by	  oestrogen	  with	  increasing	  
internal	  body	  temperature	  during	  heat	  stress	  (Stephenson	  and	  Kolka,	  1993).	  Conversely,	  
rising	  oestrogen	   (but	   low	  progesterone)	  during	  the	  pre-­‐ovulatory	  phase	   is	  characterised	  
by	  a	  lower	  resting	  core	  body	  temperature	  and	  cutaneous	  and	  sweating	  thresholds	  at	  rest	  
and	  during	  exercise	  (Stephenson	  and	  Kolka,	  1999).	  
	  
With	   regard	   to	   the	   specific	   effects	   of	   each	   hormone,	   oestrogen	   appears	   to	   have	   a	  
decreasing	   effect	   on	   core	   body	   temperature	   and	   thermoregulatory	   thresholds	  whereas	  
progesterone	   stimulates	   the	   opposite	   effect	   and	   promotes	   increases	   in	   core	   body	  
temperature	   during	   the	   menstrual	   cycle	   (Charkoudian	   and	   Johnson,	   2000),	   with	   the	  
effects	  of	  progesterone	  appearing	   to	  dominate	   the	  effects	  of	  oestrogen	  when	  both	  are	  
elevated	   (Stephenson	   and	   Kolka,	   1985,	   Stephenson	   and	   Kolka,	   1993,	   Kolka	   and	  
Stephenson,	   1989).	   In	   summary,	   female	   reproductive	   hormones	   have	   widespread	  
influences	   on	   the	   control	   of	   thermoregulatory	   mechanisms,	   specifically	   affecting	   the	  
cutaneous	  circulation,	  sweating	  responses	  and	  temperature	  control.	  	  
	  
2.2.6	  Ageing	  and	  temperature	  control	  
With	  human	  ageing,	  even	  in	  the	  absence	  of	  pathology,	  the	  vascular	  circulations	  as	  well	  as	  
their	   control	  mechanisms	  are	  attenuated	   (Holowatz	  and	  Kenney,	  2010,	  Holowatz	  et	  al.,	  
2007,	   Tew	   et	   al.,	   2012b),	   rendering	   aged	   individuals	   more	   vulnerable	   to	   heat-­‐related	  
cardiovascular	   complications	   and	   hyperthermia	   (Willie	   et	   al.,	   2014).	   It	   is	   difficult	   to	  
elucidate	   differences	   in	   male	   and	   female	   temperature	   control	   with	   ageing	   alone	   as	  
primarily	  studies	  use	  either	  older	  males	  or	  males	  and	  females	  combined	  (~65	  years	  old).	  
For	   the	   purpose	   of	   this	   section,	   ageing	   is	   reviewed	   without	   specific	   emphasis	   on	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menopausal	   status	   (see	   section	   2.8.1	   for	   temperature	   control	   in	   post-­‐menopausal	  
females).	  	  
	  
Control	   in	   reflex	  neural	  and	   local	  mechanisms	  of	   the	  cutaneous	  circulation	  change	  with	  
advancing	   age	   (Holowatz	   et	   al.,	   2007).	   The	   combined	   effect	   is	   the	   attenuation	   of	  
cutaneous	  vasodilator	  thresholds	  and	  sensitivities	  to	  whole-­‐body	  and/or	  local	  heat	  stress	  
(Holowatz	  and	  Kenney,	  2010).	   	  Ageing	   is	  known	   to	   reduce	   the	  cardiac	  output	   (due	   to	  a	  
lower	   stroke	   volume)	   and	  blood	   flow	   response	   to	  whole-­‐body	  heat	   stress,	  whilst	   ~30%	  
less	   blood	   flow	   is	   redistributed	   to	   the	   skin	   during	   thermal	   stress	   in	   older	   populations	  
(Minson	  et	  al.,	  1998).	  	  
	  
Reductions	  in	  skin	  blood	  flow	  with	  ageing	  are	  also	  a	  consequence	  of	  vasomotor	  control	  in	  
the	   skin	   itself	   (Johnson	   et	   al.,	   2014).	   A	   reduced	   magnitude	   of	   cutaneous	   vasodilation	  
during	  heat	  stress	  has	  been	  reported	  (Pierzga	  et	  al.,	  2003),	  and	  attributed	  to	  attenuation	  
in	   NO-­‐dependent	   mechanisms	   in	   older	   compared	   to	   younger	   males	   and	   females	  
(Holowatz	   et	   al.,	   2003,	   Minson	   et	   al.,	   2002).	   Furthermore,	   the	   substrate	   L-­‐arginine	   (a	  
substrate	  required	  for	  NO	  production	  by	  NOS)	  is	  reduced	  with	  age	  due	  to	  upregulation	  of	  
arginase	   (which	   competes	   with	   NOS	   to	   convert	   L-­‐arginine)	   and	   is	   associated	   with	  
endothelial	   dysfunction	   with	   advancing	   age	   (Holowatz	   et	   al.,	   2006b).	   	   This	   age-­‐related	  
decline	  in	  NOS	  has	  also	  been	  attributed	  to	  an	  age-­‐associated	  increase	  in	  oxidative	  stress	  
that	   limits	  NO-­‐bioavailability	  due	  to	  NO	  ‘quenching’	   (Holowatz	  et	  al.,	  2006a,	  Stanhewicz	  
et	  al.,	  2012).	  	  
	  
An	   age-­‐related	   decline	   in	   thermoregulatory	   sweating	   is	   observed	   due	   to	   decreased	  
thermal	  sensitivity	  to	  passive	  heat	  stress	  or	  exercise	  (Natsume	  et	  al.,	  1992,	  Armstrong	  and	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Kenney,	   1993),	   and	   sweat	   gland	   atrophy	   (Kondo	   et	   al.,	   2001,	   Kondo	   et	   al.,	   1998)	   that	  
produces	   a	   lower	   sweat	   output	   during	   thermal	   stress.	   However	   this	   has	   only	   been	  
reported	  in	  older	  males.	  	  Recently,	  Smith	  et	  al.	  (2013)	  reported	  greater	  male	  and	  female	  
(~65	   vs	   ~23	   years	   old)	   age-­‐related	   decrements	   in	   regional	   sweating	   compared	   with	  
cutaneous	   vasodilation	   during	   whole-­‐body	   heat	   stress	   that	   were	   not	   attributable	   to	  
decreased	   post-­‐synaptic	   cholinergic	   sensitivity.	   This	   suggests	   regional	   age-­‐related	  
decrements	   in	   heat-­‐activated	   sweat	   gland	   function	   but	   not	   cholinergic	   sensitivity	   that	  
exhibit	   greater	  age-­‐related	  decrements	   compared	   to	   the	  attenuation	   in	   skin	  blood	   flow	  
(Smith	  et	  al.,	  2013a).	  	  
2.2.7	  Exercise	  training	  and	  thermoregulatory	  adaptations	  in	  females	  
Exercise	   training	   has	   direct	   effects	   on	   thermoregulatory	   adaptation	   (Ichinose-­‐Kuwahara	  
et	  al.,	  2010,	  Inoue	  et	  al.,	  2005).	  Gender	  differences	  exist	  in	  the	  control	  of	  sweat	  rate	  (see	  
2.2.5	   reproductive	  hormones	  and	   temperature	   control),	   independent	  of	   training	   status,	  
with	  smaller	   increases	   in	  the	  sweat	  gland	  responses	  to	  physical	  training	   in	  females	  than	  
males	   that	   is	   suggested	   to	   be	   due	   to	   the	   inhibitory	   action	   of	   oestrogen	   on	   peripheral	  
sweat	  gland	  activation	  with	  exercise	  training	  (Ichinose-­‐Kuwahara	  et	  al.,	  2010).	  
	  
The	   function	   of	   the	   thermoregulatory	   control	   system	   (i.e.	   sweating	   and	   cutaneous	  
vasodilation)	   during	   heat	   stress	   can	   be	   enhanced	   with	   exercise	   training	   in	   pre-­‐
menopausal	  females	  (Armstrong	  et	  al.,	  2005,	  Ichinose	  et	  al.,	  2009,	  Araki	  et	  al.,	  1981).	  For	  
example,	  60	  days	  of	  endurance	  cycle	  exercise	  improved	  heat	  loss	  via	  reduced	  time	  to	  the	  
onset	  of	  sweating	  and	  increased	  peak	  sweat	  output	  in	  the	  luteal	  phase	  during	  exercise	  in	  
an	   a	   hot	   environment	   (~30ºC)	   (Araki	   et	   al.,	   1981),	   Furthermore,	   3	  months	  of	  moderate	  
intensity	  endurance	  training	  can	  enhance	  the	  efficiency	  of	  the	  thermoregulatory	  control	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system	   by	   decreasing	   the	   core	   temperature	   threshold	   for	   the	   onset,	   and	   sensitivity	   of	  
sweating	   and	   cutaneous	   vasodilation	   independent	   of	   menstrual	   phase	   (Ichinose	   et	   al.,	  
2009).	  Importantly,	  exercise	  training	  status	  has	  also	  been	  shown	  to	  lower	  basal	  core	  body	  
temperature	   and	   reduce	   physiological	   strain	   during	   both	   acute	   exercise	   and	   passive	  
heating	   in	  young	  trained	  females	  compared	  to	  untrained	  counterparts	   (Kuwahara	  et	  al.,	  
2005a,	  Kuwahara	  et	  al.,	  2005b).	  	  
	  
Enhanced	   thermoregulatory	   function	   in	   trained	   pre-­‐menopausal	   females	   is	   evident	  
irrespective	  of	  menstrual	  phase	  compared	  to	  untrained	  females	  (Kuwahara	  et	  al.,	  2005a),	  
whilst	  an	  8-­‐week	  period	  of	  exercise	  training	  (60-­‐85%	  VO2max)	  and	  passive	  heat	  acclimation	  
(using	  a	  heat	   chamber	  ~36.5ºC)	  with	  or	  without	  exogenous	  oestrogen	  administration	   in	  
females	  decreased	  basal	   core	  body	   temperature	  with	  no	   change	   in	   sweating	   sensitivity	  
(Armstrong	  et	  al.,	  2005).	  However,	  the	  study	  design	  made	  it	  difficult	  to	  establish	  whether	  
the	   effects	   of	   exercise	   training	   and	   passive	   heating	   acclimation	   were	   exclusively	  
independent	  of	  each	  other.	  Advances	   in	  sweating	  sensitivity	  with	  exercise	   training	  have	  
been	  suggested	  to	  be	  dependent	  on	  subsequent	  improvements	  in	  aerobic	  capacity	  (~15-­‐
20%)	  (Ichinose	  et	  al.,	  2009,	  Pandolf,	  1979),	  with	  such	  improvements	  unattained	  following	  
exercise	  training	  in	  the	  Armstrong	  et	  al.	  (2005)	  study.	  
	  
Heat	  acclimation,	  involving	  repeated	  exposure	  to	  heat	  stress	  (i.e.	  during	  exercise	  in	  a	  hot	  
environment)	   has	   been	   shown	   to	   improve	   thermoregulatory	   control	   by	   decreasing	   the	  
internal/body	   temperature	   threshold	   for	   the	   onset	   of	   sweating	   and	   cutaneous	  
vasodilation	   (Armstrong	   et	   al.,	   2005,	   Kuwahara	   et	   al.,	   2005a,	   Kuwahara	   et	   al.,	   2005b,	  
Lorenzo	  and	  Minson,	  2010)	  and/or	  the	  slope	  of	  the	  sweating	  and	  cutaneous	  vasodilation	  
response	  (Inoue	  et	  al.,	  2005,	  Lorenzo	  and	  Minson,	  2010,	  Takeno	  et	  al.,	  2001,	  Sawka	  et	  al.,	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1989,	   Sawka	   et	   al.,	   2000).	   Repeated	   exposure	   to	   external	   heat	   stress	   independent	   of	  
exercise	  training	  (e.g.	  resting	  in	  a	  hot	  and	  humid	  environment)	  has	  only	  been	  employed	  in	  
a	   small	   number	  of	   studies	  using	  a	   short	   time-­‐frame	   i.e.	   2	  weeks	  of	  heat	   acclimation	   to	  
induce	   thermoregulatory	   adaptations,	   including	   reduced	   basal	   core	   body	   temperature	  
and	  the	  earlier	  onset	  of	  sweating	   in	  both	  males	  and	  females	  (Eichna	  et	  al.,	  1950,	  Fox	  et	  
al.,	  1963a,	  Fox	  et	  al.,	  1963b,	  Shido	  et	  al.,	  1999,	  Armstrong	  and	  Kenney,	  1993).	  Whether	  
thermoregulatory	  adaptations	  can	  be	  enhanced	  to	  a	  similar	  degree	  with	  exercise	  training	  
or	  passive	  heat	  acclimation	  over	  a	  longer	  time-­‐frame	  i.e.	  8	  weeks,	  in	  females	  is	  yet	  to	  be	  
considered.	  
	  
In	  summary,	  temperature	  control	  is	  important	  to	  consider	  in	  females	  as	  it	  is	  regulated	  by	  
reproductive	   hormone	   status	   that	   can	   delay	   the	   temperature	   thresholds	   for	   cutaneous	  
vasodilation	  and	  sweating.	  Additionally,	  temperature	  control	  is	  affected	  in	  older	  females	  
via	   a	   reduced	   capacity	   of	   the	   cutaneous	   vasculature	   and	   function	   of	   the	   sweat	   glands.	  
However,	   in	   younger	   females,	   differences	   in	   temperature	   control	   are	   offset,	   and	  
improved,	  by	  regular	  physical	  exercise	  training	  over	  a	  number	  of	  weeks.	  It	  is	  also	  possible	  
that	  targeting	  the	  thermoregulatory	  control	  system	  with	  a	  specific	  exercise-­‐independent	  
heat	   stress	   intervention	   i.e.	   passive	   heating,	   may	   induce	   similar	   thermoregulatory	  
improvements	  in	  the	  efficiency	  of	  sweating	  and	  cutaneous	  vasodilation	  to	  that	  of	  exercise	  
training	  in	  pre-­‐menopausal	  females.	  
	  
2.3	  Conduit	  artery	  function	  
Conduit	  arteries	  are	  characterised	  by	  a	  thick	  tunica-­‐media	  that	  contain	  a	  larger	  amount	  of	  
smooth	   muscle	   cells	   compared	   to	   other	   branches	   in	   the	   arterial	   tree	   (e.g.	   resistance	  
29	  
	  
arteries	   and	   cutaneous	   vessels;	   Figure	   2.6).	   It	   is	   the	   contractility	   of	   these	   vessels	   that	  
allows	  them	  to	  actively	  vasodilate	  either	  by	  sympathetic	  control	  or	  circulating	  vasoactive	  
substances.	   	  The	  endothelium	  produces	  numerous	  paracrine	  substances,	   including	  nitric	  
oxide	  (NO)	  which	  helps	  regulate	  vasomotor	  function	  and	  the	  health	  of	  the	  vessel	  wall.	  NO	  
is	   synthesised	   in	   endothelial	   cells	   from	   the	  amino	  acid	   L-­‐arginine	   through	   the	   action	  of	  
eNOS	   (Palmer	   et	   al.,	   1988).	   NO	   rapidly	   diffuses	   into	   the	   vascular	   smooth	   muscle	   cell	  
where	   it	   binds	   to	   the	   enzyme	   guanylate	   cyclase	   (Ignarro	   et	   al.,	   1986),	   resulting	   in	   an	  
increase	  in	  cyclic	  guanosine	  monophosphate	  that	  induces	  smooth	  muscle	  relaxation	  and	  
subsequent	   vasodilation	   (Green	   et	   al.,	   2004b,	   Furchgott	   and	   Jothianandan,	   1991).	   The	  
function	   of	   the	   endothelium	   is	   vital	   to	   maintain	   arterial	   health,	   and	   in	   addition	   is	  
important	   in	   regulating	   blood	   flow	   to	   skeletal	   and	   cardiac	   muscle	   at	   rest	   and	   during	  


















NO	  is	  tonically	  secreted	  by	  the	  endothelium	  and	  contributes	  ~50%	  to	  basal	  vascular	  tone,	  
while	  NO	  production	  can	  be	  upregulated	  via	  increases	  in	  blood	  flow	  and	  shear	  stress.	  The	  
signalling	   cascade	   leading	   to	   the	   secretion	   of	   NO,	   whilst	   not	   entirely	   understood,	   has	  
been	   characterised.	   Increases	   in	   arterial	   shear	   stress	   have	   been	   reported	   to	   induce	  
endothelial	   potassium	   channel	   activation	   (Oleson	   and	   Johnson,	   1988,	   Dull	   and	   Davies,	  
1991),	  calcium	  influx	  in	  endothelial	  cells	  (Dull	  and	  Davies,	  1991)	  and	  release	  of	  bradykinin	  
and/or	   phosphorylation	   of	   serine	   residue	   (Groves	   et	   al.,	   1995)	   that	   enhance	   NO	  
bioavailability.	  Furthermore,	  prostacyclin	  and	  EDHF	  are	  also	  released	  by	  the	  endothelium	  
in	  response	  to	  shear	  stress	  and	  are	  known	  to	  be	  vasoactive	  (Grabowski	  et	  al.,	  1985,	  Spilk	  
et	  al.,	  2013).	   	  NO	  bioavailability	   is	  commonly	  used	  as	  a	  surrogate	  marker	  of	  endothelial	  
(dys)function	   (Wilk	   et	   al.,	   2013)	   and	   can	   be	   assessed	   using	   the	   flow-­‐mediated	   dilation	  
(FMD)	  technique.	  FMD	  is	  regarded	  as	  a	  surrogate	  marker	  of	  cardiovascular	  disease	  (Green	  
et	  al.,	  2011,	  Vita	  and	  Keaney,	  2002,	  Mutlu	  et	  al.,	  2011),	  with	  its	  impairment	  significantly	  
associated	  with	  future	  cardiovascular	  events	  in	  asymptomatic	  individuals	  (Shechter	  et	  al.,	  
2009,	  Inaba	  et	  al.,	  2010).	  
2.3.1	  Reproductive	  hormones	  and	  conduit	  artery	  function	  
Oestrogen	  promotes	  the	  formation	  of	  the	  vasodilator	  substance	  prostacyclin	  (Novella	  et	  
al.,	   2012),	   modulates	   numerous	   molecular	   pathways	   that	   improve	   vascular	   function	  
(Tostes	  et	  al.,	  2003),	  may	  confer	  direct	  protection	  on	  the	  vessel	  wall	  (Williams	  et	  al.,	  2001,	  
Hashimoto	   et	   al.,	   1995,	   Tostes	   et	   al.,	   2003),	   and	   is	   suggested	   to	   improve	   endothelial	  
function	   (Arora	   et	   al.,	   1998).	   A	   change	   in	   reproductive	   hormone	   levels	   affects	   the	  
circulating	   factors,	   eNOS	   and	   vascular	   endothelial	   growth	   factor	   (VEGF)	   demonstrating	  
cyclic	  variation	  in	  line	  with	  the	  menstrual	  cycle	  (Taguchi	  et	  al.,	  2000,	  Agrawal	  et	  al.,	  1999).	  	  
This	   variation	   in	   endothelial-­‐vasodilators	   has	   led	   to	   the	   idea	   that	   changes	   can	   occur	   in	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conduit	   artery	   function	   during	   the	   menstrual	   cycle.	   Changes	   in	   endothelial-­‐dependent	  
conduit	   function	   during	   the	   menstrual	   cycle	   using	   FMD	   has	   been	   numerously	  
demonstrated	   (Kawano	   et	   al.,	   1996,	   Williams	   et	   al.,	   2001,	   Hashimoto	   et	   al.,	   1995),	  
reporting	   a	   higher	   brachial	   artery	   endothelial-­‐dependent	   vasodilation	   in	   the	   follicular	  
phase	  compared	  to	  the	  luteal	  phase	  in	  pre-­‐menopausal	  females.	  One	  study	  reported	  no	  
influence	  of	  reproductive	  hormone	  status	  on	  carotid	  and	  femoral	  conduit	  artery	  function	  
across	  the	  menstrual	  cycle	  (Willekes	  et	  al.,	  1997),	  however	  the	  differences	  may	  relate	  to	  
methodological	   discrepancies	   with	   Willekes	   et	   al.	   (1997)	   using	   peripheral	   brachial	  
pressures	  to	  investigate	  changes	  in	  systemic	  responses	  i.e.	  carotid	  and	  femoral	  function.	  
It	   is	  suggested	  that	  the	  rise	  and	  fall	   in	  oestrogen	  during	  the	  follicular	  and	   luteal	  phases,	  
respectively,	   is	  responsible	  for	  these	  changes	  in	  vascular	  function	  primarily	  via	   its	  ability	  
to	  upregulate	  eNOS	  activity	  in	  the	  vasculature	  (Gonzales	  et	  al.,	  2001,	  Hayashi	  et	  al.,	  1995).	  
2.3.2	  Ageing	  and	  conduit	  function	  
Ageing	   is	   associated	   with	   a	   reduction	   in	   NO	   bioavailability	   (Nyberg	   et	   al.,	   2012)	   and	  	  
endothelial	  dysfunction	  (Holowatz	  et	  al.,	  2010,	  Parker	  et	  al.,	  2006,	  Celermajer	  et	  al.,	  1994)	  
that	   is	   accompanied	   by	   increased	   levels	   of	   several	   cardiovascular	   risk	   factors	   and	  
incidence	  of	  cardiovascular	  disease	   (Seals	  et	  al.,	  2006).	  Brachial	  artery	  FMD	   is	   impaired,	  
independent	   of	   traditional	   cardiovascular	   risk	   factors,	   in	   late	   peri-­‐	   to	   early	   post-­‐
menopausal	  females	  compared	  to	  pre-­‐menopause	  (Figure	  2.7)	  (Moreau	  et	  al.,	  2012).	  To	  
what	  extent	   the	  decline	   in	  endothelial-­‐dependent	  vascular	   function	   in	  post-­‐menopausal	  
females	  is	  a	  function	  of	  ageing	  and/or	  a	  consequence	  of	  reduced	  oestrogen	  is	  difficult	  to	  



















2.3.4	  Exercise	  training	  and	  conduit	  function	  
Exercise	   training	   improves	   endothelial	   function	   in	   populations	   at	   risk	   of	   cardiovascular	  
disease	  (Thijssen	  et	  al.,	  2010),	  with	  the	  benefits	  predominantly	  focussed	  on	  the	  vascular	  
endothelium	   (Green	   et	   al.,	   2004b).	   The	   benefits	   in	   asymptomatic	   populations	   with	  
healthy	  function	  are	   less	  consistent	  (Green	  et	  al.,	  2004b,	  Maiorana	  et	  al.,	  2003,	  Goto	  et	  
al.,	   2003).	   It	   is	   proposed	   that	   these	   differences	   occur	   due	   to	   the	   level	   of	   endothelial	  
dysfunction	  induced	  by	  exercise	  (Goto	  et	  al.,	  2003).	  Furthermore,	  Tinken	  and	  colleagues	  
recently	  examined	  the	  time	  course	  of	  change	   in	  conduit	  artery	  endothelial	   function	  and	  
subsequently	   established	   that	   vascular	   function	   increases	   initially,	   but	   then	   declines	   to	  
pre-­‐training	   levels	   in	   healthy	   young	   individuals	   suggesting	   modification	   in	   arterial	  
structure	  i.e.	  a	  larger	  vessel	  following	  initial	  improvements	  in	  endothelial	  function	  (Tinken	  
et	  al.,	  2008,	  Tinken	  et	  al.,	  2010).	  Importantly,	  the	  decline	  in	  NO	  bioavailability	  with	  ageing	  
is	  offset	  with	  lifelong	  regular	  physical	  activity	  (Black	  et	  al.,	  2009,	  Nyberg	  et	  al.,	  2012),	  with	  
trained	  older	  participants	  demonstrating	  a	  higher	  eNOS	  response	   following	  arterial	  ACh	  
	  
Figure	  2.7.	  Brachial	  artery	  FMD	  in	  premenopausal	  females	  (Pre)	  and	  across	  the	  
menopausal	  transition	  into	  late	  post-­‐menopause	  (late	  post)	  (Moreau	  et	  al.,	  2012)	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infusion	  and	  increased	  endothelial-­‐dependent	  vasodilation,	  compared	  to	  their	  untrained	  
counterparts	  (Nyberg	  et	  al.,	  2012).	  
	  
In	   summary,	   conduit	   artery	   function	   is	   altered	   by	   reproductive	   hormone	   status	  
throughout	   the	   menstrual	   cycle	   primarily	   through	   the	   actions	   of	   oestrogen	   on	  
endothelial-­‐dependent	   vasodilation.	   With	   ageing,	   pre-­‐menopausal	   females	   have	   a	  
maintained	  vascular	  function	  compared	  to	  males	  of	  a	  similar	  age,	  whilst	  reductions	  in	  NO	  
bioavailability	   with	   age	   reduce	   vascular	   function	   in	   both	   genders.	   Exercise	   training	  
enhances	  conduit	  artery	  function	  in	  the	  presence	  of	  previous	  endothelial	  dysfunction	  i.e.	  
cardiovascular	  disease,	  alongside	  attenuating	  the	  reduction	  in	  vascular	  function	  observed	  
in	  older	  individuals	  who	  have	  a	  history	  of	  exercise	  training.	  
2.4	  Cerebral	  Blood	  Flow	  
The	  regulation	  of	  cerebral	  blood	  flow	  (CBF)	  is	  critical	  for	  the	  maintenance	  of	  oxygen	  and	  
nutrient	  supply	  to	  the	  brain.	  Despite	  the	  brain	  only	  occupying	  2-­‐3%	  of	  total	  human	  body	  
mass,	   the	   metabolic	   demand	   of	   the	   cerebral	   tissue	   is	   ~20%	   of	   total	   body	   oxygen	  
consumption	  (Bain	  et	  al.,	  2014).	  Consequently,	  substantial	  reductions	  in	  CBF	  rapidly	  leads	  
to	  unconsciousness	  (Van	  Lieshout	  et	  al.,	  2003)	  and	  if	  sustained,	  brain	  damage	  and	  death	  
ensues	   (Smith	   et	   al.,	   2011).	   The	   control	   of	   CBF	   is	   a	   multifactorial	   integrated	   process,	  
influenced	  largely	  by	  the	  partial	  pressure	  of	  arterial	  carbon	  dioxide	  (PaCO2),	  mean	  arterial	  
pressure	   (MAP),	   cerebral	   metabolism	   and	   the	   autonomic	   nervous	   system	   (Figure	   2.8)	  















Steady-­‐state	   CBF	   is	   reported	   to	   remain	   relatively	   stable	   across	   a	   wide	   range	   of	   blood	  
pressures	   i.e.	  ~60-­‐160	  mmHg	  (Paulson	  et	  al.,	  1990),	  which	  requires	  reflex	  adjustment	   in	  
cerebrovascular	   resistance	   in	   response	   to	   changes	   in	   blood	   pressure.	   This	   physiological	  
response	  is	  termed	  cerebral	  autoregulation	  (Franco	  Folino,	  2007,	  ter	  Laan	  et	  al.,	  2013,	  van	  
Beek	   et	   al.,	   2008,	   Willie	   et	   al.,	   2014).	   Current	   studies	   illustrate	   that	   the	   CBF-­‐MAP	  
relationship	   is	   not	   stable	   through	   a	   broad	   range	   of	   pressures	   and	   is	   dependent	   on	   the	  
severity	  and	  direction	  of	  change	  in	  perfusion	  pressure	  above	  or	  below	  baseline	  (Tan	  and	  
Taylor,	   2014,	   Willie	   et	   al.,	   2014).	   Blood	   pressure	   is	   a	   critical	   component	   of	   cerebral	  
autoregulation	   and	  CBF	   (Lucas	   et	   al.,	   2010),	  with	   both	   hypoxia	   and	   elevations	   in	  PaCO2	  
impairing	   the	   capability	   of	   the	   brain,	   unable	   to	   defend	   against	   blood	   pressure	   changes	  
(Tzeng	  et	  al.,	  2012).	  	  
2.4.1.	  Cerebral	  blood	  flow	  and	  heat	  stress	  
Heat	  stress	  results	  in	  marked	  reductions	  in	  CBF	  and	  reduced	  orthostatic	  tolerance	  (Bain	  et	  
al.,	  2014,	  Brothers	  et	  al.,	  2009,	  Keller	  et	  al.,	  2009,	  Low	  et	  al.,	  2008b),	  with	  reductions	  in	  
central	   blood	   volume	   and	   end-­‐tidal	   carbon	   dioxide	   contributing	   to	   the	   observed	  
	  
	  
Figure	  2.8.	  Diagram	  of	  the	  main	  mechanisms	  responsible	  for	  control	  of	  cerebral	  
blood	  flow	  (CBF)	  (Ainslie	  and	  Duffin,	  2009).	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reductions	  in	  brain	  blood	  flow	  (Brothers	  et	  al.,	  2009,	  Nelson	  et	  al.,	  2011).	  As	  CBF	  is	  highly	  
sensitive	   to	   arterial	   hypocapnia	   (hyperventilation-­‐induced	   reduction	   in	   CO2)	   (Fan	   et	   al.,	  
2008),	   hyperthermia-­‐induced	   hyperventilation	   and	   consequent	   hypocapnia	   severely	  
reduces	  CBF	  (Crandall	  et	  al.,	  2008),	  and	  is	  proposed	  to	  account	  for	  ~50%	  to	  the	  reductions	  
in	  cerebrovascular	  conductance	  (Wilson	  et	  al.,	  2006).	  This	  is	  supported	  by	  Brothers	  et	  al.	  
(2009)	  who	  recently	  found	  that	  restoration	  of	  end-­‐tidal	  PaCO2	  during	  passive	  heat	  stress	  
partially	   restored	   CBF	   to	   normothermic	   levels.	   Additionally,	   the	   neurogenic	   response	  
during	   hyperthermia,	   resulting	   in	   cerebral	   vasoconstriction	   via	   increased	   sympathetic	  
nerve	  activity,	  is	  also	  suggested	  to	  account	  towards	  the	  observed	  CBF	  reduction	  (Brothers	  
et	  al.,	  2009).	  	  
	  
Steady	   state	   blood	   pressure,	   and	   hence	   perfusion	   pressure	   to	   the	   brain,	   during	   mild	  
passive	  supine	  hyperthermia	  is	  only	  moderately	  decreased,	  with	  cerebral	  autoregulation	  
unaltered	   (Crandall	   and	   González-­‐Alonso,	   2010,	   Low	   et	   al.,	   2009),	   but	   decreases	  
significantly	  under	  dynamic	  blood	  pressure	  challenges	  that	  can	  severely	  compromise	  CBF	  
i.e.	  orthostatic	  tolerance	  or	  haemorrhage	  (Brothers	  et	  al.,	  2011).	  It	  is	  suggested	  that	  the	  
redistribution	  of	   cardiac	  output	   to	   the	   cutaneous	   circulation	  during	  heat	   stress	  may	  be	  
responsible	   for	   reductions	   in	   CBF	   perfusion	   (Ogoh	   and	   Ainslie,	   2009),	   with	   passive	  
hyperthermia-­‐induced	  elevations	  in	  cardiac	  output	  relating	  to	  decreased	  middle	  cerebral	  
artery	  velocity	   (MCAv)	   (Fan	  et	  al.,	  2008).	  Nevertheless,	  cardiac	  output	  was	  unrelated	  to	  
reductions	   in	  CBF	  during	  passive	  heat	  stress	   in	  one	  study,	  that	   instead	  suggested	  stroke	  
volume	   and	   end-­‐diastolic	   volume	  were	   responsible	   for	   the	   observed	   reductions	   in	   CBF	  
during	  heat	  stress	  (Nelson	  et	  al.,	  2011).	  The	  level	  of	  heat	  stress	  in	  inducing	  reductions	  in	  
CBF,	  and	  as	  such	  the	  ranges	  of	  cardiac	  output,	  may	  be	  responsible	  for	  this	  discrepancy.	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Stroke	  volume	  shares	  a	  direct	  linear	  relationship	  with	  central	  blood	  volume	  (Levine	  et	  al.,	  
2002),	   which	   decreases	   during	   hyperthermia	   (Kempton	   et	   al.,	   2009)	   and	  may	   result	   in	  
decreases	   in	   CBF.	   However,	   acute	   blood	   volume	   expansion	   does	   not	   reverse	   the	  
hyperthermia-­‐induced	   reductions	   in	  CBF	  at	   rest	   (Schlader	  et	  al.,	  2013),	  but	  did	   improve	  
maintenance	   of	   CBF	   during	   a	   simulated	   haemorrhage	   that	   was	   likely	   a	   function	   of	  
augmented	   stroke	  volume	  and	   the	  preservation	  of	  arterial	  blood	  pressure	  prior	   to,	  and	  
during	   the	   simulation.	   This	   suggests	   a	   possible	   role	   for	   carotid	   and/or	   pulmonary	  
baroreceptor	  control	  over	  CBF	  during	  hyperthermia	  (Charkoudian	  et	  al.,	  2005,	  Nelson	  et	  
al.,	  2011,	  Levine	  et	  al.,	  2002).	  
2.4.2	  Reproductive	  hormones	  and	  cerebral	  blood	  flow	  
The	   interactions	   between	   reproductive	   hormones,	   namely	   oestrogen,	   and	   the	  
cerebrovascular	   system	  are	   complex	  and	  not	   fully	  understood	   (Diomedi	   et	   al.,	   2001).	  A	  
variety	  of	   evidence	   suggests	   oestrogen	  protects	   against	   cerebrovascular	   disease	   in	  pre-­‐
menopausal	  females	  (Sarrel,	  1999,	  Krejza	  et	  al.,	  2004),	  who	  are	  at	  a	  lower	  risk	  of	  stroke	  at	  
pre-­‐menopause	  compared	  to	  males	  of	  a	  similar	  age	  (Yoo	  et	  al.,	  1998,	  Caplan	  et	  al.,	  1986),	  
while	   risk	   dramatically	   increases	   following	   the	  menopause	   when	   oestrogen	   is	   severely	  
reduced	  (van	  der	  Schouw	  et	  al.,	  1996).	   	  Furthermore,	  treatment	  with	  oestrogen	  prior	  to	  
induced	  cerebral	  ischemia	  in	  an	  animal	  model	  of	  both	  sexes	  decreases	  brain	  injury,	  which	  
is	   suggested	   to	   be	  due	   to	   an	  oestrogen	   receptor-­‐mediated	   vasodilation	   (Alkayed	   et	   al.,	  
2000,	  Sawada	  et	  al.,	  2000).	  
	  
Diomedi	  et	  al.	  (2001)	  established	  peak	  levels	  of	  oestrogen	  during	  the	  pre-­‐ovulatory	  phase	  
are	  associated	  with	  an	  increased	  cerebrovascular	  CO2	  reactivity	  using	  the	  breath-­‐holding	  
index	   compared	   to	   the	  menstrual	   phase.	   Despite	   potential	   influences	   of	   oestrogen	   on	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cerebral	  autoregulation	  and	  thus	  vasodilatory	  capacity,	  the	  authors	  found	  no	  differences	  
on	   basal	   MCAv	   in	   the	   two	   menstrual	   phases.	   Furthermore,	   along	   with	   increases	   in	  
oestrogen	   during	   the	   late	   follicular	   phase	   and	   pre-­‐ovulation,	   a	   decrease	   in	   cerebral	  
vascular	  resistance	  (indexed	  by	   internal	  carotid	  pulsatility	   index)	  was	  observed	   in	  young	  
females	   (Krejza	   et	   al.,	   2004),	   that	   may	   promote	   the	   notion	   of	   an	   oestrogen-­‐related	  
elevation	   in	   CBF	   caused	   primarily	   via	   reductions	   in	   cerebral	   vascular	   impedance	   during	  
the	  menstrual	  cycle.	  This	  is	  further	  supported	  by	  an	  elevated	  reactivity	  to	  CO2	  in	  pre	  but	  
not	   post-­‐menopausal	   females	   which	   is	   attributed	   to	   differences	   in	   oestrogen	  
concentrations	  on	  the	  cerebrovasculature	  (Kastrup	  et	  al.,	  1998,	  Belfort	  et	  al.,	  1995).	  	  
2.4.3	  Ageing	  and	  cerebral	  blood	  flow	  
CBF	  declines	  gradually	  with	  age	  in	  adults	  between	  20-­‐80	  years	  of	  age,	  by	  ~5%	  per	  decade	  
(Ainslie	  et	  al.,	  2008,	  Scheel	  et	  al.,	  2000,	  Stoquart-­‐ElSankari	  et	  al.,	  2007,	  Fisher	  et	  al.,	  2013),	  
with	   ageing	   associated	   with	   global	   cerebral	   atrophy	   that	   reflects	   a	   global	   decrease	   in	  
cerebral	   perfusion	   without	   disturbance	   of	   regional	   perfusion	   or	   oxygen	   consumption	  
(Ainslie	   and	   Bailey,	   2013,	   Ainslie	   et	   al.,	   2008).	   The	   effect	   of	   healthy	   ageing	   on	  
cerebrovascular	   reactivity	   is	   less	   clear,	   with	   no	   or	   little	   changes	   to	   both	   hypercapnic-­‐
induced	  elevations	   and	  hypocapnic-­‐induced	   reductions	   in	   older	   populations	   (Kastrup	  et	  
al.,	  1998,	  Galvin	  et	  al.,	  2010,	  Ito	  et	  al.,	  2002,	  Tsuda	  and	  Hartmann,	  1989).	  
2.4.4	  Exercise	  training	  and	  cerebral	  blood	  flow	  
CBF	   is	   elevated	  during	   submaximal	   exercise	   in	   both	   young	   and	  older	   individuals	   by	   ~5-­‐
15%	  (Ainslie	  et	  al.,	  2008,	  Ogoh	  et	  al.,	  2005,	  Fisher	  et	  al.,	  2013,	  Marsden	  et	  al.,	  2012),	  and	  
is	  intensity-­‐dependent	  up	  to	  ~60-­‐70%	  VO2max	  	  (Hellstrom	  et	  al.,	  1996,	  Murrell	  et	  al.,	  2013)	  
and	   then	   declines	   due	   to	   hyperventilation-­‐induced	   hypocapnia	   that	   reduces	   cerebral	  
perfusion	  (Moraine	  et	  al.,	  1993).	  Furthermore,	  MCAv	  increases	  to	  a	  lesser	  extent	  in	  older	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compared	  to	  younger	  individuals	  during	  acute	  submaximal	  exercise	  (Murrell	  et	  al.,	  2013,	  
Marsden	   et	   al.,	   2012).	   Exercise	   training	   exerts	   positive	   effects	   on	   CBF,	   as	   age-­‐induced	  
cerebral	   atrophy	   appears	   to	   be	   less	   marked	   in	   those	   with	   a	   higher	   aerobic	   fitness,	  
increases	  brain	  volume	  in	  sedentary	  adults	  (Colcombe	  et	  al.,	  2003,	  Colcombe	  et	  al.,	  2006)	  
and	  improves	  cerebrovascular	  reactivity	  in	  stroke	  patients	  (Ivey	  et	  al.,	  2011),	  but	  not	  basal	  
blood	  flow,	  following	  6	  months	  of	  exercise	  training.	  Animal	  studies	  provided	  preliminary	  
evidence	  that	  the	  benefits	  of	  exercise	  training	  may	  extend	  to	  the	  cerebrovasculature	  with	  
improvements	   in	  CBF	  and	   reductions	   in	   stoke-­‐induced	   infarct	   size	   following	  a	  period	  of	  
exercise	  training	  via	  improved	  angiogenesis	  and	  elevated	  CBF	  (Gertz	  et	  al.,	  2006,	  Endres	  
et	   al.,	   2004).	   The	   corollary	   is	   that	  MCAv	   is	   increased	  by	  ~10-­‐25%	  with	   a	  higher	   aerobic	  
fitness	  across	  the	  human	  adult	   lifespan	  (Ainslie	  et	  al.,	  2008),	   resulting	   in	  enhanced	  grey	  
matter	  volume	  (Colcombe	  et	  al.,	  2006),	  improved	  NO	  bioavailability	  (Green	  et	  al.,	  2004a)	  
and	  cerebrovascular	  angiogenesis	  (Rhyu	  et	  al.,	  2010,	  Swain	  et	  al.,	  2003).	  	  
	  
Murrell	   et	   al.	   (2013)	   recently	   established	   that	   a	   12-­‐week	   aerobic	   exercise	   training	  
intervention	  resulted	  in	  an	  elevation	  in	  cerebrovascular	  reactivity	  to	  hypercapnia	  at	  rest	  
and	  during	   sub-­‐maximal	  exercise	   in	   young	  and	  old	   individuals.	   Importantly,	   this	   fitness-­‐
induced	  elevation	  in	  cerebrovascular	  reactivity	  was	  independent	  of	  age.	  This	  observation	  
may	   relate	   to	   improved	   resting	   MCAv,	   but	   when	   normalised	   for	   changes	   in	   blood	  
pressure,	   cerebrovascular	   conductance	   was	   unchanged	   (Murrell	   et	   al.,	   2013).	  
Furthermore,	  there	  was	  no	  effect	  of	  gender	  on	  the	  cerebrovascular	  reactivity	  response	  at	  
baseline	  or	  following	  exercise	  training	  across	  the	  adult	  lifespan	  (Murrell	  et	  al.,	  2013).	  
	  
In	   summary,	   there	  may	   be	   an	   oestrogen-­‐related	   increase	   in	   CBF	   during	   the	  menstrual	  
cycle,	   however	   despite	   increases	   in	   cerebrovascular	   reactivity	   and	   decreases	   to	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cerebrovascular	   resistance	   in	   the	   presence	   of	   elevated	   oestrogen	   no	   study	   to	   date	   has	  
reported	  oestrogen-­‐related	  increases	   in	  basal	  CBF	  per	  se.	  CBF	  declines	  with	  age	  but	  this	  
can	  be	  offset	  by	  both	  lifelong	  and	  short-­‐term	  (~12	  weeks)	  endurance	  exercise	  training	  in	  
individuals	  with	  or	  without	  cardiovascular	  disease	  i.e.	  stroke	  rehabilitation.	  	  
	  
2.5	  The	  Menopause	  
As	  females	  approach	  the	  menopause,	  menstruation	  becomes	  irregular	  and	  less	  frequent.	  
This	  portion	  of	  menstrual	  life	  is	  termed	  peri-­‐menopause,	  and	  is	  known	  as	  the	  menopausal	  
transition	  (Figure	  2.9).	   	  The	  peri-­‐menopause	  is	  associated	  with	  a	  gradual	  increase	  in	  FSH	  
that	  leads	  to	  irregular	  ovulation,	  lasting	  ~3-­‐5	  years	  with	  the	  lower	  limit	  of	  the	  menopausal	  
transition	   the	  onset	  of	   irregular	  menstruation	   that	  occurs	  at	  ~47	  years	  of	  age,	  with	   the	  
upper	   limit	   being	   the	   final	  menstrual	   period	   (McKinlay	   et	   al.,	   1992).	   The	  World	   Health	  
Organisation	  (WHO)	  defines	  the	  menopause	  as	  the	  permanent	  cessation	  of	  menstruation	  
resulting	   from	   loss	   of	   ovarian	   follicular	   activity	   (WHO,	   1996),	   that	   occurs	   between	   the	  
ages	  of	  45	  and	  55.	  Due	  to	  an	  increasing	  life	  expectancy	  females	  spend	  a	  larger	  portion	  of	  
their	   lifespan	   in	   the	   postmenopausal	   state.	   In	   2007,	   35	   million	   females	   in	   the	   United	  
States	  were	  postmenopausal	  with	  the	  number	  increasing	  at	  a	  rate	  of	  over	  a	  million	  each	  
year	  (Deecher	  and	  Dorries,	  2007),	  while	  the	  Office	  for	  National	  Statistics	  reported	  there	  
were	  ~5	  million	  females	  aged	  between	  45-­‐55	  in	  the	  UK	  in	  2011	  (ONS,	  2012).	  	  
	  
The	  menopause	  is	  characterised	  by	  a	  marked	  decrease	  in	  oestrogen	  production	  from	  the	  
ovaries	   that	  become	   insensitive	   to	  FSH,	  and	   results	   in	   the	   loss	  of	   reproductive	   function	  
and	  an	   increasing	   incidence	  of	  HFs	   (Figure	  2.9).	   It	  has	  become	  clearer	  over	   the	  past	  25	  
years	  that	  the	  ubiquitous	  presence	  of	  the	  oestrogen	  receptor	  in	  various	  body	  tissues	  and	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organ	   systems	   provides	   the	   substrate	   for	   oestrogenic	   regulation	   or	   the	   modulation	   of	  
multiple	   body	   functions	   (Yang	   et	   al.,	   1996).	   These	   hormonal	   changes	   affect	   the	  
thermoregulatory	   and	   cardiovascular	   systems	   in	   addition	   to	   the	   ageing	   processes	  
discussed	  previously.	  	  
	  
	  
Figure	   2.9.	   Relationship	   between	   oestrogen	   and	   reproductive	   phases.	   During	  
perimenopause,	   hormones	   fluctuate	   and	   become	   acyclic.	   During	   this	   period,	   many	  
females	   experience	   hot	   flushes;	   although	   severe	   the	   frequency	   is	   transient.	   During	   the	  
postmenopausal	  period,	  females	  can	  experience	  severe	  and	  persistent	  hot	  flushes	  due	  to	  
the	   declining	   levels	   of	   ovarian	   hormones.	   FMP	   final	   menstrual	   period	   (Deecher	   and	  
Dorries,	  2007).	  
	  
2.6	  Menopausal	  hot	  flushes	  
HFs,	   also	   known	   collectively	   as	   hot	   flashes	   or	   vasomotor	   symptoms,	   are	   a	   primary	  
symptom	  of	  the	  menopause	  that	  can	  seriously	  disrupt	  the	   lives	  of	  symptomatic	  females	  
(Kronenberg,	  1990,	  Freedman,	  2001).	  A	  HF	  is	  the	  subjective	  sudden	  sensation	  of	  heat	  that	  
is	  associated	  with	  objective	  signs	  of	   rapid	   increases	   in	  cutaneous	  vasodilation,	   sweating	  
and	   flushing	   that	   generally	   begin	   in	   the	   chest	   and	   radiate	   to	   the	   face,	   head	   and	   arms	  




Symptomatic	   females	   also	   report	   a	   range	   of	   additional	   symptoms	   such	   as	   anxiety,	  
embarrassment,	  depression,	  frustration	  and	  nausea	  (Freedman,	  2005,	  Freedman,	  2014a,	  
Dormire,	  2003).	  HF	  frequency	  and	  severity	  is	  individualised,	  with	  some	  females	  suffering	  
in	   excess	   of	   30	   daily	   severe	   flushes,	   while	   HFs	   are	   even	   higher	   in	   females	   following	  
surgically-­‐induced	  menopause	  and	  in	  female	  oncology	  patients	  (Bachmann,	  1999,	  Gupta	  
et	  al.,	  2006,	  Carpenter	  et	  al.,	  2002).	  In	  addition,	  HFs	  can	  decrease	  quality	  of	  life	  by	  having	  
adverse	  effects	  on	  concentration,	  quality	  of	  sleep,	  mood	  and	  sexual	  function	  resulting	  in	  
chronic	   fatigue	   and	   elevated	   stress	   levels	   (Kronenberg,	   1990,	   Daly	   et	   al.,	   1993,	   Katz-­‐
Bearnot,	  2010).	  	  
	  
HF	   prevalence	   among	  naturally	  menopausal	   females	   has	   been	   reported	   to	   be	   between	  
60-­‐82%	   in	   the	  United	   States	   and	   Australia	   (Feldman	   et	   al.,	   1985,	   Guthrie	   et	   al.,	   1996).	  
Kronenberg	  et	  al.	  (1990)	  reported	  ~70%	  of	  females	  experience	  HFs	  for	  the	  first	  1-­‐5	  years	  
after	   the	   onset	   of	   the	   menopausal	   transition,	   with	   10-­‐20%	   of	   symptomatic	   females	  
finding	   them	   intolerable.	   Importantly,	   HFs	   can	   persist	   for	   ~15	   years	   in	   20%	   of	   females	  
(Kronenberg,	  1994).	  In	  the	  UK,	  there	  are	  currently	  over	  10	  million	  females	  over	  the	  age	  of	  
50	  (ONS,	  2014),	  thus	  over	  7	  million	  females	  in	  the	  UK	  today	  may	  have	  had,	  or	  currently	  be	  
suffering	  from	  HFs	  that	  effect	  overall	  quality	  of	  life	  in	  this	  population.	  
2.6.1.	  Thermoregulatory	  dysfunction	  and	  hot	  flushes	  
The	  precise	  mechanisms	  underlying	  the	  pathophysiology	  of	  HFs	  are	  unclear;	  however	  it	  is	  
well	   acknowledged	   that	   they	   are	   a	   result	   of	   central	   temperature	   dysfunction	   (Deecher	  
and	   Dorries,	   2007,	   Freedman,	   2001,	   Stearns	   et	   al.,	   2002).	   It	   is	   suggested	   that	   the	  
menopausal	   reduction	   in	   oestrogen	   lowers	   the	   upper	   threshold	   of	   the	   thermo-­‐neutral	  
zone	  in	  symptomatic	  females,	  with	  Freedman	  et	  al.	  (1999)	  reporting	  the	  thermo-­‐neutral	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zone	   to	   be	   0.0°C	   in	   symptomatic	   females	   compared	   to	   0.4°C	   in	   asymptomatic	   females.	  
Thus,	   it	   is	   suggested	   that	  HFs	   are	   triggered	   by	   small	   core	   body	   temperature	   elevations	  
acting	  within	  a	  greatly	  narrowed	   thermo-­‐neutral	   zone	   (Freedman,	  2001).	  This	   is	   further	  
acknowledged	  by	  the	  fact	  that	  peripheral	  warming	  is	  used	  to	  provoke	  HFs,	  thus	  HFs	  may	  
be	   triggered	   when	   core	   body	   temperature	   exceeds	   a	   narrowed	   sweating	   threshold	  
(Kronenberg	   et	   al.,	   1984,	   Low	   et	   al.,	   2010,	   Low	   et	   al.,	   2008a,	   Freedman	   et	   al.,	   1995)	  
(Figure	  2.10).	  
	  
A	   narrowing	  of	   the	   thermo-­‐neutral	   zone	  due	   to	   increased	   sympathetic	   nervous	   activity	  
with	  the	  menopause	  has	  been	  suggested	  (Figure	  2.10)	   (Freedman,	  2014a),	  while	  Low	  et	  
al.	  (2010)	  reported	  acute	  increases	  in	  sympathetic	  neural	  activity	  to	  the	  skin	  during	  a	  HF,	  
which	   subsequently	   returned	   to	   baseline	   after	   HF	   cessation.	   Furthermore,	   HFs	   were	  
severely	   attenuated	   under	   local	   sympathetic	   cholinergic	   nerve	   blockade	   supporting	   the	  
conclusion	   that	   cutaneous	   vasodilation	   during	   a	   HF	   is	   neurally	   mediated	   (Low	   et	   al.,	  
2010).	  Alongside	   this,	  Hubing	  et	  al.	   (2010)	   reported	   that	  NO,	  but	  not	  prostaglandins,	   is	  
involved	   in	   active	   cutaneous	   vasodilation	   during	   a	   HF.	   Whether	   the	   effect	   of	   NO	   is	  
neuronally	  released,	  acetylcholine-­‐induced	  or	  shear	  rate	  mediated	  is	  currently	  unknown.	  
Additionally,	   NO	   or	   prostaglandin	   inhibition	   had	   no	   effect	   on	   sweat	   rate	   during	   HFs,	  
however	   sweat	   rate	   during	   moderate	   heat	   stress	   is	   also	   unaffected	   by	   NO	   inhibition	  























Alternatively,	  HFs	  are	  suggested	  to	  relate	  to	  neuroendocrine	  mechanisms	  (de	  Boer	  et	  al.,	  
2009),	  specifically	  increases	  in	  luteinising	  hormone	  (LH)	  pulses	  (Tataryn	  et	  al.,	  1979),	  and	  
to	  the	  hypothalamic	  neural	  circuitry	  controlling	  pulsatile	  gonadotropin-­‐releasing	  hormone	  
(GnRH)	   secretion	   (Casper	   et	   al.,	   1979,	   Freedman,	   2014a).	   HFs	   were	   reduced	   by	   ~30%	  
following	  LH	  receptor-­‐agonist	  treatment	  (van	  Gastel	  et	  al.,	  2012)	  however,	   the	  effect	  of	  
LH	  is	  inconsistent	  as	  females	  with	  no	  LH	  pulses	  due	  to	  gonadotropin	  deficiency	  (Gambone	  
et	  al.,	  1984)	  or	  females	  who	  are	  hypophysectomised	  (pituitary	  gland	  removal)	  (Mulley	  et	  
al.,	   1977)	   still	   report	   HFs.	   Recently,	   it	   has	   been	   hypothesised	   that	   marked	   changes	   in	  
hypothalamic	  kisspeptin	  neurokinin-­‐B	  and	  dynorphin	  (KNDy)	  neurons	  play	  a	  role	  in	  HFs,	  as	  
	  
	  
Figure	  2.10	  Maintenance	  of	  core	  body	  temperature	  (CBT).	  It	  has	  been	  hypothesised	  
that	   CBT	   is	   regulated	   between	   an	   upper	   threshold	   for	   sweating	   and	   a	   lower	  
threshold	   for	   shivering.	   Within	   the	   thermoneutral	   zone,	   major	   thermoregulatory	  
responses	   do	   not	   occur.	   These	   mechanisms	   maintain	   CBT	   within	   the	   designated	  
thresholds.	   A,	   normal	   temperature	   regulation;	   B,	   dysfunctional	   temperature	  





they	  relay	  oestrogen	  signals	  to	  preoptic	  structures	  regulating	  heat	  peripheral	  vasodilation	  
(Rance	  et	  al.,	  2013,	  Mittelman-­‐Smith	  et	  al.,	  2012).	  
	  
It	   is	  also	  postulated	  that	  disturbances	  to	  reflex	  and/or	   local	  cutaneous	  vasodilation	  may	  
contribute	   to	   temperature	   dysfunction,	   and	   subsequently	   HFs,	   as	   changes	   in	   vascular	  
reactivity	   may	   interfere	   with	   the	   ability	   of	   the	   blood	   vessels	   to	   respond	   rapidly	   to	  
temperature	   changes,	   resulting	   in	   exaggerated	   responses	   and	  HFs	   (Charkoudian,	   2003).	  
This	   is	   supported	   by	   low	   levels	   of	   estradiol	   post-­‐menopause,	   contributing	   to	   reduced	  
elasticity	   of	   the	   blood	   vessels	   that	  may	   result	   in	   dysfunctional	   responses	   to	   changes	   in	  
core	  temperature	  (Joswig	  et	  al.,	  1999,	  Holowatz	  et	  al.,	  2010).	  
2.6.2	  Physiological	  changes	  during	  a	  hot	  flush	  	  
Elevated	   skin	   temperature	   and	   skin	   blood	   flow	   cause	   a	   rapid	   increase	   in	   peripheral	  
cutaneous	  vasodilation	  during	  a	  HF	  (Kronenberg	  et	  al.,	  1984,	  Freedman,	  1998,	  Low	  et	  al.,	  
2010).	  This	  is	  followed	  by	  an	  increase	  in	  sweating	  in	  ~90%	  of	  females	  who	  suffer	  from	  HFs	  
(Freedman,	   1998,	   Low	   et	   al.,	   2010)	   (Figure	   2.11).	   Freedman	   et	   al.	   (1995)	   found	   small	  
elevations	   (~0.04ºC)	   in	  core	  temperature	  ~30	  mins	  prior	   to	  recorded	  HFs	  and	  replicated	  
these	   findings	   in	   two	   subsequent	   studies	   (Freedman,	   1998,	   Freedman	   and	  Krell,	   1999).	  
However,	  possible	  explanations	   for	   the	   increases	   in	   core	   temperature	  prior	   to	  a	  HF	  are	  
limited,	   with	   increases	   in	   metabolic	   rate	   (heat	   production)	   and/or	   peripheral	  
vasoconstriction	   (decreased	   heat	   loss)	   currently	   unfounded	   (Freedman,	   2014a).	  
Furthermore,	   small	   variations	   in	   mean	   core	   temperature	   are	   not	   different	   between	  
symptomatic	  and	  asymptomatic	  post-­‐menopausal	  females	  (Freedman,	  2002).	  HFs	  induce	  
modest	  increases	  in	  ventilation	  and	  heart	  rate	  by	  approximately	  10-­‐15	  beats	  per	  minute	  
(Freedman,	  1989,	   Low	  et	  al.,	   2008a)	  and	   induce	   short-­‐term	   reductions	   in	  arterial	  blood	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pressure	   in	   many	   symptomatic	   females	   (Low	   et	   al.,	   2008a).	   Recently,	   it	   was	   also	  
demonstrated	  that	  ~76%	  of	  HFs	  are	  accompanied	  by	  a	  significant	  reduction	  CBF,	  that	  are	  
not	  related	  to	  the	  observed	  drop	  in	  arterial	  blood	  pressure	  (Lucas	  et	  al.,	  2013).	  These	  data	  
indicate	   that	   a	  HF	   can	  present	   a	   significant	  physiological	   challenge	   to	  brain	  blood	   flow,	  
and	  that	  feeling	  of	  faintness	  and	  nausea	  during	  a	  HF	  may	  be	  associated	  with	  these	  short-­‐
term	  reductions	  (Dormire,	  2003,	  Lucas	  et	  al.,	  2013).	  	  
	  
In	  summary,	  the	  mechanisms	  of	  HFs	  are	  still	  unclear;	  but	  are	  primarily	  a	  consequence	  of	  
reductions	   in	   oestrogen	  during	   the	  menopause	   that	   is	   known	   to	   have	  direct	   effects	   on	  
thermoregulatory	   control	   mechanisms,	   the	   sympathetic	   nervous	   system	   and	   vascular	  
function	   (Figure	   2.12),	   while	   prior	   elevations	   in	   core	   body	   temperature	   alongside	  
cutaneous	  vasodilation	  and	  sweating	  during	  a	  HF	  coincide	  with	   reduced	  blood	  pressure	  
and	   brain	   blood	   flow	   during	   a	   HF	   per	   se.	   	   A	   treatment	   targeting	   these	   systems	   may	  
potentially	  alleviate	  HFs	  (see	  HF	  treatment	  2.7).	  
	  









Figure	  2.11	  Changes	  during	  a	  hot	  flush	  in	  (A)	  forearm	  cutaneous	  vascular	  conductance	  


























2.6.2.1	  Hot	  flushes	  and	  cardiovascular	  risk	  
Cardiovascular	  disease	   risk	   largely	   increases	   following	   the	  menopause	  due	   to	  oestrogen	  
reduction	  (van	  der	  Schouw	  et	  al.,	  1996,	  Ossewaarde	  et	  al.,	  2005,	  Zaydun	  et	  al.,	  2006).	  The	  
menopause	   is	   accompanied	   by	   unfavourable	   levels	   of	   cardiovascular	   risk	   factors,	  
including	   increases	   to	   low-­‐density	   lipoproteins,	   blood	   pressure	   (Zaydun	   et	   al.,	   2006,	  
Zanchetti	  et	  al.,	  2005),	  visceral	  adipose	  tissue	  and	  body	  mass	  index	  profiles	  (Akahoshi	  et	  
al.,	  1996,	  Casiglia	  et	  al.,	  2002).	  	  
	  
HFs	   are	   viewed	   primarily	   as	   a	   symptom	   of	   quality	   of	   life	   but	   little	   attention	   has	   been	  
focussed	  on	  the	  clinical	  implications	  of	  females	  that	  suffer	  from	  HFs.	  However,	  emerging	  
research	   suggests	   underlying	   vascular	   changes	   amongst	   females	   who	   suffer	   from	   HFs,	  
with	  the	  Women’s	  Health	  Initiative	  (WHI)	  indicating	  that	  coronary	  heart	  disease	  diagnosis	  
was	   concentrated	   among	   post-­‐menopausal	   females	   reporting	   HF	   symptoms	   at	   study	  
	  
Figure	  2.12	  Diagram	  summarising	  the	  potential	  physiological	  mechanisms	  causing	  hot	  flushes	  
48	  
	  
baseline	  (Rossouw	  et	  al.,	  2007).	  Furthermore,	  females	  with	  HFs	  have	  reduced	  endothelial-­‐
dependent	  vasodilation	  and	  greater	  aortic	  calcification	  (Thurston	  et	  al.,	  2008b)	  that	  have	  
been	   prospectively	   linked	   to	   increased	   cardiovascular	   disease	   morbidity	   and	   mortality	  
(Yeboah	   et	   al.,	   2007,	   Widlansky	   et	   al.,	   2003,	   Greenland	   et	   al.,	   2004).	   Additionally,	  
increased	   vascular	   inflammation	   has	   been	   linked	   to	   HF	   severity,	   indicating	   increased	  
atherosclerotic	  risk	  in	  this	  symptomatic	  group	  (Bechlioulis	  et	  al.,	  2012).	  This	  suggests	  HFs	  
may	   be	   a	   marker	   of	   adverse	   vascular	   changes	   and	   that	   the	   vasculature	   may	   play	   an	  
important	  role	  in	  the	  physiology	  of	  HFs	  (Thurston	  et	  al.,	  2008b).	  Endothelial	  dysfunction	  
was	  found	  to	  be	  the	  main	  determinant	  of	  HF	  severity	   in	  early	  post-­‐menopausal	   females	  
(Bechlioulis	   et	   al.,	   2010).	   This	   supports	   the	   potential	   role	   of	   HFs	   in	   cardiovascular	   risk	  
prognosis,	  whilst	   it	   is	   unknown	   if	   the	   targeted	   alleviation	   of	  HF	   severity	   coincides	  with	  
reductions	  in	  cardiovascular	  risk	  factors.	  
2.7	  Hormone	  Replacement	  Therapy	  
Due	   to	   the	   causal	   association	   between	   HFs	   and	   oestrogen	   depletion,	   hormone	  
replacement	  therapy	  (HRT),	  which	  involves	  exogenous	  administration	  of	  oestrogen,	  with	  
or	  without	  progesterone,	   is	  the	  first	   line	  of	  treatment	  for	  HFs.	  HRT	  can	  be	  administered	  
orally,	   intravaginally	  or	  transdermally	  (Stearns	  et	  al.,	  2002).	   In	   large,	  randomised	  clinical	  
trials	   HRT	   decreased	   HFs	   by	   50-­‐100%	   in	   post-­‐menopausal	   females	   (McNagny,	   1999,	  
Maclennan	  et	  al.,	  2004,	  Utian	  et	  al.,	  2004).	  	  
	  
Despite	   the	   benefits	   of	   HRT	   in	   reducing	   HFs,	   the	   prescription	   rates	   of	   HRT	   have	  
plummeted	  in	  recent	  years	  (Isaacs	  et	  al.,	  2005,	  Townsend	  and	  Nanchahal,	  2005,	  Hersh	  et	  
al.,	  2004)	  and	  by	  ~50%	  in	  the	  UK	  since	  2002	  (Watson	  et	  al.,	  2007).	  This	  is	  due	  primarily	  to	  
the	   results	  of	   the	  WHI	   (Rossouw	  et	  al.,	  2002)	  and	  other	  clinical	   trials	   (Sare	  et	  al.,	  2008,	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Archer	   and	   Oger,	   2012,	  Manson	   et	   al.,	   2003)	   which	   reported	   increased	   risk	   of	   several	  
vascular	  outcomes	  including	  myocardial	  infarction,	  stroke	  and	  venous	  thromboembolism.	  
Furthermore,	   an	   increased	   risk	   of	   hormone-­‐dependent	   cancer	   is	   associated	   with	   HRT	  
(Holmberg	   et	   al.,	   2008,	  Manson,	   2014,	   Hou	   et	   al.,	   2013,	   Beral,	   2003,	   Tworoger	   et	   al.,	  
2005).	  HRT	  treatment	   is	  also	   limited	  by	   time	  since	  menopause	   (Hage	  and	  Oparil,	  2013),	  
whilst	   females	   with	   a	   prior	   history	   of	   cardiovascular	   disease	   or	   cancer	   are	   not	  
recommended	   to	   use	   HRT	   (NICE,	   2009),	   as	   a	   result	   females	   are	   declining	   HRT	   or	   not	  
visiting	  their	  G.P.	   for	   treatment	  because	  of	   the	  associated	  risk	  of	  cardiovascular	  disease	  
and	   cancer	   (Rossouw	   et	   al.,	   2002,	   Luo	   et	   al.,	   2013).	   As	   such,	   symptomatic	   females	   are	  
attempting	  to	  live	  everyday	  life	  with	  these	  debilitating	  symptoms	  with	  little	  help	  because	  
of	  a	  lack	  of	  therapeutic	  alternatives.	  	  
	  
The	  administration	  of	  HRT	  is	  known	  to	  affect	  body	  temperature	  control.	  	  The	  exogenous	  
administration	   of	   oestrogen	   reduces	   basal	   core	   body	   temperature	   and	   in	   response	   to	  
heat	  stress	  in	  some,	  but	  not	  all,	  post-­‐menopausal	  females	  (Brooks	  et	  al.,	  1997,	  Freedman	  
and	   Blacker,	   2002,	   Cagnacci	   et	   al.,	   1992).	   Freedman	   and	   Blacker	   (2002)	   further	  
investigated	   the	   mechanism	   by	   which	   oestrogen	   effects	   temperature	   control	   and	   HFs,	  
with	   symptomatic	   post-­‐menopausal	   females	   receiving	   either	   1mg·∙day	   17β-­‐estradiol	   or	  
placebo	   for	   3	   months.	   The	   sweating	   threshold	   was	   significantly	   elevated	   alongside	  
reductions	  in	  HF	  frequency	  following	  17β-­‐estradiol,	  compared	  to	  placebo	  (Freedman	  and	  
Blacker,	   2002).	   Dacks	   and	   Rance	   (2010)	   established	   that	   ovariectomised	   rats	   without	  
estradiol	   treatment	  exhibited	  a	   shift	  of	   the	   thermo-­‐neutral	   zone	   to	   lower	   temperatures	  
and	  an	  elevated	  skin	  vasodilation.	  Conversely,	  an	  estradiol-­‐induced	  shift	   in	   the	   thermo-­‐
neutral	   zone	   resulted	   in	   a	   delayed	   threshold	   for	   skin	   vasodilation,	   whilst	   core	   body	  
temperature	   was	   lowered	   when	   exposed	   to	   high	   ambient	   temperatures	   following	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estradiol	  treatment	  compared	  to	  ovariectomised	  rats	  receiving	  no	  treatment	  (Dacks	  and	  
Rance,	  2010).	  	  Thus,	  in	  both	  animal	  and	  human	  studies,	  the	  exogenous	  administration	  of	  
oestrogen	   following	   menopause	   directly	   effects	   core	   body	   temperature	   and	   heat	   loss	  
responses	   involved	   in	   the	   control	   of	   core	   body	   temperature,	   although	   the	   precise	  
mechanisms	  responsible	  for	  this	  are	  not	  yet	  understood.	  Interventions,	  such	  as	  HRT,	  may	  
ameliorate	  HFs	  through	  improvements	  in	  this	  control	  system.	  
	  
2.8	  Exercise	  training	  and	  hot	  flushes	  
Based	   on	   the	   evidence	   that	   menopausal-­‐aged	   females	   have	   low	   participation	   rates	   in	  
exercise	  (Daley	  et	  al.,	  2009)	  and	  severe	  menopausal	  symptoms	  correlate	  with	  lower	  levels	  
of	  physical	  activity	   (Gold	  et	  al.,	  2000,	  Wilbur	  et	  al.,	  2005,	   Ivarsson	  et	  al.,	  1998,	  Karacan,	  
2010),	   recent	   research	   studies	   have	   begun	   to	   investigate	   the	   feasibility	   of	   exercise	  
training	   as	   a	   non-­‐pharmacological	   alternative	   to	   HRT.	   Several	   longitudinal	   studies	   have	  
reported	  HFs	   to	  be	  more	   common	   in	   females	   reporting	   lower	   levels	  of	  physical	   activity	  
(Gold	   et	   al.,	   2000,	   Di	   Donato	   et	   al.,	   2005,	   Ivarsson	   et	   al.,	   1998),	   conversely,	   habitual	  
physical	   activity	   has	   been	   reported	   to	   have	   no	   effect	   on	   HFs	   (Sternfeld	   et	   al.,	   1999,	  
Mirzaiinjmabadi	  et	  al.,	  2006).	  However,	  comparisons	  between	  studies	  are	  difficult	  due	  to	  
differences	   in	   definitions	   of	   physical	   activity	   and/or	   exercise	   history	   in	   these	   female	  
cohorts.	  	  
	  
A	  Cochrane	  Review	  on	  the	  evidence	  for	  the	  effect	  of	  exercise	  training	  on	  HFs	  conducted	  in	  
2009	   was	   inconclusive	   primarily	   due	   to	   the	   lack	   of	   robust	   studies	   (n=6)	   (Daley	   et	   al.,	  
2009).	   More	   recently,	   randomised	   control	   trials	   have	   reported	   a	   reduction	   in	   HF	  
symptoms	   (Moilanen	   et	   al.,	   2012,	   Luoto	   et	   al.,	   2012,	   Karacan,	   2010,	   Reed	   et	   al.,	   2014,	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Lindh-­‐Astrand	  et	  al.,	  2004),	  or	  no	  effect	   (Wilbur	  et	  al.,	  2005,	  Sternfeld	  et	  al.,	  2014).	  Six-­‐
months	  of	  unsupervised	  aerobic	  exercise	  (~60%	  HRmax),	   that	  consisted	  predominantly	  of	  
walking	  and/or	  aerobics	  reported	  via	  participant	  diary-­‐logs	  improved	  the	  number	  of	  self-­‐
reported	  HFs,	  alongside	  improvements	  to	  mood	  and	  sleep	  quality	  compared	  to	  a	  control	  
condition	   receiving	   lifestyle	   advice	   (Mansikkamaki	   et	   al.,	   2012,	   Luoto	   et	   al.,	   2012,	  
Moilanen	  et	  al.,	  2012).	  However	  only	  a	  single	  study	  reported	  physiological	   responses	  to	  
exercise	  training,	  with	  little	  differences	  observed	  in	  both	  aerobic	  fitness	  (Pre	  exercise	  31.0	  
vs.	  32.5	  ml-­‐1.kg.min-­‐1	  post	  exercise)	  and	  fat-­‐free	  mass	  following	  the	  exercise	  intervention	  
(Luoto	  et	  al.,	  2012).	   	  Conversely,	  Sternfeld	  et	  al.	   (2014)	   reported	  short-­‐term	  (12	  weeks)	  
supervised	  exercise	   training	   (3	   sessions	  per	  week	   at	   ~50-­‐70%	  HRR)	  did	  not	   significantly	  
reduce	  HF	  frequency	  in	  peri-­‐	  and	  post-­‐menopausal	  females	  compared	  to	  a	  control	  group	  
that	  maintained	  their	  usual	  activity,	  but	  did	  improve	  depression	  symptoms,	  sleep	  quality	  
and	   insomnia	   following	   exercise	   training.	   However	   no	   differences	   were	   observed	   in	  
pedometer	   steps	   or	   BMI	   along	   with	   no	   direct	   measure	   of	   cardiorespiratory	   fitness	  
following	  the	  exercise	  training	  study	  compared	  to	  control,	  making	  it	  difficult	  to	  elucidate	  
any	  physiological	  adaptations	  from	  the	  exercise	  intervention.	  	  
	  
Significantly,	  no	  study	  to	  date	  has	  investigated	  the	  effect	  of	  exercise	  training	  on	  objective	  
measures	   of	   HFs,	   or	   the	   potential	   mechanisms	   responsible	   for	   how	   exercise-­‐mediated	  
changes	   in	   thermoregulatory	   and/or	   cardiovascular	   control	   might	   reduce	   HFs	   in	  
symptomatic	  post-­‐menopausal	  females.	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2.8.1	  Exercise	  training	  and	  thermoregulatory	  control	  in	  post-­‐menopausal	  females	  
It	   is	   well	   known	   that	   HFs	   are	   a	   consequence	   of	   severe	   temperature	   dysfunction,	   with	  
elevated	  basal	   core	   temperature	  and	  a	  narrowed	   thermo-­‐neutral	   zone	   suggested	   to	  be	  
primary	   explanations	   (see	   2.6.1	   thermoregulatory	   dysfunction	   and	   hot	   flushes).	  
Therefore,	  the	  thermoregulatory	  system	  may	  be	  a	  useful	  target	  in	  alleviating	  HFs	  in	  post-­‐
menopausal	   females	   using	   aerobic	   exercise	   training	   that	   targets	   central	   and	   peripheral	  
thermoregulatory	   adaptations.	   Studies	   investigating	   thermoregulatory	   control	  
mechanisms	   i.e.	   core	   body	   temperature	   thresholds	   for	   cutaneous	   vasodilation	   and	  
sweating	  in	  post-­‐menopausal	  females	  do	  not	  currently	  exist	  without	  prior	  intervention	  at	  
baseline	   i.e.	   HRT	   (Freedman	   and	   Blacker,	   2002,	   Freedman	   and	   Dinsay,	   2000),	   nor	  
following	  a	  period	  of	  exercise	  training.	  The	  literature	  has	  established	  a	  body	  of	  evidence	  
for	  a	  blunted	  effect	  of	  sweating	  and	  cutaneous	  vasodilation	   in	  older	   females	   (~65	  years	  
old;	   see	   2.2.6	   ageing	   and	   temperature	   control),	   however	   the	   direct	   effect	   of	   the	  
menopause	  on	  temperature	  control	   is	  difficult	  to	  elucidate	  as	  the	  studies	  do	  not	  specify	  
about	   precise	   menopausal	   status.	   A	   study	   investigating	   the	   temperature	   thresholds	   in	  
early	   post-­‐menopausal	   females	  when	  HF	   symptoms	   are	  most	   commonly	   reported,	   and	  
the	  effects	  of	  ageing	  are	  less	  prominent,	  is	  warranted.	  
	  
Currently,	  the	  research	  evidence	  suggests	  improvements	  in	  thermoregulatory	  control	  via	  
exercise	   training	   in	   post-­‐menopausal	   females	  may	   be	   linked	   to	   changes	   in	   sympathetic	  
nerve	   activity	   and/or	   the	   responses	   of	   the	   peripheral	   vasculature	   to	   exercise	   training.	  
Sympathetic	   nerve	   outflow	   has	   been	   shown	   to	   increase	   following	   the	   menopause	  
(Freedman,	  2014b,	  Hart	  et	  al.,	  2011)	  and	  during	  HFs	  (Low	  et	  al.,	  2010)	  and	  is	  suggested	  to	  
affect	   the	   thermoregulatory	   and	   vascular	   control	   systems	   (Charkoudian	   and	   Wallin,	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2011).	  However,	   sympathetic	   outflow	   is	   reduced	   in	   post-­‐menopausal	   females	   following	  
an	  acute	  cycling	  exercise	  bout	   (45	  min	  at	  50%	  VO2peak)	   (Oneda	  et	  al.,	  2008)	  and	  chronic	  
aerobic	   exercise	   training	   (Oneda	   et	   al.,	   2014)	   that	   may	   have	   direct	   effects	   on	  
thermoregulatory	  and	  cardiovascular	  function	  in	  this	  population.	  	  
	  
Oneda	   et	   al.	   (2014)	   reported	   an	   increase	   in	   forearm	   blood	   flow	   following	   12-­‐weeks	   of	  
moderate	  intensity	  exercise	  training	  (HR	  at	  ~anaerobic	  cycling	  threshold)	  in	  healthy	  post-­‐
menopausal	   females	   compared	   to	   a	   no-­‐exercise	   control	   group.	   Maximal	   cutaneous	  
vasodilation	   and	   microvascular	   reactivity	   were	   enhanced	   after	   24	   weeks	   of	   moderate	  
intensity	   exercise	   (~45-­‐70%	   HRR)	   in	   post-­‐menopausal	   females	   with	   improvements	  
correlating	   to	   aerobic	   fitness	   (Tew	   et	   al.,	   2012a,	  Hodges	   et	   al.,	   2010),	   highlighting	   that	  
vasodilatory	   responses	   of	   the	   cutaneous	   vasculature	   to	   exercise	   training	   is	   not	   lost	   in	  
post-­‐menopausal	   females,	   suggesting	   the	   training	   effects	   on	   endothelial	   function	   are	  
potent,	  and	  not	  blunted	  by	  the	  absence	  of	  oestrogen	  or	  ageing	  (Oneda	  et	  al.,	  2014).	  Post-­‐
menopausal	  females	  with	  a	  history	  of	  exercise	  training	  exhibited	  similar	  basal	  core	  body	  
temperatures	   and	   sweat	   rate	   thresholds	   and	   sensitivities	   to	   pre-­‐menopausal	   females	  
during	   both	   exercise-­‐induced	   and	   passive	   heat	   stress	   (Kenney	   and	   Anderson,	   1988,	  
Drinkwater	   et	   al.,	   1982),	   but	   sweat	   rate	   sensitivities	   are	   blunted	   in	   both	   pre	   and	   post-­‐
menopausal	  cohorts	  that	  demonstrated	  sedentary	  lifestyles	  	  (Drinkwater	  et	  al.,	  1982).	  	  
	  
2.8.2	  Exercise	  training	  and	  conduit	  function	  in	  post-­‐menopausal	  females	  
A	  reduced	  brachial	  artery	  FMD	  in	  early	  and	  late	  menopausal	  females	  is	  common	  (Moreau	  
et	   al.,	   2012).	   This	   is	   primarily	   due	   to	   the	   loss	   of	   protective	   effects	   of	   oestrogen	  on	   the	  
vascular	  endothelium	  in	  post-­‐menopausal	  females	  (Nyberg	  et	  al.,	  2014,	  Celermajer	  et	  al.,	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1994)	   (see	   2.3	   conduit	   artery	   function).	   However,	   distinguishing	   reduced	   function	   as	   a	  
consequence	  of	  the	  menopause	  and/or	  ageing	  is	  difficult.	  
	  
Interestingly,	  a	  recent	  study	  investigated	  the	  effects	  of	  exercise	  training	  on	  pre-­‐	  and	  post-­‐
menopausal	  females	  that	  were	  only	  separated	  by	  ~5	  years,	  reducing	  the	  effect	  of	  ageing	  
on	  the	  vasculature	  (Nyberg	  et	  al.,	  2014).	  At	  baseline,	  post-­‐menopausal	  females	  had	  higher	  
levels	  of	  vascular	  inflammatory	  markers	  that	  were	  indicative	  of	  vascular	  dysfunction	  and	  
early-­‐stage	  atherosclerosis;	  however	  12-­‐weeks	  of	  exercise	  training	  (Indoor	  hockey,	  30min	  
twice	  per	  week	  characterised	  by	  4-­‐6	  min	  >85%	  HRmax	  separated	  by	  1-­‐3	  mins	  of	  recovery)	  
improved	  biomarkers	  of	  vascular	  function	  and	  cardiovascular	  disease	  risk	  profiles	  in	  both	  
pre-­‐	   and	   post-­‐menopausal	   females	   (Nyberg	   et	   al.,	   2014).	   The	   exercise	   training-­‐induced	  
reduction	   in	   markers	   of	   vascular	   inflammation	   suggests	   that	   improved	   function	   and	  
integrity	  of	  the	  vasculature	  is	  possible	  even	  in	  the	  absence	  of	  oestrogen.	  
	  
However,	  unsupervised	  moderate	  intensity	  exercise	  training	  in	  post-­‐menopausal	  females	  
had	   no	   effect	   on	   brachial	   artery	   FMD	   compared	   to	   age-­‐matched	   men	   and	   pre-­‐
menopausal	   females	   (Pierce	   et	   al.,	   2011,	  Moreau	   et	   al.,	   2013),	  whilst	   post-­‐menopausal	  
females	   receiving	   exogenous	   oestrogen	   treatment	   and	   exercise	   training	   improved	   FMD	  
(Moreau	   et	   al.,	   2013).	   The	   authors	   suggested	   that	   the	   lack	   of	   vascular	   improvement	   in	  
oestrogen-­‐deficient	   post-­‐menopausal	   females	   was	   due	   to	   increases	   in	   oxidative	   stress	  
that	  had	  a	  direct	  influence	  on	  endothelial	  function	  and	  potentially	  outweighed	  the	  effect	  
of	  exercise	  training.	  The	  explanation	  for	  unresponsive	  conduit	  vessels	  following	  exercise	  
training	   in	   post-­‐menopausal	   females	   is	   unknown,	   but	  may	   be	   due	   to	   reductions	   in	   NO	  




However,	  acute	  exercise	  (~60%	  VO2max	  for	  60	  minutes)	  increased	  brachial	  artery	  FMD	  in	  
post-­‐menopausal	   females	   to	   pre-­‐menopausal	   levels	   60	   minutes	   following	   the	   exercise	  
bout,	   and	   was	   proposed	   to	   be	   due	   to	   exercise-­‐induced	   increases	   in	   NO	   bioavailability	  
(Harvey	   et	   al.,	   2005),	   while	   the	   level	   of	   immediate	   endothelial	   dysfunction	   induced	   by	  
exercise	   may	   also	   play	   a	   role	   in	   the	   functional	   adaptation	   of	   that	   artery	   (Goto	   et	   al.,	  
2003).	  On	  this	  evidence,	  there	  is	  the	  potential	  to	  suggest	  that	  brachial	  artery	  dysfunction	  
may	  be	  immediately	  reduced	  in	  post-­‐menopausal	  females	  following	  exercise	  training	  but	  
is	   intensity	  and	  duration-­‐dependent,	  as	  currently	  only	  predominantly	  self-­‐paced	  walking	  
exercise	   has	   been	   used	   lasting	   ~40	  minutes	   (Moreau	   et	   al.,	   2013,	   Pierce	   et	   al.,	   2011).	  
Kretzchmar	  et	  al.	  (2014)	  also	  revealed	  that	  mild-­‐intensity	  exercise	  training	  (~50%	  VO2max)	  
improved	   LDL	   and	   early	   stage	   endothelial-­‐dysfunction	   markers	   (CD62E+	   endothelial	  
microparticles)	  in	  post-­‐menopausal	  females	  (Kretzschmar	  et	  al.,	  2014).	  The	  usefulness	  of	  
exercise	   training	   to	   offset	   menopause	   induced	   changes	   in	   vascular	   function	   warrants	  
further	  exploration.	  Furthermore,	  the	  ability	  of	  the	  conduit	  vessels	  to	  dilate	  may	  improve	  
the	  distribution	  of	  blood	  flow	  during	  heat	  stress	  and	  enhance	  thermoregulatory	  control.	  
2.8.3	  Exercise	  training	  and	  cerebral	  blood	  flow	  in	  post-­‐menopausal	  females	  
The	  effect	  of	   exercise	   training	  on	  CBF	   in	   symptomatic	  post-­‐menopausal	   females	   at	   rest	  
and	  during	  passive	  heat	  stress	  is	  unknown.	  Although	  previous	  research	  has	  incorporated	  
post-­‐menopausal	   females	   into	   study	   design	   and	   suggests	   improved	   CBF	   during	   and	  
following	   exercise	   training	   (Murrell	   et	   al.,	   2013)	   (see	   2.3.2	   ageing	   and	   cerebral	   blood	  
flow),	   gender	   and/or	   menopause-­‐related	   differences	   in	   CBF	   in	   response	   to	   exercise	  
training	  were	  not	   reported.	   It	   is	  plausible	   to	   suggest	   that	  enhancements	   in	  brain	  blood	  
flow	   may	   serve	   to	   reduce	   HFs	   in	   post-­‐menopausal	   females	   via	   improved	   central	  
thermoregulatory	   functioning.	   Additionally,	   improvements	   in	   brain	   blood	   flow	   at	   rest	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following	   exercise	   training	   may	   also	   attenuate	   reductions	   in	   brain	   blood	   flow	   during	  
objectively	  measured	  HFs.	  
	  
2.8.4	  Exercise	  training	  and	  body	  composition	  in	  post-­‐menopausal	  females	  
The	   impact	   of	   a	   reduction	   in	   BMI	   with	   exercise	   training	   on	   HFs	   also	   deserves	  
consideration.	   The	   relationship	  of	   adiposity	   and	  HFs	   is	   complex,	  with	   a	  higher	  body	   fat	  
traditionally	   assumed	   to	   protect	   against	   HFs	   via	   peripheral	   aromatisation	   of	   androgens	  
into	   estrogens	   in	   body	   fat	   (Thurston	   et	   al.,	   2013).	   Notably,	   findings	   from	   large	   cohort	  
studies	   suggest	   that	   higher	   adiposity	   is	   indeed	   a	   risk	   factor	   for	   HFs	   earlier	   in	   the	  
menopausal	   transition,	   and	  may	  actually	  be	  protective	   later	   in	  menopause	   (Gold	  et	   al.,	  
2006).	   Preliminary	   evidence	   suggests	   an	   existing	   relationship	   between	   HFs	   and	   higher	  
levels	   of	   leptin,	   a	   key	   pro-­‐inflammatory	   adipokine	   that	   is	   down	   regulated	  with	   obesity.	  
Furthermore,	   another	   key	   adipokine	   adiponectin	   is	   inversely	   related	   to	   BMI	   and	   exerts	  
anti-­‐inflammatory	   effects	   (Thurston	   et	   al.	   2013).	   Recently,	   Thurston	   et	   al.	   (2013)	  
associated	  an	  adverse	  adipokine	  profile	  attributed	  to	  increased	  BMI	  levels,	  with	  a	  higher	  
HF	   frequency	   in	   a	   longitudinal	   cohort	   study	   over	   8	   years.	   It	   is	   suggested	   that	   the	  
proinflammatory	   properties	   of	   adipose	   tissue	   may	   act	   directly	   on	   the	   central	   nervous	  
system,	  with	  a	  potential	  thermoregulatory	  effect	  that	  increases	  HFs	  (Luheshi	  et	  al.,	  1999)	  
	  
To	  date,	  it	  is	  unknown	  if	  improving	  the	  ability	  of	  central	  temperature	  control	  and	  vascular	  
function	   mechanisms	   with	   exercise	   training	   to	   respond	   to	   increases	   in	   core	   body	  
temperature	   and/or	   improved	   peripheral	   blood	   flow	   during	   increases	   in	   core	  




In	   summary,	   the	   hypothalamic	   region	   of	   the	   brain	   can	   be	   related	   to	   a	   thermostat	   that	  
controls	   internal	   core	   body	   temperature.	   When	   the	   body	   is	   too	   hot	   heat	   dissipation	  
responses	   of	   cutaneous	   vasodilation	   and	   sweating	   are	   initiated	   (Charkoudian	   and	  
Stachenfeld,	   2014).	   During	   the	   menopause,	   reductions	   in	   oestrogen	   lead	   to	  
thermoregulatory	   dysfunction	   and	   consequently	   HFs	   in	   post-­‐menopausal	   females.	  
Reductions	  in	  oestrogen	  also	  leads	  to	  increases	  in	  cardiovascular	  risk	  factors	  and	  reduced	  
vascular	  function	  in	  this	  population.	  Exercise	  training	  improves	  thermoregulatory	  function	  
in	  pre-­‐menopausal	   females,	  and	  vascular	   function	   in	  pre-­‐	  and	  post-­‐menopausal	   females	  
(Hodges	   et	   al.,	   2010,	   Ichinose	   et	   al.,	   2009).	   Currently,	   it	   remains	   uncertain	   if	   exercise	  
training	  improves	  cardiovascular	  and	  thermoregulatory	  function	  in	  symptomatic	  females	  
that	  leads	  to	  reductions	  in	  HFs.	  









CHAPTER	  3:	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The	   majority	   of	   measurements	   and	   protocols	   undertaken	   in	   this	   thesis	   are	   adopted	  
throughout	   chapters	   4	   to	   6.	   Therefore,	   this	   methods	   chapter	   describes	   general	  
information	   for	   the	   techniques	   used	   for	   physiological	   measurements,	   and	   will	   briefly	  
discuss	  the	  reliability	  and	  limitations	  of	  these	  techniques.	  The	  specific	  protocols	  employed	  
for	  each	  study,	  including	  participant	  cohort,	  can	  be	  found	  within	  the	  methods	  section	  of	  
their	  respective	  chapters.	  
3.1	  Participants	  
A	   meaningful	   change	   in	   resting	   core	   body	   temperature	   of	   0.20ºC	   has	   been	   observed	  
following	  12-­‐weeks	  of	  exercise	  training	   in	  young	  healthy	   females	   (Ichinose	  et	  al.,	  2009),	  
and	  is	  used	  as	  the	  primary	  mechanistic	  variable	  in	  this	  thesis.	   	  Using	  dedicated	  software	  
(NQUERY,	   statistical	   solutions,	   Ireland)	   it	  was	  estimated	   that	  a	   sample	   size	  of	  7	   in	  each	  
intervention	  group	  will	   have	  80%	  power	   to	  detect	   a	  pre-­‐post	   intervention	  difference	   in	  
core	  body	  temperature	  of	  0.20ºC	  assuming	  a	  common	  standard	  deviation	  of	  0.15ºC	  using	  
a	  t-­‐test	  with	  a	  0.05	  two-­‐sided	  significance	  level.	  To	  see	  participant	  specificity,	  please	  see	  
individual	  Chapters	  4-­‐6.	  
3.2	  Anthropometric	  Measurements	  
Height	  was	  measured	  in	  a	  freestanding	  position	  to	  the	  nearest	  0.1	  cm	  using	  a	  stadiometer	  
measuring	  device	  (SECA,	  model	  230,	  Germany).	  Body	  mass	  was	  measured	  to	  the	  nearest	  
0.05	  kg	  using	  calibrated	  electronic	  digital	  scales	  (SECA,	  model	  767,	  Germany).	  From	  these	  
variables,	  Body	  Mass	   Index	  (BMI;	  mass	   (kg)	  /	  height	   (m)2)	  was	  calculated.	  Resting	  blood	  
pressure	   (mmHg)	   and	   resting	   heart	   rate	   (beats·∙min-­‐1)	   were	   also	   determined	   from	   an	  
average	   of	   three	   measures	   in	   the	   seated	   position	   using	   an	   automated	   blood	   pressure	  
monitor	  (Dinamap,	  G&E	  Medical,	  Tampa,	  Florida).	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3.3	  Vascular	  Function	  
All	  vascular	  function	  assessments	  were	  performed	  in	  a	  quiet,	  temperature-­‐controlled	  (21-­‐
23ºC)	   laboratory.	   Upon	   arrival,	   participants	   rested	   in	   the	   supine	   position	   for	  
approximately	   20	   minutes	   in	   order	   to	   gain	   an	   accurate	   assessment	   of	   baseline	   mean	  
arterial	  pressure	  (MAP)	  and	  resting	  heart	  rate	  (HR).	  Following	  the	  rest	  period,	  MAP	  and	  
HR	  were	   determined	   from	   an	   average	   of	   three	  measures	   on	   the	   left	   arm.	   Participants	  
were	  then	  positioned	  with	  their	  right	  arm	  extended,	  comfortable	  and	  relaxed	  at	  an	  angle	  
of	  ~80°	  from	  the	  torso.	  
3.3.1	  Brachial	  Artery	  Flow-­‐Mediated	  Vasodilation	  
Brachial	  artery	  endothelium-­‐dependent	  function	  was	  measured	  using	  the	  flow-­‐mediated	  
dilation	  (FMD)	  technique.	  Participants	  were	  fasted	  for	  12h	  and	  free	  from	  exercise,	  alcohol	  
and	  caffeine	  for	  24h	  previous.	  All	  measurements	  were	  recorded	  at	  the	  same	  time	  of	  day	  
to	  avoid	  the	  effects	  of	  circadian	  rhythm	  vascular	  function.	  A	  rapid	  inflation	  and	  deflation	  
pneumatic	   cuff	   (D.E.	   Hokanson,	   Bellevue,	   WA)	   was	   positioned	   on	   the	   forearm,	  
immediately	   distal	   to	   the	   olecranon	   process	   to	   provide	   a	   stimulus	   to	   forearm	   ischemia	  
(Thijssen	  et	  al.,	  2011).	  A	  10-­‐MHz	  multi-­‐frequency	  linear	  array	  probe,	  attached	  to	  a	  high-­‐
resolution	  ultrasound	  machine	  (T3000;	  Terason,	  Burlington,	  MA)	  was	  then	  used	  to	  image	  
the	   brachial	   artery	   in	   the	   distal	   third	   of	   the	   upper	   arm.	   	  When	   an	   optimal	   image	  was	  
obtained,	  the	  probe	  was	  held	  stable	  and	  the	  ultrasound	  parameters	  were	  set	  to	  optimize	  
the	   longitudinal,	   B-­‐mode	   image	   of	   the	   lumen-­‐arterial	   wall	   interface.	   Settings	   were	  
identical	   between	   FMD	   assessments.	   Continuous	   Doppler	   velocity	   assessments	   were	  
obtained	   using	   ultrasound	   and	  were	   collected	   using	   the	   lowest	   isonation	   angle	   (<60°).	  
Endothelial-­‐dependent	   function	   was	   assessed	   by	   measuring	   FMD	   in	   response	   to	   a	   5	  
minute	   ischaemic	   stimulus,	   induced	  by	   forearm	   cuff	   inflation	   (Thijssen	   et	   al.,	   2011).	   All	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images	  were	  recorded	  using	  specialised	  recording	  software	  (Camtasia	  Studio,	  Techsmith,	  
US).	  Following	  a	  1	  min	  recording	  period	  of	  diameter	  and	  flow,	  the	  cuff	  was	  inflated	  (>220	  
mmHg)	  for	  5	  minutes.	  	  Artery	  diameter	  and	  velocity	  recordings	  resumed	  30	  seconds	  prior	  
to	  cuff	  deflation	  and	  continued	  for	  3	  min	  thereafter,	  in	  accordance	  with	  recent	  technical	  
specifications	   (Black	   et	   al.,	   2008b,	   Woodman	   et	   al.,	   2001,	   Thijssen	   et	   al.,	   2011).	   Peak	  
brachial	  artery	  diameter	  and	  blood	  flow	  velocity,	  and	  the	  time	  taken	  to	  reach	  these	  peaks	  
following	  cuff	  release	  were	  recorded.	  
	  
Figure	   3.1	   Schematic	   representations	   of	   diameter	   and	   shear	   stress	   responses	   following	  
cuff	  deflation,	  in	  response	  to	  a	  5-­‐min	  ischemic	  stimulus,	  during	  a	  flow-­‐mediated	  dilation	  
(FMD)	   assessment.	   The	   grey	   area	   represents	   the	   shear	   rate	   under	   the	   curve	   (SRAUC).	  
Taken	  from	  (Thijssen	  et	  al.,	  2011).	  
	  
3.3.2	  Brachial	  artery	  diameter	  and	  blood	  flow	  analysis	  
Analysis	   of	   brachial	   artery	   diameter	   was	   performed	   using	   custom-­‐designed	   edge-­‐
detection	   and	  wall-­‐tracking	   software,	  which	   is	   largely	   independent	   of	   investigator	   bias.	  
The	   image	   was	   taken	   directly	   from	   the	   ultrasound	   machine	   and	   saved	   as	   an	   AVI	   file.	  
Subsequent	   software	   analysis	   of	   this	   data	  was	   performed	   at	   30Hz	   using	   an	   icon-­‐based	  
graphical	   programming	   language	  and	   toolkit	   (LabVIEW	  6.02,	  National	   Instruments).	   The	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initial	  phase	  of	   image	  analysis	   involved	   the	   identification	  of	   regions	  of	   interest	   (ROI)	  on	  
the	   first	   frame	  of	  every	   individual	   study.	  These	  ROI’s	  allowed	  automated	  calibration	   for	  
arterial	  diameter	  on	  the	  B-­‐mode	  image	  and	  velocities	  on	  the	  Doppler	  strip	  (Figure	  3.2).	  A	  
ROI	  was	  then	  drawn	  around	  the	  optimal	  area	  of	  the	  B-­‐mode	  image	  and	  within	  this	  ROI	  a	  
pixel-­‐density	   algorithm	  automatically	   identified	   the	  angle-­‐corrected	  near	   the	   far	  wall	   e-­‐
lines	  for	  every	  pixel	  column	  within	  the	  ROI.	  The	  algorithm	  begins	  by	  dividing	  the	  ROI	  into	  
an	   upper	   half,	   containing	   the	   near	   wall	   lumen-­‐intima	   interface,	   and	   a	   lower	   half	  
containing	   the	   far	   wall	   interfaces.	   The	   near-­‐wall	   intimal	   edge	   is	   identified	   by	   a	   Rake	  
routine	  that	  scans	  from	  the	  bottom	  to	  the	  top	  of	  the	  upper	  half	  of	  the	  ROI.	  The	  position	  
of	   the	   edge	   is	   established	   by	   determining	   the	   point	   where	   the	   pixel	   intensity	   changes	  
most	   rapidly.	   Typical	   B-­‐mode	   ROI’s	   therefore	   contained	   approximately	   200	   to	   300	  
diameter	   measures	   per	   frame,	   the	   average	   of	   which	   was	   calculated	   and	   stored.	   This	  
process	   occurred	   at	   30	   frames	   per	   second.	   A	   final	   ROI	  was	   drawn	   around	   the	   Doppler	  
waveform	   and	   automatically	   identified	   the	   peak	   of	   the	  waveform.	   The	  mean	   diameter	  
measures	  derived	  from	  within	  the	  B-­‐mode	  ROI	  were	  then	  synchronised	  with	  the	  velocity	  
measure	  derived	  from	  the	  Doppler	  ROI	  at	  30Hz.	  
	  
From	  synchronised	  diameter	  and	  velocity	  data,	  blood	  flow	  (the	  product	  of	   lumen	  cross-­‐	  
sectional	  area	  and	  Doppler	  velocity)	  was	  calculated	  at	  30	  Hz.	  Shear	  rate	  (an	  estimate	  of	  
shear	   stress	   without	   viscosity)	   was	   calculated	   as	   4	   times	   mean	   blood	   velocity/vessel	  
diameter	   (Black	  et	  al.,	  2008a).	  All	  data	  were	  written	   to	   file	  and	  retrieved	   for	  analysis	   in	  
the	  custom-­‐designed	  analysis	  package.	  Reproducibility	  of	  diameter	  measurements	  using	  
this	   semi-­‐automated	   software	   is	   significantly	   better	   than	  manual	  methods	   and	   reduces	  
observer	  error	  significantly	  (Woodman	  et	  al.,	  2001).	  Reproducibility	  of	  the	  FMD	  using	  this	  
semi-­‐automated	  software	  possesses	  a	  CV	  of	  6.7%	  (Thijssen	  et	  al.,	  2009,	  Woodman	  et	  al.,	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2001).	  	  Additionally,	  this	  method	  of	  blood	  flow	  assessment	  is	  closely	  correlated	  with	  the	  
actual	  flow	  through	  a	  “phantom”	  arterial	  flow	  system	  (Green	  et	  al.,	  2002).	  	  
	  
Figure	  3.2	  Example	  of	  Doppler	  ultrasound	  of	  a	  brachial	  artery	  allowed	  automated	  
calibration	  for	  arterial	  diameter	  on	  the	  B-­‐mode	  image	  (A)	  and	  velocities	  (B)	  on	  the	  
Doppler	  strip	  
	  
3.4	  Passive	  Heat	  Stress	  Challenge	  
Experiments	   were	   performed	   in	   a	   temperature-­‐controlled	   laboratory	   (22±1	   ºC)	   in	   the	  
morning	   or	   early	   afternoon	   and	   were	   performed	   at	   least	   2	   hours	   post-­‐prandial.	   Upon	  
arrival	   to	   the	   laboratory	   participants	   were	   asked	   to	   wear	   a	   vest	   and	   shorts,	   and	  were	  
clothed	   in	   a	   tube-­‐lined	   jacket	   and	   trousers	   (Med-­‐Eng;	  Ottawa,	   Canada),	  which	   covered	  
the	  entire	  body	  except	  for	  the	  head,	  feet	  and	  one	  forearm	  (Figure	  3.3).	  The	  suit	  permitted	  
the	   control	   of	   skin	   and	   core	   body	   temperature,	   thereby	   mean	   body	   temperature,	   by	  
changing	  the	  temperature	  of	  the	  water	  perfusing	  the	  suit.	  Participants	  rested	  quietly	  in	  a	  
semi-­‐recumbent	  position	  while	  water	  (34°C)	  was	  perfused	  through	  the	  suit	  at	  5.5	  L/min,	  
using	   a	   heated	   water-­‐bath	   (Eco	   Silver,	   Lauda;	   New	   Jersey,	   USA)	   and	   electronic	   water-­‐
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pump	  (Magnetically	  coupled	  pump	  FL5.5,	  RS	  components;	  Northants,	  UK)	  for	  a	  15	  minute	  
resting	   baseline	   period.	   Participants	   were	   then	   exposed	   to	   a	   moderate	   heat	   stress	   by	  
perfusing	  ~48oC	  water	  through	  the	  suit	  for	  60	  minutes	  or	  until	  a	  rise	  of	  ~1°C	  in	  core	  body	  
temperature.	   All	   data	   during	   the	   heat	   stress	   challenge	   were	   sampled	   at	   50Hz	   with	   an	  
analogue-­‐to-­‐digital	   converter	   data	   acquisition	   system	   (PowerLab/16SP	   ML795,	  
ADInstruments,	  Oxford	  UK),	  and	  displayed	  in	  real-­‐time	  on	  a	  PC	  laptop	  using	  commercially	  
available	   software	   (Chart	   version	   7.02,	   ADinstruments;	   Figure	   3.4).	   All	   data	   were	   then	  
stored	   for	   subsequent	   analysis.	   During	   the	   passive	   heat	   stress	   challenge,	   a	   host	   of	  
physiological	  measures	  were	  recorded.	  All	  data	  were	  sampled	  as	  a	  60	  seconds	  average	  at	  
baseline,	   and	   at	   every	   0.1°C	   increase	   in	   core/mean	   body	   temperature	   during	   passive	  
heating.	  These	  variables	  are	  discussed	  below.	  	  
3.5	  Electrocardiogram	  
Heart	  rate	  was	  obtained	  from	  a	  3-­‐lead	  electrocardiogram	  (ECG)	  (ADInstruments,	  Oxford,	  
UK),	   and	   recorded	   continuously	   (Antonicelli	   et	   al.,	   2012).	   The	   electrode	   sites	   were	  
prepared	  and	  cleaned	  with	  an	  antiseptic	  medical	  swab	  before	  the	  application	  of	  positive	  
and	   negative	   ECG	   electrodes	   (Tyco	   Healthcare,	   Mansfield:	   MA),	   on	   the	   right	   and	   left	  
clavicle	   respectively,	   close	   to	   the	   acromioclavicular	   joint.	   The	   earth	   electrode	   was	  
positioned	   between	   the	   seventh	   and	   eighth	   intercostal	   space.	   The	   ECG	   signal	   was	  
displayed	  in	  real-­‐time	  in	  the	  Chart	  software	  and	  heart	  rate	  was	  calculated	  from	  the	  beat-­‐
to-­‐beat	  R-­‐R	  interval	  values	  by	  using	  the	  formula:	  
HR	  =	  60	  /	  R-­‐R	  interval	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3.6	  Beat-­‐to-­‐beat	  arterial	  blood	  pressure	  
Continuous	   beat-­‐to-­‐beat	   arterial	   blood	   pressure	   (BP)	   was	   measured	   by	   finger	  
photoplethysmography	   (Finometer	   Pro,	   Finapress	   Medical	   Systems,	   Biomedical	  
Instruments,	  Amsterdam:	  The	  Netherlands).	  	  The	  Finometer	  was	  developed	  by	  Wesseling	  
et	  al.	  (1995)	  and	  uses	  the	  voltage-­‐clamp	  method	  (Penaz,	  1973)	  to	  clamp	  the	  diameter	  of	  
the	  digital	  artery	  in	  a	  constant	  ‘unloaded’	  condition,	  thereby	  tracking	  variations	  in	  intra-­‐
arterial	  pressure	  (Bogert	  and	  van	  Lieshout,	  2005,	  Imholz	  et	  al.,	  1992,	  Imholz	  et	  al.,	  1998).	  
To	   achieve	   this,	   the	   Finometer	   apparatus	   has	   three	  main	   components	   that	   includes;	   a	  
finger	  cuff	  containing	  an	  inflatable	  air	  bladder	  and	  infrared	  plethymograph	  (light	  detector	  
and	   light	   source),	   a	   fronted	  unit	   containing	   a	   fast-­‐acting	   servo-­‐controller	   system,	   and	  a	  










	   	  
	  
Figure	   3.5	   (A)	   Finometer	   apparatus	   including	   finger	   cuff,	   fronted	   unit	  
containing	   servo-­‐controller,	   and	   a	   main	   unit	   containing	   the	   air	   pump	   and	  





The	  method	  is	  based	  on	  the	  development	  of	  the	  dynamic	  pulsatile	  unloading	  of	  the	  finger	  
arterial	  walls.	  The	  diameter	  of	  the	  artery	  under	  a	  cuff	  wrapped	  around	  the	  finger	  is	  kept	  
clamped	   (constant)	   at	   a	   specific	   diameter	   (set	   point),	   despite	   any	   changes	   to	   arterial	  
pressure	   during	   each	   heartbeat.	   Changes	   in	   diameter	   are	   detected	   by	   means	   of	   an	  
infrared	   photo-­‐plethysmograph	   built	   into	   a	   finger	   cuff	   (Figure	   3.5B),	   with	   the	   servo-­‐
controller	   system	   detecting	   a	   difference	   between	   the	   light	   detector	   signal	   and	   the	   set	  
point,	   sending	   a	   signal	   to	   the	  microcontroller	  within	   the	  unit.	   	   If	   an	   increase	   in	   arterial	  
diameter	  is	  detected	  during	  systole	  the	  finger	  cuff	  is	  immediately	  inflated	  via	  increased	  air	  
delivery	  into	  the	  inflatable	  air	  bladder	  of	  the	  cuff	  to	  prevent	  the	  diameter	  change	  in	  the	  
digital	   artery.	   Therefore,	   the	   transmural	   pressure	   of	   the	   artery	   is	   maintained	   at	   zero	  
(unloaded).	  At	  this	  point	  the	  pressure	  of	  the	  finger	  cuff	  pressure	  equals	  the	  intra-­‐arterial	  
pressure	  (Bogert	  and	  van	  Lieshout,	  2005).	  	  	  
	  
To	  ensure	  accurate	  measurement	  it	  is	  essential	  to	  define	  the	  correct	  unloaded	  diameter	  
of	   a	   finger	   artery,	   however	   this	   is	   not	   straightforward,	   due	   to	   changes	   in	   haematocrit,	  
stress	   and	   the	   tone	   of	   smooth	   muscle	   in	   the	   arterial	   wall	   that	   directly	   affect	   arterial	  
diameter	  (Bogert	  and	  van	  Lieshout,	  2005).	  	  The	  optimal	  unloaded	  diameter	  is	  close	  to	  the	  
average	   diameter	   at	   a	   pressure	   where	   the	   amplitude	   of	   the	   pulsations	   in	   the	  
plethysmogram	  is	   largest	  (Bogert	  and	  van	  Lieshout,	  2005,	  Imholz	  et	  al.,	  1998,	  Wesseling	  
et	   al.,	   1995).	   This	   is	   achieved	   using	   an	   expert	   inbuilt	   physiologic	   calibration	   system	  
(Physiocal,	   Finometer	  Medical	   Systems,	   Amsterdam),	   consisting	   of	   a	   dynamic	   servo	   set	  
point	  adjuster	  used	  to	  define	  and	  maintain	  the	  diameter	  at	  which	  the	  finger	   is	  clamped	  




The	   calibration	   explores	   part	   of	   the	   pressure-­‐diameter	   relationship	   by	   analysing	   the	  
plethysmogram	  at	  a	  number	  of	  steady	  pressure	  levels,	  and	  is	  able	  to	  track	  the	  unloaded	  
diameter	  of	  a	   finger	  artery	  even	   if	   smooth	  muscle	   tone	  changes,	  and	  adjusts	   the	   finger	  
cuff	  accordingly	  (Bogert	  and	  van	  Lieshout,	  2005,	  Imholz	  et	  al.,	  1998).	  
	  
Once	  the	  correct	  finger	  cuff	  size	  was	  selected,	   it	  was	  placed	  around	  the	  mid-­‐phalanx	  on	  
the	  middle	  finger	  of	  the	  left	  hand.	  Care	  was	  taken	  to	  position	  the	  emission	  and	  detection	  
light	   sensors	   symmetrically	   and	   to	  wrap	   the	   cuff	   firmly	   around	   the	   finger.	  Hand	   height	  
was	   corrected	   to	   heart	   level	   using	   the	   hydrostatic	   height	   correction	   unit	   (FMS	   Height	  
Correction	  Unit).	  The	  height	  correction	  unit	  comprises	  of	  a	  liquid-­‐filled	  tube	  with	  one	  end	  
attached	   to	   an	   adjustable	   reference	   component	   and	   the	   other	   end	   connected	   to	   a	  
transducer	  (Figure	  3.5A).	  	  
	  
Prior	  to	  data	  collection	  participants	  were	  in	  the	  supine	  position	  with	  the	  arm	  resting	  flat,	  
supported	  by	  a	  pillow.	   The	   reference	   component	   and	   the	   transducer	  were	  both	  placed	  
upon	   the	   middle	   finger	   cuff	   (attached	   with	   Velcro),	   and	   a	   ‘zeroing’	   procedure	   was	  
performed	   on	   the	   transducer	   to	   the	   hydrostatic	   reference.	   In	   preparation	   for	   data	  
collection,	  the	  reference	  component	  was	  then	  moved	  from	  the	  finger	  cuff	  and	  placed	  at	  
the	   level	   of	   the	   heart	   on	   the	   upper	   arm.	   This	   process	   ensures	   that	   any	   changes	   in	   the	  
vertical	   displacement	   of	   the	   finger	   cuff,	   relative	   to	   the	   heart	   are	   corrected	   for	   by	   the	  
reference	  probe	  and	  artery	  pressure	  is	  reported.	  	  
	  
To	  prevent	  peripheral	  vasoconstriction	   in	   the	  situation	  of	  participants	  experiencing	  cold	  
hands	   and/or	   fingers,	   the	   hand	   was	   gently	   warmed	   using	   a	   warm	   compress	   (when	  
warranted).	  During	  the	  experimental	  session	  the	  raw	  artery	  pressure	  wave	  was	  visualised	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and	  recorded	  using	   the	  PowerLab©	  software.	  From	  the	  waveform	  profile,	  SBP,	  DBP	  and	  
MAP	  were	  obtained	  which	  was	  calculated	  by:	  
	  
MAP	  =	  1/3	  SBP	  +	  2/3	  DBP	  (mmHg)	  
Where	  MAP	   is	  mean	   arterial	   blood	   pressure,	   SBP	   is	   systolic	   blood	   pressure	   and	  DBP	   is	  
diastolic	  blood	  pressure.	  
	  
A	  limitation	  with	  using	  finger	  photoplethysmography	  is	  that	  the	  arterial	  waveform	  varies	  
throughout	  the	  arterial	   tree,	  causing	  augmentation	  between	   intrabrachial	  and	  finger	  BP	  
due	   to	   distortion	   of	   the	   waveform	   and	   gradient	   along	   the	   arterial	   tree,	   caused	   by	  
transmission	  of	  the	  pressure	  pulse	  along	  the	  arm	  arteries	  (Imholz	  et	  al.,	  1990).	  Peripheral	  
reflection	  amplifies	  the	  pressure	  wave	  influencing	  an	  over-­‐estimation	  of	  systolic	  pressure	  
when	   compared	   to	   intra-­‐arterial	   measurements	   in	   healthy	   participants	   (Imholz	   et	   al.,	  
1992).	  
	  
Furthermore,	  MAP	  in	  the	  hand	  tends	  to	  be	  lower	  than	  in	  the	  arm	  as	  a	  result	  of	  a	  pressure	  
gradient	  across	  the	  vascular	  tree	  caused	  by	  flow,	  as	  mentioned	  previously.	  The	  pressure	  
decay	   related	   to	   flow	   in	   arteries	   is	   greatest	   for	   a	   high	   pulse-­‐pressure	   at	   a	   low	   mean	  
pressure,	  while	  the	  arterial	  pressure	  frequency	  transfer	   function	  between	  the	  hand	  and	  
the	  arm	  has	   a	   significance	  of	   ~8Hz	   (Gizdulich	  et	   al.,	   1997).	   This	  difference	   translates	   to	  
finger	  MAP	  being	  ~8-­‐10	  mmHg	  lower	  than	  brachial	  values	  (Gizdulich	  et	  al.,	  1997),	  while	  in	  
the	  supine	  position	  the	  bias	  for	  systolic	  BP	  is	  ~2	  mmHg	  (Bogert	  and	  van	  Lieshout,	  2005).	  
To	   correct	   this,	   one	   approach	   is	   to	   reference	   finger	   arterial	   pressure	   against	   brachial	  




Several	   studies	   have	   compared	   finger	   photoplethysmography	   against	   a	   gold-­‐standard,	  
invasive	   intra-­‐arterial	  measurement	  of	  blood	  pressure.	  Little	  differences	  are	  reported	   in	  
photoplethysmography	   blood	   pressure	   measurements	   in	   comparison	   to	   intra-­‐radial	  	  
resting	  measurements,	  during	  standing	  or	  head-­‐up	  tilt	  (Imholz	  et	  al.,	  1990),	  exercise	  (Silke	  
et	  al.,	  1994),	  Valsalva	  (Imholz	  et	  al.,	  1988)	  or	  under	  pharmacological	  manipulation	  (Imholz	  
et	  al.,	  1992).	   	  Additionally,	  photoplethysmography	  has	  been	  used	  to	  monitor	  alterations	  
in	  BP	  during	  heat	  stress	  (Bain	  et	  al.,	  2013,	  Keller	  et	  al.,	  2009),	  manipulations	   in	  cerebral	  
blood	  flow	  (Ainslie	  et	  al.,	  2008,	  Ainslie	  et	  al.,	  2007),	  and	  importantly,	  previous	  HF	  research	  
in	  post-­‐menopausal	  females	  (Low	  et	  al.,	  2010,	  Lucas	  et	  al.,	  2013,	  Hubing	  et	  al.,	  2010,	  Low	  
et	   al.,	   2008a).	   These	   studies	   imply	   finger	   photoplethysmography	   is	   a	   suitable	   tool	   in	  
monitoring	   dynamic	   changes	   in	   blood	   pressure.	   Alongside	   photoplethysmography,	   an	  
automated	   blood	   pressure	   cuff	   (Dinamap,	   G&E	   Medical,	   Tampa,	   Florida)	   worn	   on	   the	  
same	  arm	   (upper),	  was	  used	   to	   verify	   and	   calibrate	   finger	  blood	  pressure	  as	  previously	  
demonstrated	  (Low	  et	  al.,	  2008b,	  Lucas	  et	  al.,	  2013,	  Nelson	  et	  al.,	  2011,	  Willie	  et	  al.,	  2013,	  
Lewis	  et	  al.,	  2014).	  
	  
3.6.1	  Estimation	  of	  cardiac	  output	  and	  stroke	  volume	  
Despite	   various	   methods	   of	   measuring	   cardiac	   output	   and	   stroke	   volume,	   such	   as	  
techniques	  that	  use	  thermo-­‐dilution,	  CO2	  or	   rebreathing	  of	   inert	  gas,	   it	   is	  advantageous	  
during	   clinical	   based	   research	   if	   measurements	   can	   be	   continuous	   and	   non-­‐invasive	  
(Bogert	   and	   van	   Lieshout,	   2005).	   Doppler	   Ultrasound	   can	   be	   used	   in	   the	   non-­‐invasive	  
tracking	  of	  changes	  in	  stroke	  volume	  (Van	  Lieshout	  et	  al.,	  2003),	  but	  is	  methodologically	  
limited	  due	   the	  probe	  being	  placed	  over	   the	   root	  of	   the	   aorta	   at	   a	   fixed	   angle	   (usually	  
held)	   or	   by	   using	   a	   transesophageal	   approach	   (Bogert	   and	   van	   Lieshout,	   2005).	   The	  
72	  
	  
continuous	  monitoring	  of	   cardiac	  output	  and	   stroke	  volume	  allows	   for	   the	  detection	  of	  
rapid	  changes	  in	  systemic	  flow	  and	  conductance	  that	  would	  otherwise	  be	  undetected	  by	  
recording	   heart	   rate	   and	   arterial	   blood	   pressure	   alone	   (Leonetti	   et	   al.,	   2004).	   Stroke	  
volume	  and	  cardiac	  output	  were	  calculated	  using	  the	  ModelFlow	  method,	  obtained	  from	  
the	  BP	  waveform	  from	  photoplethysmography	  that	  uses	  age	  (years),	  sex,	  height	  (cm)	  and	  
weight	   (kg)	   in	   its	   algorithm.	  The	  ModelFlow	  method	   is	  based	  on	   the	  Windkessel	  model	  
(Figure	   3.6)	   of	   arterial	   stress	   (Wesseling	   et	   al.,	   1995).	   The	   ModelFlow	   method	   uses	   a	  
three-­‐element	  model	  of	  the	  aortic	  input	  impedance	  to	  compute	  flow	  from	  the	  pulsation	  
of	   the	   arterial	   pressure	   (Wesseling	   et	   al.,	   1993),	   and	   is	   based	   upon	   the	   relationship	  
between	  SV	  and	  arterial	  pressure	  wave	  in	  the	  form	  of	  an	  algorithm,	  which	  then	  creates	  an	  
aortic	   flow	   waveform	   from	   arterial	   blood	   pressure	   pulsation	   via	   simulation	   of	   a	   non-­‐
linear,	  self-­‐adaptive	  model	  of	  the	  aortic	  input	  impedance	  (Harms	  et	  al.,	  1999)	  (Figure	  3.6).	  
Modelflow	  is	  a	  three	  element	  model	  that	  uses	  the	  following	  characteristics;	  impedance	  of	  
the	   aorta	   and	   arterial	   compliance	   (Westerhof	   et	   al.,	   1971),	   and	   peripheral	   vascular	  
resistance	  (ratio	  of	  mean	  pressure	  to	  mean	  blood	  flow),	  SV	  is	  subsequently	  calculated	  by	  
integrating	  the	  aortic	  flow	  waveform	  per	  beat	  (Harms	  et	  al.,	  1999).	  Cardiac	  output	  is	  then	  
calculated	   by	   multiplying	   stroke	   volume	   by	   HR.	   The	   Finometer	   uses	   ModelFlow	   by	  
calculating	  proximal	  aortic	  impedance	  and	  arterial	  compliance	  using	  an	  in-­‐built	  database	  
of	   human	   aorta	   arctangent	   area-­‐pressure	   relationships	   that	   rely	   on	   manually	   entered	  
participant	   characteristics	   (mentioned	   above).	   The	   calculation	   of	   cardiac	   output	   and	  
stroke	   volume	   from	   the	   ModelFlow	   technique	   has	   been	   seen	   to	   produce	   accurate	  
measurements	  when	   compared	   to	   invasive	   intra-­‐brachial	  methods	   (Harms	   et	   al.,	   1999)	  
and	  when	  using	  thermodilution	  during	  cardiac	  surgery	  (Wesseling	  et	  al.,	  1993),	  but	  does	  
slightly	  underestimate	  cardiac	  output	  and	  stroke	  volume	  during	  heat	  stress	  compared	  to	  
the	   gold-­‐standard	   thermodilution	   method	   (Shibasaki	   et	   al.,	   2011).	   However,	   the	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underestimation	   is	   consistent	   and	   thus	   the	   technique	   can	   still	   track	   changes	   to	   cardiac	  
output	  and	  stroke	  volume	  between	  trials	  and	  over	   time.	  Additionally,	   this	  methodology	  
tracks	  rapid	  changes	  in	  cardiac	  output	  experimental	  protocols	  including	  static	  (van	  Dijk	  et	  
al.,	  2005)	   	  stepping	  (Matsukawa	  et	  al.,	  2004)	  and	  dynamic	  cycling	  exercise	  (Sugawara	  et	  
al.,	  2003,	  Tam	  et	  al.,	  2004).	  
	  
	  
Figure	   3.6	   Diagram	   of	   flow	   modelling	   from	   measurements	   of	   arterial	   pressure.	   (A)	  
Illustrates	  input	  to	  the	  model	  from	  the	  Finometer	  during	  one	  cardiac	  cycle.	  (B)	  Illustrates	  
the	   three	   element	   model	   of	   the	   aortic	   input	   impedance	   used	   to	   compute	   flow	   from	  
pressure.	  (C)	  illustrates	  the	  computer	  output	  from	  the	  model;	  the	  aortic	  flow	  as	  a	  function	  
of	   time.	   Z0,	   proximal	   aortic	   characteristic	   impedence;	   Cw,	   arterial	   compliance;	   Rp,	  
systemic	  vascular	  resistance;	  ∫,	  indicates	  the	  non-­‐linear	  pressure-­‐dependent	  properties	  of	  
Z0	   and	   Cw;	   the	   arrow	   indicates	  where	   Rp	   varies	  with	  Windkessel	   pressure.	  ModelFlow	  
diagram	  adapted	  from	  Harms	  et	  al.	  (1999).	  
	  
3.7	  Middle	  cerebral	  blood	  velocity	  
The	  high	  temporal	  resolution	  and	  non-­‐invasive	  nature	  of	  transcranial	  Doppler	  ultrasound	  
(TCD)	   make	   it	   a	   useful	   tool	   in	   measuring	   blood	   velocities	   in	   cerebral	   vessels,	   in	  
centimetres	   per	   second	   (cm·∙s-­‐1)	   (Willie	   et	   al.,	   2011).	   In	   contrast	   to	   other	   methods	   of	  
measuring	   CBF,	   including	   MRI	   and	   proton	   emission	   tomography,	   TCD	   has	   several	  
advantages	   because	   it	   is	   non-­‐invasive,	   allows	   repeated	   measures	   and	   continuous	  
monitoring	  within	   the	   laboratory,	   is	   portable	   and	   has	   a	   high	   temporal	   resolution	   (<0.1	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seconds)	  that	  rapidly	  monitors	  changes	  in	  CBF	  (van	  Beek	  et	  al.,	  2008).	  TCD	  is	  based	  on	  the	  
use	  of	  a	  range-­‐gated,	  pulsed	  Doppler	  ultrasonic	  beam	  of	  2MHz	  frequency,	  with	  the	  probe	  
emitting	  an	  ultrasonic	  beam	  that	  crosses	  the	  intact	  skull	  and	  the	  into	  the	  cerebral	  vessel	  
of	  interest	  via	  ‘windows’	  (Moppett	  and	  Mahajan,	  2004).	  The	  ultrasonic	  beam	  is	  reflected	  
off	  moving	   red	  blood	   cells	   in	   the	   field	  of	   transmission	   and	  detected	  by	   the	   transducer,	  
which	   are	   both	   contained	   in	   the	   Doppler	   probe	   (Figure	   3.7)	   (Willie	   et	   al.,	   2011).	   	   The	  
resultant	  Doppler-­‐shift	   is	   proportional	   to	   red	   blood	   cell	   velocity	   (DeWitt	   and	  Wechsler,	  
1988),	   and	   is	   the	   difference	   between	   the	   transmitted	   signal	   and	   the	   received	   signal,	  
expressed	  by	  the	  following	  formula	  (Moppett	  and	  Mahajan,	  2004):	  
	  
Doppler	  frequency	  shift	  =	  2·∙V·∙Ft·∙cosƟ/C	  
Where	  V	  is	  the	  velocity	  of	  the	  reflector	  (red	  blood	  cells),	  Ft	  is	  the	  transmitted	  frequency	  (2	  
MHz),	  C	  is	  the	  speed	  of	  sound	  in	  soft	  tissue	  (1540	  m·∙s-­‐1),	  and	  cosƟ	  is	  the	  correction	  factor	  
based	  on	  the	  angle	  of	  insonation	  (Ɵ).	  
	  
	  
The	  Doppler	  frequency	  shift	  depends	  upon	  the	  constant	  variables	  blood	  velocity	  and	  the	  
angle	  of	  insonation	  of	  the	  TCD	  probe.	  TCD	  cannot	  measure	  CBF	  per	  se,	  but	  measures	  red	  
blood	  cell	  velocity	  within	  the	  insonated	  vessel	  (Willie	  et	  al.,	  2011).	  For	  an	  overview	  of	  the	  
cerebral	  circulation	  please	  see	  Figure	  3.8.	  The	  middle	  cerebral	  artery	  (MCA)	  runs	  laterally	  
and	   somewhat	   anteriorly	   after	   bifurcating	   from	   the	   internal	   carotid	   artery	   (ICA).	  When	  
possible,	   it	   is	  best	  to	   insonate	  the	  MCA	  from	  the	  anterior	  window	  because	  it	  provides	  a	  
near-­‐zero	   insonation	   angle	   meaning	   absolute	   velocity	   measurements	   are	   obtainable	  
(Willie	  et	  al.,	  2011).	  	  






























Figure	   3.7	   Schematic	   showing	   the	   components	   of	   the	   Doppler	   ultrasound	   probe	   and	  










The	   MCA	   is	   most	   commonly	   used	   because	   of	   the	   quality	   of	   the	   signal	   through	   the	  
temporal	  window	  and	   the	  ease	  of	  access	  of	   insonation,	  whilst	   the	  MCA	  also	  carries	  50-­‐
60%	  of	  the	  ICA	  blood	  flow	  (Moppett	  and	  Mahajan,	  2004).	  Additionally,	  the	  MCA	  receives	  
80%	  of	  the	  blood	  volume	  delivered	  to	  the	  circle	  of	  Willis	  (Lindegaard	  et	  al.,	  1987),	  and	  can	  
be	   taken	   to	   represent	   blood	   flow	   to	   the	   brain	   (Moppett	   and	   Mahajan,	   2004).	   The	  
technique	   for	   insonating	   the	  MCA	  has	  been	  described	   in	  detail	  elsewhere	   (Aaslid	  et	  al.,	  
1982,	  Moppett	  and	  Mahajan,	  2004,	  Willie	  et	  al.,	  2011).	  
	  
In	   this	   thesis,	   middle	   cerebral	   artery	   blood	   velocity	   (MCAV;	   1	   cm	   distal	   to	   the	   MCA-­‐
anterior	  cerebral	  artery	  bifurcation)	  was	  measured	  continuously,	  with	   the	  participant	   in	  
the	   semi-­‐supine	   position,	   through	   the	   right	   and	   left	   temporal	   window	   using	   TCD	  
ultrasonography.	  Acoustic	  gel	  was	  applied	  to	  the	  temporal	  window	  (region	  just	  above	  the	  
zygomatic	  arch)	  and	  a	  2-­‐MHz	  Doppler	  probe	  (Spencer	  Technologies,	  Seattle	  WA,	  USA)	  was	  
adjusted,	  and	  applied	  gently	  with	  a	  consistent	  force,	  until	  an	  optimal	  signal	  was	  identified	  
as	  described	  in	  detail	  previously	  (Willie	  et	  al.,	  2011),	  and	  held	  in	  place	  using	  a	  headband	  
strap	  	  (1500,	  Spencer	  Technologies,	  Seattle	  WA,	  USA)	  to	  prevent	  subtle	  movement	  of	  the	  














Figure	  3.9	  Transcranial	  Doppler	  probe	  held	  in	  place	  using	  headband	  and	  strap	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The	  MCA	  was	  identified	  by	  firstly	  setting	  the	  probe	  to	  an	  insonation	  depth	  of	  50mm	  (the	  
MCA	  is	  usually	  viewed	  at	  depths	  between	  35-­‐60mm)	  and	  then	  moving	  the	  probe	  slowly	  
perpendicular	   to	   the	   assumed	   vessel	   direction.	   Once	   a	   strong	   red	   signal	   (blood	   flow	  
towards	  the	  transducer)	  was	  seen	  within	  the	  depth	  range	  on	  the	  Power	  M-­‐mode	  screen,	  
the	  signal	  was	  optimised	  by	  altering	  the	  gain	  of	  the	  signal	  and	  the	  insonation	  angle	  of	  the	  
probe	  with	  slight	  corrections.	   	  During	  this	   technique,	   flow	  should	  be	  towards	  the	  probe	  
(strong	   red	   signal)	   until	   the	   MCA	   trifurcation	   where	   there	   should	   be	   flow	   in	   both	  
directions.	   The	  MCA-­‐anterior	   carotid	   artery	   bifurcation	   is	   a	   useful	   anatomical	   landmark	  
upon	  which	  to	  standardise	  a	  within-­‐participant	  point	  of	  measurement	  during	  repeat	  tests	  
(Willie	   et	   al.,	   2011).	   The	   spectrogram	   screen	   then	   shows	   a	   Doppler	   spectral	   waveform	  
that	   indicates	   the	   velocity	   profile	   of	   the	   blood	   flow	   at	   the	   selected	   depth	   of	   the	  
corresponding	  M-­‐mode	  screen.	  Observing	  peak	  blood	  velocity	  also	  assisted	  in	  confirming	  
the	  MCA,	  with	  velocities	  peaking	  between	  85-­‐130	  cm/s,	  however	  there	  is	  large	  variability	  
in	   peak	   blood	   velocity,	   specifically	   in	   patient	   groups	   and	   with	   ageing	   populations,	   and	  
care	  should	  be	  taken	  when	  using	  this	  to	  identify	  the	  MCA	  (Moppett	  and	  Mahajan,	  2004).	  
Once	  the	  optimal	  MCA	  signal	  was	  attained	  on	  the	  right	  and	   left	   temporal	  windows,	   the	  
probe	  and	  machine	  settings	  (depth,	  gain	  and	  power)	  were	  recorded	  to	  help	   identify	  the	  
same	  imaging	  site	  during	  future	  assessments.	  To	  ensure	  angle	  accuracy	  with	  and	  between	  
experimental	  sessions,	  the	  probe	  was	  constantly	  secured	  in	  place	  during	  the	  passive	  heat	  
stress	  challenge,	  whilst	  the	  same	  researcher	  positioned	  the	  probe	  each	  time.	  
	  
When	   bilateral	   MCAv	   was	   obtained,	   the	   average	   value	   was	   used	   unless	   there	   was	   a	  
significant	  difference	  between	  the	  two	  sites.	  In	  the	  instance	  when	  there	  was	  a	  significant	  
difference	  between	  signal	  velocities	  the	  strongest	  MCAv	  signal	  was	  used	  and	  repeated	  in	  
the	   post-­‐tests.	   The	  MCAv	  was	   transmitted	   and	   displayed	   in	   real-­‐time	   on	   the	   PowerLab	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Chart	   file.	  Within	   the	  Chart	   file,	   the	  mean	  middle	  cerebral	  artery	  velocity	   (MCAv;	  cm/s)	  
was	  calculated	  for	  each	  cardiac	  cycle	  by:	  
	  
Mean	  MCAv	  =	  1/3	  SMCAv	  +	  2/3	  DMCAv	  




As	   the	   anterior	   and	   posterior	   cerebral	   arteries	   can	   both	   be	   visualised	   through	   the	  
temporal	  window,	   there	  are	  a	  number	  of	   identification	  procedures	  used	   to	  ensure	   that	  
the	  insonated	  artery	  is	  the	  MCA	  (Table	  3.1).	  The	  anterior	  cerebral	  artery	  lies	  deeper	  than	  
the	  MCA	   (~65mm)	   and	   the	   velocity	   also	   flows	   away	   from	   the	   transducer	   (away	   –	   blue	  
signal),	   whilst	   the	   posterior	   cerebral	   artery	   lies	   even	   deeper	   (~70mm)	   (Moppett	   and	  
Mahajan,	  2004,	  Willie	  et	  al.,	  2011).	  	  
	  
A	  major	   limitation	  of	   TCD	   is	   that	   it	  measures	  blood	  velocity	  and	  not	  blood	   flow	  per	   se.	  
However,	   as	   long	   as	   the	   diameter	   of	   the	   insonated	   vessel	   and	   the	   angle	   of	   insonation	  
remain	  constant,	  blood	  velocity	  is	  a	  reliable	  index	  of	  blood	  flow	  (Giller	  et	  al.,	  1998):	  
	  



















To	  date,	  there	  is	  no	  widely	  accepted,	  reliable	  method	  of	  assessing	  vessel	  diameter	  using	  
TCD.	  However,	  collective	  evidence	  suggests	  that	  changes	  in	  MCAv	  are	  a	  reliable	  index	  of	  
CBF	   (Schreiber	   et	   al.,	   2000,	   Serrador	   et	   al.,	   2000).	   The	   diameter	   of	   the	  MCA	   has	   been	  
found	   to	   remain	   constant	   in	   response	   to	   a	   variety	   of	   physiological	   stimuli	   including	  
changes	  in	  partial	  pressure	  (Peebles	  et	  al.,	  2007)	  pharmacologically	  induced	  changes	  in	  BP	  
(Larsen	  et	  al.,	  1994),	  and	  handgrip	  exercise	  including	  post-­‐exercise	  muscle	  ischemia	  (Pott	  
et	  al.,	  1997).	  	  Additionally,	  TCD	  has	  been	  used	  in	  various	  heat-­‐stress	  protocols	  (Low	  et	  al.,	  
2008b,	  Nelson	  et	  al.,	  2011)	  and	  to	  measure	  CBF	  during	  HFs	   in	  post-­‐menopausal	  females	  
(Lucas	  et	  al.,	  2013).	  To	  ensure	  accurate	  measurement	  of	  MCAv	  it	  is	  important	  the	  angle	  of	  
insonation	   is	   considered	   and	   kept	   constant,	   as	   the	   observed	   velocity	   is	   inversely	  
proportional	  to	  the	  cosine	  angle	  of	  the	  incidence	  between	  the	  ultrasound	  beam	  and	  the	  
vessel	   (Moppett	  and	  Mahajan,	  2004).	   Insonation	  angles	  up	  to	  30º	  have	  been	  associated	  
with	  an	  acceptable	  error	  of	  ~15%	  (Aaslid	  et	  al.,	  1982).	  However,	  an	  inherent	  advantage	  of	  
Table	  3.1	  Typical	  patterns	  for	  the	  identification	  of	  cerebral	  arteries	  with	  ‘normal’	  Circle	  of	  Willis	  anatomy.	  
Adapted	  from	  Moppett	  &	  Mahajan	  (2004).	  


















































Abbreviations;	  ACA,	  anterior	  cerebral	  artery;	  MCA,	  middle	  cerebral	  artery;	  PCA,	  posterior	  cerebral	  artery.	  




insonating	  MCA	   is	   that	   blood	   flows	   directly	   towards	   the	   probe	   allowing	   for	   easy	   signal	  
acquisition	  with	  a	  small	  angle	  of	  insonation	  (Willie	  et	  al.,	  2014).	  
	  
3.8	  Cerebrovascular	  conductance	  
Cerebrovascular	   conductance	   (CBVC)	   measures	   the	   flow	   conductance	   in	   the	   cerebral	  
vasculature	  and	  was	  calculated	  by:	  
CBVC	  =	  mean	  MCAv	  /	  MAP	  
Where	  CBVC	  is	  cerebrovascular	  conductance,	  mean	  MCAv	  is	  mean	  middle	  cerebral	  artery	  
velocity	  and	  MAP	  is	  mean	  arterial	  pressure.	  
	  
	  
The	  CBVC	   index	   is	  used	  as	   it	   considers	   the	   response	  of	  arterial	  BP	  on	  CBF	   (Willie	  et	  al.,	  
2014).	  Willie	  et	  al.,	   (2014)	   also	   suggest	   that	   few	   current	   research	   concepts	   incorporate	  
the	   effects	   of	   both	   CO2	   and	   MAP	   on	   CBF,	   simultaneously.	   However,	   whilst	   MAP	   and	  
arterial	  CO2	   should	  be	   considered,	   it	   is	   recommended	   they	  are	  expressed	   separately	   to	  
provide	  a	  better	  impression	  of	  its	  effect	  on	  CBF	  (Willie	  et	  al.,	  2012).	  
	  
3.9	  The	  partial	  pressure	  of	  end-­‐tidal	  carbon	  dioxide	  (PETCO2)	  
Prior	   to	   experimental	   sessions,	   the	  PowerLab©	   gas	   analyser	  was	   calibrated	  with	   known	  
oxygen	   and	   CO2	   beta	   grade	   gas	   concentrations.	   The	   pneumotachometer	   was	   also	  
calibrated	   using	   a	   3-­‐Litre	   syringe	   (Hans-­‐Rudolph	   8980,	   Kansas	   City,	  Mo,	   USA)	   that	   was	  
attached	  to	  a	  3-­‐way	  non	  rebreathing	  valve.	  	  An	  expiratory	  airline	  connected	  the	  facemask	  
to	   the	  gas	  analysers	   (Model	  CD-­‐3A	  CO2	  analyser,	  AEI	  Tech,	  Pittsburgh,	  USA)	   from	  which	  
CO2	  concentrations	  at	  a	  flow	  rate	  of	  30·∙mL·∙min-­‐1	  were	  sampled,	  and	  recorded	  in	  real-­‐time	  
using	  the	  Chart	  file.	  Total	  apparatus	  dead	  space	  ranged	  between	  260-­‐290	  mL	  depending	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on	  the	  size	  of	  the	  facemask	  (small-­‐medium).	  Alongside	  mean	  CO2,	  peak	  maximum	  cyclic	  
CO2	  responses	  for	  end	  tidal	  CO2	  were	  identified	  via	  Chart	  and	  analysed.	  
	  
3.10	  Core	  body	  temperature	  
Core	   body	   temperature	   was	   measured	   from	   an	   ingestible	   pill	   telemetry	   system	  
(CoreTemp,	   HQInc;	   Palmetto,	   FL,	   US).	   The	   pill	   was	   ingested	   ~5h	   before	   the	   participant	  
arrived	   to	   the	   laboratory	  as	   recommended,	  due	   to	   the	   influence	  of	   ingestion	   timing	  on	  
the	   consistency	   of	   core	   temperature	   measures	   	   (Goodman	   et	   al.,	   2009).	   Core	   body	  
temperature	  measurement	  is	  fundamental	  to	  the	  study	  of	  human	  temperature	  regulation	  
during	  heat	  stress	   (Byrne	  and	  Lim,	  2007).	  However,	   the	  term	  ‘core’	  does	  not	  describe	  a	  
single	   anatomical	   location	   as	   the	  body	   interior	   is	   not	   at	   one	  uniform	   temperature.	   The	  
temperature	  of	  the	  blood	  in	  the	  pulmonary	  artery	  is	  considered	  the	  best	  representation	  
of	  the	  average	  internal	  temperature	  of	  the	  human	  body	  however	  this	  site	  is	  not	  accessible	  
(Byrne	  and	  Lim,	  2007).	  Due	  to	  its	  inaccessibility,	  core	  body	  temperature	  is	  often	  measured	  
using	  an	   ingestible	   telemetric	  pill	   that	   transmits	  an	   internal	   temperature	   relative	   to	   the	  
surrounding	  gastrointestinal	  temperature	  by	  radio	  waves	  to	  an	  external	  receiver	  for	  data	  
logging	  (O'Brien	  et	  al.,	  1998).	  
	  
The	  telemetry	  pill	  has	  been	  deemed	  reliable	  when	  using	  repeat	  assessments	  (Gant	  et	  al.,	  
2006)	  and	  validated	  previously	  against	  other	  measures	  of	   core	   temperature	   (O'Brien	  et	  
al.,	  1998),	  including	  both	  oesophageal	  and	  rectal	  temperature	  measures	  (Byrne	  and	  Lim,	  
2007,	  Sparling	  et	  al.,	  1993,	  Gibson	  et	  al.,	  1981).	  O’Brien	  et	  al.	  (1998)	  used	  a	  quantitative	  
review	  of	   valid	  measures	   of	   core	   body	   temperature	   reliability	   and	   reported	   agreement	  
between	   the	   ingestible	   pill	   and	   oesophageal	   temperature	   measurements,	   with	   a	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systematic	  bias	  of	  <0.1ºC	  and	  95%	  limits	  of	  agreement	  within	  ±0.04ºC.	  They	  also	  reported	  
a	  bias	  against	  rectal	  temperature	  of	  >0.1ºC	  that	  was	  still	  deemed	  acceptable,	  particularly	  
as	  rectal	  temperature	  elicited	  a	  time	  delay	  on	  true	  internal	  temperature	  (Byrne	  and	  Lim,	  
2007).	  
	  
3.11	  Mean	  skin	  temperature	  	  
Skin	  temperature	  plays	  a	  fundamental	  role	  in	  thermoregulation	  (Johnson	  et	  al.,	  2014)	  and	  
was	   obtained	   from	   the	   weighted	   average	   of	   4	   regional	   temperatures	   (chest,	   forearm,	  
thigh	   and	   calf)	   measured	   from	   wireless	   thermocouples	   (iButtons	   data	   logger,	   Maxim	  
Integrated;	   San	   Jose,	   CA,	   US)	   .Skin	   temperature	   was	   automatically	   measured	   and	  
recorded	  temperature	  every	  60	  seconds	  at	  each	  site.	  Measurements	  of	  skin	  temperature	  
are	  often	  complicated	  due	  to	  the	  use	  of	  wired	  sensors,	  however	  the	  thermocouples	  are	  
advantageous	  to	  traditional	  skin	  temperature	  recording	  devices	  in	  that	  they	  are	  wireless	  
and	  do	  not	  interfere	  with	  other	  measurements	  i.e.	  wires,	  do	  not	  require	  auxiliary	  control,	  
or	  a	  control-­‐recording	  receiver	  that	  must	  remain	  within	  a	  set	  distance	  (Smith	  et	  al.,	  2010).	  
	  
iButtons®	   have	   been	   validated	   previously	   using	   a	   waterbath	   and	   skin	   temperature	  
measurement,	  with	  an	  accuracy	  of	   -­‐0.09ºC	  and	  precision	  of	  0.05ºC	  when	  compared	  to	  a	  
reference	  thermometer	  (van	  Marken	  Lichtenbelt	  et	  al.,	  2006).	  The	  response	  time	  of	  the	  
thermocouples	   on	   human	   skin	   is	   ~15	   seconds	   compared	   to	   ~2	   seconds	   with	   wired	  
thermistors	   (van	   Marken	   Lichtenbelt	   et	   al.,	   2006),	   however	   because	   of	   the	   closely	  
controlled	  elevation	  of	  skin	  temperature	  using	  a	  water-­‐perfused	  suit	  the	  response	  time	  of	  
the	  iButtons	  is	  acceptable.	  iButtons	  have	  also	  been	  validated	  for	  accurate	  measurements	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of	   skin	   temperature	   during	   exercise,	   sleep	   research	   and	   clinical	   settings	   (Smith	   et	   al.,	  
2010).	  
	  
The	  wireless	   thermistors	  were	   secured	   to	   the	   lateral	   calf,	   lateral	   thigh,	   upper	   arm	   and	  
chest.	   Mean	   skin	   temperature	   was	   calculated	   using	   the	   weighting	   system	   for	   mean	  
surface	  temperature	  (Hardy	  and	  DuBois,	  1938)	  and	  the	  equation	  (Ramanathan,	  1964):	  
	  
Tsk	  =	  (0.3*Tchest)	  +	  (0.3*Tarm)	  +	  (0.2*Tthigh)	  +	  (0.2*Tcalf)	  
Where	  Tsk	  is	  the	  mean	  skin	  temperature,	  Tchest	  is	  chest	  skin	  temperature,	  Tarm	  is	  arm	  skin	  
temperature,	  Tthigh	  is	  thigh	  skin	  temperature	  and	  Tcalf	  is	  calf	  skin	  temperature.	  
	  
	  
Ignoring	  the	  head	  and	  extremities	   in	  the	  weighting	  was	  not	   found	  to	  produce	  any	  error	  
when	   compared	   to	   other	   methods	   (Ramanathan,	   1964).	   The	   4-­‐point	   system	  
(Ramanathan,	   1964)	   has	   been	   found	   to	   correlate	   closely	   (r	   >0.97)	   (Mitchell	   and	  
Wyndham,	  1969)	  with	  12-­‐	  and	  6-­‐point	  systems	  previously	  proposed	  (Hardy	  and	  DuBois,	  
1938).	  
	  
3.12	  Mean	  body	  temperature	  
Mean	  body	  temperature	  was	  calculated	  as	  (Stolwijk	  and	  Hardy,	  1966):	  
Tbody	  =	  (0.8*Tcore)	  +	  (0.2*Tsk)	  
Where	  Tbody	  is	  mean	  body	  temperature,	  Tcore	  is	  core	  body	  temperature	  and	  Tsk	  is	  mean	  
skin	  temperature.	  
	  
The	  calculation	  of	  mean	  body	  temperature	  relates	   the	  average	  evaporative	  heat	   loss	   to	  
mean	   body	   temperature	   and	   uses	   the	   assumption	   that	   primary	   thermoregulatory	  
function	  is	  to	  maintain	  body	  temperature	  within	  a	  set	  physiological	  range.	  This	  implicates	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both	  core	  temperature	  and	  skin	  temperature	  through	  weighting	  factors	  that	  when	  taken	  
into	  account	  provides	  a	  mean	  body	  temperature	  (Hardy,	  1961,	  Hardy	  and	  Dubois,	  1937).	  
	  
3.13	  Local	  sweat	  rate	  	  
Local	   sweat	   rate	   was	   recorded	   continuously	   from	   the	   dorsal	   forearm	   and	   the	   mid-­‐
sternum	   (not	   covered	   by	   the	   water-­‐perfused	   suit)	   using	   capacitance	   hygrometry	  
(Brengelmann	  et	  al.,	  1975).	  Dry	  100%	  nitrogen	  gas	  was	  supplied	  through	  acrylic	  capsules	  
(surface	  area=	  2.32cm2)	  attached	  to	  the	  skin’s	  surface	  at	  a	  flow	  rate	  of	  150mL/min,	  with	  
the	   humidity	   of	   the	   gas	   flowing	   out	   of	   the	   capsules	   measured	   by	   the	   capacitance	  
hygrometer	   (Viasala	   HMP155,	   Helsinki,	   Finland).	   The	   flow	   rate	   of	   the	   gas	   was	  
continuously	   monitored	   using	   a	   rotameter.	   Alongside	   humidity,	   the	   capacitance	  
hygrometer	   also	   measured	   the	   temperature	   of	   the	   nitrogen	   gas	   as	   it	   exits	   the	   acrylic	  
capsule.	  The	  relative	  humidity	  and	  temperature	  of	  the	  gas	  were	  collected	  via	  LabChart	  (in	  
real-­‐time),	  and	   local	   sweat	   rate	  was	  calculated	   from	  the	   ideal	  gas	   laws	   (Graichen	  et	  al.,	  
1982):	  
SR	  =	  (RH	  /	  FR)	  /	  3.464	  *	  A	  *	  Tcap	  
Where	   SR	   is	   sweat	   rate	   (mg·∙cm2·∙min-­‐1),	   RH	   is	   relative	   humidity	   (%)	   obtained	   from	   the	  
capacitance	  hygrometer,	  FR	  is	  the	  flow	  rate	  of	  dry	  gas	  through	  the	  capsule	  (L·∙min-­‐1),	  3.464	  
is	   the	   water	   vapour	   (dew	   point)	   gas	   constant,	   A	   is	   the	   area	   (2.32	   cm2)	   of	   the	   capsule	  
enclosing	   the	   skin	   site	   and	   Tcap	   is	   the	   temperature	   (ºC)	   of	   the	   air	   leaving	   the	   capsule	  
(Graichen	  et	  al.,	  1982).	  
	  
	  
Local	  sweat	  rate	  was	  sampled	  across	  60	  second	  segments,	  as	  this	   interval	   is	  well	  within	  
the	  latency	  period	  that	  extends	  between	  sweat	  gland	  stimulation	  and	  sweat	  emergence	  
(Bullard,	  1971),	  and	  also	  produces	  less	  scatter	  and	  retains	  higher	  analytical	  certainty	  than	  
averaging	  across	  20	  seconds	  (Motulsky	  and	  Brown,	  2006).	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3.13.1	  Sweating	  threshold	  and	  sensitivity	  
Thermoregulatory	  sweating	  can	  be	  viewed	  as	  two	  line	  segments	  with	  a	  breakpoint,	  with	  
sweating	  possessing	  an	  additional	  slope	  of	  zero	  that	  changes	  in	  abrupt	  monotonic	  fashion	  
in	  response	  to	  heat	  stress	  (Vieth,	  1989).	  The	  temperature	  threshold	  for	  the	  onset	  of	  local	  
sweat	  rate	  is	  often	  defined	  from	  the	  intersection	  of	  the	  baseline	  flow	  (no	  sweating)	  of	  a	  
linear	  regression	  of	  the	  effector	  response	  versus	  core	  body	  temperature	  (Brengelmann	  et	  
al.,	   1994).	   In	   addition,	   visual	   estimation	   including	   any	   mean	   local	   sweat	   rate	   value	   in	  
excess	  of	  the	  detection	  limit	  of	  the	  dew	  point	  capsule	  may	  also	  be	  used	  (Graichen	  et	  al.,	  
1982,	  Sawka	  et	  al.,	  1989,	  Kolka	  et	  al.,	  1987,	  Montain	  et	  al.,	  1995).	  Very	  often	  however,	  
the	   methodologies	   employed	   in	   the	   detection	   of	   temperature	   thresholds	   are	   not	  
provided	  in	  detail.	  	  
	  
For	   the	   purpose	   of	   this	   thesis,	   the	   temperature	   threshold	   for	   local	   sweat	   rate	   will	   be	  
defined	  as:	  
“….the	  core	  temperature	  at	  which	  there	  is	  an	  abrupt,	  exponential	  rise	  in	  local	  sweat	  rate	  
from	  baseline.”	  
	  
This	  method	  of	   local	  sweat	  rate	  threshold	  detection	  has	  been	  found	  to	  be	  reproducible	  
(<0.1ºC)	   previously	   (Brengelmann	   et	   al.,	   1994).	   Cheuvront	   et	   al.	   (2009)	   requested	   16	  
‘raters’	  to	  calculate	  the	  local	  sweat	  rate	  thresholds	  and	  sensitivities	  for	  a	  complete	  data	  
set	  using	   their	  own	  empirical	   approaches.	   Interestingly,	   the	  differences	  between	   ‘rater’	  
approaches	  were	  found	  to	  be	  both	  quantitatively	  and	  qualitatively	  acceptable,	  whilst	  also	  
valid	   when	   compared	   with	   a	   standardised	   linear	   regression	   model	   using	   software	  
(Cheuvront	  et	  al.,	  2009).	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Sweating	  sensitivity	  was	  calculated	  from	  the	  slope	  of	  the	  relationship	  between	  sweat	  rate	  
per	   unit	   change	   in	   mean	   body	   temperature	   beyond	   the	   core	   temperature	   thresholds,	  
whilst	   any	   observed	   plateau	   (sweating	   <0.01	   mg·∙cm2·∙min-­‐1/per	   ºC)	   in	   sweat	   rate	   was	  
excluded	  from	  the	  slope	  calculation.	  When	  comparing	  sweat	  rate	  sensitivity	  calculations	  
using	  slope	  estimation	  (see	  above)	  and	  a	  standardised	  linear	  regression	  model,	  324	  inter-­‐
rater	   differences	  were	  within	   73%	   of	   the	   qualitative	   limits	   of	   agreement	   (which	   define	  
performance	  acceptability)	  (Cheuvront	  et	  al.,	  2009).	  
	  
Sweating	   threshold	   temperature	   and	   sweating	   sensitivity	   are	   frequently	   reported	   to	  
evaluate	   changes	   in	   thermoregulatory	   control	   (Cheuvront	   et	   al.,	   2009,	   Ichinose	   et	   al.,	  
2009,	   Ichinose-­‐Kuwahara	  et	  al.,	  2010,	   Inoue	  et	  al.,	  2005),	   yet	   currently	  no	  standardised	  
method	  exists	   in	   thermoregulatory	   research	   (Vieth,	  1989).	  A	   standard	  procedure	  would	  
logically	   reduce	   inter-­‐rater	  measurement	   error	   (Cheuvront	   et	   al.,	   2009),	   and	   focus	   the	  
interpretation	  of	  sweating	  control	  around	  common	  factors	  of	   influence	  (Shibasaki	  et	  al.,	  
2006).	   However,	   it	   should	   also	   be	   noted	   that	   improving	   threshold	   and	   sensitivity	  
calculations	   are	   the	   responsibility,	   and	   in	   the	   care	   of,	   the	   end	   user	   (Cheuvront	   et	   al.,	  
2009).	   Greater	   methodological	   details	   and	   more	   precise	   identification	   of	   analysis	  
parameters	   are	   recommended	   to	   reduce	   inter-­‐rater	   variability.	   For	   the	   purpose	   of	   this	  
thesis,	   all	   temperature	   thresholds	   and	   sensitivities	   are	   reported	   by	   one	   observer	   in	   a	  
blinded	  fashion	  (observer	  was	  unaware	  of	  assessment	  time	  or	  intervention).	  
	  
3.14	  Skin	  blood	  flow	  
An	  index	  of	  local	  cutaneous	  blood	  flow	  was	  obtained	  using	  Laser	  Doppler	  Flowmetry	  (LDF:	  
Periflux	  System	  5001,	  Perimed;	  AB,	  Sweden).	  Cutaneous	  red	  blood	  cell	  flux	  was	  measured	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by	  affixing	   integrated	   laser-­‐Doppler	  probes	   (each	  consisting	  of	  a	   seven-­‐laser	  array)	  with	  
an	  adhesive-­‐ring	  in	  close	  proximity	  to	  the	  ventilated	  sweat	  rate	  capsule	  at	  both	  the	  chest	  
and	  forearm	  sites.	  At	  both	  sites,	  care	  was	  taken	  to	  place	  the	  probe	  away	  from	  hairy	  skin	  
or	   over	   veins.	   	   The	   laser-­‐Doppler	   probe	   signals	   (laser	   Doppler	   flux)	   were	   continuously	  
monitored	   using	   LabChart	   and	   averaged	   into	   60-­‐second	   segments;	   this	   produces	   less	  
physiological	   scatter	   and	   retains	   higher	   analytical	   certainty	   than	   averaging	   across	   20	  
seconds	   time-­‐points	   (Motulsky	   and	  Brown,	   2006).	   Absolute	   skin	   blood	   flux	   values	   from	  
laser	   Doppler	   flowmetry	   provide	   an	   index	   (in	   arbitrary	   units,	   AU)	   of	   skin	   blood	   flow	  
(Wingo	  et	  al.,	  2010).	  
	  
LDF	  is	  based	  on	  the	  reflection	  of	  a	  beam	  of	  light	  that	  undergoes	  a	  change	  in	  wavelength	  
(Doppler	   shift)	   when	   it	   is	   reflected	   by	   moving	   red	   blood	   cells.	   The	   magnitude	   and	  
frequency	  of	  distribution	  of	  these	  changes	  in	  wavelength	  are	  related	  to	  both	  the	  number	  
and	   velocity	   of	   red	   blood	   cells	   (Cracowski	   et	   al.,	   2006).	   LDF	   allows	   the	   evaluation	   of	  
cutaneous	  microvessels	  over	  a	  specific	  time-­‐period	  and	  its	  alterations	  during	  physiological	  
challenges,	   such	  as	  during	  heat	   stress	   (Kuwahara	  et	  al.,	   2005b,	  Wingo	  et	  al.,	   2010)	  and	  
post-­‐menopausal	  HFs	   (Low	  et	  al.,	  2010,	   Low	  et	  al.,	  2008a).	  The	  major	  advantage	  of	   the	  
laser	  Doppler	  technique	  is	  that	  it	  is	  continuous,	  has	  high	  temporal	  and	  spatial	  resolution	  
beyond	  venous	  occlusion	  plethysmography	   (Charkoudian	  and	  Stachenfeld,	  2014),	  and	   is	  
sensitive	   in	  detecting	   relative	   changes	   in	   skin	  blood	   flow	   in	   response	   to	  a	   stimulus	   (i.e.	  
heat	  stress)	  or	  an	  intervention	  (i.e.	  exercise	  training).	  Additionally,	  during	  heat	  stress,	  LDF	  
at	  the	  forearm	  displayed	  a	  highly	   linear	  correlation	  (r	  =	  0.9)	  with	  forearm	  blood	  flow	  as	  
measured	   by	   venous	   occlusion	   plethysmography	   (Saumet	   et	   al.,	   1986).	   The	   major	  
variation	   with	   LDF	   is	   the	   site	   of	   measurement	   (Johnson	   et	   al.,	   2014),	   but	   when	   it	   is	  
standardised	   the	   day-­‐to-­‐day	   variability	   compares	   with	   flow-­‐mediated	   dilation	   of	   the	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brachial	  artery,	  with	  a	  coefficient	  of	  variation	  <10%	  (Kubli	  et	  al.,	  2000).	  At	  baseline,	   the	  
site	  of	  skin	  blood	  flow	  was	  measured	  from	  the	   inguinal	  crease	  of	  the	  forearm	  and	  from	  
the	  mid-­‐sternum	  at	  the	  chest	  that	  was	  subsequently	  recorded	  for	  repeat	  assessments.	  
	  
3.14.1	  Cutaneous	  vascular	  conductance	  
Cutaneous	   vascular	   conductance	   (CVC)	   has	   proven	   useful	   in	   studies	   investigating	   the	  
mechanisms	  of	  skin	  blood	  flow	  when	  using	  laser	  Doppler	  flux	  as	  it	  normalises	  blood	  flow	  	  
in	   relation	   to	  mean	   arterial	   blood	   pressure,	   and	   enables	   comparison	   between	   areas	   of	  
skin	  across	  a	  given	  participant	  and/or	  between	  participants	  (Kellogg	  et	  al.,	  1993).	  There	  is	  
no	   theoretical	   maximum	   to	   skin	   blood	   flow,	   but	   there	   is	   a	   maximal	   CVC,	   when	   the	  
resistance	   vessels	   are	   completely	   relaxed.	   This	   is	   commonly	   used	   in	   tests	   assessing	  
mechanisms	  of	  control	  in	  the	  cutaneous	  circulation	  (Charkoudian	  and	  Stachenfeld,	  2014).	  
Cutaneous	  vascular	  conductance	  (CVC)	  was	  calculated	  as:	  
	  
CVC	  =	  LDF	  /	  MAP	  
Where	  CVC	   (PU	  mmHg)	   is	  cutaneous	  vascular	  conductance,	  LDF	   (measured	   in	  perfusion	  




CVC	  values	  were	  also	  expressed	  relative	  to	  maximal	  CVC	  achieved	  during	  heating	  the	  skin	  
to	  42ºC,	  as	  %CVCmax,	  as	  this,	  along	  with	  CVC,	  is	  the	  preferred	  method	  of	  data	  expression	  
adopted	  in	  the	  literature	  (Cracowski	  et	  al.,	  2006).	  	  
3.14.2	  Local	  maximal	  skin	  blood	  flow	  
Following	  the	  passive	  heat	  stress	  protocol	  in	  the	  water	  perfused	  suit,	  a	  test	  for	  maximal	  
NO-­‐mediated	  vasodilation	  was	  performed.	  The	  temperature	  of	  the	  heating	  unit	  (that	  the	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laser	  Doppler	  probe	  sits	  in)	  was	  set	  to	  32ºC	  and	  increased	  to	  42ºC,	  at	  a	  rate	  of	  0.5ºC·∙10s-­‐1,	  
to	  obtain	  maximal	  skin	  blood	  flow	  (Tew	  et	  al.,	  2012a,	  Black	  et	  al.,	  2008b,	  Cracowski	  et	  al.,	  
2006)	   following	   ~30-­‐40	   minutes	   of	   localised	   heating.	   This	   temperature-­‐dependent	  
increase	   in	  cutaneous	  blood	  flow	  achieves	  a	  maximal	  vasodilation	  between	  42-­‐44ºC	  and	  
corresponds	  to	  the	  maximal	  vasodilator	  capacity	  of	  the	  vessels	  (Charkoudian,	  2003).	  Local	  
heating–mediated	   cutaneous	   vasodilation	   is	   bi-­‐phasic	   and	   evoked	   by	   two	   independent	  
mechanisms,	  an	  initial	  peak	  in	  cutaneous	  blood	  flow	  is	  known	  as	  the	  axon	  reflex	  (relies	  on	  
local	  sensory	  nerves),	  and	  a	  second	  longer	  peak	  (and	  plateau)	  after	  ~20-­‐30	  minutes	  that	  is	  
largely	   NO-­‐mediated	   (Minson	   et	   al.,	   2001).	   Peak	   laser	   Doppler	   flux	  was	   taken	   as	   a	   60-­‐
second	  average	  of	  the	  highest	  point	  of	  the	  second	  curve	  (plateau)	  (Minson	  et	  al.,	  2001)	  at	  
the	  chest	  and	  the	  forearm.	  Maximal	  cutaneous	  vasodilation	  (maximal	  cutaneous	  vascular	  
conductance)	  was	  then	  calculated	  as:	  
CVCmax	  =	  LDFmax	  /	  MAP	  
Where	  CVCmax	  is	  maximal	  cutaneous	  vascular	  conductance,	  LDFmax	  is	  maximal	  Laser	  
Doppler	  Flux	  and	  MAP	  is	  mean	  arterial	  pressure	  obtained	  at	  maximal	  LDF.	  
	  
At	  baseline,	  and	  during	  the	  heat	  stress,	  CVC	  was	  then	  expressed	  relative	  to	  CVCmax	  as	  a	  
percentage	  by:	  
%CVCmax	  =	  (CVC	  /	  CVCmax)*100	  
	  
Where	  %CVCmax	  is	  cutaneous	  vascular	  conductance	  relative	  to	  maximal	  cutaneous	  
vascular	  conductance,	  CVC	  is	  cutaneous	  vascular	  conductance	  and	  CVCmax	  is	  maximal	  
cutaneous	  vascular	  conductance	  
	  
3.14.3	  Skin	  blood	  flow	  threshold	  and	  sensitivity	  
Similar	   to	  the	  calculation	  of	   the	  mean	  body	  temperature	  threshold	   for	   local	  sweat	  rate,	  
the	   onset	   of	   cutaneous	   vasodilation	   can	   be	   viewed	   as	   two	   line	   segments	   with	   a	  
breakpoint,	  with	   skin	  blood	   flow	   (laser	  Doppler	   flux,	   LDF)	  possessing	  baseline	   flow	   that	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changes	   in	   an	   abrupt	   	   fashion	   (threshold)	   in	   response	   to	   heat	   stress.	   The	   temperature	  
threshold	   for	   the	   onset	   of	   skin	   blood	   flow	   (vasodilation)	   is	   often	   defined	   from	   the	  
intersection	   of	   the	   baseline	   flow	   of	   a	   linear	   regression	   of	   the	   effector	   response	   versus	  
core	   temperature	   (Brengelmann	   et	   al.,	   1994).	   	   Very	   often	   however,	   the	  methodologies	  
employed	  in	  the	  detection	  of	  temperature	  thresholds	  are	  not	  provided	  in	  detail.	  	  
	  
A	  non-­‐linear	  relationship	  exists	  between	  skin	  blood	  flow	  and	  local	  temperature,	  such	  that	  
small	  increments	  in	  blood	  flow	  at	  lower	  local	  skin	  temperatures	  (20-­‐35ºC)	  become	  much	  
more	  pronounced	  at	  skin	  temperatures	  >37ºC	  (Johnson	  and	  Kellogg,	  2010a).	  Warming	  of	  
core	   body	   temperature	   (and	   locally	   at	   the	   skin),	   such	   as	   during	   heat	   stress	   using	   the	  
water-­‐perfused	  suit	  (~38	  ºC)	  causes	  an	  initial	  vasoconstriction	  followed	  by	  vasodilation	  of	  
the	   skin	   in	   response	   to	   heat	   stress.	   It	   is	   the	   core	   body	   temperature	   at	   this	   initial	  
vasodilation	  that	  is	  set	  as	  the	  temperature	  threshold	  for	  cutaneous	  vasodilation	  (Minson	  
et	   al.,	   2001,	   Hodges	   et	   al.,	   2009,	   Houghton	   et	   al.,	   2006),	   whilst	   this	   visual	   estimation	  
technique	  to	  assess	  the	  threshold	  for	  cutaneous	  vasodilation	  has	  been	  used	  previously	  in	  
assessing	  thermoregulatory	  function	  following	  exercise	  training	  (Kuwahara	  et	  al.,	  2005a,	  
Kuwahara	  et	  al.,	  2005b,	  Lorenzo	  and	  Minson,	  2010).	  
	  
For	   this	   thesis,	   the	   temperature	   threshold	   for	   the	   onset	   of	   cutaneous	   vasodilation	  was	  
defined	  as:	  
	  “The	  core	  body	  temperature	  at	  the	  abrupt	  onset,	  and	  continuation	  of,	  cutaneous	  
vasodilation	  from	  baseline.”	  
	  
Cutaneous	   vasodilation	   sensitivity	   was	   calculated	   from	   the	   slope	   of	   the	   relationship	  
between	   skin	   blood	   flow	   and	   core	   temperature	   beyond	   the	   threshold	   (CVC	   per	   unit	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change	  in	  core	  body	  temperature)	  (Wingo	  et	  al.,	  2010,	  Kuwahara	  et	  al.,	  2005a).	  The	  slope	  
for	   CVC,	   per	   unit	   change	   in	   core	   body	   temperature	   beyond	   the	   core	   temperature	  
thresholds	   was	   also	   calculated.	   In	   line	   with	   assessing	   thermoregulatory	   sweat	   rate	  
thresholds	   and	   sensitivities,	   core	   body	   temperature	   thresholds	   and	   sensitivities	   are	  
frequently	  reported	  for	  cutaneous	  vasodilation	  to	  evaluate	  changes	  in	  thermoregulatory	  
control	   (Cheuvront	   et	   al.,	   2009,	   Ichinose	   et	   al.,	   2009,	   Ichinose-­‐Kuwahara	   et	   al.,	   2010,	  
Inoue	  et	  al.,	  2005).	  	  
	  
3.15	  Cardiorespiratory	  fitness	  (VO2peak)	  
Cardiorespiratory	   fitness	   (VO2peak)	   was	   assessed	   to	   quantify	   aerobic	   capacity.	   This	  
comprised	   of	   a	   2-­‐minute	   warm-­‐up	   followed	   by	   incremental	   exercise	   to	   volitional	  
exhaustion	  on	  a	   treadmill	   (H/P	  Cosmos,	   Pulsar	   4.0,	  Nussdorf-­‐Traunstein,	  Germany)	   in	   a	  
temperature-­‐controlled	  environment	  (Bruce	  et	  al.,	  1973).	  The	  Bruce	  protocol	  (1973)	  was	  
used	  in	  female	  participants	  <40	  years	  of	  age,	  whilst	  female	  participants	  >40	  years	  of	  age	  
followed	   a	  modified	   Bruce	   protocol	   that	   has	   been	   used	   in	   other	   sedentary,	   high-­‐risk	  
populations	  previously	  (Pugh	  et	  al.,	  2013,	  Sprung	  et	  al.,	  2013).	  VO2peak	  during	  exercise	  was	  
calculated	   from	   minute	   ventilation,	   measured	   using	   a	   pneumotach	   and	   simultaneous	  
breath	   by	   breath	   analysis	   of	   expired	   gas	   fractions	   (Oxycon	   Pro,	   Jaeger,	   Germany).	   Gas	  
analysers	  and	  flow	  probes	  were	  calibrated	  prior	  to	  each	  test.	  The	  results	  were	  expressed	  
relative	   to	   body	   weight	   (ml/kg/min).	   Peak	   oxygen	   consumption	   was	   calculated	   as	   the	  
highest	  consecutive	  15-­‐second	  period	  of	  gas	  exchange	  data	  occurring	  in	  the	  final	  minute	  
before	  volitional	  exhaustion,	  which	  usually	  occurred	  due	  to	  breathlessness	  or	  leg	  fatigue.	  
Physiological	  criteria	  for	  the	  assessment	  of	  VO2peak	  included	  a	  plateau	  in	  VO2peak	  and/or	  a	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respiratory	  exchange	  ratio	  >1.15	  combined	  with	  a	  heart	  rate	  in	  the	  region	  of	  >90%	  of	  age-­‐
predicted	  maximal	  heart	  rate	  (220-­‐age)	  (Miller	  et	  al.,	  1993).	  
3.15.1	  Bruce	  protocol	  	  
The	  fitness	  test	  was	  performed	  on	  a	  treadmill	   (H/P	  Cosmos,	  Germany)	  to	  quantify	  peak	  
aerobic	  capacity.	  After	  a	  2	  min	  warm	  up,	  treadmill	  speed	  began	  at	  6	  kmh-­‐1	  for	  continuous	  
2-­‐min	  stages,	  speed	  then	  increased	  by	  2	  kmh-­‐1	  per	  2	  min	  to	  a	  maximal	  running	  speed	  of	  
16	  kmh-­‐1	  or	  until	  volitional	  exhaustion.	  Heart	  rate	  was	  measured	  continuously	  using	  short	  
range	   telemetry	   (RS800,	  Polar,	   Finland)	   alongside	   subjective	  effort	   (RPE)	  using	   the	  6-­‐20	  
Borg	  scale	  (Borg,	  1970).	  	  
3.15.2	  Modified	  Bruce	  protocol	  	  
The	  fitness	  test	  was	  performed	  on	  a	  treadmill	   (H/P	  Cosmos,	  Germany)	  to	  quantify	  peak	  
aerobic	  capacity.	  Following	  a	  2-­‐minute	  warm-­‐up	  at	  2.2km/h	  on	  a	  flat	  gradient,	  the	  initial	  
workload	  was	  set	  at	  2.7km/h	  at	  5%	  grade.	  Thereafter,	  stepwise	  increments	  in	  speed	  and	  
grade	   were	   employed	   every	   minute.	   Heart	   rate	   was	   continuously	   measured	   at	   rest,	  
during,	  and	  in	  recovery	  from	  exercise	  via	  12-­‐lead	  ECG	  (Oxycon	  Pro,	  Jaeger,	  Germany),	  and	  
the	  participant’s	  RPE	  was	  monitored	  (Borg,	  1970).	  	  
3.16	  Statistical	  Analysis	  
Analyses	  were	   performed	   using	   the	   Statistical	   Package	   for	   Social	   Sciences	   Version	   17.2	  
(SPSS	   Inc.	  Chicago,	   IL,	  USA).	  Data	  were	  presented	   in	   the	   text	  as	  mean	   (95%	  Confidence	  
Interval),	   unless	   otherwise	   stated.	   Statistical	   significance	   was	   delimited	   at	   P<0.05	   and	  
exact	   P	   values	   are	   cited	   (values	   of	   P	   of	   “0.000”	   provided	   by	   SPSS	   are	   reported	   as	  










CHAPTER	  4:	  EXERCISE	  TRAINING	  REDUCES	  THE	  
FREQUENCY	  OF	  MENOPAUSAL	  HOT	  FLUSHES	  BY	  




Menopausal	   HFs	   can	   seriously	   disrupt	   the	   lives	   of	   symptomatic	   females	   (Kronenberg,	  
1990,	  Freedman,	  2001).	  Approximately	  70%	  of	  females	  experience	  HFs	  1	  to	  5	  years	  after	  
the	  onset	  of	  the	  menopausal	  transition	  (Shanafelt	  et	  al.,	  2002,	  Kronenberg,	  1994).	  A	  HF	  is	  
typically	   defined	   as	   the	   subjective	   sudden	   intense	   sensation	   of	   heat	   causing	   cutaneous	  
vasodilation	   and	   profuse	   sweating	   (Stearns	   et	   al.,	   2002,	   Freedman,	   2002).	   HRT	   is	   an	  
effective	  treatment	  for	  HFs	  (McNagny,	  1999,	  Maclennan	  et	  al.,	  2004,	  Utian	  et	  al.,	  2004)	  
but	  has	  poor	  uptake	  (Hersh	  et	  al.,	  2004,	  Isaacs	  et	  al.,	  2005).	  Furthermore,	  not	  all	  females	  
can	   be	   prescribed	   HRT	   due	   to	   their	   age,	   time	   since	   menopause	   and	   a	   history	   of	  
cardiovascular	  disease	  or	  breast	  cancer	  (NICE,	  2009).	  The	  current	  alternatives	  to	  HRT	  are	  
limited	   but	   one	   non-­‐pharmacological	   option	   is	   exercise	   training.	   A	   number	   of	   research	  
studies,	   but	   not	   all,	   have	   shown	   exercise	   training	   can	   reduce	   the	   frequency	   of	   HFs	  
(Moilanen	  et	  al.,	  2012,	  Luoto	  et	  al.,	  2012,	  Karacan,	  2010,	  Reed	  et	  al.,	  2014,	  Lindh-­‐Astrand	  
et	   al.,	   2004)	   and	   reduce	   other	   non-­‐vasomotor	   symptoms	   including	   depression,	   anxiety	  
and	  insomnia	  (Daley	  et	  al.,	  2009,	   Ivarsson	  et	  al.,	  1998,	  Reed	  et	  al.,	  2014).	  To	  date	  these	  
studies	   have	   solely	   relied	   on	   subjective	   questionnaires	   as	   the	   primary	   outcome	   and/or	  
ambulatory	   skin	   conductance	  monitors	   (Daley	   et	   al.,	   2009,	   Sternfeld	   and	   Dugan,	   2011,	  
Luoto	  et	  al.,	  2012,	  Sternfeld	  et	  al.,	  2014).	  No	   study	   to	  date	  has	  examined	   the	  potential	  
physiological,	   specifically	   thermoregulatory	   and	   vascular,	   mechanisms	   of	   how	   exercise	  
training	  can	  improve	  menopausal	  HFs.	  
	  
Although	   the	   mechanisms	   of	   HFs	   are	   not	   completely	   understood,	   it	   is	   thought	   that	  
thermoregulatory	  dysfunction	  due	   to	   the	   reduction	   in	  oestrogen	   leads	   to	  HFs	   (Deecher	  
and	  Dorries,	  2007,	  Freedman,	  2001,	  Rance	  et	  al.,	  2013).	  	  An	  elevation	  in	  basal	  core	  body	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temperature	   and	   a	   narrowed	   thermo-­‐neutral	   zone	   are	   thought	   to	   be	   primary	  
explanations	  (Freedman	  (2001),	  and	  reduced	  skin	  vascular	  reactivity	  to	  increases	  in	  core	  
body	   temperature	   is	   also	   proposed	   (Charkoudian,	   2003,	   Deecher	   and	   Dorries,	   2007).	  
Therefore,	   examining	   the	   changes	   in	   the	   thermoregulatory	   control	   system	   and	  
vasculature	   function	   following	   exercise	   training	   may	   provide	   insight	   into	   the	   potential	  
mechanisms	  that	  cause	  reductions	  in	  the	  frequency	  of	  post-­‐menopausal	  HFs.	  	  
	  
Exercise	   training	   has	   been	   shown	   to	   enhance	   the	   efficiency	   of	   the	   thermoregulatory	  
control	   system	   by	   decreasing	   core	   body	   temperature,	   and	   improving	   thermoregulatory	  
control	   by	   changing	   both	   the	   threshold	   for	   the	   onset,	   and	   sensitivity,	   of	   sweating	   and	  
cutaneous	   vasodilation	   in	   pre-­‐menopausal	   females	   (Ichinose	   et	   al.,	   2009).	   	   HRT	   is	  
reported	   to	   affect	   thermoregulatory	   control	   mechanisms	   via	   lowering	   core	   body	  
temperature	   and	   altering	   the	   threshold	   at	   which	   cutaneous	   vasodilation	   and	   sweating	  
responses	  are	  initiated	  (Freedman	  and	  Blacker,	  2002,	  Dacks	  and	  Rance,	  2010,	  Tankersley	  
et	   al.,	   1992,	   Brooks	   et	   al.,	   1997).	   Moreover,	   exercise	   training	   improves	   endothelial	  
function	  in	  the	  cutaneous	  and	  conduit	  vessels	  in	  post-­‐menopausal	  females	  (Nyberg	  et	  al.,	  
2014,	  Hodges	  et	  al.,	  2010),	  and	  CBF	  in	  older	  individuals	  (Ainslie	  et	  al.,	  2008,	  Murrell	  et	  al.,	  
2013).	   Therefore,	   the	   aim	   of	   this	   study	   was	   to	   determine	   the	   effects	   of	   a	   structured	  
progressive	   aerobic	   exercise	   training	   intervention	   on	   subjective	   HFs,	   and	   secondly,	   to	  
explore	   whether	   these	   improvements	   are	   linked	   to	   positive	   thermoregulatory	   and	  
vascular	   adaptations	   in	   symptomatic	  post-­‐menopausal	   females.	   .	  We	  hypothesised	   that	  
exercise	  training	  reduces	  HFs	  via	   improving	  sweat	  rate	  and	  skin	  blood	  flow	  efficiency	  to	  






Twenty-­‐one	  symptomatic	  post-­‐menopausal	  females	  were	  recruited	  from	  the	  gynaecology	  
and	  reproductive	  medicine	  clinic	  at	  Liverpool	  Women’s	  Hospital,	   local	  G.P.	  practices	  and	  
via	   local	   advertisement.	   Participants	   were	   1-­‐4	   years	   since	   their	   last	   menstrual	   period	  
suffering	  from	  >4	  hot	  flushes	  over	  a	  24h	  period.	  All	  participants	  presented	  with	  no	  history	  
of	   type	   II	   diabetes,	   cardiovascular	  or	   respiratory	  disease,	  were	  non-­‐smokers,	  drank	  <14	  
units	  of	  alcohol	  per	  week,	  and	  had	  no	  contraindications	  to	  exercise.	  Participants	  who	  had	  
used	  HRT,	  metformin,	  vasoactive	  or	  BP	  lowering	  medications,	  or	  medication	  which	  could	  
alter	  vascular	  structure	  and/or	  function,	  within	  the	  last	  6	  months	  were	  excluded	  from	  the	  
study.	  Similarly,	   females	  who	  were	  currently	  taking	  part	   in	  regular	  exercise	  (>2h	  a	  week	  
based	  on	  a	  self-­‐reported	  questionnaire)	  were	  also	  excluded.	  Participants	  were	   informed	  
of	   the	  methods	   verbally	   and	   in	  writing	  before	  providing	  written	   informed	   consent.	   The	  
study	  conformed	  to	   the	  Declaration	  of	  Helsinki	  and	  was	  approved	  by	   the	   local	   research	  
ethics	  committee.	  	  
	  
4.2.2	  Research	  Study	  Design	  
Participants	   reported	   to	   the	   laboratory	   on	   two	   separate	   occasions.	   Visit	   one	   included	  
anthropometric	  measurements,	  assessment	  of	  brachial	  artery	  endothelial	  function	  using	  
FMD	  and	  a	  cardiorespiratory	  test	  (Modified	  Bruce	  protocol).	  Visit	  2	  consisted	  of	  a	  passive	  
heat	   stress	   challenge.	   For	   details	   of	   experimental	   procedures	   for	   these	  measurements	  




Fourteen	   (n=14,	   52±4y,	   29±6	   kg/m2)	   symptomatic	   females	   received	   a	   16-­‐week	  
programme	  of	  supervised	  moderate-­‐intensity	  aerobic	  exercise	  training	  while	  seven	  (n=7,	  
52±6y,	   30±7	   kg/m2)	   symptomatic	   females	   were	   used	   as	   a	   no-­‐exercise	   control	   group	  
(Figure	   4.1).	   All	   participants	   underwent	   visit	   1	   and	   2	   prior	   to	   and	   following	   either	   16-­‐
weeks	   of	   exercise	   or	   the	   no-­‐exercise	   control	   period.	   The	   control	   group	   continued	  with	  
their	   normal	   everyday	   routine	   in	   terms	   of	   physical	   activity	   and	   diet,	   and	   received	   no	  
contact	  with	  the	  research	  team	  at	  any	  point	  during	  the	  16-­‐week	  intervention	  period.	  
	   	  
	  
	  





4.2.3	  Hot	  Flush	  Frequency	  and	  Severity	  Questionnaire	  
Participants	  were	  asked	  to	  complete	  a	  7-­‐day	  HF	  frequency	  and	  severity	  diary	  (Sloan	  et	  al.,	  
2001)	  prior	  to,	  and	  following	  the	  16-­‐week	  intervention	  period.	  Participants	  were	  asked	  to	  
record	  on	  a	  daily	  basis	  how	  many	  HFs	   they	  experienced	  per	  day	  as	  well	   as	   information	  
regarding	   the	  severity	  of	  each	  HF	  on	  a	  scale	  of	  1-­‐4	   (1	  being	  mild,	  2	  moderate,	  3	  severe	  
and	  4	   very	   severe).	   From	   this,	   a	   7	  day	   sum	  of	  HFs	  provided	  a	  weekly	  HF	   score.	  A	  daily	  
severity	   score	  was	   calculated	   by	   the	   sum	  of	  HFs	   recorded	   into	   each	   severity	   rating	   i.e.	  
[(3*mild)+(4*moderate)+(1*severe)+(0*very	   severe)	   =	   daily	   severity	   score	   of	   14].	   	   A	  HF	  
severity	  index	  was	  then	  calculated	  by	  the	  total	  sum	  of	  daily	  severity	  scores	  over	  the	  7	  day	  
period.	  The	  use	  of	  subjective	  diaries	  has	  been	  established	  as	  a	  valid	  approach	  to	  obtaining	  
data	  on	  subjective	  HFs	  when	   reporting	  patient	   symptoms	  and	  perceptions	   (Sloan	  et	  al.,	  
2001)	  and	  in	  a	  number	  of	  HF	  research	  studies	  (Luoto	  et	  al.,	  2012,	  Moilanen	  et	  al.,	  2012,	  
Carpenter	  et	  al.,	  1999,	  Carpenter	  et	  al.,	  2002,	  Sternfeld	  et	  al.,	  2014).	  	  
4.2.4	  Supervised	  Exercise	  Training	  Intervention	  
Prior	   to	  commencing	   the	  exercise	   intervention,	  participants	   in	   the	  exercise	   intervention	  
group	  attended	  a	  gym-­‐based	  exercise	  familiarisation	  session	  at	  the	  Research	  Institute	  for	  
Sport	  and	  Exercise	  Sciences	  research	  gymnasium.	  In	  the	  first	   instance,	  participants	  were	  
required	   to	   undertake	   30	  minutes	   of	  moderate-­‐intensity	   aerobic	   exercise	   consisting	   of	  
treadmill	   walking/jogging,	   upright	   cycling,	   cross-­‐training	   and	   rowing.	   Participants	   were	  
required	   to	   attend	   the	   University	   gym	   at	   least	   once	   per	   week	   during	   which	   time	   they	  
wore	   a	   heart	   rate	  monitor	   (Polar	   Fitness,	   Polar	   Electro	  Oy,	   Finland)	   and	  were	  provided	  
with	   full	   exercise	   supervision	  and	  guidance	   from	  a	   trained	  exercise	  physiologist.	  During	  
these	   sessions,	  participants	  were	   issued	  with	  a	  weekly	  progressive	  exercise	  programme	  
that	   was	   specific	   to	   their	   own	   rate	   of	   progression.	   Exercise	   was	   primarily	   directed	   by	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heart	  rate	  responses	  and	  utilisation	  of	  the	  Borg	  scale	  (Borg,	  1970),	  with	  training	  protocol’s	  
specific	   to	   each	  participant’s	   basal	   fitness	   level	   (Sprung	  et	   al.,	   2013,	   Pugh	  et	   al.,	   2013).	  
During	   the	   initial	   4	   weeks	   of	   the	   intervention,	   participants	   underwent	   30	   minutes	   of	  
exercise	  three	  times	  per	  week	  at	  ~30%	  of	  heart	  rate	  reserve	  (HRR).	  This	  routine	  continued	  
from	   weeks	   5-­‐8,	   however	   during	   this	   period	   exercise	   workload	   was	   modified	   so	   that	  
participants	  maintained	  ~45%HRR.	  From	  week	  9	  to	  12	  participants	  continued	  to	  maintain	  
a	  45%	  HRR	  workload	  whilst	  the	  duration	  of	  each	  session	  increased	  to	  45	  minutes.	  Finally,	  
from	   week	   13	   to	   16	   the	   duration	   of	   each	   session	   lasted	   between	   45-­‐60	   minutes	   at	  
60%HRR	  and	  participants	  underwent	  5	  sessions	  per	  week	  (Figure	  4.2).	  HRR	  was	  calculated	  
as	  [(Max	  HR-­‐Resting	  HR)	  x	  Intensity]	  +	  Resting	  HR.	  Maximal	  and	  resting	  HR	  measures	  were	  
calculated	   during	   the	   maximal	   oxygen	   consumption	   test	   completed	   prior	   to	   exercise	  
training.	   Participants	   were	   closely	   monitored	   to	   ensure	   the	   maintenance	   of	   their	  
individually	   prescribed	   RPE	   and	   HRR.	   Furthermore,	   to	   facilitate	   maximum	   compliance	  
throughout	   the	   16-­‐week	   period,	   all	   participants	   used	   the	   Wellness	   Key©	   system	  
(TechnoGym,	   UK).	   This	   is	   a	   software	   programme	   that	   enables	   remote	   and	   accurate	  
tracking	  of	  exercise	  activity.	  No	  dietary	  modifications	  were	  made	  throughout	  the	  course	  
of	   the	  exercise	   intervention,	   confirmed	  by	  use	  of	  a	   standard	   food	  diary	  at	  baseline	  and	  
post	  intervention.	  	  
	   	  
	  
Figure	  4.2	  Schematic	  of	  study	  design	  including	  the	  progressive	  exercise	  training	  protocol	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4.2.5	  Statistical	  Analysis	  
The	   mean	   body/core	   temperature	   thresholds	   for	   the	   onset	   of	   sweating	   (mean	   body	  
temperature)	  and	  cutaneous	  vasodilation	   (core	  body	   temperature)	  were	  calculated	   in	  a	  
blinded	   fashion	   by	   the	   same	   analyst	   (Cheuvront	   et	   al.,	   2009).	   The	   sensitivity	   of	   the	  
sweating	   responses	  were	  estimated	   from	   the	   slope	  of	   the	   relationships	  between	   sweat	  
rate	   per	   unit	   change	   in	   mean	   body	   temperature	   beyond	   the	   mean	   body	   temperature	  
threshold,	   and	   any	   sweat	   rate	   plateau,	   or	   increase	   during	   a	   hot	   flush	   episode,	   was	  
excluded	  from	  the	  slope	  calculation.	  Skin	  blood	  flow	  sensitivity	  was	  estimated	  in	  the	  same	  
way,	   instead	   using	   the	   rate	   of	   CVC	   per	   unit	   change	   in	   core	   temperature.	   A	   two	  
(intervention*time)	  factor	  linear	  mixed	  model	  was	  employed	  to	  analyse	  HF	  frequency,	  HF	  
severity	  index,	  VO2peak,	  and	  FMD	  [with	  baseline	  diameter	  entered	  as	  a	  covariate	  to	  control	  
for	   exercise-­‐induced	   changes	   in	   baseline	   (Atkinson	   and	   Batterham,	   2013)],	   alongside	  
resting	  baseline	  variables	  and	  temperature	  thresholds	  and	  sensitivities	  of	  sweat	  rate	  and	  
skin	   blood	   flow	   during	   the	   passive	   heat	   stress.	   A	   three-­‐way	  
(intervention*time*temperature)	   linear	  mixed	  model	  was	   employed	   for	   the	   analysis	   of	  
CBF	  in	  response	  to	  each	  0.1ºC	  increase	  in	  core	  body	  temperature,	  during	  the	  passive	  heat	  
stress.	   Statistically	   significant	   interactions	   were	   followed	   up	   with	   the	   least	   significant	  
difference	   (LSD)	   approach	   to	   multiple	   comparisons	   (Perneger,	   1998).	   Due	   to	   variable	  
increments	   in	   core	   body	   temperature	   during	   the	   passive	   heat	   stress,	   data	   up	   to	   an	  
increase	  of	  0.6ºC	  were	  used	  for	  CBF	  analysis.	  




Females	  that	  completed	  the	  exercise	  training	  intervention	  demonstrated	  93%	  compliance	  
to	  exercise	  sessions.	  
4.3.1	  Cardiorespiratory	  Fitness	  
There	   was	   a	   significant	   intervention*time	   interaction	   (P<0.001)	   in	   cardiorespiratory	  
fitness	   (VO2peak).	   VO2peak	   improved	   by	   4.45	   ml·∙kg-­‐1·∙min-­‐1	   (95%	   CI,	   3.40,	   6.49;	   P<0.001)	  
following	  exercise	  training	  compared	  to	  a	  negligible	  change	  of	  -­‐0.60	  ml·∙kg-­‐1·∙min-­‐1	  (95%	  CI,	  
-­‐2.07,	  0.88;	  P=0.41)	  in	  the	  no-­‐exercise	  control	  group.	  
4.3.2	  Hot	  flush	  frequency	  and	  severity	  
There	  was	  a	   significant	  main	  effect	  of	   time	   (P<0.001)	  and	   intervention*time	   interaction	  
(P<0.001)	  for	  both	  HF	  weekly	  frequency	  and	  weekly	  HF	  severity	  index	  (Table	  4.1).	  Exercise	  
training	  reduced	  HF	  weekly	  frequency	  by	  39	  HF·∙wk	  (95%	  CI,	  31-­‐47;	  P<0.001)	  compared	  to	  
a	  negligible	  change	  of	  5	  HF·∙wk	  (95%	  CI,	  -­‐6	  to	  16;	  P=0.33)	  in	  the	  no-­‐exercise	  control	  group.	  
This	  coincided	  with	  a	  reduction	  in	  HF	  severity	  index	  by	  101	  AU	  (95%	  CI,	  80	  to	  121;	  P=0.01)	  
following	  exercise	  training	  compared	  a	  negligible	  change	  of	  9	  (95%	  CI,	  -­‐20	  to	  37;	  P=0.56)	  
in	  the	  no-­‐exercise	  control	  group.	  
4.3.3	  Conduit	  brachial	  artery	  endothelial	  function	  
There	  was	  a	  significant	  intervention*time	  interaction	  (P=0.008)	  for	  FMD%.	  FMD	  increased	  
by	  2.32%	  (95%	  CI	  1.33,	  3.31;	  P<0.001)	  following	  exercise	  training	  compared	  to	  a	  negligible	  
change	   of	   -­‐0.6%	   (95%	   CI,	   -­‐1.3,	   1.24;	   P=0.96)	   in	   the	   no-­‐exercise	   control	   group.	   The	  
intervention	  did	  not	  impact	  on	  brachial	  artery	  diameter,	  time-­‐to-­‐peak	  diameter	  and	  shear	  









































































































































































































































































































































































































































































































































































































































































































































































































4.3.4	  Haemodynamic	  and	  thermoregulatory	  measurements	  prior	  to	  heating	  
4.3.4.1	  Haemodynamics	  
	  
Heart	   rate	   was	   3	   beats·∙min-­‐1	   (95%	   CI,	   1,	   5;	   P=0.03)	   lower	   following	   exercise	   training	  
compared	  to	  no	  change	  in	  control	  [0	  beats·∙min-­‐1	  (95%	  CI,	  -­‐1,	  1)].	  There	  was	  no	  main	  effect	  
of	   intervention	   or	   intervention*time	   interaction	   in	   mean	   arterial	   pressure	   or	   cardiac	  
output.	   Stroke	   volume	   was	   7	   ml	   (95%	   CI,	   -­‐3,	   10)	   higher	   following	   exercise	   training	  
compared	   to	   a	   difference	   of	   2	  ml	   (95%	   CI,	   -­‐4.8,	   2.5)	   in	   the	   no-­‐exercise	   control	   group,	  
however	  this	  did	  not	  reach	  statistical	  significance	  (P=0.14;	  Table	  4.2).	  
	  
4.3.4.2	  Thermoregulatory	  	  
Skin	   temperature	  was	   not	   different	   between	   interventions	   or	   over	   time	   (P>0.05;	   Table	  
4.2).	   There	  was	   a	   significant	   intervention*time	   interaction	   (P=0.05)	   for	   basal	   core	  body	  
temperature.	   Basal	   core	   body	   temperature	   was	   0.14°C	   (95%	   CI,	   0.03,	   0.20)	   lower	  
following	   exercise	   training	   compared	   to	   no	   change	   in	   control	   [0.01°C	   (95%	   CI,	   -­‐0.01,	  
0.03)].	  	  
	  
There	  were	  no	  significant	  main	  effects	  for	  resting	  skin	  blood	  flow	  at	  the	  chest	  or	  forearm	  
(Table	   4.2).	   	   There	   was	   a	   significant	   intervention*time	   interaction	   for	   forearm	   CVCmax	  
(P=0.03)	   during	   local	   maximal	   heating,	   which	   was	   0.70	   AU/mmHg	   (95%	   CI,	   0.25,	   1.15;	  
P=0.004)	  higher	  following	  exercise	  compared	  to	  no	  change	  following	  no-­‐exercise	  control	  
[0.18	  AU/mmHg	  (95%	  CI,	  -­‐0.21,	  0.43;	  P=0.65)].	  There	  were	  no	  significant	  main	  effects	  for	  




4.3.4.3	  Cerebral	  Blood	  Flow	  	  
There	  was	  a	  significant	  intervention*time	  interaction	  in	  basal	  MCAv	  (P=0.04).	  MCAv	  was	  
3.1	   cm/s	   (95%	   CI,	   1.2,	   5.0;	   P=0.03)	   higher	   following	   exercise	   training	   compared	   to	   a	  
negligible	   change	   of	   0.2	   cm/s	   (95%	   CI,	   -­‐2.2,	   2.3;	   P=0.98;	   Table	   4.2).	   Cerebral	   vascular	  
conductance	   (CBVC)	  was	  also	  0.05	  cm·∙s-­‐1·∙mmHg-­‐1	   (95%	  CI,	   -­‐0.01	   to	  0.07;	  P=0.02)	  higher	  
following	  exercise	  training	  compared	  to	  no	  change	  following	  the	  no-­‐exercise	  control	  [0.02	  
(95%	   CI,	   -­‐0.02,	   0.03;	   P=0.83)].	   There	   was	   no	   significant	   main	   effects	   of	   intervention	  
(P=0.21),	  time	  (P=0.88)	  or	  intervention*time	  interaction	  (P=0.85)	  for	  PETCO2	  at	  rest.	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4.3.5	  Haemodynamic	  and	  thermoregulatory	  responses	  during	  the	  heat	  stress	  challenge	  
6.3.5.1	  Haemodynamics	  
Changes	  in	  heart	  rate,	  mean	  arterial	  pressure,	  stroke	  volume	  and	  cardiac	  output	  were	  not	  
different	  between	  interventions	  or	  over	  time	  (P<0.05).	  
4.3.5.2	  Thermoregulatory	  
Changes	   in	   core	   body	   temperature	   and	   skin	   temperature	   were	   similar	   between	  
interventions	   and	  over	   time,	  whilst	   there	  was	  no	   interaction	  between	   intervention	   and	  
time	  (P>0.05).	  
4.3.5.3	  Sweat	  rate	  
There	   was	   a	   significant	   intervention*time	   interaction	   for	   chest	   and	   forearm	   sweating	  
mean	   body	   temperature	   thresholds	   (P<0.05,	   Figure	   4.3).	   The	   onset	   of	   chest	   sweating	  
occurred	   at	   a	   0.22°C	   (95%	   CI,	   0.13,	   0.32;	   P<0.001)	   lower	   mean	   body	   temperature	  
following	  exercise	  training	  compared	  to	  a	  negligible	  change	   in	  control	   [0.01°C	  (95%	  CI,	   -­‐
0.08,	  0.09;	  P=0.98);	  Figure	  4.3A].	  Similarly,	   the	  onset	  of	   forearm	  sweating	  occurred	  at	  a	  
0.21°C	   (95%	   CI,	   0.12,	   0.31;	   P<0.001)	   lower	  mean	   body	   temperature	   following	   exercise	  
training	  compared	  to	  a	  negligible	  change	  in	  control	  [0.02°C	  (95%	  CI,	  -­‐0.12,	  0.13;	  P=0.89);	  
Figure	  4.3B].	  
	  
There	   was	   a	   significant	   intervention*time	   interaction	   for	   sweat	   rate	   sensitivity	   at	   the	  
chest	   (P=0.01;	   Figure	   4.3).	   The	   rate	   of	   sweating	   at	   the	   chest	   increased	   by	   0.26	  
mg·∙cm2·∙min-­‐1	   (95%	   CI,	   0.10,	   0.41;	   P=0.002)	   following	   exercise	   training	   compared	   to	   a	  
negligible	  change	  in	  control	  [0.04	  (95%	  CI,	  -­‐0.06,	  0.09;	  P=	  0.35);	  Figure	  4.3C].	  Similarly	  at	  
the	  forearm,	  there	  was	  a	  significant	  intervention*time	  interaction	  (P=0.01)	  with	  the	  rate	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of	   sweating	   increased	   by	   0.18	   mg·∙cm2·∙min-­‐1	   (95%	   CI,	   0.09,	   0.27;	   P=0.001)	   following	  
exercise	  training	  compared	  to	  a	  negligible	  change	  in	  control	  [0.03	  (95%	  CI,	  -­‐0.06,	  0.09;	  P=	  
0.59)].	  
	   	  
	  
Figure	  4.3	  Mean	  body	  temperature	  threshold	  for	  the	  onset	  of	  chest	  (A)	  and	  forearm	  (B)	  sweating.	  
Sweat	  rate	  sensitivity	  (slope)	  at	  the	  chest	  (C)	  and	  forearm	  (D).	  Error	  bars	  are	  SD.	  
*significant	  difference	  between	  pre	  (black	  bars)	  and	  post	  (grey	  bars);	  #denotes	  significant	  
interaction	  between	  interventions	  (P<0.05).	  
108	  
	  
4.3.5.4	  Cutaneous	  blood	  flow	  
There	   was	   a	   significant	   interaction	   between	   intervention	   and	   time	   for	   core	   body	  
temperature	   threshold	   for	   cutaneous	   vasodilation	   at	   the	   chest	   (P=0.004)	   and	   forearm	  
(P=0.004).	  	  The	  onset	  of	  chest	  cutaneous	  vasodilation	  occurred	  at	  a	  0.21°C	  (95%	  CI,	  0.14,	  
0.29;	  P<0.001)	   lower	   core	   body	   temperature	   following	   exercise	   training	   compared	   to	   a	  
negligible	   change	   following	   control	   [0.02°C	   (95%	   CI,	   -­‐0.07,	   0.09;	   P=0.70);	   Figure	   4.4A].	  
Similarly,	   the	   onset	   of	   arm	   cutaneous	   vasodilation	   occurred	   at	   a	   0.21°C	   (95%	   CI,	   0.14,	  
0.27;	  P<0.001)	   lower	   core	   body	   temperature	   following	   exercise	   training	   compared	   to	   a	  
negligible	  change	  following	  control	  [0.04°C	  (95%	  CI,	  -­‐0.05,	  0.09;	  P=0.70)	  Figure	  4.4B].	  The	  
CVC	  slope	  was	  not	  significantly	  different	  between	  interventions	  (chest,	  P=0.29;	  forearm,	  
P=0.67),	  over	  time	  (chest,	  P=0.64;	  forearm,	  P=0.26)	  with	  no	  significant	  intervention*time	  
interaction	  (chest,	  P=0.90;	  forearm,	  P=0.22;	  Figure	  4.4C&D).	  	  
4.3.5.5	  Cerebral	  blood	  flow	  
CBF	  decreased	  during	  the	  heat	  stress	  (P<0.001).	  There	  was	  a	  significant	  intervention*time	  
interaction	   (P<0.001),	  where	   the	   reduction	   in	  MCAv	   during	   heat	   stress	  was	   attenuated	  
following	  exercise	  training	  compared	  to	  a	  negligible	  change	  in	  control	  (Table	  4.3).	  MCAv	  
was	  4.5	  cm/s	  (95%	  CI,	  3.6,	  5.5,	  P<0.001)	  higher	  during	  heating	  following	  exercise	  training	  
compared	  to	  0.6	  cm/s	  (95%	  CI,	  -­‐0.4,	  1.4;	  P=0.24)	  in	  control.	  PETCO2	  decreased	  during	  heat	  
stress	  (P<0.001),	  with	  no	  significant	  main	  effects	  or	   intervention*time	  interaction	  (Table	  
4.3;	   P<0.05).	   Similarly,	   CBVC	   decreased	   during	   the	   heat	   stress	   (P<0.001).	   There	   was	   a	  
significant	  intervention*time	  interaction	  (P=0.01).	  CBVC	  was	  0.07	  cm·∙s-­‐1·∙mmHg-­‐1	  (95%	  CI,	  
0.04,	   0.09;	   P<0.001;	   Figure	   4.5A)	   higher	   during	   heat	   stress	   following	   exercise	   training	  
compared	   to	  no	  difference	   following	   the	  control	   intervention	   [0.01	  cm·∙s-­‐1·∙mmHg-­‐1	   (95%	  
CI,	  -­‐0.01,	  0.02;	  P=0.49);	  Figure	  4.5B].	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Figure	  4.4	  Mean	  core	  body	  temperature	  threshold	  values	  for	  onset	  of	  chest	  (A)	  and	  forearm	  (B)	  
cutaneous	  vasodilation.	  CVC	  sensitivity	  at	  the	  chest	  (C)	  and	  forearm	  (D).	  Error	  bars	  are	  SD.	  
*significant	  difference	  between	  pre	  (black	  bars)	  and	  post	  (grey	  bars);	  #denotes	  significant	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The	  novel	  findings	  of	  the	  present	  study	  were	  that	  reductions	  in	  the	  subjective	  ratings	  of	  
frequency	   and	   severity	   of	   HFs	   with	   exercise	   training	   coincided	   with	   improved	  
thermoregulatory,	   conduit	   and	   cerebrovascular	   function	   in	   post-­‐menopausal	   females.	  
These	   findings	  provide	  evidence	  that	   improving	  thermoregulatory	  and	  (cerebro)vascular	  
control	   with	   moderate-­‐intensity	   aerobic	   exercise	   training	   can	   be	   effective	   in	   the	  
treatment	  of	  HFs	  in	  post-­‐menopausal	  females.	  
	  
Exercise	   training	  has	  previously	  been	  shown	  to	   improve	   the	  subjective	   ratings	  of	  HFs	   in	  
post-­‐menopausal	  females	  (Moilanen	  et	  al.,	  2012,	  Luoto	  et	  al.,	  2012,	  Karacan,	  2010,	  Reed	  
et	  al.,	  2014,	  Lindh-­‐Astrand	  et	  al.,	  2004),	  but	  the	  underlying	  physiological	  mechanisms	  of	  
how	   this	   occurs	   has	   not	   been	   previously	   investigated.	   The	   results	   of	   the	   current	   study	  
suggest	  that	  the	   improvements	   in	  the	  occurrence	  of	  post-­‐menopausal	  HFs	  following	  16-­‐
weeks	   of	   moderate-­‐intensity	   aerobic	   exercise	   training	   are	   linked	   to	   improvements	   in	  
thermoregulatory	   efficiency.	   The	   data	   suggest	   that	   exercise	   training	   improves	  
thermoregulatory	   dysfunction	   via	   stabilisation	   of	   central	   thermoregulatory	   control	   i.e.	  
lowering	   core	   body	   temperature	   and	   improving	   heat	   dissipation	   thresholds,	   alongside	  
improvements	  in	  peripheral	  mechanisms	  that	  allow	  for	  greater	  heat	  dissipation	  (sweating	  
sensitivity),	  and	  thus	  thermoregulatory	  efficiency.	  Importantly,	  these	  findings	  of	  improved	  
thermoregulatory	  efficiency	  with	  exercise	  training	  support	  previous	  studies	  that	  suggest	  
an	   improvement	   in	   VO2peak	   in	   the	   range	   of	   ~15-­‐20%	   mediates	   positive	   adaptations	   to	  
thermoregulatory	   function	   (Pandolf,	   1979,	   Ichinose	   et	   al.,	   2009).	   For	   example,	   this	   has	  
been	   shown	   in	   pre-­‐menopausal	   females	   following	   a	   similar	   intensity	   exercise	   training	  
intervention	   (Ichinose	   et	   al.,	   2009).	  Nevertheless,	   this	   is	   the	   first	   study	   to	   demonstrate	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that	  post-­‐menopausal	   females	  can	   improve	  thermoregulatory	   function,	  and	   intriguingly,	  
that	  this	  can	  contribute	  to	  alleviating	  the	  frequency	  and	  severity	  of	  HFs.	  	  
	  
The	  precise	  mechanisms	  underlying	  the	  pathophysiology	  of	  HFs	   is	  unclear;	  however	   it	   is	  
acknowledged	   that	   thermoregulatory	   dysfunction	   is	   a	   key	   contributing	   factor	   (Deecher	  
and	   Dorries,	   2007,	   Freedman,	   2014a,	   Stearns	   et	   al.,	   2002).	   Elevated	   basal	   core	   body	  
temperature	  and	  a	  narrowing	  of	  the	  thermo-­‐neutral	  zone	  (null	  zone	  where	  shivering	  and	  
sweating	  do	  not	  occur)	  are	  thought	  to	  be	  responsible	  for	  the	  large,	  rapid	  increases	  in	  skin	  
blood	   flow,	   sweating	   and	   flushing	   that	   characterise	   HFs	   (Freedman,	   2001).	   However,	   a	  
narrowing	  of	   the	   thermo-­‐neutral	   zone	   to	  ~0.0ºC	  as	   reported	  by	   Freedman	  et	  al.	   (2001)	  
would	   suggest	   that	   any	   increase	   in	   core	   body	   temperature	   (>0.01ºC)	  would	   continually	  
trigger	  cutaneous	  vasodilation	  and/or	  sweating,	  yet	  this	  does	  not	  characterise	  the	  rapid	  
increases	  observed	  during	  HFs	  (Low	  et	  al.,	  2010,	  Low	  et	  al.,	  2008a).	  Instead,	  it	  is	  possible	  
that	  a	  fluctuating	  core	  body	  temperature	  and	  threshold(s)	  for	  cutaneous	  vasodilation	  and	  
sweating	   are	   responsible	   for	   HFs	   in	   symptomatic	   females.	   This	   study	   suggests	   that	  
improving	   the	   control	   of	   the	   thermoregulatory	   system	   through	   lowering	   core	   body	  
temperature	  and	   improving	  heat	  dissipation	  mechanisms	  per	  se	  reduces	  the	  occurrence	  
of	  HFs.	  	  
	  
The	  improvements	  in	  thermoregulatory	  efficiency	  (lowered	  thresholds,	  increased	  slopes),	  
may	  be	  due	  a	  variety	  of	  central	  and/or	  peripheral	  adaptations	  as	  a	  result	  of	  the	  exercise	  
training	  intervention.	  These	  mechanisms	  are	  likely	  mediated	  via	  changes	  in	  the	  sweating	  
response	   and	   include	   increases	   in	   the	   number	   of	   sweat	   expulsions	   per	  minute	   (Ogawa	  
and	   Sugenoya,	   1993),	   sweat	   gland	   hypertrophy	   (Inoue	   et	   al.,	   1999),	   increased	   NO	  
availability	   (Welch	   et	   al.,	   2009),	   and/or	   	   enhanced	   sweat	   gland	   recruitment	   at	   a	   given	  
114	  
	  
internal	  temperature,	  or	  indeed,	  a	  combination	  of	  all	  of	  the	  above	  (Shibasaki	  et	  al.,	  2006).	  
Regardless	  of	  the	  exact	  mechanism,	  this	  study	  suggests	  that	  improved	  thermoregulatory	  
function	   in	  post-­‐menopausal	   females	   following	  exercise	  training,	   leads	  to	  a	  reduction	   in	  
the	  occurrence	  of	  HFs.	  
	  
The	   ability	   of	   the	   blood	   vessels	   (including	   the	   cutaneous,	   conduit	   and	   cerebral	  
vasculature)	   to	   vasodilate	   and	   thus	   deliver	   blood	   flow	   systemically	   also	   contributes	   to	  
thermoregulatory	   control.	   The	   reduction	   in	   oestrogen	   associated	   with	   the	   menopause	  
causes	  endothelial	  dysfunction	  via	  decreased	  NO	  bioavailability	  (Virdis	  et	  al.,	  2000)	  and/or	  
increased	   reactive	   oxygen	   species	   scavenging	   NO	   (Kojda	   and	   Harrison,	   1999).	   Exercise	  
increases	  eNOS	  expression	  via	  similar	  mechanisms	  of	  transcriptional	  regulation	  to	  that	  of	  
oestrogen	  (Chambliss	  and	  Shaul,	  2002).	  Arterioles	  exposed	  to	  oestrogen	  in	  vitro	  exhibit	  an	  
upregulation	  of	  eNOS	  and	  augmented	  NO-­‐mediated	  vasodilation	  in	  response	  to	  increased	  
flow	  and	  shear	  stress	  (Huang	  et	  al.,	  2000),	  similar	  to	  the	  responses	  observed	  with	  exercise	  
training	  (Green	  et	  al.,	  2004b).	  A	  novel	  finding	  of	  the	  current	  study	  was	  that	  NO-­‐mediated	  
conduit	   artery	   endothelial	   function,	   measured	   using	   FMD,	   improved	   following	   the	  
exercise	   training	   intervention.	   Previous	   studies	   in	   post-­‐menopausal	   females	   have	   not	  
observed	  exercise-­‐mediated	   increases	   in	  endothelial	   function	  using	  FMD	  (Moreau	  et	  al.,	  
2013,	   Pierce	   et	   al.,	   2011).	   The	   exercise	   stimulus	   (unsupervised	  walking	   (Moreau	   et	   al.,	  
2013)	  vs	  supervised	  moderate	  intensity	  exercise	  in	  the	  current	  study)	  is	  likely	  responsible	  
for	  these	  differing	  findings	  given	  that	  supervised	  moderate	  intensity	  exercise	  training	  has	  
been	   shown	   to	   enhance	   cutaneous	   endothelial	   function	   and	  microvascular	   reactivity	   in	  
post-­‐menopausal	   females	   previously	   (Hodges	   et	   al.,	   2010,	   Tew	   et	   al.,	   2012a).	  
Nevertheless,	   this	   is	   the	   first	   investigation	   of	   exercise	  mediated	   changes	   in	   endothelial	  
function	   in	   symptomatic	   post-­‐menopausal	   females.	   Recent	   research	   studies	   have	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suggested	   that	   menopausal	   HFs	   are	   associated	   with	   greater	   vascular	   impairments	  
including	  endothelial	  dysfunction	  (Thurston	  et	  al.,	  2008b),	  with	  endothelial	  dysfunction	  a	  
main	   determinant	   of	   HF	   severity	   in	   early	   post-­‐menopausal	   females	   (Bechlioulis	   et	   al.,	  
2010).	   Therefore,	   it	   is	   likely	   that	   this	   group	   of	   females	   have	   greater	   impairments	   in	  
endothelial	  function	  and	  cardiovascular	  disease	  risk,	  a	  condition	  that	  exercise	  training	  in	  
this	  study	  appears	  to	  ameliorate.	  
	  
Reductions	  in	  CBF	  are	  evident	  during	  a	  HF	  (Lucas	  et	  al.,	  2013)	  and	  during	  a	  passive	  heat	  
stress	  challenge	  (Brothers	  et	  al.,	  2009,	  Low	  et	  al.,	  2009,	  Low	  et	  al.,	  2008b)	  and	  thus	  are	  
implicated	   in	   thermoregulatory	   control,	   via	  a	   reduction	   in	   the	  delivery	  of	  blood	   flow	   to	  
the	   thermoregulatory	   centre	   in	   the	   brain.	   Improved	   basal	   blood	   flow	   delivery	   to	   the	  
cerebral	   circulation	   was	   observed	   with	   exercise	   training	   along	   with	   attenuation	   in	   the	  
reduction	  of	  CBF	  typically	  observed	  with	  passive	  heat	  stress	  in	  the	  current	  study.	  Whilst,	  
Murrell	  et	  al.	   (2013)	   recently	   suggested	   that	  a	   short-­‐term	  exercise	   training	   intervention	  
improved	   cerebrovascular	   health	   across	   the	   lifespan;	   this	   is	   the	   first	   study	   to	   establish	  
that	  short-­‐term	  exercise	  training	  enhances	  basal	  MCAv	  in	  post-­‐menopausal	  females,	  and	  
that	  this	  reduction	  remains	  evident	  when	  normalised	  for	  blood	  pressure	  (CBVC),	  with	  no	  
differences	   in	   PETCO2.	  No	   study	   to	   date	   has	   examined	   the	   exercise	  mediated	   change	   in	  
CBF	  during	  passive	  heat	   stress,	   yet	   given	   that	  CBF	   reductions	  occur	  during	   a	  HF	   (which	  
could	   be	   described	   as	   a	   heat	   stress	   response)	   it	   is	   plausible	   that	   an	   exercise	  mediated	  
attenuation	  in	  CBF	  decreases	  during	  heat	  stress	  may	  positively	  impact	  on	  cerebrovascular	  
control	   during	   a	  HF.	   The	  mechanisms	   responsible	   for	   these	   adaptions	   could	   include	   an	  
exercise-­‐mediated	   increases	   in	   stroke	   volume	   (Stratton	   et	   al.,	   1994)	   related	   to	   plasma	  
volume	   expansion	   (Nielsen	   et	   al.,	   1993,	   Schlader	   et	   al.,	   2013)	   and/or	   improved	  
endothelial	  function	  (Ainslie	  et	  al.,	  2007)	  (see	  Chapter	  6	  for	  further	  discussion).	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An	   alternative	   although	   not	  mutually	   exclusive	   explanation	   for	   the	   improvement	   in	   HF	  
occurrence	   could	  be	   related	   to	   the	   central	   sympathetic	   nervous	   system	   that	   influences	  
cutaneous,	   conduit	   and	   cerebral	   vasculature	   by	   activating	   decreases	   and	   increases	   in	  
blood	   flow	   via	   the	   noradrenergic	   and	   cholinergic	   systems,	   respectively	   (Johnson	   et	   al.,	  
2014,	  Ainslie	  and	  Duffin,	  2009),	  whilst	  the	  latter	  also	  activates	  sweating	  onset	  (Shibasaki	  
et	   al.,	   2006).	   Sympathetic	   noradrenergic	   nerve	   outflow	   increases	   following	   the	  
menopause	  (Hart	  et	  al.,	  2011),	  and	  elevates	  peripheral	  vascular	  resistance	  (Charkoudian	  
and	  Wallin,	   2014),	  while	   sympathetic	   cholinergic	   nerve	   activity	   is	   also	   increased	   during	  
HFs	   (Low	   et	   al.,	   2010).	   Moreover,	   Oneda	   et	   al.	   (2014)	   reported	   reduced	   muscle	  
sympathetic	   nerve	   activity	   (MSNA),	   an	   index	   of	   sympathetic	   nerve	   activity	   measured	  
using	   microneuography,	   in	   post-­‐menopausal	   females	   following	   6-­‐months	   of	   moderate-­‐
intensity	   cycling	   exercise	   alongside	   improvements	   in	   forearm	   blood	   flow.	   Although	   not	  
directly	  assessed	  in	  this	  study,	  reductions	  in	  sympathetic	  nerve	  activity	  are	  likely	  following	  
exercise	  training	  that	  could	  have	  directly	  reduced	  the	  occurrence	  of	  HFs	  in	  this	  study,	  or	  
indirectly,	  by	  reducing	  vascular	  resistance.	  
	  
The	   impact	   of	   a	   reduction	   in	   BMI	   with	   exercise	   training	   on	   HFs	   also	   deserves	  
consideration.	  Reductions	  in	  BMI	  were	  evident	  with	  exercise	  training	  in	  the	  current	  study	  
in	   accordance	   with	   one	   previous	   study	   that	   reported	   lower	   BMI	   and	   HF	   symptoms	  
following	  increases	  in	  self-­‐reported	  physical	  activity	  (van	  Poppel	  and	  Brown,	  2008).	  Whilst	  
the	   role	   of	   BMI	   on	   HF	   prevalence	   is	   unclear,	   observational	   studies	   have	   reported	   that	  
females	  with	  low	  (Schwingl	  et	  al.,	  1994)	  and	  high	  (Thurston	  et	  al.,	  2008a,	  van	  Poppel	  and	  
Brown,	   2008)	   body	   fat	   are	   at	   increased	   risk	   of	   HFs.	   Although	   speculative,	   increased	  




Despite	  the	  benefits	  of	  the	  exercise	  training	  intervention	  on	  reducing	  both	  the	  frequency	  
and	   severity	   of	   HFs,	   HFs	   were	   not	   completely	   abolished	   (~62%	   reduction	   in	   weekly	  
frequency)	   following	   exercise	   training.	   Nevertheless,	   these	   responses	   mimic	   those	  
observed	   (~50-­‐72%	   reduction	   in	   HFs)	   following	   HRT	   administration	   in	   symptomatic	  
females	  over	  a	  short-­‐time	  frame	  i.e.	  12-­‐16	  weeks	  (Utian	  et	  al.,	  2004).	  HRT	  administration	  
over	  a	   longer	   time-­‐frame	  (i.e.	  12	  months)	   further	  reduces	  HFs	   (MacLennan	  et	  al.,	  1993,	  
Maclennan	  et	  al.,	  2004)	  and	  thus	  the	  effects	  of	  exercise	  training	  may	  also	  further	  alleviate	  
HFs	   in	   a	   similar	   dose-­‐response	   manner,	   and	   should	   be	   considered	   in	   future	   studies.	  
Despite	   a	   similar	   effect	   i.e.	   reduction	   in	   HFs,	   it	   is	   currently	   unknown	   if	   the	   effects	   of	  
exercise	  and/or	  HRT	  act	  via	  the	  same	  mechanisms.	  A	  distinct	  difference	  with	  HRT	   is	  the	  
re-­‐introduction	   of	   oestrogen,	   known	   to	   be	   the	   primary	   cause	   of	   HFs	   (in	   its	   absence)	  
during	   the	   menopause	   (Freedman,	   2001),	   and	   thus	   potentially	   restoring	   ‘normal	  
function’.	   Conversely,	   exercise	   training	  may	   directly	   target	   the	   area	   of	   dysfunction	   i.e.	  
thermoregulatory	  control	  in	  the	  absence	  of	  oestrogen.	  Whether	  the	  combined	  effects	  of	  
exercise	  training	  and	  HRT	  further	  improve	  HFs	  and	  offset	  the	  increases	  in	  cardiovascular	  
risk	   observed	   with	   HRT	   (Sare	   et	   al.,	   2008,	   Rossouw	   et	   al.,	   2002)	   is	   worth	   considering.	  
Furthermore,	  whether	  the	  positive	  effects	  of	  exercise	  on	  reducing	  HFs	  remain	  following	  
cessation	  of	  exercise	  training	  is	  currently	  unknown;	  however	  it	  can	  be	  speculated	  that	  the	  
positive	  effects	  may	  be	  transient	  in	  the	  absence	  of	  exercise	  training	  i.e.	  ~4	  weeks,	  in	  line	  
with	   the	   reductions	   observed	   in	   thermoregulatory	   function	   following	   the	   cessation	   of	  
exercise	  training	  in	  young	  females	  (Ichinose	  et	  al.,	  2009).	  
	  
One	  limitation	  of	  this	  study	  is	  that	  it	  was	  not	  a	  randomised	  control	  trial,	  with	  participants	  
free	   to	   choose	  which	   treatment	   group	   they	   entered.	  Whilst	   these	   findings	   are	   labelled	  
preliminary	  and	  need	   to	  be	  confirmed	   in	  a	   larger	   randomised	  control	   intervention	   trial,	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the	  reduction	  in	  HF	  frequency	  in	  the	  exercise	  group	  is	  similar	  to	  that	  observed	  in	  previous	  
studies,	   and	   the	  HF	   frequency	   remained	  unchanged	   in	   the	   control	   group.	   Furthermore,	  
thermoregulatory	   measurements	   are	   objective	   and	   cannot	   be	   influenced	   by	   the	  
participant	  (Cheuvront	  et	  al.,	  2009),	  and	  were	  analysed	  in	  a	  blinded	  fashion.	  Nonetheless,	  
it	  is	  acknowledged	  that	  the	  current	  findings	  are	  specific	  to	  early	  post-­‐menopausal	  females	  
(1-­‐4y	   since	   last	   menstrual	   period)	   that	   were	   free	   of	   cardiovascular	   disease	   and	   not	  
engaged	   in	   regular	  physical	  activity.	  The	   impact	  of	  exercise	   training	   in	  alleviating	  HFs	   in	  
individuals	   with	   cardiovascular	   risk	   factors,	   or	   disease,	   or	   other	   populations	   who	  
experience	  HFs	  (e.g.	  cancer	  patients)	  warrants	  further	  research.	  	  
	  
In	  summary,	  improvements	  in	  the	  occurrence	  of	  HFs	  with	  short-­‐term	  exercise	  training	  are	  
mediated	  via	   thermoregulatory	  and	   (cerebro)vascular	  adaptation(s).	  This	   study	  provides	  
mechanistic	   evidence	   that	   exercise	   training	   is	   indeed	   a	   useful	   non-­‐pharmacological	  
alternative	  intervention	  in	  the	  treatment	  of	  HFs.	  These	  findings	  suggest	  that	  targeting	  the	  
thermoregulatory	  and	  (cerebro)vascular	  control	  systems	  with	  interventions	  may	  be	  useful	  













CHAPTER	  5:	  EXERCISE	  TRAINING	  ALTERS	  THE	  ACUTE	  
PHYSIOLOGICAL	  RESPONSES	  THAT	  OCCUR	  DURING	  




A	  HF	  is	  broadly	  defined	  as	  a	  sudden	  subjective	  intense	  sensation	  of	  heat	  that	  is	  associated	  
with	  rapid	   increases	   in	  skin	  blood	  flow	  and	  profuse	  sweating	  and	  flushing	  that	  begins	   in	  
the	  chest	  and	  radiates	  to	  the	  face,	  head	  and	  arms	  (Stearns	  et	  al.,	  2002,	  Freedman,	  2002).	  
Thus,	  HFs	  are	  physiologically	   identified	  as	  a	  transient	  and	  pronounced	  increase	   in	  sweat	  
rate	  that	  is	  preceded	  by	  a	  rapid	  surge	  in	  cutaneous	  vasodilation	  (Low	  et	  al.,	  2010,	  Low	  et	  
al.,	  2008a,	  Freedman,	  2001).	  
	  
In	   order	   to	   establish	  mechanistic	   understanding	   of	   HFs,	   thermoregulatory,	   cardio-­‐	   and	  
cerebro-­‐vascular	  responses	  have	  been	  observed	  prior	  to,	  during,	  and	  following	  acute	  HFs	  
using	  peripheral	  warming	   in	   the	   laboratory	   (Kronenberg,	  2010,	  Freedman,	  2001,	  Low	  et	  
al.,	   2008a)	   allowing	   for	   objective	   physiological	   insight.	   Elevations	   in	   limb	   blood	   flow	  
during	  HFs	  were	  first	  observed	  using	  plethysmographic	  techniques	  (Ginsburg	  et	  al.,	  1981),	  
however	   despite	   the	   suggestion	   of	   increased	   skin	   blood	   flow	   during	   a	   HF,	   technique	  
constraints	  meant	  that	  regional	  differences	  in	  blood	  flow	  i.e.	  skin	  vs.	  muscle,	  could	  not	  be	  
distinguished.	  Low	  et	  al.	  (2008)	  confirmed	  increases	  in	  cutaneous	  vasodilation	  and	  sweat	  
rate	   during	   a	   HF	   alongside	   elevated	   HR	   and	   transient	   decreases	   in	   MAP	   (in	   certain	  
individuals).	  In	  a	  series	  of	  elegant	  studies	  by	  the	  same	  group	  they	  found	  that	  increases	  in	  
cutaneous	  vasodilation	  and	   sweating	  during	  HFs	  are	  mediated	  by	   sympathetic	  neurally-­‐
mediated	  mechanisms	  similar	  to	  those	  observed	  during	  heat	  stress	  (Hubing	  et	  al.,	  2010,	  
Low	   et	   al.,	   2010).	   Hubing	   et	   al.	   (2010)	   established	   that	   NO,	   and	   not	   prostaglandins,	  
contribute	  to	  cutaneous	  vasodilation	  during	  a	  HF	  and	  that	  a	  different	  pathway	  other	  than	  
NO	  or	   prostaglandin	   is	   responsible	   for	   sweating	   during	   a	  HF	   (Hubing	   et	   al.,	   2010).	   In	   a	  
separate	   study	   by	   the	   same	   group,	   acute	   reductions	   (~5-­‐30%)	   in	   CBF	   were	   observed	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during	  menopausal	   HFs,	   further	   highlighting	   the	   significant	   physiological	   challenge	   that	  
HFs	  induce	  (Lucas	  et	  al.,	  2013).	  	  
	  
Chapter	  4,	  and	  others	  (Moilanen	  et	  al.,	  2012,	  Luoto	  et	  al.,	  2012,	  Karacan,	  2010)	  suggest	  
that	  exercise	  training	  can	  improve	  the	  frequency	  and	  severity	  of	  subjectively	  reported	  HFs	  
compared	  to	  a	  no-­‐exercise	  control	  group	  and	  also	  chapter	  4	  has	  for	  the	  first	  time	  shown	  
that	  this	  could	  be	  due	  to	  improvements	  in	  the	  thermoregulatory	  control	  system	  and	  the	  
distribution/delivery	  of	  blood	  flow	  across	  the	  vascular	  tree.	  Despite	  the	  recent	  insight	  into	  
the	  acute	  physiological	  changes	  that	  occur	  during	  a	  HF,	  only	  one	  study	  (that	  specifically	  
investigated	  CBF)	  has	  examined	  if	  these	  changes	  are	  related	  to	  the	  severity	  of	  HFs	  (Lucas	  
et	  al.,	  2013),	  whilst	  no	  study	  has	  investigated	  if	  any	  of	  the	  physiological	  changes	  during	  an	  
acute	  HF	  are	  responsive	  to	  interventions	  (pharmacological	  or	  non-­‐pharmacological).	  Such	  
information	  may	  provide	  valuable	  insight	  into	  the	  treatment	  of	  menopausal	  HFs.	  
	  
Importantly,	  profuse	  sweating,	   skin	   reddening	   (cutaneous	  vasodilation)	  and	   increases	   in	  
HR	  typically	  define	  the	  severity	  of	  a	  HF,	  as	  shown	  in	  chapter	  4.	  Therefore,	  the	  aim	  of	  this	  
study	   was	   to	   compare	   the	   acute	   physiological	   thermoregulatory	   and	   (cerebro)vascular	  
changes	   that	   occur	   during	   HFs	   prior	   to	   and	   following	   a	   16-­‐week	   exercise	   intervention	  
compared	   to	   changes	   in	   a	   no-­‐exercise	   control	   group.	   In	   line	   with	   improved	  
thermoregulatory	  and	  (cerebro)vascular	  control	  observed	  in	  chapter	  4,	  we	  hypothesised	  
that	  exercise	   training	  would	  reduce	  the	  physiological	   responses	  during	  a	  HF,	  specifically	  
attenuating	   cutaneous	   vasodilation,	   sweat	   rate	   and	   CBF	   responses	   compared	   to	   a	   no-­‐






Exercise	   training	   (n=14)	   and	  no-­‐exercise	   control	   (n=7)	  participants	   from	  chapter	  4	  were	  
used	   as	   the	   population	   for	   the	   current	   study	   (see	   Table	   4.1	   &	   4.2).	   Participants	   were	  
informed	   of	   the	   methods	   verbally	   and	   in	   writing	   before	   providing	   written	   informed	  
consent.	   The	   study	   conformed	   to	   the	  Declaration	   of	  Helsinki	   and	  was	   approved	   by	   the	  
local	  research	  ethics	  committee	  (LREC).	  	  
5.2.2	  Research	  Study	  Design	  
Participants	  reported	  to	  the	  laboratory	  for	  a	  passive	  heat	  stress	  challenge.	  For	  details	  of	  
experimental	   procedures	   please	   see	   Chapter	   3,	   General	   Methods.	   All	   participants	  
underwent	  visit	  1	  at	  baseline	  and	  following	  either	  16-­‐weeks	  of	  exercise	  or	  a	  no-­‐exercise	  
control	  period.	  The	  exercise-­‐training	  group	  took	  part	  in	  an	  exercise	  training	  intervention	  
(see	  chapter	  4.2.5	  methodology).	  	  
5.2.3	  Hot	  Flush	  Analysis	  
A	  total	  of	  twenty-­‐six	  HFs	  were	  recorded	  in	  18	  participants	  at	  baseline	  (11	  exercise	  and	  7	  
control	   participants).	   HFs	   recorded	   in	   participants	   both	   at	   baseline,	   and	   following	   the	  
exercise	   training	   (n=9)	   and	   control	   (n=6)	   interventions	   were	   used	   for	   analysis.	   Mild	  
heating	  was	  used	  to	  provoke	  the	  onset	  of	  HFs	  (Kronenberg,	  1990,	  Low	  et	  al.,	  2010),	  with	  
the	  onset	  of	  a	  HF	  objectively	  identified	  as	  a	  transient	  and	  pronounced	  increase	  in	  sternal	  
sweat	   rate	   (>0.002	  mg·cm-­‐2·min-­‐1	  per	   second)	   as	   has	   been	   used	   previously	   (Low	   et	   al.,	  
2010,	  Low	  et	  al.,	  2008a,	  Freedman,	  2001).	  Participants	  also	   informed	  the	  research	  team	  
of	  a	  subjective	   feeling	  of	  a	  HF	  and	  once	   the	   feeling	  had	  dissipated.	  The	  end	  of	  each	  HF	  
was	  objectively	  recorded	  as	  the	  return	  of	  sweat	  rate	  to	  pre	  HF	  baseline.	  Because	  of	  the	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variance	   in	   the	   length	   of	  HFs,	   each	  HF	   episode	  was	   divided	   into	   eight	   equal	   segments,	  
with	   each	   segment	   representing	   12.5%	   of	   HF	   duration	   (Low	   et	   al.,	   2010).	   Five-­‐second	  
periods	  of	  data	  at	   the	  end	  of	  each	  segment,	  and	  over	  a	  period	  of	  2	  minutes	  before	   i.e.	  
baseline,	   and	   2	   minutes	   following	   the	   HF	   i.e.	   post	   HF	   recovery,	   were	   used	   for	   data	  

























	   	  
	  
Figure	  5.1	  Representative	  data	  of	  middle	  artery	  cerebral	  velocity	  (CBF),	  stroke	  volume	  (SV),	  cardiac	  output	  (Q),	  
core	  temperature	  (Tcore)	  chest	  arm	  sweat	  rate	  (SR),	  chest	  and	  arm	  skin	  blood	  flow	  (LDF),	  and	  mean	  arterial	  
pressure	  (MAP)	  from	  a	  participant	  during	  a	  hot	  flush.	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5.2.6	  Statistical	  Analysis	  
HFs	  were	  analysed	  in	  a	  blinded	  fashion	  by	  the	  same	  observer.	  A	  two	  (intervention*time)	  
factor	   linear	  mixed	  model	  was	  employed	   to	   analyse	  HF	  duration	  prior	   to	   and	   following	  
exercise	  training	  or	  no-­‐exercise	  control.	  A	  three-­‐way	  (intervention*time*segment)	  linear	  
mixed	  model	  was	  employed	  for	  the	  analysis	  of	  HF	  variables	  during	  each	  12.5%	  segment,	  
following	   exercise	   training	   or	   no-­‐exercise	   control.	   Statistically	   significant	   interactions	  
were	   followed	   up	   with	   the	   least	   significant	   difference	   (LSD)	   approach	   to	   multiple	  
comparisons	  (Perneger,	  1998).	  	  
	  
5.3	  Results	  
5.3.1	  Hot	  flush	  duration	  
HF	   duration	   reduced	   by	   63	   seconds	   (95%	   CI,	   14,	   113;	   Figure	   5.2)	   following	   exercise	  
training	   compared	   to	   a	   negligible	   decrease	   of	   17	   seconds	   (95%	   CI,	   -­‐43,	   66)	   in	   the	   no-­‐
exercise	  control	  group,	  however	  this	  did	  not	  reach	  statistical	  significance	  (P=0.08).	  
5.3.2	  Haemodynamic	  responses	  during	  hot	  flushes	  
HR	  significantly	   increased	  by	  8	  b·min-­‐1	   (95%	  CI,	  6,	  11;	  P<0.001;	  Table	  5.1	  and	  Table	  5.2)	  
during	   all	   HFs.	   There	   was	   no	   main	   effect	   of	   intervention,	   time,	   or	   intervention*time	  
interaction	  for	  HR	  responses	  during	  HFs	  (P>0.05).	  MAP	  significantly	  decreased	  by	  5	  mmHg	  
(95%	   CI,	   1,	   10;	   P<0.001)	   during	   the	   HFs	   with	   no	   main	   effect	   of	   intervention,	   time	   or	  
intervention*time	  interaction	  (P>0.05).	  Cardiac	  output	  and	  stroke	  volume	  did	  not	  change	  
during	  the	  hot	  flushes	  (P>0.05).	  	  
	  
	   	  
125	  
	  






























































































































































	  	  	  


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































	  	  	  














































































































































































































































































































































































































































































































































































































































































































































































































































































































5.3.3	  Thermoregulatory	  responses	  during	  hot	  flushes	  
5.3.3.1	  Core	  body	  temperature	  responses	  during	  hot	  flushes	  
The	   changes	   in	   core	   body	   temperature	   during	   HFs	   prior	   to,	   and	   following,	   exercise	  
training	   or	   control	   are	   summarised	   in	   Table	   5.1	   and	   Table	   5.2,	   respectively.	   Core	   body	  
temperature	  tended	  to	  decrease	  [by	  0.06°C	  (95%	  CI,	  0.02,	  0.11)]	  during	  HFs,	  however	  this	  
did	  not	  reach	  statistical	  significance	  (P=0.15).	  There	  was	  no	  significant	  intervention*time	  
interaction	  for	  core	  body	  temperature.	  
5.3.3.2	  Skin	  blood	  flow	  responses	  during	  hot	  flushes	  
Skin	  blood	  flow	  significantly	   increased	  during	  all	  HFs	  (P<0.001;	  Figure	  5.3).	  At	  the	  chest,	  
there	   was	   a	   significant	   intervention*time	   interaction	   with	   a	   reduction	   of	   9	   %CVCmax	  
(95%CI,	  6,	  11;	  P=0.01;	  Figure	  5.3A)	  during	  HFs	  following	  exercise	  training	  compared	  to	  a	  
mean	  difference	  of	  4	  %CVCmax	   (95%CI,	   -­‐6,	  8;	  P=0.34;	  Figure	  5.3B)	   in	  no-­‐exercise	  control.	  
There	  was	  also	  a	  significant	  intervention*time	  interaction	  for	  CVC	  at	  the	  chest	  during	  HFs,	  
with	   a	   reduction	  of	   0.5	  AU/mmHg	   (95%	  CI,	   0.2,	   0.8;	  P=0.01)	   following	  exercise	   training	  
compared	   to	   a	   negligible	   change	   in	   control	   [0.2	   AU/mmHg	   (95%	   CI,	   -­‐0.3,	   0.4;	   P=0.32;	  
Table	  5.1	  and	  5.2).	  	  
	  
Similarly,	   at	   the	   forearm	   there	   was	   a	   significant	   intervention*time	   interaction	   with	   a	  
reduction	  of	  7	  %CVCmax	   (95%CI,	  4,	  9;	  P=0.05;	  Figure	  5.4A)	  during	  HFs	   following	  exercise	  
training	   compared	   to	   a	   mean	   difference	   of	   3	   %CVCmax	   (95%	   CI,	   -­‐3,	   6;	   P=0.44;	   Figure	  
5.4B).	  This	  difference	  at	  the	  forearm	  was	  not	  significant	  when	  expressed	  as	  CVC,	  with	  no	  
intervention*time	  interaction	  (P<0.05;	  Table	  5.1	  and	  5.2).	  





































































































































	   	  
	  



































































































































5.3.3.3	  Sweat	  rate	  responses	  during	  hot	  flushes	  
Sweat	   rate	  significantly	   increased	  at	   the	  chest	  during	  HFs	   (P<0.001)	  before	   returning	   to	  
pre	  baseline	  levels.	  There	  was	  a	  significant	  intervention*time	  interaction	  with	  a	  reduction	  
of	   0.04	   mg·∙cm2·∙min-­‐1	   (95%	   CI,	   0.02,	   0.06;	   P=0.01;	   Figure	   5.5A)	   in	   chest	   sweat	   rate	  
following	  exercise	  training	  compared	  to	  no	  change	  in	  control	  [0.01	  mg·∙cm2·∙min-­‐1	  (95%	  CI,	  
-­‐0.02,	   0.03;	   P=0.19;	   Figure	   5.5B)].	   The	   largest	   difference	   was	   observed	   in	   peak	   chest	  
sweat	   rate	   that	  decreased	  by	  0.11	  mg·∙cm2·∙min-­‐1	   (95%	  CI,	  0.05,	  0.17;	  P=0.001)	   following	  
exercise	  training	  compared	  to	  a	  negligible	  difference	  of	  0.03	  mg·∙cm2·∙min-­‐1	  (95%	  CI,	  -­‐0.03,	  
0.09;	  P=0.34)	  in	  the	  control	  group.	  	  
	  
Similarly,	   sweat	   rate	   significantly	   increased	   at	   the	   forearm	  during	  HFs	   (P<0.001)	   before	  
returning	  to	  baseline	  levels.	  There	  was	  a	  significant	  intervention*time	  interaction	  with	  a	  
reduction	  of	  0.03	  mg·∙cm2·∙min-­‐1	  (95%	  CI,	  0.02,	  0.05;	  P=0.01;	  Figure	  5.6A)	  in	  forearm	  sweat	  
rate	   following	   exercise	   training	   compared	   to	   negligible	   change	   in	   control	   [0.01	  
mg·∙cm2·∙min-­‐1	  (95%	  CI,	  -­‐0.01,	  0.02;	  P=0.78);	  Figure	  5.6B].	  The	  largest	  difference	  was	  seen	  
in	   peak	   forearm	   sweat	   rate	   that	   decreased	   by	   0.07	   mg·∙cm2·∙min-­‐1	   (95%	   CI,	   0.02,	   0.12;	  
P=0.01)	   following	   exercise	   training	   compared	   to	   a	   negligible	   difference	   of	   0.03	  
mg·∙cm2·∙min-­‐1	  (95%	  CI,	  -­‐0.03,	  0.08;	  P=0.22)	  in	  the	  control	  group.	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5.3.4	  Cerebral	  blood	  flow	  responses	  during	  hot	  flushes	  
MCAv	   significantly	   decreased	   during	   HFs	   (P<0.001)	   and	   returned	   to	   pre-­‐baseline	   levels	  
following	  HF	  cessation.	  There	  was	  a	  significant	  intervention*time	  interaction	  in	  changes	  in	  
MCAv	  during	  HFs	  (P=0.04),	  with	  the	  size	  of	  the	  decrease	  reduced	  by	  3.4	  cm/s	  (95%	  CI,	  0.7,	  
5.1;	   P<0.001;	   Figure	   5.7A)	   following	   exercise	   training	   compared	   to	   no	   differences	   in	  
control	   [mean	   difference	   0.6	   cm/s	   (95%	   CI,	   -­‐0.7,	   1.8;	   P=0.41;	   Figure	   5.7B).	   The	   largest	  
improvements	  in	  CBF	  during	  hot	  flushes	  following	  exercise	  training	  was	  an	  attenuation	  in	  
the	  peak	  MCAv	  decrease	  of	  4.7	  cm/s	  (95%	  CI,	  1.1,	  7.4;	  P=0.005)	  compared	  to	  a	  negligible	  
difference	  of	  1.6	  cm/s	  (95%	  CI,	  -­‐2.2,	  4.4;	  P=0.93)	  in	  the	  control	  group.	  
	  
Similarly,	  CBVC	  decreased	  during	  HFs	  (P=0.01)	  and	  returned	  to	  pre	  baseline	  levels.	  There	  
was	   a	   significant	   intervention*time	   interaction	   in	   CBVC	   (P=0.04)	   during	   HFs.	   CBVC	  was	  
0.04	   cm·∙s-­‐1·∙mmHg-­‐1	   (95%	   CI,	   0.02,	   0.08;	  P=0.03;	   Table	   5.1)	   higher	   during	   HFs	   following	  
exercise	   training	   compared	   to	   a	   difference	   of	   0.01	   cm·∙s-­‐1·∙mmHg-­‐1	   (95%	   CI,	   -­‐0.03,	   0.04;	  
P=0.12;	  Table	  5.2)	  in	  the	  control	  group.	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The	   novel	   findings	   of	   the	   present	   study	   were	   that	   a	   short-­‐term	   exercise	   training	  
intervention	   reduced	   the	   amount	   of	   sweating	   and	   cutaneous	   vasodilation	   that	   occurs	  
during	   a	   HF	   in	   post-­‐menopausal	   females.	   Importantly,	   sweating	   and	   skin	   reddening	  
(cutaneous	  vasodilation)	  typically	  define	  the	  subjective	  severity	  of	  a	  HF.	  An	  attenuation	  of	  
the	   reduction	   in	   CBF	   typically	   observed	  during	   a	  HF	  was	   also	   detected.	   Taken	   together	  
these	   findings	   suggest	   that	   exercise	   training	   can	   positively	   impact	   upon	   the	   acute	  
physiological	  responses	  that	  occur	  during	  a	  HF.	  These	  data	  provide	  evidence	  that	  exercise	  
training	  directly	  reduces	  the	  severity	  of	  a	  HF	  by	  improving	  thermoregulatory	  and	  vascular	  
responses	   in	   the	   cerebral	   and	   cutaneous	   circulations	   and	   provides	   support	   to	   the	  
decreased	   subjective	   frequency	   and	   severity	   of	   HFs	   with	   exercise	   training	   observed	   in	  
chapter	  4.	  
	  
Chapter	  4,	  alongside	  others	  (Luoto	  et	  al.,	  2012,	  Moilanen	  et	  al.,	  2012),	  established	  that	  a	  
short-­‐term	   exercise	   training	   intervention	   reduced	   the	   subjective	   frequency	   of	   HFs.	  
Chapter	  4	  also	  suggests	  that	  exercise	  training	  can	  reduce	  the	  subjective	  severity	  of	  HFs.	  
Physiologically,	  sweating	  and	  cutaneous	  vasodilation	  typically	  define	  the	  severity	  of	  a	  HF	  
on	  the	  subjective	  scale.	  This	  is	  the	  first	  study	  to	  investigate	  if	  the	  physiological	  responses,	  
and	   thus	   potentially	   severity,	   can	   be	   altered	   with	   an	   intervention.	   The	   results	   of	   the	  
current	   study	   suggest	   exercise	   training	   mediates	   acute	   amelioration	   of	   physiological	  
perturbations	   (sweating	   and	   cutaneous	   vasodilation)	   observed	   during	   HFs	   which	  
potentially	   explains	   the	   improvements	   in	   HF	   severity	   corresponding	   with	   reduced	   skin	  




The	   onset	   of	   a	   HF	   was	   objectively	   identified	   in	   the	   current	   study	   as	   a	   transient	   and	  
pronounced	  elevation	  in	  sternal	  sweat	  rate	  (Hubing	  et	  al.,	  2010,	  Low	  et	  al.,	  2010,	  Low	  et	  
al.,	  2008a).	  Nevertheless,	  a	  HF	  typically	  begins	  with	  a	  pronounced	  cutaneous	  vasodilation	  
closely	   followed	  by	  profuse	  sweating;	   these	  responses	  are	   likely	  neurally	  mediated,	  and	  
are	   preceded	   by,	   a	   large	   increase	   in	   sympathetic	   nerve	   activity	   (Low	   et	   al.,	   2010).	  
Although	   not	   directly	  measured	   in	   the	   current	   study,	   a	   reduction	   in	   basal	   sympathetic	  
nerve	   activity	   has	   been	   observed	   in	   post-­‐menopausal	   females	   following	   short-­‐term	  
exercise	  training	  (Oneda	  et	  al.,	  2014),	  and	  may	  translate	  into	  a	  reduction	  in	  sympathetic	  
nerve	   activity	   prior	   to	   and	   during	   HFs	   in	   this	   study,	   and/or	   reductions	   in	   sympathetic	  
cholinergic	   vasodilator	   activity	   that	   can	   directly	   affect	   cutaneous	   vasodilation	   and	  
sweating	  during	  a	  HF	  (Low	  et	  al.,	  2010).	  	  
	  
The	  NO	  system	  is	  also	   likely	   involved	   in	  the	  exercise	  mediated	  attenuated	  sweating	  and	  
cutaneous	   vasodilation	   during	   a	   HF,	   although	   the	   impact	   of	   shear	   stress	  mediated	   NO	  
production	  would	  occur	   later	   in	   the	  HF	   rather	   than	   immediately.	  HF	   induced	  cutaneous	  
vasodilation	  is	  proposed	  to	  cause	  an	  increase	  in	  shear	  stress	  and	  NO	  within	  the	  cutaneous	  
vasculature	  that	  further	  facilitates	  vasodilation	  (Hubing	  et	  al.,	  2010).	  Whilst	  NO	  does	  not	  
influence	   sweating	   during	   a	   HF	   directly	   (Hubing	   et	   al.,	   2010),	   the	   attenuated	   sweating	  
response	   during	   HFs	   following	   the	   exercise	   training	   may	   be	   due	   to	   the	   decrease	   in	  
cutaneous	   vasodilation	   and	   a	   subsequent	   effect	   on	   sweat	   glands.	   Shear-­‐related	   NO	  
release	  associated	  with	  a	  higher	  skin	  blood	  flow	  amplifies	  sweating	  (Lee	  and	  Mack,	  2006),	  
while	  NO	  inhibition	  decreases	  the	  sweating	  response	  (Welch	  et	  al.,	  2009)	  to	  increases	  in	  
core	   body	   temperature.	   Taken	   together,	   it	   is	   probable	   that	   the	   reduced	   cutaneous	  
vasodilation	  (and	  potentially	  sweating)	  may	  be	  a	  consequence	  of	  a	  smaller	  engagement	  of	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the	   sympathetic	   cholinergic	   system,	   potentially	   reducing	   the	   direct	   or	   ACh-­‐induced	  
release	  of	  NO	  from	  the	  endothelium	  during	  HFs.	  
	  
During	   passive	   heat	   stress	   both	   cutaneous	   vasodilation	   and	   sweating	   are	   neurally	  
mediated	   via	   the	   sympathetic	   cholinergic	   system	   and	   the	   release	   of	   ACh,	   and	  
subsequently	  NO	   (Charkoudian	  and	  Wallin,	  2014,	   Shibasaki	  et	   al.,	   2006).	  Although	  a	  HF	  
mimics	  these	  heat	  dissipation	  responses	  and	  a	  functional	  relationship	  between	  cutaneous	  
vasodilation	  and	  sweating	  is	  suggested	  (Love	  and	  Shanks,	  1962,	  Smith	  et	  al.,	  2013b),	  it	  is	  
possible	   that	   cutaneous	   vasodilation	   via	   cholinergic	   nerves	   is	   partially	   mediated	   via	  
additional	   putative	   vasodilator	   peptides	   separate	   to	   sweating,	   such	   as	   other	   co-­‐
transmitters	  	  i.e.	  TRVP	  and	  VIP	  (see	  section	  2.2.1.1).	  This	  concept	  is	  potentially	  supported	  
by	  the	  current	  data	  as	  there	  was	  a	  reduction	  in	  the	  sweating	  response	  at	  both	  the	  chest	  
and	   forearm	   with	   only	   significant	   reductions	   to	   chest	   cutaneous	   vasodilation.	   Other	  
explanations	   for	   the	   lack	   of	   change	   in	   forearm	   cutaneous	   vasodilation	   could	   be	   due	   to	  
regional	  differences	   in	  exercise-­‐mediated	  changes	  to	  cholinergic	  sensitivity	  (Smith	  et	  al.,	  
2013b)	   or	   eNOS	   activity	   (Del	   Pozzi	   et	   al.,	   2013).	   Regional	   differences	   exist	   in	   impaired	  
cutaneous	   vasodilator	   systems	   with	   ageing	   (Inoue	   et	   al.,	   1998)	   that	   may	   respond	  
differently	  to	  exercise	  training.	  The	  forearm	  also	  has	  a	  larger	  surface	  area	  (long	  and	  thin)	  
compared	   to	   the	   chest	   (flat)	   for	   cutaneous	   blood	   flow	   and	   thus	   heat	   loss,	   which	  may	  
suggest	   when	   heat	   dissipation	  mechanisms	   are	   triggered	   during	   a	   HF	   the	   forearm	   is	   a	  
priority	  in	  thermoregulatory	  control	  compared	  to	  the	  chest.	  Additionally,	  chest	  cutaneous	  
vasodilation	  has	  a	  higher	  basal	  blood	  flow	  than	  the	  forearm	  (irrespective	  of	  pre	  or	  post	  
intervention)	   in	   both	   chapter	   4	   and	   this	   study,	   suggesting	   there	   is	   more	   scope	   for	   a	  




The	   acute	   reductions	   in	   CBF	   during	   HFs	   observed	   in	   this	   study	   were	   similar	   to	   those	  
observed	  previously	  (Lucas	  et	  al.,	  2013).	  In	  line	  with	  the	  findings	  in	  chapter	  4	  of	  improved	  
basal	   CBF	   and	  maintenance	   during	   passive	   heat	   stress	   following	   exercise	   training,	   this	  
study	  established,	  for	  the	  first	  time,	  that	  the	  acute	  reductions	  in	  CBF	  during	  HFs	  in	  post-­‐
menopausal	  females	  are	  attenuated	  following	  a	  short-­‐term	  exercise	  training	  intervention.	  
Importantly,	   the	   exercise-­‐mediated	   attenuated	   reductions	   in	   CBF	   during	   HFs	   were	   not	  
explained	   by	   alterations	   in	   the	   blood	   pressure	   responses	   in	   the	   current	   study,	   in	  
agreement	  with	  Lucas	  et	  al.,	   (2013).	  Other	  modulators	  of	  CBF	  consist	  of	  cardiac	  output,	  
arterial	   CO2	   content	   and	   sympathetic	   nerve	   activity	   (Ainslie	   and	   Duffin,	   2009).	   Cardiac	  
output	   (along	   with	   stroke	   volume)	   remained	   unchanged	   during	   HFs	   following	   exercise	  
training	  in	  the	  current	  study.	  	  A	  hyperventilatory-­‐induced	  reduction	  in	  arterial	  CO2	  during	  
HFs	   is	  possible	  but	  this	  was	  not	  measured	  during	  HFs	   in	  the	  current	  or	  previous	  studies	  
(Lucas	  et	  al.,	  2013)	  and	  warrants	  further	  investigation.	  A	  reduction	  in	  basal	  or	  HF-­‐induced	  
sympathetic	  nerve	  activity	  (as	  discussed	  above)	  may	  also	  reduce	  cerebral	  vasoconstriction	  
and	  elevate	  CBF	  during	  HFs.	  
	  
Feelings	  of	  faintness	  during	  HFs	  are	  common	  (Ekblad	  et	  al.,	  2000,	  Dormire,	  2003),	  and	  are	  
associated	  with	  the	  short-­‐term	  reductions	  in	  brain	  blood	  flow	  observed	  during	  HFs	  (Lucas	  
et	   al.,	   2013),	   and	   is	   included	   as	   a	   symptom	   of	   subjective	   severity.	   Despite	   this,	   peak	  
reductions	   in	   CBF	   observed	   during	   HFs	   did	   not	   correlate	   with	   subjective	   ratings	   of	  
severity,	  nor	  sweat	  rate	  or	  skin	  blood	  flow	  in	  a	  previous	  study	  although	  the	  number	  of	  HFs	  
was	   small	   to	   interpret	   the	   correlations	   (Lucas	   et	   al.,	   2013).	   Regardless	   of	   whether	   a	  
relationship	   exists	   between	   CBF	   and	   HF	   severity,	   improvements	   in	   the	   control	   of	   CBF	  
during	   a	  HF	  with	   exercise	   training	  may	   be	   important	   for	   reducing	   feelings	   of	   faintness,	  
and	  also	  in	  maintaining	  cerebrovascular	  health	  as	  reductions	  in	  CBF	  with	  the	  menopause	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are	   associated	  with	   reduced	   cerebral	   reactivity	   and	   cerebral	  microvascular	   tone	   in	   the	  
absence	  of	  oestrogen	  (Ohkura	  et	  al.,	  1995,	  Belfort	  et	  al.,	  1995,	  Matteis	  et	  al.,	  1998).	  	  
	  
This	  study	  supports	  the	  findings	  of	  chapter	  4	  that	  exercise	  training	  reduces	  the	  severity	  of	  
HFs	   in	  post-­‐menopausal	   females	  via	   thermoregulatory	  and	  cerebrovascular	  adaptations,	  
and	   uses	   objective	   measures	   that	   cannot	   be	   influenced	   by	   the	   participant	   and	   were	  
analysed	  in	  a	  blinded	  fashion.	  A	  limitation	  of	  this	  study	  is	  that	  it	  is	  currently	  unclear	  if	  the	  
passive	  heat	  stress	  stimulus	  is	  a	  reproducible	  model	  that	  can	  be	  used	  to	  assess	  objective	  
severity	  of	  HFs	  following	  intervention.	  In	  this	  study,	  objective	  HF	  severity	  was	  unchanged	  
in	   the	   control	   intervention	   following	   a	   16-­‐week	   no-­‐contact	   period	   that	   serves	   some	  
preliminary	  evidence	  to	  suggest	  HFs	  can	  be	  reliably	  monitored	  using	  the	  protocol	  in	  this	  
study.	  Also,	  subjective	  HF	  severity	  was	  not	  measured	  during	  the	  acute	  HFs	  assessed	  in	  the	  
laboratory,	   and	   thus	   it	   is	   currently	   unknown	   if	   a	   reduction	   in	   subjective	   HF	   severity	  
coincides	   with	   a	   similar	   reduction	   in	   objective	   HF	   severity	   following	   exercise	   training.	  
Nonetheless,	  exercise	   training	   reduces	   the	   severity	  of	  post-­‐menopausal	  HFs	  assessed	   in	  
the	   community	  by	  101	   (95%	  CI=	  80,	   121;	  P=0.01)	   in	   chapter	   4,	   thus	   it	   is	   likely	   that	   the	  
current	   findings	   support	   the	   notion	   that	   exercise	   training	   reduces	   the	   severity	   of	   post-­‐
menopausal	   HFs	   through	   physiological	   adaptations	   that	   directly	   affect	   the	   acute	  
responses	  observed	  during	  HFs.	  Such	   information	  may	  provide	  valuable	   insight	   into	   the	  
treatment	  of	  menopausal	  HFs.	  
	  
In	   summary,	   this	   is	   the	   first	   study	   to	   demonstrate	   an	   improvement	   in	   objective	  
physiological	  markers	  (sweating	  and	  cutaneous	  vasodilation)	  of	  HF	  severity	  using	  exercise	  
training	   as	   a	   non-­‐pharmacological	   treatment	   in	   symptomatic	   post-­‐menopausal	   females.	  
These	  findings	  confirm	  that	  exercise	  training	  has	  a	  direct	   influence	  on	  thermoregulatory	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and	   cerebrovascular	   responses	   during	   HFs	   per	   se,	   which	   may	   explain	   reductions	   in	  













CHAPTER	  6:	  WARM	  WATER	  IMMERSION	  TRAINING	  
INDUCES	  SIMILAR	  THERMOREGULATORY	  AND	  
CEREBROVASCULAR	  RESPONSES	  TO	  EXERCISE	  TRAINING	  IN	  




The	   function	   of	   the	   thermoregulatory	   control	   system	   (i.e.	   sweating	   and	   cutaneous	  
vasodilation)	   during	   internal	   or	   external	   heat	   stress	   can	   be	   enhanced	   with	   exercise	  
training	  as	  observed	  in	  chapter	  4,	  and	  previously	  (Armstrong	  et	  al.,	  2005,	  Ichinose	  et	  al.,	  
2009).	  For	  example,	  3	  months	  of	  moderate	  intensity	  endurance	  training	  can	  enhance	  the	  
efficiency	   of	   the	   thermoregulatory	   control	   system	   by	   decreasing	   the	   core	   body	  
temperature	   threshold	   for	   the	   onset	   (central	   function)	   of,	   and	   the	   sensitivity	   (slope;	  
peripheral	   function)	   of	   sweating	   and	   cutaneous	   vasodilation	   (Ichinose	   et	   al.,	   2009).	  
Improvement	  of	  thermoregulatory	  function	  is	  important	  in	  a	  sporting	  context	  for	  athletes	  
exercising	   in	   the	   heat	   but	   also	   in	   a	   clinical	   context	   for	   individuals	   with	   heat	   related	  
illnesses	  (e.g.,	  heat	  induced	  syncope)	  or	  thermoregulatory	  dysfunction	  (e.g.	  symptomatic	  
postmenopausal	  females	  in	  chapters	  4	  and	  5,	  heart	  failure	  patients	  or	  spinal	  cord	  injured	  
individuals).	   In	   addition,	   in	   some	   individuals	   exercise	   may	   be	   contraindicated,	   and	  
therefore	   research	   examining	   alternative	   interventions	   that	   may	   improve	  
thermoregulatory	  control	  is	  warranted.	  	  
	  
Heat	  acclimation,	  involving	  repeated	  exposure	  to	  internal	  heat	  stress	  (during	  exercise	  in	  a	  
temperate	   environment	   for	   example)	   has	   been	   shown	   to	   improve	   thermoregulatory	  
control	  by	  decreasing	  the	  core	  body	  temperature	  threshold	  for	  the	  onset	  of	  sweating	  and	  
cutaneous	  vasodilation	  (Armstrong	  et	  al.,	  2005,	  Kuwahara	  et	  al.,	  2005a,	  Kuwahara	  et	  al.,	  
2005b,	   Lorenzo	   and	   Minson,	   2010)	   and/or	   the	   slope	   of	   the	   sweating	   and	   cutaneous	  
vasodilation	  response	  (Inoue	  et	  al.,	  2005,	  Lorenzo	  and	  Minson,	  2010,	  Takeno	  et	  al.,	  2001,	  
Sawka	   et	   al.,	   1989,	   Sawka	   et	   al.,	   2000).	   It	   is	   also	   possible	   that	   targeting	   the	  
thermoregulatory	   control	   system	   with	   a	   specific	   exercise-­‐independent	   heat	   stress	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intervention	   may	   induce	   similar	   thermoregulatory	   improvements	   in	   the	   efficiency	   of	  
sweating	   and	   cutaneous	   vasodilation.	   Repeated	   exposure	   to	   external	   heat	   stress	   (e.g.	  
resting	   in	  a	  hot	  and	  humid	  environment)	  has	  only	  been	  employed	   in	  a	  small	  number	  of	  
studies	   using	   a	   short	   time-­‐frame	   i.e.	   2	   weeks	   of	   heat	   acclimation	   to	   induce	  
thermoregulatory	   (Eichna	  et	   al.,	   1950,	   Fox	   et	   al.,	   1963a,	   Fox	   et	   al.,	   1963b,	   Shido	  et	   al.,	  
1999,	   Armstrong	   and	   Kenney,	   1993),	   	   vascular	   and/or	   cardiac	   (Imamura	   et	   al.,	   2001,	  
Kihara	   et	   al.,	   2002)	   adaptations.	   This	   strategy	   is	   challenging	   in	   terms	   of	   inducing	   an	  
appropriate	   level	   of	   hyperthermia	   as	   participants	   have	   often	   been	   allowed	   to	   dress	  
minimally	   in	   order	   to	   promote	   heat	   loss	   and/or	   it	   has	   taken	   unacceptable	   amounts	   of	  
time	   to	   reach	   an	   appropriate	   level	   of	   hyperthermia	   to	   subsequently	   induce	  
thermoregulatory	   and/or	   vascular	   adaptations.	   In	   addition,	   the	   beneficial	   thermal	  
adaptations	  can	  be	  lost	  soon	  after	  the	  end	  of	  the	  intervention	  (Ichinose	  et	  al.,	  2009).	  One	  
external	  heating	  intervention	  that	  could	  be	  more	  effective	  than	  these	  previous	  attempts	  
in	  enhancing	  thermoregulatory	  function	   is	  repeated	  episodes	  of	  warm	  water	   immersion	  
where	   skin	   temperatures	   are	  maintained	  high	  enough	   to	   favour	  heat	   gain.	   Few	   studies	  
have	  examined	  the	  impact	  of	  acute	  warm	  water	  immersion	  (Nguyen	  and	  Tokura,	  2003)	  or	  
repeated	  warm	  water	  immersion	  ‘training’	  on	  thermal	  and	  vascular	  responses	  (Green	  et	  
al.,	  2010,	  Naylor	  et	  al.,	  2011).	  One	  recent	  study	  investigated	  the	  local	  (forearm)	  responses	  
of	   skin	   blood	   flow	   to	   repeated	   forearm	  warm	  water	   immersion	   (42ºC)	   over	   an	   8-­‐week	  
period	  and	  found	  improvements	  in	  skin	  blood	  flow	  responses	  to	  local	  heating	  that	  were	  
attributed	  to	  increased	  blood	  flow	  and	  subsequent	  shear	  stress	  during	  the	  forearm	  water	  
immersion	  bouts	  (Green	  et	  al.,	  2010).	  Therefore,	   it	   is	  possible	  that	  a	  whole	  body	  warm-­‐
water	   immersion	   training	   intervention	   could	   cause	   similar	   favourable	   thermoregulatory	  
and	  vascular	  changes	  to	   that	  of	  exercise	   training	  and	  thus	  might	  be	  a	  useful	  alternative	  
intervention	  to	  exercise.	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The	  preservation	  of	  brain	  blood	  flow	  (CBF)	  is	  critical	  for	  maintaining	  appropriate	  cognitive	  
function.	  In	  contrast	  to	  elevations	  during	  acute	  bouts	  of	  exercise	  (Ide	  et	  al.,	  2000,	  Ogoh	  et	  
al.,	   2007),	   CBF	   is	   significantly	   reduced	  during	  passive	  heat	   stress	   (Brothers	   et	   al.,	   2009,	  
Low	  et	  al.,	  2010).	  Precipitous	  reductions	  in	  cerebral	  perfusion	  can	  have	  significant	  clinical	  
consequences	   (Van	   Lieshout	   et	   al.,	   2003).	   In	   addition,	   chronic	   reductions	   in	   CBF,	   as	  
observed	  in	  aging,	  are	  linked	  to	  an	  increased	  risk	  of	  cerebrovascular	  disease	  (de	  la	  Torre,	  
2012,	  Ivey	  et	  al.,	  2011,	  Ainslie	  et	  al.,	  2008,	  Stoquart-­‐ElSankari	  et	  al.,	  2007).	  Murrell	  et	  al.,	  
(2013)	   have	   recently	   shown	   that	   12-­‐weeks	   of	   aerobic	   exercise	   training	   enhances	  
cerebrovascular	   reactivity	   (for	   the	   same	   changes	   in	   carbon	   dioxide	   content	   there	   is	   a	  
greater	   change	   in	   cerebral	   perfusion)	   suggesting	   an	   improvement	   in	   the	   control	   of	  CBF	  
and	  consequently	   cerebrovascular	  health.	   Furthermore,	  Ainslie	  et	  al.,	   (2008)	  also	   found	  
that	  lifelong	  endurance	  exercise	  training	  may	  offset	  the	  age-­‐related	  decline	  in	  CBF,	  whilst	  
chapter	  4	  established	  that	  CBF	  at	  rest	  and	  during	  heat	  stress	  improved	  following	  exercise	  
training	  in	  post-­‐menopausal	  females.	  However,	  no	  study	  to	  date	  has	  examined	  the	  impact	  
of	  repeated	  heat	  stress	  exposure	  on	  CBF	  at	  rest	  or	  during	  passive	  heat	  stress.	  	  It	  is	  unclear	  
if	  repeated	  bouts	  of	  heat	  stress	  and	  likely	  reductions	  in	  CBF	  result	  in	  a	  modification	  of	  the	  
cerebrovascular	  response	  to	  passive	  heat	  stress.	  Therefore,	  the	  aim	  of	  this	  study	  was	  to	  
employ	  a	  randomised	  control	  intervention	  to	  compare	  the	  effects	  of	  8-­‐weeks	  of	  exercise	  
training	   with	   8-­‐weeks	   of	   warm	   water	   immersion	   training	   in	   young	   females	   on	  
thermoregulatory,	  conduit	  and	  cerebrovascular	  function.	  We	  hypothesised	  that	  a	  passive	  
heating	   intervention	   using	   warm-­‐water	   immersion	   elicits	   similar	   thermoregulatory,	  





Eighteen	  healthy	  females	  (aged,	  25±5	  y;	  BMI,	  24.2±4.1	  kg.m2)	  were	  recruited.	  Participants	  
were	  recreationally	  active	  and	  typically	  engaged	  in	  low	  (e.g.,	  walking)	  and	  moderate	  (e.g.,	  
running,	   stationary	  cycling)	   intensity	  aerobic	  activities	   (2–3	  days/week)	  assessed	  using	  a	  
self-­‐report	  questionnaire.	  Participants	  reported	  regular	  menstrual	  cycles	  (~28	  days),	  had	  
no	  history	  of	  cardiovascular	  or	  metabolic	  disease,	  were	  non-­‐smokers	  and	  not	  taking	  any	  
form	  of	  medication,	  including	  hormonal	  contraceptives.	  Participants	  were	  informed	  of	  the	  
methods	   and	   study	   design	   verbally	   and	   in	   writing	   before	   providing	   written	   informed	  
consent.	   The	   study	   conformed	   to	   the	  Declaration	   of	  Helsinki	   and	  was	   approved	  by	   the	  
institutional	  ethics	  committee.	  	  
6.2.2	  Research	  Study	  Design	  
Participants	   underwent	   two	   initial	   visits	   to	   the	   laboratory,	   and	   were	   asked	   to	   fast	  
overnight,	  refrain	  from	  alcohol	  and	  exercise	  for	  24h	  and	  caffeine	  for	  12h	  before	  each	  visit.	  
Visit	  1	  consisted	  of	  assessment	  of	  brachial	  artery	  endothelial	  function	  (FMD)	  followed	  by	  
a	  maximal	  cardiorespiratory	  fitness	  test	  (VO2peak).	  Visit	  2	  consisted	  of	  a	  passive	  heat	  stress	  
challenge	   to	   assess	   thermoregulatory	   and	   (cerebro)vascular	   responses.	   For	   details	   of	  
experimental	   procedures	   please	   see	   Chapter	   3,	   General	   Methods.	   Both	   visits	   were	  
completed	  within	  7	  days	  and	  assessments	  were	   conducted	   in	   a	   temperature-­‐controlled	  
laboratory	  (23±1°C).	  Participants	  were	  then	  randomly	  assigned	  to	  either	  an	  exercise	  [n=9;	  
mid-­‐follicular	  6;	  mid-­‐luteal	  3)]	  or	  warm	  water	  immersion	  (n=9;	  mid	  follicular	  5;	  mid-­‐luteal	  
4)	   intervention.	   All	   assessments	   described	   in	   visits	   1	   and	   2	   were	   repeated	   (repeat	  
assessment	  in	  same	  menstrual	  phase)	  2-­‐5	  days	  following	  the	  8-­‐week	  training	  program.	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6.2.3	  Training	  interventions	  
6.2.3.1	  Exercise	  training	  programme	  
Participants	   exercised	   on	   a	   cycle	   ergometer	   (Ergo	   Bike	   Premium8i,	   Daum	   Electronic;	  
Germany)	  at	  ~70%	  of	  maximal	  heart	  rate	  (HRmax)	  [average	  exercise	  heart	  rate	  (HR)	  during	  
training	  135±12	  beat·∙min-­‐1],	  which	  was	   achieved	  by	  manipulating	  power	  output	   (watts)	  
until	  the	  target	  HR	  was	  attained.	  Each	  session	  was	  supervised	  and	  lasted	  for	  30	  min,	  was	  
conducted	  3	  times	  per	  week	   (94%	  compliance)	   for	  8-­‐weeks	   in	  a	   temperature-­‐controlled	  
laboratory	   (21°C	   and	   relative	   humidity	   (RH)	   of	   45%).	   Pilot	   data	   from	   the	   laboratory	  
illustrate	   these	   exercise	   bouts	   typically	   increase	   core	   body	   temperature	   by	   0.4-­‐0.7ºC	  
which	  is	  similar	  to	  previous	  studies	  (Kuwahara	  et	  al.,	  2005b,	  Kuwahara	  et	  al.,	  2005a).	  
6.2.3.2	  Water	  Immersion	  training	  programme	  
Participants	  were	  supervised	  and	  immersed	  (seated)	  in	  a	  water	  tank	  (ECB,	  Gloucester,	  UK)	  
to	   top-­‐sternal	   level	   (arms	  were	  not	   immersed)	   at	   a	   constant	   temperature	   (42ºC)	   for	  30	  
min,	   3	   times	   per	   week	   (91%	   compliance)	   for	   8-­‐weeks.	   Laboratory	   temperature	   was	  
controlled	  (21°C	  and	  45%	  RH).	  Pilot	  data	  from	  the	   laboratory	   illustrate	  that	  these	  water	  
immersion	   sessions	   increase	   core	   body	   temperature	   by	   0.5-­‐0.8ºC,	   which	   is	   similar	   to	  
previous	   studies	   (Fox	   et	   al.,	   1963b,	   Armstrong	   and	   Kenney,	   1993,	   Nguyen	   and	   Tokura,	  
2003,	  Inoue	  et	  al.,	  2005,	  Carter	  et	  al.,	  2014a).	  
6.2.4	  Statistical	  analysis	  	  
For	  analysis	  of	   thermoregulatory	  variables	   see	  Chapter	  4.2.6.	  A	  two	   (intervention*time)	  
factor	   linear	   mixed	   model	   was	   employed	   to	   analyse	   VO2peak	   and	   FMD	   [with	   baseline	  
diameter	   entered	   as	   a	   covariate	   to	   control	   for	   variability	   in	   baseline	   (Atkinson	   and	  
Batterham,	  2013)],	  alongside	  resting	  baseline	  variables	  and	  temperature	  thresholds	  and	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sensitivities	  of	  sweat	  rate	  and	  skin	  blood	  flow	  during	  the	  passive	  heat	  stress.	  A	  three-­‐way	  
(intervention*time*temperature)	   linear	  mixed	  model	  was	   employed	   for	   the	   analysis	   of	  
CBF	  in	  response	  to	  each	  0.1ºC	  increase	  in	  core	  body	  temperature,	  during	  the	  passive	  heat	  
stress.	   Statistically	   significant	   interactions	   were	   followed	   up	   with	   the	   least	   significant	  
difference	   (LSD)	   approach	   to	   multiple	   comparisons	   (Perneger,	   1998).	   Due	   to	   variable	  
increments	   in	   core	   body	   temperature	   during	   the	   passive	   heat	   stress,	   data	   up	   to	   an	  
increase	   of	   0.6ºC	  were	   used	   for	   CBF	   analysis	   (n=18).	   Data	   are	   presented	   in	   the	   text	   as	  
mean	  (95%	  confidence	  interval)	  unless	  otherwise	  stated.	  	  
	   	  
	   	  
Figure	  6.1.	  Consort-­‐style	  flowchart	  regarding	  inclusion,	  randomisation	  and	  drop-­‐out	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6.3	  Results	  	  
6.3.1	  Conduit	  brachial	  artery	  flow-­‐mediated	  dilation	  
Brachial	  artery	  FMD	  increased	  by	  1.71	  %	  (95%	  CI,	  0.56,	  2.19)	  following	  both	  interventions	  
(P=0.003;	  Figure.	  6.2A).	  There	  was	  no	  main	  effect	  of	  intervention	  (P=0.11)	  or	  interaction	  
between	  intervention	  and	  time	  (P=0.18).	  	  
6.3.2	  Cardiorespiratory	  Fitness	  
VO2peak	   improved	  by	  2.26	  ml·∙kg-­‐1·∙min-­‐1	   (95%	  CI,	  1.27,	  3.25)	   following	  both	   interventions	  
(P<0.001;	  Figure	  6.2B).	  There	  was	  no	  main	  effect	  of	   intervention	  (P=0.78)	  or	   interaction	  
between	  intervention	  and	  time	  (P=0.43).	  	  
6.3.3	  Resting	  baseline	  measurements.	  
6.3.3.1	  Haemodynamics	  
Heart	  rate	  [2	  beats·∙min-­‐1	  (95%	  CI,	  -­‐1,	  4)]	  and	  mean	  arterial	  pressure	  [3	  mmHg	  (95%	  CI,	  0.2,	  
5)]	   were	   lower	   following	   the	   interventions,	   although	   this	   did	   not	   reach	   statistical	  
significance	   (P=0.07;	   Table	   6.1).	   There	   was	   no	   main	   effect	   of	   intervention	   or	  
intervention*time	   interaction	   for	   heart	   rate	   and	  mean	   arterial	   pressure.	   Stroke	   volume	  
was	   3.8	  ml	   (95%	  CI=0.6,	   4.9)	   higher	   following	   the	   interventions	   (P=0.02),	  with	   no	  main	  
effect	  of	   intervention	  (P=0.24)	  or	   intervention*time	  interaction	  (P=0.17).	  Cardiac	  output	  
was	  0.6	  L·∙min-­‐1	  (95%	  CI,	  0.1,	  1.1)	  higher	  following	  the	  interventions	  (P=0.07),	  with	  no	  main	  









	   	  
	  
	  
Figure	   6.2	   Cardiorespiratory	   fitness	   (A;	   VO2peak)	   and	   Flow	   mediated-­‐dilation	   (B;	   FMD)	  
before	  and	  after	  exercise	  and	  water	  training	  interventions.	  Error	  bars	  are	  SD.	  *significant	  










































































































































































































































































































































































































































































































































	  	  	  
















	  	  	  
	  	  	  
	  	  	  
	  	  	  
	  	  	  
	  	  	  
	  	  	  
	  	  	  
	  	  	  



















































6.3.3.2	  Thermoregulatory	  	  
Skin	   temperature	  was	   not	   different	   between	   interventions	   or	   over	   time	   (P>0.05;	   Table	  
6.1).	  Core	  body	  temperature	  was	  0.14ºC	  (95%	  CI,	  0.04,	  0.23;	  P=0.004)	  lower	  following	  the	  
interventions,	   with	   no	   main	   effect	   of	   intervention	   (P=0.74)	   or	   intervention*time	  
interaction	   (P=0.70).	   There	  was	   no	  main	   effect	   of	   intervention	   or	   time	   for	   resting	   skin	  
blood	   flow	  at	   the	   chest,	  however	   skin	  blood	   flow	  at	   the	   forearm	  was	  2.2%CVCmax	   (95%	  
CI=0.83,	   3.4;	   P=0.04)	   higher	   following	   the	   interventions	   with	   no	   main	   effect	   of	  
intervention	  (P=0.22),	  or	  intervention*time	  interaction	  (P=0.17).	  
	  
6.3.3.3	  Cerebral	  Blood	  Flow	  	  
Basal	   MCAv	   was	   2.30	   cm/s	   (95%	   CI,	   1.20,	   3.34)	   higher	   following	   the	   interventions	  
(P<0.001;	   Table	   6.1),	  with	   no	  main	   effect	   of	   intervention	   (P=0.55)	   or	   intervention*time	  
interaction	   (P=0.83).	   Basal	   CBVC	   was	   also	   0.03	   cm·∙s-­‐1·∙mmHg-­‐1	   (95%	   CI,	   -­‐0.01	   to	   0.05;	  
P=0.05;	   Table	   6.1)	   higher	   following	   the	   interventions.	   There	   was	   no	   main	   effect	   of	  
intervention	  (P=0.73)	  or	  intervention*time	  interaction	  (P=0.89).	  There	  was	  no	  main	  effect	  
of	   intervention	   (P=0.12),	   time	   (P=0.17)	   or	   intervention*time	   interaction	   (P=0.43)	   for	  
PETCO2	  at	  rest.	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6.3.6	  Responses	  during	  the	  heat	  stress	  challenge	  
6.3.6.1	  Haemodynamics	  
Changes	  in	  heart	  rate,	  mean	  arterial	  pressure,	  stroke	  volume	  and	  cardiac	  output	  were	  not	  
different	   between	   interventions	   or	   over	   time,	  whilst	   there	  was	  no	   interaction	  between	  
intervention	  and	  time	  (P>0.05).	  	  
6.3.6.2	  Thermoregulatory	  
Changes	   in	   core	   body	   temperature	   and	   skin	   temperature	   were	   similar	   between	  
interventions	   and	  over	   time,	  whilst	   there	  was	  no	   interaction	  between	   intervention	   and	  
time	  (P>0.05).	  
6.3.6.3	  Sweat	  rate	  
The	   onset	   of	   chest	   sweating	   occurred	   at	   a	   0.10ºC	   (95%	  CI,	   -­‐0.14,	   0.33,	  P<0.001;	   Figure	  
6.3A)	   lower	   mean	   body	   temperature	   following	   the	   exercise	   and	   water	   interventions.	  
Similarly,	  the	  onset	  of	  forearm	  sweating	  occurred	  at	  a	  0.19ºC	  (95%	  CI,	  0.12,	  0.23,	  P<0.001;	  
Figure	   6.3B)	   lower	  mean	   body	   temperature	   following	   the	   interventions.	   There	   was	   no	  
main	  effect	  of	   intervention	  at	  either	  site	  (chest,	  P=0.49;	  forearm,	  P=0.43).	  There	  was	  no	  
intervention*time	  interaction	  at	  the	  chest	  (P=0.18)	  or	  forearm	  (P=0.73).	  
	  
The	   rate	   of	   sweating	   at	   the	   chest	   and	   the	   forearm,	   per	   1ºC	   increase	   in	   mean	   body	  
temperature,	  increased	  following	  both	  interventions	  (P<0.001).	  At	  the	  chest,	  a	  significant	  
main	   effect	   for	   intervention	   was	   observed	   (P=0.03),	   alongside	   a	   significant	  
intervention*time	   interaction	   (P=0.015),	   where	   the	   intervention-­‐mediated	   change	   in	  
sweating	   sensitivity	   was	   1.18	   mg·∙cm2·∙min-­‐1	   (95%	   CI,	   0.68,	   1.67;	   P<0.001)	   compared	   to	  
0.28	  mg·∙cm2·∙min-­‐1	  (95%	  CI,	  0.23,	  0.78)	  higher	  following	  the	  water	  immersion	  and	  exercise	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training	  interventions,	  respectively	  (Figure	  6.3C).	  Furthermore,	  the	  rate	  of	  sweating	  per	  1	  
oC	  increase	  in	  mean	  body	  temperature	  was	  0.53	  mg·∙cm2·∙min-­‐1	  (95%	  CI,	  0.34,	  0.74)	  higher	  
at	   the	   forearm	   following	  both	   interventions	   (P<0.001;	   Figure	  6.3D).	   There	  was	  no	  main	  
effect	  of	  intervention	  (P=0.48)	  or	  intervention*time	  interaction	  (P=0.39)	  at	  the	  forearm.	  
	  
	   	  
	  
Figure	  6.3	  Mean	  body	  temperature	  threshold	  (Tb)	  for	  the	  onset	  of	  chest	  (A)	  and	  forearm	  (B)	  sweating.	  
Sweat	  rate	  sensitivity	  (slope)	  at	  the	  chest	  (C)	  and	  forearm	  (D).	  Error	  bars	  are	  SD.	  *	  significant	  difference	  





6.3.6.4	  Cutaneous	  blood	  flow	  
The	   onset	   of	   chest	   cutaneous	   vasodilation	   occurred	   at	   a	   0.20ºC	   (95%	   CI,	   0.14,	   0.26,	  
P<0.001;	  Figure	  6.4A)	  lower	  core	  body	  temperature	  following	  the	  interventions.	  Similarly,	  
the	   onset	   of	   forearm	   cutaneous	   vasodilation	   occurred	   at	   0.19ºC	   (95%	   CI,	   0.12,	   0.25,	  
P<0.001;	   Figure	   6.4B)	   lower	   core	   body	   temperature	   following	   the	   interventions.	   	   There	  
was	   no	   main	   effect	   of	   intervention	   at	   the	   chest	   (P=0.58)	   or	   forearm	   (P=0.42),	   or	  
intervention*time	  interaction	  (chest,	  P=0.64;	  forearm,	  P=0.25).	  The	  change	  in	  CVC	  per	  1oC	  
change	   in	   core	  body	   temperature	  was	  not	   significantly	   different	   between	   interventions	  
(chest,	   P=0.92;	   forearm,	   P=0.71),	   over	   time	   (Figure	   6.4C:	   chest,	   P=0.74;	   Figure	   6.4D:	  
forearm,	  P=0.84)	  with	  no	  interaction	  (chest,	  P=0.93;	  forearm,	  P=0.87).	  	  
	  
6.3.6.5	  Cerebral	  blood	  flow	  
CBF	   decreased	   during	   the	   heat	   stress	   (P<0.001).	   There	   was	   a	   significant	  
time*temperature	   interaction	   in	  MCAv	   (P=0.003),	  where	   the	   reduction	   in	  MCAv	   during	  
heat	   stress	  was	  decreased	   following	   the	   interventions	   (Table	  6.2).	  MCAv	  was	  6.38	  cm/s	  
(95%	  CI=	  5.50,	  7.26,	  P<0.001)	  higher	  post-­‐	  compared	  with	  pre-­‐intervention.	  There	  was	  no	  
main	  effect	  of	  intervention	  (P=0.63).	  	  
	  
There	   was	   a	   significant	   intervention*time*temperature	   interaction	   in	   CBVC	   (P=0.004,	  
Figure	  6.5).	  CBVC	  was	  significantly	  higher	  post	  exercise	  training	  at	  0.1,	  0.2,	  0.3,	  0.5,	  0.6	  oC	  
increments	  in	  core	  body	  temperature	  compared	  to	  pre	  exercise	  training	  (P=0.008).	  	  Mean	  
CBVC	   (mean	   for	   0.6	   ºC	   increase	   in	   core	  body	   temperature	  during	  heat	   stress)	  was	  0.86	  
cm·∙s-­‐1·∙mmHg-­‐1	  (95%	  CI,	  0.80,	  0.92)	  post-­‐exercise	  training	  compared	  to	  0.80	  cm·∙s-­‐1·∙mmHg-­‐1	  
(95%	  CI,	  0.73,	  0.86)	  pre-­‐exercise	  training.	  CBVC	  was	  significantly	  higher	  post	  warm	  water	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immersion	   at	   rest	   and	   at	   0.1,	   0.2,	   0.3,	   0.4,	   0.6oC	   increment	   in	   core	   body	   temperature	  
(P<0.001).	  Mean	  CBVC	  (mean	  for	  0.6ºC	  in	  core	  body	  temperature	  during	  heat	  stress)	  was	  
0.84	  cm·∙s-­‐1·∙mmHg-­‐1	  (95%	  CI,	  0.77,	  0.90)	  post-­‐water	  immersion	  training	  compared	  to	  0.81	  
cm·∙s-­‐1·∙mmHg-­‐1	  (95%	  CI,	  0.75,	  0.88)	  pre	  warm	  water	  immersion.	  
	  
	   	  
	  
Figure	   6.4	  Mean	   core	   body	   temperature	   threshold	   values	   for	   onset	   of	   chest	   (A)	   and	   forearm	   (B)	  
cutaneous	  vasodilation.	  CVC	  sensitivity	  at	  the	  chest	  (C)	  and	  forearm	  (D).	  Error	  bars	  are	  SD.	  *significant	  




	   	  







































































































































6.4	  Discussion	  	  
The	   primary	   findings	   of	   this	   chapter	   were	   that	   warm	   water	   immersion	   training	   elicits	  
similar	  thermoregulatory,	  conduit-­‐	  and	  cerebrovascular	  improvements	  to	  that	  of	  exercise	  
training	   in	   young	   females.	   This	   is	   the	   first	   study	   to	   directly	   compare	   an	   exercise-­‐
independent	  passive	  heating	   ‘training	  stimulus’	  against	  a	   traditional	  endurance	  exercise	  
training	  intervention.	  These	  findings	  provide	  evidence	  for	  warm-­‐water	  immersion	  training	  
as	  a	  useful	  alternative	   intervention	   in	   improving	   thermoregulatory,	  cerebrovascular	  and	  
vascular	  function	  in	  young	  healthy	  individuals.	  
	  
This	  study	  established	  that	  8-­‐weeks	  of	  warm	  water	  immersion	  training	  improved	  central	  
thermoregulatory	   function.	   These	   enhancements	   occurred	   via	   reduced	   body	   and	   core	  
temperature	  thresholds	  for	  sweating	  and	  cutaneous	  vasodilation,	  respectively,	  and	  were	  
attributed	   to	   absolute	   decreases	   in	   resting	   core	   body	   temperature	   mediated	   by	   the	  
training	   intervention	   rather	   than	   absolute	   changes	   in	   skin	   temperature	   (Wingo	   et	   al.,	  
2010).	  Whilst	   these	   findings	   reflect	  previous	   studies	  using	   short-­‐term	   (9	  days)	   repeated	  
passive	  heating	  (e.g.	  repeated	  30	  min	  leg	  immersion	  in	  warm	  water	  (Shido	  et	  al.,	  1999)),	  
and	  repeated	  active	  heating	  acclimation	  (Armstrong	  et	  al.,	  2005),	  this	  study	  shows	  for	  the	  
first	  time	  that	  these	  thermoregulatory	  adjustments	  are	  of	  a	  similar	  magnitude	  as	  8-­‐weeks	  
of	   normothermic	   cycling	   training.	   Enhancements	   in	   sweat	   rate	   sensitivity	   with	   both	  
interventions	   at	   the	   chest	   and	   the	   forearm,	   with	   no	   changes	   in	   the	   sensitivity	   of	  
cutaneous	   vasodilation	   were	   observed	   suggesting	   peripheral	   sweat	   gland	   adaptations.	  
Nevertheless,	   a	  greater	  enhancement	   in	   sweat	   rate	   sensitivity	  at	   the	  chest	  was	  evident	  
with	   the	  water	   immersion	   intervention	   compared	   to	   the	   exercise	   training	   intervention,	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which	   could	   suggest	   that	   water	   immersion	   is	   more	   favourable	   in	   improving	  
thermoregulatory	  function.	  	  
	  
The	  exercise	  training	  findings	  in	  this	  study	  are	  in	  accordance	  with	  previous	  research	  work	  
in	  terms	  of	  both	  central	  (Yamazaki	  and	  Hamasaki,	  2003,	  Patterson	  et	  al.,	  2004,	  Okazaki	  et	  
al.,	   2002,	   Armstrong	   et	   al.,	   2005,	   Ichinose	   et	   al.,	   2009)	   and	   peripheral	   (Ichinose	   et	   al.,	  
2009,	  Thomas	  et	  al.,	  1999,	  Okazaki	  et	  al.,	  2002)	  adaptations.	  Enhancements	   in	  heat	   loss	  
responses	   with	   exercise	   training	   are	   thought	   to	   occur	   via	   a	   decreased	   temperature	  
threshold	   for	  sweating	  and	  cutaneous	  vasodilation	   (Thomas	  et	  al.,	  1999,	   Ichinose	  et	  al.,	  
2009),	  followed	  by	  a	  transient	  change	  in	  sweating	  sensitivity	  alone	  (Ichinose	  et	  al.,	  2009,	  
Kuwahara	  et	  al.,	  2005a).	  The	   larger	   improvements	   in	   sweat	   rate	   sensitivity	  at	   the	  chest	  
following	  warm	  water	   immersion	  could	  be	  related	   to	   the	  chest	  being	  submerged	   in	   the	  
water	   during	   immersion,	   thereby	   causing	   a	   greater	   local	   heat	   stress	   (e.g.,	   chest	   skin	  
temperature)	   and	   reducing	   the	   surface	   area	   for	   evaporative	  heat	   loss.	   Enhanced	   sweat	  
rate	   sensitivity	  may	   be	   due	   a	   variety	   of	   temperature-­‐induced	   adaptations	  mediated	   by	  
the	  interventions.	  These	  include	  improved	  central	  sudomotor	  neural	  activity	  that	  results	  
in	   an	   enhanced	   number	   of	   sweat	   expulsions	   per	  minute	   (Ogawa	   and	   Sugenoya,	   1993),	  
sweat	   gland	   hypertrophy	   (Inoue	   et	   al.,	   1999),	   increased	   NO	   availability	   (Welch	   et	   al.,	  
2009),	   and/or	   	   enhanced	   sweat	   gland	   recruitment	   at	   a	   given	   internal	   temperature,	   or	  
indeed,	  a	  combination	  of	  the	  above	  (Shibasaki	  et	  al.,	  2006).	  Regardless	  of	  the	  mechanism	  
this	   study	   suggests	   that	   improved	   thermoregulatory	   function	   with	   warm-­‐water	  





Despite	   no	   change	   in	   the	   sensitivity	   of	   cutaneous	   vasodilation	   during	   the	   passive	   heat	  
stress	  challenge,	  an	  increased	  cutaneous	  blood	  flow	  at	  rest	  was	  observed	  following	  both	  
interventions.	   Reductions	   in	   core	   body	   temperature	   in	   response	   to	   heat	   acclimation	   or	  
exercise	  training	  have	  been	  suggested	  to	  be	  due	  to	  enhanced	  cutaneous	  blood	  flow	  and	  
blood	  volume	  that	  enhance	  heat	  flow	  from	  the	  core	  to	  the	  body	  surface	  (Ichinose	  et	  al.,	  
2009).	  Both	  exercise	  training	  and	  local	  (arm)	  warm	  water	   immersion	  training	  are	  known	  
to	   increase	  cutaneous	  blood	  flow	  and	  brachial	  artery	  function	  via	  up-­‐regulation	  of	  nitric	  
oxide	  (NO)	  associated	  with	  repeated	  increases	  in	  shear	  stress	  (Green	  et	  al.,	  2010,	  Black	  et	  
al.,	   2008b,	   Naylor	   et	   al.,	   2011).	   Furthermore,	   enhanced	   sweat	   rate	   sensitivity	   is	   also	  
thought	  to	  be	  mediated	  by	  shear	  stress	  mediated	  release	  of	  NO	  due	  to	  a	  higher	  skin	  blood	  
flow	  (Lee	  and	  Mack,	  2006,	  Wingo	  et	  al.,	  2010).	   It	   is	  probable	   that	  both	   interventions	   in	  
the	   current	   study	   increased	   NO	   bioavailability	   given	   that	   brachial	   artery	   endothelial	  
function	   (FMD)	   was	   significantly	   enhanced.	   Assessment	   of	   conduit	   artery	   endothelial	  
function	  using	  FMD	  is	  a	  non-­‐invasive	  assessment	  of	  NO	  dilator	  function,	  with	  at	  least	  50%	  
of	  the	  dilator	  response	  to	  FMD	  NO-­‐mediated	   in	  healthy	   individuals	   (Green	  et	  al.,	  2014).	  
Enhanced	   endothelial	   function	   with	   exercise	   training	   is	   thought	   to	   be	   mediated	   by	  
repeated	  episodic	  bouts	  of	  increased	  blood	  flow	  and	  associated	  shear	  stress	  on	  the	  artery	  
wall	   (Tinken	   et	   al.,	   2008)	  which	   up-­‐regulates	   eNOS	   phosphorylation	   (Hambrecht	   et	   al.,	  
2003).	   It	  has	   recently	  been	  demonstrated	   that	   increases	   in	  brachial	  FMD	  with	   repeated	  
lower	   limb	   warm	   water	   immersion	   (and	   cutaneous	   function	   with	   local	   warm	   water	  
immersion)	   occur	   via	   the	   same	   shear	   stress	   related	   mechanism	   A	   number	   of	   central	  
factors	  that	   influence	  vascular	  adaption	  may	  also	  be	  possible	   including	  the	  upregulation	  
of	  circulating	  hormones	  or	  neural	  outflow,	  although	  due	  to	  the	  recent	  findings	  of	  Carter	  
et	  al.	  (2014)	  this	  is	  unlikely.	  Taken	  together,	  these	  findings	  suggest	  that	  both	  whole	  body	  




Another	   important	   observation	  was	   resting	  MCAv	  was	   higher	   following	   both	   the	  warm	  
water	   and	   exercise	   training	   interventions.	   Recent	   research	   studies	   have	   suggested	   that	  
exercise	   training	   and	   fitness	   are	   associated	   with	   superior	   cerebrovascular	   health	   and	  
cerebrovascular	   reactivity	   (Ainslie	  et	  al.,	  2008,	  Murrell	  et	  al.,	  2013).	  Yet,	   this	   is	   the	   first	  
study	  to	  demonstrate	  that	  repeated	  passive	  heating	  can	  also	  enhance	  basal	  MCAv.	  MCAv	  
is	  extremely	  sensitive	  to	  changes	  in	  BP	  and/or	  arterial	  CO2	  (Ainslie	  and	  Duffin,	  2009),	  and	  
is	   also	   influenced	   by	   the	   distribution	   of	   cardiac	   output	   (Ogoh	   and	   Ainslie,	   2009).	   This	  
study	   did	   not	   find	   differences	   in	   resting	   PETCO2	   following	   both	   interventions;	   and	   the	  
higher	   basal	   MCAv	   post-­‐intervention	   persisted	   even	   when	   normalised	   for	   changes	   in	  
MAP,	  thereby	  providing	  evidence	  that	  these	  variables	  are	  unlikely	  to	  be	  the	  explanation	  
for	   the	   increase	   in	   basal	   CBF.	   Resting	   cardiac	   output	   tended	   to	   be	   higher	   after	   both	  
interventions	   (P=0.07),	   suggesting	   that	   this	   could	   have	   contributed	   to	   a	   higher	   MCAv	  
following	  both	  interventions.	  One	  mechanistic	  explanation	  for	  the	  improved	  MCAv	  could	  
be	   related	   to	   improvements	   in	   cerebrovascular	   endothelial	   function	   following	   both	  
interventions	   via	   shear	   stress	   related	  mechanisms	   described	   above,	   as	   cerebrovascular	  
function	   is	   partly,	   nitric	   oxide	   dependent	   (Peebles	   et	   al.,	   2007)	   and	   is	   linked	   to	   FMD	  
(Ainslie	  et	  al.,	  2007).	  	  
	  
During	  a	  bout	  of	  exercise	  (up	  until	  very	  high	  exercise	  intensities)	  CBF	  increases	  (Murrell	  et	  
al.,	   2013)	   and	   thus	   exercise	   training	   causes	   increases	   in	   cerebrovascular	   shear	   stress.	  
However,	  during	  acute	  exposure	  to	  passive	  heating	  a	  gradual	  reduction	  in	  CBF	  occurs	  with	  
increases	  in	  core	  body	  temperature	  (Low	  et	  al.,	  2008b,	  Nelson	  et	  al.,	  2011,	  Wilson	  et	  al.,	  
2006),	  an	  observation	  evident	  during	  the	  heat	  stress	  challenge	  in	  the	  current	  study.	  This	  
heat	  stress-­‐induced	  reduction	   in	  CBF	   is	  partly	  attributed	  to	  hyperventilatory	  hypocapnia	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leading	   to	   cerebral	   vasoconstriction	   (Brothers	  et	   al.,	   2009,	  Wilson	  et	   al.,	   2006).	  Despite	  
these	  different	  responses	  to	  CBF	  during	  acute	  exercise	  and	  passive	  heat	  stress,	  a	  greater	  
maintenance	  of	  MCAv	  was	   observed	  during	   the	  passive	   heat	   stress	   challenge	   following	  
both	   interventions	   suggesting	   improvements	   in	   CBF	   control	   that	   may	   not	   be	   solely	  
explained	   by	   changes	   in	   vascular	   function.	   This	   study	   did	   not	   observe	   an	   attenuated	  
decrease	  in	  PETCO2	  during	  heat	  stress	  following	  the	  interventions,	  and	  therefore	  the	  heat	  
stress	  CBF	  findings	  cannot	  be	  explained	  by	  changes	  in	  hyperventilatory	  hypocapnia	  (e.g.,	  
less	   hyperventilation	  or	   hypocapnia	   did	   not	   occur)	   (Brothers	   et	   al.,	   2009,	  Wilson	   et	   al.,	  
2006).	  Although	  the	  method	  of	  stroke	  volume	  and	  cardiac	  output	  estimation	  used	  in	  the	  
present	  study	  underestimates	  the	  changes	  in	  these	  variables	  during	  heat	  stress	  (Shibasaki	  
et	  al.,	  2011),	  the	  changes	  in	  stroke	  volume	  and	  cardiac	  output	  were	  similar	  pre-­‐	  and	  post-­‐
interventions	   suggesting	   that	   differences	   in	   the	   acute	   alterations	   in	   stroke	   volume	   and	  
cardiac	   output	   do	   not	   explain	   the	   better	   maintained	   CBF	   during	   heat	   stress	   post-­‐
intervention	   (Nelson	   et	   al.,	   2011).	   An	   alternative	   explanation	   may	   relate	   to	   chronic	  
increases	   in	  stroke	  volume,	  that	  may	  have	  been	  a	  function	  of	  plasma	  volume	  expansion	  
(Nielsen	   et	   al.,	   1993,	   Schlader	   et	   al.,	   2013)	   following	   the	   interventions.	   In	   respect	   of	  
chronic	   adaptations,	   stroke	   volume	   is	   increased	   following	   endurance	   exercise	   training	  
(Stratton	  et	  al.,	  1994)	  and	  along	  with	  venous	   return	  has	  been	  strongly	   linked	   to	  central	  
blood	   volume	   (Convertino,	   1993,	   Levine	   et	   al.,	   2002,	   Convertino	   et	   al.,	   1980).	   It	   is	  well	  
established	   that	   endurance	   training	   (Sawka	   et	   al.,	   2000,	   Convertino,	   1993)	   and	  
potentially,	   repeated	   heating	   (Nielsen	   et	   al.,	   1993,	   Shapiro	   et	   al.,	   1981,	   Epstein	   et	   al.,	  
1975)	  results	  in	  blood	  volume	  expansion	  over	  a	  number	  of	  weeks.	  Therefore,	  whilst	  this	  
study	   did	   not	   measure	   blood	   volume,	   it	   is	   possible	   that	   both	   interventions	   increased	  
central	   blood	   volume,	   which	   may	   have	   contributed	   to	   an	   attenuated	   decrease	   in	   CBF	  
during	  heat	   stress	  post-­‐intervention.	  That	   said,	  although	  acute	  blood	  volume	  expansion	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during	   heat	   stress	   enables	   a	   better	  maintenance	   of	  MAP	   and	   attenuates	   reductions	   in	  
cerebral	   perfusion	   during	   simulated	   haemorrhage	   it	   does	   not	   increase	   CBF	   during	   heat	  
stress	   alone	   (Crandall	   et	   al.,	   2008,	   Keller	   et	   al.,	   2009,	   Schlader	   et	   al.,	   2013).	   	   Similarly,	  
greater	   increases	   in	  plasma	  volume	   improvements	   following	  exercise	  relative	   to	  passive	  
heating	   interventions	  have	  previously	  been	  reported	  and	  attributed	  to	  exercise-­‐induced	  
non-­‐thermal	   factors	   such	   as	   increased	   vasopressin,	   plasma	   osmotic	   and	   resting	   plasma	  
protein	  content	  (Convertino	  et	  al.,	  1980).	  
	  
Exercise	   training	   is	   a	  well-­‐established	   intervention	   to	   improve	   cardio-­‐respiratory	   fitness	  
(VO2peak)(Bassett	   and	   Howley,	   2000).	   Whilst	   not	   the	   primary	   aim,	   it	   is	   interesting,	   and	  
somewhat	   surprising,	   that	   this	   study	   observed	   for	   the	   first	   time	   that	   cardio-­‐respiratory	  
fitness	  was	  also	  improved	  following	  the	  warm	  water	  immersion	  intervention.	  There	  are	  a	  
number	  of	  potential	  reasons	  for	  this	  observation.	  Central	  physiological	  improvements	  to	  
stroke	   volume,	   cardiac	   output	   and	   potentially,	   blood	   volume	   represent	   several	  
physiological	   mechanisms	   that	   influence	   maximal	   exercise	   performance	   (Saltin	   and	  
Calbet,	  2006,	  Sawka	  et	  al.,	  2000).	  Analogous	  to	  exercise	  training,	  repeated	  elevations	   in	  
cardiac	  output	  and	  stroke	  volume	  during	  warm	  water	  immersion	  (Gabrielsen	  et	  al.,	  1993,	  
Begin	  et	  al.,	  1976,	  Boussuges,	  2006,	  Weston	  et	  al.,	  1987,	  Carter	  et	  al.,	  2014b)	  may	  induce	  
similar	   favourable	   cardiac	   and	   haemodynamic	   adaptations	   and	   directly	   influence	   blood	  
flow	  during	  maximal	  exercise.	  Additionally,	  peripheral	   improvements	  in	  conduit	  vascular	  
function	   found	   in	   this	   study	  may	   also	   contribute	   to	   improvements	   in	  maximal	   aerobic	  
capacity	  via	  enhancements	  in	  muscle	  blood	  flow	  and	  oxygen	  delivery.	  
	  
The	  current	  study	  has	  a	  number	  of	  noteworthy	  strengths	  including	  the	  inclusion	  of	  both	  
central	  and	  peripheral	   thermoregulatory	  control	  measurements	  combined	  with	  vascular	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function	   in	   conduit,	   cerebral	   and	   cutaneous	   blood	   vessels	   to	   gain	   insight	   into	   the	  
integrative	   impact	   of	   the	   interventions	   at	   a	   systemic	   level.	   Although,	   this	   study	   only	  
included	  healthy	  young	  females	  who	  were	  free	  of	  disease,	  non-­‐smokers	  and	  moderately	  
trained,	   exercise	   training	   has	   previously	   been	   shown	   to	   enhance	   both	   temperature	  
(Wingo	  et	  al.,	  2008)	  and	  cerebrovascular	  regulation	  (Bailey	  et	  al.,	  2013,	  Ivey	  et	  al.,	  2011)	  
in	  older	   individuals	   (Bailey	   et	  al.,	  2013)	  and	   those	  with	  cerebrovascular	  disease	   (Ivey	   et	  
al.,	  2011).	  Furthermore,	   this	  study	   illustrates	  that	  warm	  water	   immersion	  could	  have	  at	  
least	   similar	   benefits	   on	   both	   thermal	   and	   vascular	   function	   which	   may	   be	   useful	   in	  
patients	  with	  chronic	  conditions	  (e.g.	  spinal	  cord	  injured),	  symptomatic	  post-­‐menopausal	  
females	   suffering	   from	   HFs,	   or	   those	   that	   have	   a	   limited	   exercise	   capacity	   (e.g.	   heart	  
failure).	   Despite	   a	   relatively	   small	   enhancement	   in	   MCAv	   at	   rest	   (2.30	   cm/s	   higher	  
following	  both	  interventions),	   it	   is	  suggested	  that	  these	  improvements	  may	  have	  clinical	  
significance,	  and	  be	  magnified	  in	  populations	  whereby	  CBF	  is	  already	  compromised	  such	  
as	  following	  acute	  stroke	  (Ivey	  et	  al.,	  2011)	  or	  with	  ageing	  (Stoquart-­‐ElSankari	  et	  al.,	  2007,	  
Bailey	  et	  al.,	  2013).	  
	  
In	   summary,	   this	   chapter	   demonstrates	   for	   the	   first	   time	   that	   short-­‐term	  warm	  water	  
immersion	   training	   elicits	   similar	   thermoregulatory,	   conduit-­‐	   and	   cerebrovascular	  
adaptations	  to	  a	  period	  of	  moderate-­‐intensity	  exercise	  training	   in	  young	  females.	  These	  
results	  may	  serve	  as	  an	  important	  indication	  that	  warm	  water	  immersion	  can	  be	  a	  useful,	  
alternative	   intervention	  to	  enhance	  thermoregulatory	  control	  and	  vascular	   function	  and	  
its	  therapeutic	  use	  on	  both	  healthy	  and	  diseased	  populations	  warrants	  further	  study.	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7.1	  Aims	  and	  objectives	  
The	   research	   work	   described	   in	   the	   current	   thesis	   was	   designed	   to	   investigate	  
thermoregulatory	   and	   (cerebro)vascular	   (dys)function	   in	   post-­‐menopausal	   females	  
suffering	   from	   HFs,	   and	   to	   establish	   whether	   supervised	   exercise	   training	   could	  
ameliorate	   HFs	   (subjectively	   and	   objectively)	   via	   thermoregulatory	   and	   cardiovascular	  
adaptation.	   Furthermore,	   this	   thesis	   investigated	   the	   usefulness	   of	   warm	   water	  
immersion	   training	   as	   an	   alternative	   to	   exercise	   training	   in	   targeting	   thermoregulatory	  
and	  (cerebro)vascular	  adaptation.	  
7.2	  Major	  findings	  
7.2.1	  Exercise	  training	  reduces	  hot	  flushes	  in	  post-­‐menopausal	  females	  
Chapter	   4	   reported	   that	   a	   moderate-­‐intensity	   exercise	   training	   intervention	   in	  
symptomatic	  post-­‐menopausal	  females	  reduced	  both	  the	  frequency	  and	  severity	  of	  HFs,	  
and	   for	   the	   first	   time	   linked	   the	   improvement	   to	   enhanced	   thermoregulatory	   and	  
(cerebro)vascular	  function	  following	  exercise	  training	  compared	  to	  a	  no-­‐exercise	  control	  
group.	  Specifically,	  core	  body	  temperature	  and	  the	  temperature	  thresholds	  for	  cutaneous	  
vasodilation	   and	   sweating	   were	   significantly	   reduced,	   alongside	   improved	   sweating	  
sensitivity	   that	   together	   improved	   thermoregulatory	   efficiency.	   Furthermore,	   basal	   CBF	  
(MCAv	  and	  CBVC)	  was	  enhanced	  following	  exercise	  training	  alongside	  an	  attenuation	  of	  
the	   typical	   reduction	   in	  CBF	  observed	  during	  heat	  stress.	  The	   improved	  cerebrovascular	  
control,	   in	  concert	  with	  enhanced	  brachial	  artery	  FMD,	  suggests	  a	   role	  of	  enhanced	  NO	  
bioavailability	  in	  the	  absence	  of	  oestrogen	  following	  the	  exercise	  training	  in	  symptomatic	  




7.2.2	  Exercise	  training	  reduces	  the	  physiological	  response	  during	  acute	  hot	  flushes	  
In	  support	  of	  the	  findings	  of	  chapter	  4,	  chapter	  5	  established	  that	  a	  short-­‐term	  exercise	  
training	   intervention	   reduced	   the	   acute	   thermoregulatory	   and	   (cerebro)vascular	  
responses	  typically	  observed	  during	  a	  HF	  in	  symptomatic	  post-­‐menopausal	  females.	  This	  
is	  the	  first	  study	  to	  objectively	  assess	  whether	  exercise	  training	  reduces	  the	  physiological	  
severity	   during	   a	   HF.	   Specifically,	   reductions	   in	   sweating	   and	   cutaneous	   vasodilation	  
during	  a	  HF	  were	  observed	  following	  exercise	  training	  compared	  to	  a	  no-­‐exercise	  control	  
group,	  suggesting	  a	  reduced	  thermoregulatory	  response	  during	  a	  HF.	  Attenuation	  in	  the	  
acute	   reduction	   in	   CBF	   during	   HFs	   was	   also	   observed.	   The	   reduction	   in	   cutaneous	  
vasodilation	   and	   improved	  CBF	  during	   the	  HF	  per	   se	   suggests	   improved	   systemic	  blood	  
flow	  distribution	  during	  a	  HF.	  Together,	  chapters	  4	   and	  5	   confirm	   that	  exercise	   training	  
decreases	   the	   subjective/objective	   frequency	   and	   severity	   of	   HFs	   via	   thermoregulatory	  
and	  (cerebro)vascular	  adaptations.	  
7.2.3	  Warm	  water	  immersion	  and	  exercise	  training	  in	  pre-­‐menopausal	  females	  
Chapters	   4	   and	   5	   demonstrated	   improved	   thermoregulatory	   and	   (cerebro)vascular	  
function	  that	   impacted	  upon	  the	  prevalence	  of	   	  HFs,	  and	  chapter	  6	   investigated	  if	  these	  
exercise-­‐mediated	  thermoregulatory	  and	  (cerebro)vascular	  responses	  were	  possible	  with	  
a	   	   warm	   water	   (42ºC)	   whole-­‐body	   immersion	   training	   intervention.	   The	   findings	   from	  
chapter	   6	   suggest	   that	  warm	  water	   immersion	   training	   elicits	   similar	   thermoregulatory	  
and	   (cerebro)vascular	  adaptations	   to	  exercise	   training	   in	  pre-­‐menopausal	   females.	  Both	  
warm	   water	   immersion	   and	   exercise	   training	   significantly	   reduced	   resting	   core	   body	  
temperature	  and	  the	  temperature	  thresholds	  for	  cutaneous	  vasodilation	  and	  sweating,	  to	  
a	   similar	   degree	   to	  post-­‐menopausal	   females	   in	   chapter	   4.	   Additionally,	   the	   increase	   in	  
resting	  CBF	  following	  exercise	  and	  the	  attenuation	  in	  CBF	  during	  heat	  stress	  observed	  in	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chapter	   4	   was	   also	   found	   in	   pre-­‐menopausal	   females	   in	   chapter	   6,	   and	   again	  was	   also	  
evident	   following	  warm	  water	   immersion.	   Similarly,	   this	   coincided	  with	   improved	   FMD	  
following	   both	   interventions,	   implying	   a	   role	   for	   improved	   blood	   flow	   distribution	   via	  
enhanced	   NO-­‐mediated	   endothelial	   function.	   This	   suggests	   warm	   water	   immersion	  
training	   may	   also	   be	   useful	   in	   symptomatic	   post-­‐menopausal	   females	   via	   targeting	  
thermoregulatory	  and	  (cerebro)vascular	  adaptations.	  	  
	  
7.3	  Implications	  
In	   order	   to	   provide	   context,	   a	  menopausal	   HF	  mimics	   the	   physiological	   responses	   that	  
occur	  during	  a	  moderate	  heat	  stress	  challenge,	  but	  over	  a	  much	  shorter	  time	  period.	  HFs	  
are	   characterised	   by	   large	   increases	   in	   cutaneous	   vasodilation	   (~80%	   change	   from	  
baseline)	   that	   precede	   rapid	   surges	   in	   sweating	   (by	   ~2-­‐3	   minutes),	   that	   can	   last	   ~10	  
minutes	  in	  some	  females.	  This	  corresponds	  to	  the	  thermoregulatory	  responses	  that	  occur	  
to	  cutaneous	  vasodilation	  and	  sweating	  observed	  with	  changes	  in	  core	  body	  temperature	  
of	  ~0.4-­‐0.6ºC	  that	  are	  typically	  apparent	  during	  an	  acute	  30	  minute	  exercise	  bout	  at	  50%	  
VO2peak	   (Ichinose	   et	   al.,	   2009),	   or	   during	   60	   minutes	   of	   passive	   heating	   (Wingo	   et	   al.,	  
2010).	  After	  a	  HF,	  a	  drop	  in	  core	  body	  temperature	  usually	  occurs	  as	  the	  heat	  dissipation	  
response	  is	  so	  pronounced	  over	  such	  a	  short	  time-­‐frame.	  Subjective	  HF	  severity	  (using	  the	  
HF	  questionnaire)	  ranges	  from	  a	  feeling	  of	  mild	  warmth	  with	  elevations	  in	  skin	  blood	  flow	  
to	   very	   severe	   subjective	   sensations	   of	   boiling	   heat,	   rolling	   sweat	   with	   a	   stinging	   skin	  
sensation,	  an	  increase	  in	  heart	  rate,	  dizziness	  and	  nausea.	  The	  shear	  range	  of	  severity	  of	  
HFs	   that	   affect	   >70%	   of	   post-­‐menopausal	   females	   highlights	   the	   need	   for	   an	   effective	  
treatment.	   Despite	   the	   extraordinary	   amount	   of	   individuals	   affected	   by	  HFs,	   treatment	  
options	  are	  severely	  limited;	  the	  causal	  mechanisms	  responsible	  remain	  ambiguous,	  and	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the	   basic	   biological	   effects	   of	   oestrogen	   on	   thermoregulatory	   function	   are	   not	   fully	  
understood.	  
	  
7.3.1	  Implications	  for	  hot	  flush	  treatment	  
The	  current	  first	  line	  treatment	  for	  HFs	  is	  HRT,	  yet	  symptomatic	  post-­‐menopausal	  females	  
are	  avoiding	  this	  pathway,	  or	  not	  even	  reporting	  symptoms	  to	  their	  G.P.	  (Watson	  et	  al.,	  
2007,	   Isaacs	  et	  al.,	  2005,	  Townsend	  and	  Nanchahal,	  2005),	  due	  to	  the	   increased	  risks	  of	  
cardiovascular	  disease	  (Rossouw	  et	  al.,	  2002,	  Manson	  et	  al.,	  2003)	  and	  cancer	  (Hou	  et	  al.,	  
2013,	   Holmberg	   et	   al.,	   2008).	   	   In	   addition,	   some	   females	   cannot	   be	   prescribed	   this	  
treatment	  due	   to	   their	  age,	  history	  of	   cardiovascular	  disease	  or	  breast	   cancer,	  or	  other	  
gynaecological	   interventions	  (NICE,	  2009).	  As	  such,	  symptomatic	  females	  are	  attempting	  
to	   live	   with	   the	   debilitating	   symptoms	   of	   HFs	   in	   the	   absence	   of	   effective	   alternative	  
treatment.	  This	  thesis	  provides	  support	  for	  exercise	  training	  as	  an	  effective	  treatment	  in	  
reducing	  the	  frequency	  and	  severity	  of	  HFs	  (Luoto	  et	  al.,	  2012,	  Mansikkamaki	  et	  al.,	  2012,	  
Moilanen	   et	   al.,	   2012,	   Lindh-­‐Astrand	   et	   al.,	   2004,	   Reed	   et	   al.,	   2014),	   and	   importantly	  
highlights	   that	   these	   reductions	  may	   occur	   via	   improvements	   to	   thermoregulatory	   and	  
(cerebro)vascular	   systems	   following	   a	   short-­‐term	   moderate	   intensity	   exercise	   training	  
intervention.	   To	   prescribe	   exercise	   as	   an	   effective	   treatment	   for	   symptomatic	   post-­‐
menopausal	   females	   the	  mechanism(s)	   responsible	   for	   improvements	   in	   the	  occurrence	  
of	  HFs	  must	  be	  established.	  The	  current	  findings	  in	  chapters	  4	  and	  5	  are	  preliminary	  pilot	  
data,	   thus	   before	   meaningful	   exercise	   guidelines	   can	   be	   advocated	   in	   the	   community	  
setting,	  a	  RCT	  that	  directly	  investigates	  the	  effect	  of	  exercise	  training	  compared	  to	  a	  no-­‐
exercise	   control	   group	  on	  HFs	   and	   thermoregulatory	   and	   (cerebro)vascular	   adaptations	  
should	   be	   conducted.	   Moreover,	   a	   high	   and	   low	   intensity	   exercise	   group	   should	   be	  
incorporated	   into	   the	   research	   design	   compared	   to	   a	   no-­‐exercise	   control,	   in	   order	   to	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investigate	   the	   level	   of	   exercise	   intensity	   required	   to	   induce	   the	   requisite	  
thermoregulatory	  and	  (cerebro)vascular	  adaptations	  that	  lead	  to	  reductions	  in	  HFs.	  	  
7.3.2	  Implications	  for	  cardiovascular	  risk	  
The	   menopause	   is	   a	   time	   of	   life	   associated	   with	   increased	   cardiovascular	   disease	   risk	  
(Zaydun	  et	  al.,	  2006,	  Ossewaarde	  et	  al.,	  2005,	  van	  der	  Schouw	  et	  al.,	  1996),	  and	  therefore	  
interventions	  that	  also	  directly	  impact	  on	  the	  cardiovascular	  system	  in	  a	  positive	  way	  are	  
essential.	   Furthermore,	  markers	   of	   vascular	   inflammation	   (Bechlioulis	   et	   al.,	   2012)	   and	  
endothelial	   dysfunction	   (Bechlioulis	   et	   al.,	   2010)	   are	   correlated	  with	   severity	   of	   HFs	   in	  
symptomatic	  post-­‐menopausal	  females.	  This	  thesis	  reported,	  for	  the	  first	  time,	  improved	  
FMD	   (~2.32%)	   and	   reductions	   in	   subjective	   and	  objective	  HF	   severity	   that	   supports	   the	  
notion	  that	  enhancing	  endothelial	   function	  with	  exercise	  training	  (in)directly	   impacts	  on	  
HFs.	   FMD	   is	   predictive	  of	   cardiovascular	   events,	  with	   the	   risk	  of	   a	   cardiovascular	   event	  
increased	  by	  21%	  for	  every	  1	  standard	  deviation	  (~3.5%)	  decrease	  in	  brachial	  FMD	  (Inaba	  
et	  al.,	  2010).	  Improvements	  in	  cerebral	  and	  cutaneous	  function	  were	  also	  evident.	  These	  
findings	  demonstrate	  that	  vascular	  dysfunction	  as	  a	  consequence	  of	  low	  oestrogen	  levels	  
with	  the	  menopause	  can	  be	  ameliorated	  in	  the	  absence	  of	  oestrogen,	  and	  is	  likely	  due	  to	  
increases	   in	   exercise-­‐induced	   shear	   stress	   and	   the	   upregulation	   of	   NO	   (Green	   et	   al.,	  
2004b).	  As	  higher	  levels	  of	  NO	  confer	  anti-­‐atherogenic	  benefit,	  the	  findings	  of	  this	  thesis	  
have	   potentially	   important	   implications	   for	   the	   prevention	   of	   atherosclerosis,	   coronary	  
heart	  disease	  and	  stroke	  in	  post-­‐menopausal	  females,	  as	  well	  as	  improving	  quality	  of	  life	  
by	  reducing	  the	  negative	  effects	  of	  HFs.	  
	  
Exercise	   training	   as	   an	   alternative	   intervention	   to	   HRT	  would	   also	   be	   beneficial	   to	   the	  
NHS.	   Whilst	   the	   costs	   of	   HRT	   per	   patient	   is	   low	   (~£280	   annually),	   the	   alternative	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treatment	  of	  exercise	  training	  could	  be	  implemented	  easily	  at	  low	  cost	  to	  the	  NHS.	  Once	  
recommendations	   about	   exercise	   prescription	   are	   established,	   this	   information	   can	   be	  
communicated	   via	   community	   nurses,	  G.P.s	   and	   other	   health	   related	   professionals	   and	  
implemented	  via	  community	  G.P.	  referral	  schemes.	  Furthermore,	  given	  the	  potential	  dual	  
benefits	   on	   HFs	   and	   cardiovascular	   disease	   risk	  with	   exercise	   training,	   this	  would	   have	  
direct	   impact	  on	  decreasing	  healthcare	  costs	  to	  the	  NHS	  via	  reducing	  a	  range	  of	  disease	  
morbidities	  and	  risk	  factors	  (Health,	  2004,	  NICE,	  2009).	  	  
7.3.3	  Implications	  for	  understanding	  the	  causal	  mechanisms	  of	  hot	  flushes	  
It	  is	  currently	  proposed	  that	  HFs	  are	  induced/triggered	  by	  (i)	  prior	  elevations	  (~0.04ºC)	  in	  
core	  body	  temperature	  (Freedman,	  2001,	  Freedman,	  2005,	  Freedman,	  2014a,	  Freedman,	  
1998),	  (ii)	  a	  narrowing	  of	  the	  thermo-­‐neutral	  zone	  (the	  zone	  when	  shivering	  and	  sweating	  
do	  not	  occur)	  to	  ~0.0ºC,	  and	  (iii)	  subsequent	  lower	  core	  body	  temperature	  thresholds	  for	  
skin	   blood	   flow	   and	   sweating	   (i.e.	   any	   slight	   elevation	   in	   core	   body	   temperature	   will	  
trigger	   dramatic	   increases	   in	   cutaneous	   vasodilation	   and	   sweating);	   in	   the	   absence	   of	  
oestrogen.	  Chapter	   5,	   however,	   suggests	   core	   body	   temperature	   is	   not	   elevated	   in	   the	  
period	   that	   precedes	   a	   HF	   episode	   and	   that	   the	   increase	   in	   core	   body	   temperature	  
required	   to	   initiate	  cutaneous	  vasodilation	  and	  sweating	   (i.e.	   thresholds)	  during	  passive	  
heating	   in	  symptomatic	   females	  was	  ~0.22ºC	   (chapter	  4),	  which	  contrasts	   the	  0.0ºC	  null	  
zone	   hypothesis	   proposed	   by	   Freedman	   et	   al.,	   (2001).	   Furthermore,	   the	   absolute	   core	  
body	   temperature	   preceding	   a	   HF	   in	   chapter	   5	   (~37.0ºC)	   was	   less	   than	   the	   core	   body	  
temperature	   thresholds	   for	   cutaneous	   vasodilation	  and	   sweating	  observed	   in	  chapter	  4	  
(~37.2ºC);	   thus	   the	   data	   in	   this	   thesis	   suggest	  HFs	   are	   triggered	   prior	   to	   the	   core	   body	  
temperature	   thresholds	   for	   cutaneous	   vasodilation	   and	   sweating	   measured	   during	  
passive	   heat	   stress.	   Nevertheless,	   HFs	   still	   occurred	   despite	   reductions	   in	   core	   body	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temperature	   and	   associated	   temperature	   thresholds	   with	   exercise	   training.	   This	   may	  
suggest	   an	   alternative	   theory	   that	   a	   fluctuating	   core	   body	   temperature	   threshold	   for	  
cutaneous	  vasodilation	  and	  sweating	  is	  responsible	  for	  HFs	  in	  symptomatic	  females,	  and	  
not	  an	  increase	  in	  core	  body	  temperature	  per	  se.	  	  
	  
An	  alternative	  explanation	  for	  the	  initiation/trigger	  of	  a	  HF	  and/or	  a	  fluctuating	  core	  body	  
temperature	   threshold,	   if	   not	   an	   increase	   in	   absolute	   core	  body	   temperature,	   could	  be	  
linked	  to	  absolute	  increases	  in	  sympathetic	  nerve	  activity,	  as	  it	  is	  increased	  following	  the	  
menopause	   (Hart	   et	   al.,	   2011).	   As	   oestrogen	   modulates	   adrenergic	   receptors	   in	   many	  
tissues	  (Rettberg	  et	  al.,	  2014),	  it	  is	  possible	  that	  hypothalamic	  alpha-­‐adrenoreceptors	  are	  
affected	  by	  diminished	  oestrogen	  during	  the	  menopause	  (e.g.,	  they	  become	  up-­‐regulated	  
or	  ‘supersensitive’	  to	  changes	  in	  oestrogen).	  Fluctuations,	  or	  surges,	  in	  sympathetic	  nerve	  
activity	   would	   explain	   sudden	   increases	   in	   neurally	   mediated	   (increases	   in	   skin	  
sympathetic	  nerve	  activity)	  cutaneous	  vasodilation	  and	  sweating	  that	  are	  observed	  during	  
HFs	  (Low	  et	  al.,	  2010),	  irrespective	  of	  changes	  in	  core	  body	  temperature,	  and	  would	  also	  
provide	   an	   explanation	   for	   endothelial	   dysfunction	   evident	   in	   symptomatic	   post-­‐
menopausal	  females	  (Bechlioulis	  et	  al.,	  2010,	  Bechlioulis	  et	  al.,	  2012)	  if	  sympathetic	  tone	  
is	   elevated	   post-­‐menopause	   (Holowatz	   et	   al.,	   2003,	   Holowatz	   and	   Kenney,	   2010).	  
Although	  not	  directly	  measured	  in	  this	  study,	  one	  previous	  study	  has	  shown	  a	  reduction	  
in	   sympathetic	   nerve	   activity	   following	   exercise	   training	   in	   post-­‐menopausal	   females	  
(Oneda	  et	  al.,	  2014),	  although	  symptomatic	  HF	  status	  was	  undisclosed.	  	  
	  
A	   decline	   in	   the	   number	   or	   sensitivity	   of	   inhibitory	   pre-­‐synaptic	   alpha-­‐adrenoreceptors	  
implicated	   in	   the	   thermoregulatory	   neural	   pathway	   in	   the	   absence	   of	   oestrogen	   could	  
also	   be	   possible.	  Chapter	   4	   suggested	   that	   enhancing	   thermoregulatory	   efficiency	  with	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exercise	   training	   decreased	   the	   occurrence	   of	   HFs	   by	   improving	   central	   core	   body	  
temperature	   control	   and	   thresholds	   for	   cutaneous	   vasodilation	   and	   sweating,	   and	   via	  
improved	   vascular	   function	   and	   blood	   flow	   distribution.	   Chapter	   5	   demonstrated	  
attenuation	   in	   the	   acute	  physiological	   severity	  of	   a	  HF	  with	  exercise	   training.	   It	   is	   clear	  
from	  these	  studies	  that	  improving	  thermoregulatory	  and	  vascular	  (dys)function	  supports	  
the	   alleviation	   in	   the	   frequency	   and	   severity	   of	  HFs.	  Whether	   exercise	   training	   reduces	  
surges/fluctuations	   in	   sympathetic	   nerve	   activity,	   or	   improves	   the	   number	   or	  
(de)sensitivity	  of	   alpha-­‐adrenoreceptors	   and	   reverses	   ‘abnormal’	   hypothalamic	   function	  
in	   the	   absence	   of	   oestrogen,	   which	   is	   subsequently	   responsible	   for	   reductions	   in	   the	  
frequency	  and	  severity	  of	  HFs,	  needs	  further	  investigation.	  	  
7.3.4	  Implications	  for	  improving	  thermoregulatory	  control	  in	  females	  
This	   thesis	   has	   provided	   evidence	   that	   thermoregulatory	   function	   is	   improved	   by	   the	  
same	  mechanisms	  (absolute	  reduction	  in	  core	  body	  temperature	  and	  a	  subsequent	  shift	  
in	   temperature	   thresholds	   for	   cutaneous	   vasodilation	   and	   sweating)	   in	   pre-­‐	   and	  
symptomatic	   post-­‐menopausal	   females	   with	   either	   exercise	   or	   warm	  water	   immersion	  
training.	   These	   improvements	   in	   thermoregulatory	   function	  with	   exercise	   training	   (and	  
warm	  water	   immersion)	   suggests	  a	   central	   adaptation	  and	  a	   change	   in	   the	   set	  point	  of	  
core	  body	  temperature	  control,	  with	  cutaneous	  vasodilation	  and	  sweating	  initiated	  earlier	  
during	  passive	  heat	  stress.	  In	  concert	  with	  this	  central	  adaptation,	  an	  increase	  in	  sweating	  
sensitivity	   was	   also	   evident,	   likely	   due	   to	   peripheral	   sweat	   gland	   adaptation,	   either	   by	  
increased	   sweat	   gland	   output	   or	   the	   number	   of	   activated	   glands	   during	   heat	   stress	  
(Shibasaki	   et	   al.,	   2006).	   A	   change	   in	   neural	   drive	  may	   also	   be	   responsible	   for	   either	   of	  
these	  adaptations	  thus	  suggesting	  a	  central	  influence	  on	  sweat	  rate	  sensitivity	  rather	  than	  
solely	  peripheral	  adaptations.	  Given	  that	  both	  exercise	  and	  warm	  water	  training	  targeted	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the	   thermoregulatory	   system	  via	   similar	   pathways,	   it	   is	   possible	   that	   interventions	   that	  
target	  the	  thermoregulatory	  system	  in	  this	  way	  could	  also	  be	  used	  as	  an	  intervention	  for	  
improving	  the	  severity	  of	  HFs.	  
	  
Interestingly,	  the	  studies	  in	  this	  thesis	  and	  others	  (Ichinose	  et	  al.,	  2009,	  Armstrong	  et	  al.,	  
2005,	  Kuwahara	  et	  al.,	  2005b,	  Kuwahara	  et	  al.,	  2005a,	  Simmons	  et	  al.,	  2011,	  Yamazaki	  and	  
Hamasaki,	   2003)	   report	   no	   changes	   to	   the	   sensitivity	   of	   cutaneous	   vasodilation	   with	  
exercise	  or	  warm	  water	  immersion	  (heat)	  training.	  This	  may	  suggest	  that	  the	  increase	  in	  
sweating	  sensitivity	   is	   the	  dominant	  mediator	  responsible	   for	   improved	  heat	  dissipation	  
following	   thermoregulatory	   adaptation,	   and	   that	   systemic	   blood	   flow	   distribution	  
including	  the	  cutaneous	  circulation,	  is	  only	  required	  for	  delivery	  of	  heat	  from	  the	  core	  to	  
the	   periphery	   i.e.	   for	   the	   same	   amount	   of	   cutaneous	   blood	   flow	   a	   larger	   increase	   in	  
sweating	  occurs	  following	  thermoregulatory	  adaptation.	  A	  complete	  understanding	  of	  the	  
mechanisms	  of	   reflex	   cutaneous	   vasodilation	   and	   its	   relationship	  with	   eccrine	   sweating	  
remains	   uncertain.	   Whether	   cutaneous	   vasodilation	   is	   required	   for	   the	   initiation	   and	  
duration	   of	   sweating	   in	   response	   to	   heat	   stress	   is	   still	   unclear.	   Wingo	   et	   al.	   (2010)	  
established	  that	  local	  temperature	  and	  skin	  blood	  flow	  independently	  modify	  sweat	  rate,	  
whilst	  during	  limb	  ischemia	  i.e.	  near-­‐complete	  blood	  flow	  restriction,	  sweating	  is	  severely	  
attenuated	   (MacIntyre	   et	   al.,	   1968,	   Collins	   et	   al.,	   1959),	   supporting	   a	   relationship	  
between	  skin	  blood	  flow	  and	  sweating	  responses.	  Furthermore,	  during	  passive	  heating	  in	  
individuals	  with	  anhidrotic	  ectodermal	  dysplasia	   (absence	  of	   sweat	  glands)	  only	  a	   slight	  
elevation	   in	   forearm	   blood	   flow	   is	   evident	   (Brengelmann	   et	   al.,	   1981).	   It	   would	   seem	  
logical	  to	  suggest	  then	  that	  with	  a	  higher	  skin	  blood	  flow	  an	  increase	  in	  local	  sweat	  rate	  
would	  occur,	  however	  no	  correlation	  was	  reported	  between	  regional	  sweat	  rate	  and	  skin	  
blood	  flow	  in	  response	  to	  ACh	  or	  whole-­‐body	  passive	  heating	  (Smith	  et	  al.,	  2013b).	  Given	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that	   during	   passive	   heat	   stress,	   core	   body	   temperature	   thresholds	   for	   cutaneous	  
vasodilation	   slightly	   precede	   those	   of	   sweat	   rate	   activation,	   it	   may	   be	   likely	   that	  
cutaneous	  vasodilation	  only	  initiates	  sudomotor	  activity	  and	  the	  sweating	  response,	  and	  
that	   with	   further	   increases	   in	   core	   body	   temperature	   cutaneous	   vasodilation	   and	  
sweating	   responses	   then	   diverge.	   Additional	   studies	   are	   necessary	   to	   explore	   the	  
functional	  link	  between	  skin	  blood	  flow	  and	  sweating	  during	  heat	  stress.	  
	  
Nevertheless,	  a	  larger	  increase	  in	  sweating	  sensitivity	  was	  reported	  at	  the	  chest	  following	  
warm	  water	   immersion	   compared	   to	   the	   forearm	   (increases	  were	  evident	  at	  both	   sites	  
following	  exercise	   training)	   that	  may	  have	  been	  due	   to	  a	   local	   temperature	   stimulus	  of	  
the	  warm	  water	  on	  the	  chest	  compared	  to	  the	  forearm	  (which	  was	  not	  immersed	  in	  the	  
water).	  As	  described	  earlier,	   increases	   in	   sweating	   sensitivity	   is	   likely	  a	   central	   systemic	  
adaptation	  to	  exercise	  training,	  that	  can	  then	  be	  further	  enhanced	  with	   local	  peripheral	  
responses	   (i.e.	   local	   temperature)	   as	   observed	   with	   the	   chest	   during	   warm	   water	  
immersion,	   as	   is	   supported	   by	   the	   findings	   of	   Wingo	   et	   al.	   (2010)	   discussed	   above.	  
Furthermore,	   a	   direct	   haemodynamic	   response	   (e.g.	   hydrostatic	   pressure)	   to	   the	  water	  
immersion	   itself	  cannot	  be	  discounted.	   It	  has	   recently	  been	  established	  that	   lower	   limb	  
water	  immersion	  induces	  acute	  increases	  in	  haemodynamic	  responses,	  specifically	  mean	  
arterial	  pressure	  and	  cardiac	  output	  (Carter	  et	  al.,	  2014b),	  that	  may	  also	  further	  enhance	  
sweat	   gland	   adaptation,	   possibly	   via	   increased	   blood	   flow	   delivery	   during	   water	  
immersion.	   Whether	   local	   temperature	   or	   haemodynamic	   responses	   influence	   sweat	  
gland	  adaptation	  directly	  with	  warm	  water	  immersion	  training,	  and	  to	  what	  degree	  they	  
separately	  improve	  sweating	  sensitivity,	  warrants	  further	  investigation.	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7.4	  Methodological	  considerations	  and	  limitations	  
This	   thesis	   adds	   to	   previous	   findings	   that	   subjective	   HFs	   decline	   following	   a	   period	   of	  
exercise	   training	   (Luoto	   et	   al.,	   2012,	  Mansikkamaki	   et	   al.,	   2012,	  Moilanen	   et	   al.,	   2012,	  
Lindh-­‐Astrand	  et	  al.,	  2004,	  Reed	  et	  al.,	  2014),	  and	  adds	  a	  number	  of	  novel	  key	  strengths.	  
The	  thesis	  includes	  both	  central	  and	  peripheral	  thermoregulatory	  control	  measurements	  
combined	   with	   vascular	   function	   in	   conduit,	   cerebral	   and	   cutaneous	   blood	   vessels	   in	  
order	  to	  gain	  insight	  into	  the	  integrative	  impact	  of	  the	  interventions	  on	  HFs	  at	  a	  systemic	  
level.	   For	   the	   first	   time,	   this	   thesis	   objectively	   assesses	   (cerebro)vascular	   and	  
thermoregulatory	   dysfunction	   in	   symptomatic	   post-­‐menopausal	   females	   prior	   to	   and	  
following	   a	   supervised,	   progressive,	   short-­‐term	   exercise	   training	   intervention.	  
Furthermore,	  measures	  of	  thermoregulatory	  and	  (cerebro)vascular	  function	  are	  objective,	  
and	  cannot	  be	  influenced	  by	  the	  participant	  or	  the	  observer	  when	  analysed	  in	  a	  blinded	  
fashion.	  Chapter	  5	  is	  the	  first	  study	  to	  directly	  measure	  physiological	  HF	  severity	  following	  
an	  exercise	  training	  intervention,	  with	  previous	  studies	  relying	  on	  subjective	  reports	  only.	  
	  
The	  method	  of	   stroke	   volume	  and	   cardiac	  output	  estimation	  used	   in	   the	  present	   study	  
underestimates	  the	  changes	  in	  these	  variables	  during	  heat	  stress	  (Shibasaki	  et	  al.,	  2011).	  
However	  the	  data	  provides	  insight	  into	  the	  changes	  in	  resting	  stroke	  volume	  and	  cardiac	  
output	   pre-­‐	   and	   post-­‐interventions,	   whilst	   the	   changes	   observed	   during	   passive	   heat	  
stress	   were	   of	   a	   similar	   magnitude.	   A	   measure	   of	   plasma	   volume	   pre	   and	   post	  
interventions	  would	  strengthen	  the	  suggestion	  of	  increases	  in	  stroke	  volume	  (Schlader	  et	  
al.,	  2013,	  Nielsen	  et	  al.,	  1993)	  following	  exercise	  training	  (and	  warm	  water	  immersion)	  in	  
chapters	  4	  and	  6.	  This	  would	  provide	   insight	   into	  the	  potential	   reasons	   for	   the	   findings,	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including	   improved	   CBF	   at	   rest	   and	   during	   heat	   stress	   that	   may	   be	   responsible	   for	  
improved	  thermoregulatory	  function	  via	  enhanced	  systemic	  blood	  flow	  distribution.	  
	  
A	  measure	  of	  skin	  sympathetic	  nerve	  activity	  during	  heat	  stress	   (chapters	  4	  and	  6),	  and	  
during	  acute	  HFs	  (chapter	  5)	  prior	  to	  and	  following	  the	  interventions,	  would	  provide	  novel	  
insight	  into	  the	  effect	  of	  exercise-­‐induced	  reductions	  in	  sympathetic	  nerve	  activity	  and	  its	  
potential	   impact	  on	   thermoregulatory,	   cerebrovascular	   and	   conduit	   function.	   If	  HFs	   are	  
mediated	  by	  increased	  sympathetic	  nerve	  impulses	  as	  suggested	  in	  chapters	  4	  and	  5,	  then	  
a	  measure	  of	  sympathetic	  nerve	  activity	  is	  vital	  for	  future	  studies.	  
	  
A	  limitation	  to	  chapters	  4	  and	  5	  is	  it	  was	  not	  a	  large	  RCT.	  However,	  for	  the	  first	  time,	  this	  
thesis	   provides	   novel	   preliminary	   insight	   into	   the	   potentially	   positive	   effect	   of	  
thermoregulatory	   and	   cerebrovascular	   adaptation	   on	   HFs	   in	   post-­‐menopausal	   females	  
that	   should	   be	   further	   established	   with	   a	   RCT	   that	   incorporates	   a	   range	   of	   exercise	  
intensities	   and	   a	   control	   group.	   A	   limitation	   to	   chapter	   5	   was	   that	   no	   measures	   of	  
subjective	   HF	   severity	   were	   reported	   during	   acute	   HFs	   in	   the	   laboratory	   prior	   to	   and	  
following	  exercise	  training.	  It	  is	  important	  for	  future	  research	  to	  establish	  the	  relationship	  
between	  subjective	  and	  objective	  HF	  severity	  that	  may	  further	  support	  interventions	  that	  
target	  reductions	  in	  physiological	  responses	  during	  HFs.	  Additionally,	  a	  larger	  sample	  size	  
would	  also	  promote	  the	  use	  of	  a	  mediation	  analysis	  (Kraemer	  et	  al.,	  2002)	  to	  determine	  
the	  relative	  contribution	  of	  causal	  mediators	  in	  the	  reduction	  of	  HFs	  with	  exercise	  training	  
i.e.	  the	  causal	  mediator	  may	  be	  related	  to	  sweat	  rate	  sensitivity	  adaptation	  or	  improved	  




7.5	  Future	  direction	  
7.5.1	  Randomised	  control	  trial	  
In	  light	  of	  the	  discussion	  in	  section	  7.3.1,	  this	  thesis	  provides	  preliminary	  evidence	  for	  the	  
benefits	   of	   exercise	   training	   on	   HFs	   in	   post-­‐menopausal	   females	   via	   improvements	   to	  
thermoregulatory	   and	   (cerebro)vascular	   function.	   To	   further	   establish	   these	   positive	  
effects,	   a	   RCT	   that	   assesses	   the	   effects	   of	   exercise	   training	   compared	   to	   a	   no-­‐exercise	  
control	   is	   warranted.	   Furthermore,	   this	   should	   include	   an	   extra	   arm	   to	   the	   study	   that	  
compares	  high-­‐	  versus	  low-­‐intensity	  exercise	  training	  so	  the	  appropriate	  exercise	  intensity	  
can	  be	  established	  and	  appropriately	  prescribed.	  Importantly,	  a	  RCT	  would	  also	  allow	  for	  
a	  mediation	  analysis	  to	  be	  performed	  on	  the	  data	  to	  highlight	  the	  causal	  pathway(s)	  for	  
the	   benefits	   of	   exercise	   training	   on	   HFs	   in	   this	   thesis.	   Moreover,	   in	   progression	   from	  
chapter	   6,	   a	   preliminary	   study	   investigating	   the	   effect	   of	   warm	   water	   immersion	  
compared	   to	   exercise	   training	   on	   thermoregulatory	   and	   (cerebro)vascular	   function	   in	  
symptomatic	  post-­‐menopausal	  females	  is	  warranted.	  
7.5.2	  Trigger	  of	  a	  hot	  flush	  
Following	   on	   from	   section	   7.3.3,	   it	   is	   apparent	   that	   there	   is	   a	   current	   requirement	   to	  
further	  understand	   the	   trigger	  of	  HFs	   in	  post-­‐menopausal	   females.	  A	   study	  designed	   to	  
investigate	  whether	  HFs	  are	  mediated	  via	  increases	  in	  central	  sympathetic	  nerve	  activity	  
is	   warranted,	   and	   leads	   on	   from	   the	   findings	   of	   this	   thesis.	   	   To	   do	   this,	   observing	   the	  
effect	  of	  increases	  in	  sympathetic	  nerve	  activity	  (using	  measures	  of	  SSNA	  and/or	  MSNA),	  
such	   as	   during	   isometric	   handgrip	   exercise	   (Lalande	   et	   al.,	   2014),	   on	   triggering	   HFs	   in	  
symptomatic	   females	   may	   be	   useful.	   If	   HFs	   are	   truly	   triggered	   by	   rapid	   surges	   in	  
sympathetic	   nerve	   activity,	   using	   isometric	   handgrip	   exercise	   (or	   other	   acute	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interventions	   that	   increase	   sympathetic	  nerve	  activity)	  may	  be	  useful	   in	  elucidating	   the	  
physiological	  trigger	  of	  a	  HF.	  
7.5.3	  Sweat	  rate	  adaptation	  with	  exercise	  training	  
In	   response	   to	   the	   implications	   of	   section	   7.3.4,	   a	   mechanistic	   study	   investigating	   the	  
effect	  of	  cutaneous	  blood	  flow	  on	  the	  adaptations	  of	  sweating	  responses	  to	  heat	  stress	  is	  
warranted.	   This	   could	   be	   interrogated	   using	   a	   study	   that	   investigates	   the	   combined	  
influence	   of	   skin	   blood	   flow	   (shear	   rate)	   and	   local	   temperature	   on	   thermoregulatory	  
adaptation,	   and	   could	   be	   accomplished	   through	   bilateral	   forearm	   interventions	   using	  
water	   immersion	   training	   (arm	   1;	   increases	   in	   temperature	   and	   skin	   blood	   flow)	   and	  
handgrip	   exercise	   (arm	   2;	   local	   increases	   in	   skin	   blood	   flow	   alongside	   no	   increases	   in	  
temperature).	  This	  would	  establish	  the	  effects	  of	   increases	   in	  skin	  blood	  flow	  alone,	  and	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7-­‐DAY	  HOT	  FLUSH	  QUESTIONNAIRE	  
Name……………………………………………………….	  
Date	  started……………………………………………..	  Date	  completed…………………………………………….	  
Hot	  flush	  categories	  are	  described	  overleaf.	  Where	  possible,	  please	  note	  how	  long	  each	  
hot	  flush	  lasts.	  
 
















































































































	  	  	  	  	  	  	  	  	  	  	  	  
flushes	  
*one	  day	  should	  be	  considered	  as	  a	  24h	  period	  (i.e.	  7am	  to	  7am)	  
Please	  also	  note	  any	  of	  the	  following	  symptoms:	  
	   NO	   YES	   	   NO	   YES	  
Appetite	  loss	   …..	  
	  
…..	   Constipation	   …..	   …..	  
Sleeplessness	   …..	  
	  
…..	   Trouble	  Sleeping	   …..	   …..	  
Nausea	   …..	  
	  
…..	   Nervousness	   …..	   …..	  
Dizziness	   …..	  
	  
…..	   Mood	  Changes	   …..	   …..	  
Tiredness	   …..	  
	  
…...	   	   	   	  
Dry	  mouth	   …..	  
	  





…..	   	   	   	  
Other	   …..	   If	  YES,	  please	  describe…………………………………………………………………	  












FEMALE	  HOT	  FLUSH	  DEFINITIONS	  
Please	  refer	  to	  these	  examples	  of	  hot	  flushes	  that	  have	  been	  given	  by	  post-­‐menopausal	  
females	  in	  previous	  studies	  when	  describing	  their	  hot	  flush	  severity.	  One	  or	  more	  of	  these	  
descriptions	  may	  help	  to	  categorise	  your	  hot	  flush	  as	  mild,	  moderate,	  severe,	  or	  very	  
severe.	  
MILD:	  
Physical	  symptoms:	  Warmth,	  felt	  uncomfortable,	  red	  face.	  
Emotional	  symptoms:	  Not	  expected.	  
Action	  needed:	  Usually	  no	  action	  taken	  
MODERATE:	  
Physical	  symptoms:	  Head,	  neck,	  ears,	  or	  whole	  body	  felt	  warm;	  tense,	  tight	  muscles;	  
clammy	  (wet	  skin);	  a	  change	  in	  heart	  rate	  or	  rhythm	  (heart	  speeds	  up	  or	  changes	  beat);	  
some	  sweating;	  dry	  mouth.	  
Emotional	  symptoms:	  Felt	  irritated,	  felt	  agitated	  (restless),	  felt	  as	  though	  energy	  had	  been	  
drained	  out,	  felt	  embarrassed	  when	  having	  a	  hot	  flush	  in	  front	  of	  others,	  felt	  tired,	  felt	  
annoyed.	  
Action	  needed:	  Needed	  to	  use	  a	  fan,	  awakened	  sometimes	  at	  night,	  needed	  to	  uncover,	  
took	  off	  layers	  of	  clothing,	  drank	  water,	  opened	  the	  windows	  even	  when	  cold	  outside,	  
and	  wore	  lighter	  clothing.	  
SEVERE:	  
Physical	  symptoms:	  Warmth,	  sometimes	  described	  as	  a	  raging	  furnace	  or	  burning	  up;	  a	  
change	  in	  heart	  rate	  or	  rhythm	  (heart	  speeds	  up	  or	  changes	  beat);	  felt	  faint;	  headache;	  
severe	  sweating;	  weakness;	  a	  prickling,	  stinging	  sensation	  over	  skin;	  chest	  heaviness.	  
Emotional	  symptoms:	  Embarrassment,	  anxiety,	  feelings	  of	  having	  a	  panic	  attack.	  
Action	  needed:	  Needed	  to	  stop	  what	  was	  being	  done	  at	  the	  time,	  usually	  awakened	  at	  
night	  and	  removed	  the	  covers;	  needed	  to	  remove	  clothes;	  opened	  windows;	  kept	  the	  
house	  a	  cooler	  temperature,	  frequently	  used	  fans.	  
VERY	  SEVERE:	  
Physical	  symptoms:	  Boiling	  heat,	  rolling	  sweat,	  difficulty	  breathing,	  felt	  faint,	  dizzy,	  feet	  
and/or	  legs	  cramping,	  a	  change	  in	  the	  heart	  rate	  or	  rhythm	  (heart	  speeds	  up	  or	  changes	  
beat),	  felt	  slightly	  sick	  to	  stomach.	  
Emotional	  symptoms:	  Felt	  distressed,	  had	  the	  urge	  to	  escape,	  had	  difficulty	  functioning.	  
Action	  needed:	  Awakened	  frequently	  at	  night,	  needed	  to	  change	  sheets	  and	  pyjamas,	  
need	  to	  take	  a	  cold	  shower,	  cold	  compress	  on	  skin.	  
	  
	  
